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Abstract 
 
This thesis explores treatment satisfaction and dissatisfaction in patients with 
chronic low back pain (CLBP).  
Chapters 1 and 2 provide background on CLBP, and treatment satisfaction and 
dissatisfaction. 
Chapter 3 presents study 1, the systematic review which identified research 
concerning treatment satisfaction and dissatisfaction in patients with CLBP. Findings 
indicated a need to define the concept, and establish appropriate measurement based on 
patient input and evidence to support the reliability and validity of items.  
Chapter 4 presents study 2, a qualitative study. Ten patients with CLBP taking 
medication and/or receiving physiotherapy were interviewed. A conceptual model of 
CLBP and a thematic map of treatment satisfaction and dissatisfaction were developed. 
Satisfaction was related to being ‗happy‘ or ‗pleased‘, and maintaining normal functioning. 
Treatment not working, causing discomfort, or negatively affecting health-related quality 
of life, as well as inconvenience of medication, lack of information, not feeling involved in 
treatment decisions, lack of trust and confidence in healthcare professionals, and being 
misdiagnosed or undiagnosed, were associated with dissatisfaction.  
Chapter 5 documents the development of the CLBP Treatment Satisfaction 
Questionnaire, based on patient input from study 2. Cognitive debriefing showed items 
were relevant and understood by patients.     
Chapter 6, study 3, explored the psychometric properties of the questionnaire. The 
longitudinal design involved data collection from 249 patients, some of whom participated 
in follow-ups. Results indicated that treatment satisfaction/dissatisfaction involves an 
appraisal of the following seven domains: ‗Information Provided about Back Pain and 
Treatment, ‗Burden of Back Pain‘, ‗Impact of Back Pain and Treatment on Relationships‘, 
‗Satisfaction with the Treatment Process‘, ‗Problems with Side Effects of Medication‘, 
‗Adherence to Physiotherapy‘, and ‗Medication Acceptability‘. Some evidence of 
reliability and validity are presented. 
This thesis concludes with Chapter 7, a discussion of the main findings of the 
studies, strengths and limitations, and recommendations for future research.  
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NCQA National Committee for Quality Assurances 
NHS National Health Service 
NSAIDs Non-Steroidal Anti-Inflammatory Drugs 
NSAIMs Non-Steroidal Anti-Inflammatory Medicines 
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Chapter 1 - An Overview of Chronic Low Back Pain 
The aim of this Chapter is to provide an overview of chronic low back pain (CLBP) 
including definitions of CLBP, prevalence and aetiology of CLBP, predisposing factors of 
CLBP, the management and treatment options of CLBP, as well as direct and indirect cost 
implications of CLBP.  
1.1 Definition of CLBP 
Low back pain is defined as pain, tension in the muscles, or stiffness between the 
rib cage and the top of the thighs, with or without sciatica (leg pain) (see for example, 
Loney & Stratford, 1999). There is an ever-growing body of literature on low back pain, 
but there is less information about CLBP (Andersson, 1999). One possible reason for this 
is that the symptoms of CLBP are quite varied and are sometimes described as feelings of 
shooting, stabbing, tingling or numbness. The pain can be localized or related to another 
part of the body (Stop Pain, 2008. What are the Symptoms? section, para. 1). In addition to 
back pain, many individuals experience limited range of motion, some cannot function as 
they would like to, and some may experience fever or weight loss indicative of illness 
(Stop Pain, 2008. What are the Symptoms? section, para. 1). Psychological symptoms may 
also occur, and depression has been shown to be three or four times more prevalent in 
patients with CLBP compared to the general population (Sullivan, Reesor, Mikail, & 
Fisher, 1992). 
Though there is ambiguity and a lack of consensus regarding the transition from 
acute to chronic pain (Cedraschi et al., 1999; Andersson, 1999; Skevington, 1996), the 
duration of symptoms is characteristic of CLBP. For example, some suggest ‗chronicity‘ is 
back pain that lasts beyond the expected period of healing (Andersson, 1999), or that 
which lasts more than seven weeks (Andersson, 1999; Spitzer, Leblanc, & Dupuis, 1987). 
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Others have referred to CLBP as pain lasting at least half the days in a 12-month period in 
single or multiple episodes (Von Korff, 1994). However, more commonly, CLBP is 
defined as ‗persistent‘ or ‗sustained‘ low back pain lasting more than three months or 
twelve weeks (Frank, 1993; Nachemson & Bigos, 1984; Frymoyer, 1988; Bogduk & 
McGuirk, 2002; Bogduk, 2004; Wheeler, 1995).  
Warning signs for individuals with CLBP include severe pain that gets worse over 
several weeks instead of better, as well as the following symptoms: difficulty passing or 
controlling urine; numbness around the back passage or genitals; general numbness, pins 
and needles, or weakness in both legs; and unsteadiness on feet (Roland, Waddell, Moffett, 
Burton, & Main, 2007). 
1.2 Prevalence of CLBP 
Almost half the adult population in the U.K. (49%) reported experiencing low back 
pain lasting for at least twenty-four hours over the last year (Palmer, Walsh, Bendall, 
Cooper, & Coggon, 2000), and it is estimated that 80% of the adult U.K. population will 
experience back pain at some stage in their life (Maniadakis & Gray, 2000).  Further, a 
Department of Health study showed that two and a half million people in the U.K. reported 
back pain that lasted throughout the year (i.e. chronic) (The Department of Health 
Statistics Division, 1999). These figures show that CLBP is a significant public health 
problem. 
1.3 Aetiology of CLBP 
CLBP is usually classed by clinicians as ‗specific‘ or ‗non-specific‘ (Nordin, 
Balague, & Cedraschi, 2006). A ‗specific‘ diagnosis infers that there is a causal link 
between the pain experienced by the individual and a structural problem (e.g. systemic 
disease, infection, injury, trauma, or structural deformity) (Nordin et al., 2006). Individuals 
     Page 21 of 458 
may have experienced pulled or strained muscles, ligaments, tendons, or ruptured discs. 
These may be cumulative effects of (for example) poor posture, and/or improper lifting 
techniques over periods of weeks, months, or years (Hunter, 1998; Mckenzie, 1986; Key, 
2000). A definite somatic cause of low back pain is identified in about 10% to 20% of 
cases (Cedraschi et al., 1999). In clinical practice, ‗red flags‘ are used to indicate possible 
underlying pathology and includes nerve root problems (Table 1) (Koes, van Tulder, & 
Thomas, 2006; Kendall, 1999). 
Table 1: ‗Red Flag‘ Conditions Indicating Possible Underlying Spinal Pathology or Nerve 
Root Problems (Koes et al., 2006) 
 
Red Flags 
  Onset age <20 or > 55 years 
  Non-mechanical pain (unrelated to time or activity) 
  Thoracic pain 
  Previous history of carcinoma, steroids, HIV 
  Feeling unwell 
  Weight loss 
  Widespread neurological symptoms 
  Structural spinal deformity 
Indicators for nerve root problems 
  Unilateral leg pain > low back pain 
  Radiates to foot or toes 
  Numbness and paraesthesiae [sensation of tingling or prickling]  
  Straight leg test induces more leg pain 
  Localised neurology (limited to one nerve root) 
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In the absence of these red flags, a ‗non-specific‘ diagnosis is provided to indicate 
there is no precise structure causing the pain (e.g., lumbago, myofascial syndromes, muscle 
spasms, back sprain, or back strain) (Nordin et al., 2006). No clear pathology of back pain 
can be identified in approximately 85% of individuals seeking care (Nachemson, Waddelll, 
& Norlund, 2000). Healthcare professionals (HCPs) have created a list of ‗yellow flags‘ 
factors that help identify individuals at risk of chronic pain and disability. Examples of 
‗yellow flags‘ are low mood, workplace issues, or signs of psychosocial barriers to 
recovery (Koes et al., 2006; Kendall, 1999; Davidson, 2003) (see section 1.4). 
1.4 Predisposing Risk Factors of CLBP 
Predisposing risk factors are any characteristics that might make an individual 
susceptible to a condition (Drummond, Obrien, Stoddart, & Torrance, 1987). There are 
three main types of predisposing factors (primary, secondary, and tertiary) that differ 
according to the population that they impact (Gatchel, Polatin, & Kinney, 1995). Primary 
predictors identify the percentage of an ‗uninjured population‘ who are likely to incur a 
LBP incident. However, since the focus of this thesis is on CLBP, primary predisposing 
factors are generally beyond the scope of this review. This review focuses on secondary 
predictors, which identify individuals with an acute LBP incident who are most likely to 
develop chronic problems, and tertiary predictors, which relate to factors that determine the 
likelihood of treatment success or failure in an individual with CLBP (Gatchel et al., 
1995).  
Gatchel et al (1995) studied secondary factors in a prospective study in 324 acute 
low back patients that explored CLBP disability problems (as measured by job-work status 
at six months follow-up) using clinical predictors of psychopathology (pain and disability, 
and whether individuals had experienced at least one personality disorder). The logistic 
regression model accurately identified 87% of cases of CLBP disability and concluded that 
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age, race, pain, disability, and personality disorders were linked to not working due to the 
original back injury. Specifically, individuals who were older, with higher pain levels, non-
Caucasian, and those with at least one personality disorder were more likely to be in the 
disabled group. In addition, a post hoc exploration of medical reviews of patients‘ charts 
showed that the severity of initial acute back injury may be related to not returning to work 
after six months, although these results did not reach statistical significance.  One possible 
reason for not reaching statistical significance is that the post hoc analysis groups (disabled 
versus non-disabled group) comprised 20 randomly selected patients each, and 
consequently the sample size may not have warranted sufficient power to determine 
statistical significance between groups. Another explanation for this is that the analysis 
was performed retrospectively, and a physician who had been uninformed about the return-
to-work status of patients was required to rate physical signs of severity on a five-point 
Likert scale, from one (minor) to five (severe). Consequently the physician rating as a 
proxy of patients‘ experiences may not have been an accurate reflection of severity of back 
injury. 
Other secondary variables include proficiency in English (Lacroix et al., 1990), wage 
level (Volinn, Van Koevering, & Loeser, 1991; Deyo & Tsui-Wu, 1987), educational level 
(Deyo & Tsui-Wu, 1987; van Tulder, Assendelft, Koes, & Bouter, 1997), obesity (van 
Tulder et al., 1997), the workplace environment such as the type of chair used (Link, 
Nicholson, Shaddeau, Birch, & Gossman, 1990), prolonged sitting (Ratzon, Jarus, Baranez, 
Gilutz, & Erez, 1998), and time spent seated at work due to computerisation (Link et al., 
1990). Occupational factors such as job dissatisfaction, and unavailability of light duty on 
return to work are also related to chronicity (van Tulder et al., 1997).  
Tertiary predisposing factors are those that determine the likelihood of treatment 
success or failure in an individual with CLBP (Gatchel et al., 1995). Individuals‘ beliefs 
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that the pain is stable and unchanging has been linked to poor adherence with physical and 
psychological treatments (Williams & Thorn, 1989), and Harkapaa (1991) found that when 
individuals believe they have control over their pain, they are more likely to participate in 
and benefit from rehabilitation programs. Similarly, those who believe that their pain is 
controlled by powerful others (e.g. doctor or family member) rather than chance are also 
more likely to adhere to pain management programmes (Gibson & Helme, 2000). In 
addition, individuals‘ beliefs about the cause of their pain and the potential effects of 
treatment are likely to affect the outcome of treatment (Schwartz, DeGood, & Shutty, 
1985).  
It should be noted that there are other factors associated with CLBP that can broadly 
be termed ‗psychological‘ and include personality, psychiatric, behavioural and cognitive 
aspects. However, these factors are beyond the scope of this thesis. 
1.5 Management of CLBP 
1.5.1 Treatment Models Used in CLBP 
The two most commonly used treatment models in CLBP are the medical model 
and the biopsychosocial model (Nordin et al., 2006). The medical model proposes that 
illness is the result of a disturbance to some biological process, such as a chemical 
imbalance in the brain (See Marks, Murray, Evans & Willig (2000) and Ogden (2000) for 
reviews). Applying the medical model to CLBP, as well as other illnesses involves the 
following steps: 1) recognising patterns of symptoms and signs by history and 
examination; 2) identifying the underlying injury or disease by diagnosis; 3) treating 
underlying injury or disease by specific therapy; and 4) expecting the patient to recover 
once the disease or injury is addressed (Nordin et al., 2006). However, the medical model 
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has been critiqued as insufficient to explain the complexities of  health and illness (e.g., as 
cited in Engel (1977) and Engel (1980)).     
The medical approach is reductionist, suggesting that complex phenomena (such as 
CLBP) can be understood in terms of their most basic components. Since illness is seen as 
a consequence of biological changes that are beyond an individual‘s control, individuals 
are not responsible for their illness but are victims of external influences that cause internal 
changes (see Ogden (2000) for review). The medical model also assumes that health and 
illness are qualitatively different and independent of each other rather than a continuum, 
and that the mind and body function independently. The mind is incapable of affecting 
physical matter (such as muscles and bones), and physical matter are independent of 
changes in state of mind. For example, under this model, CLBP may cause depression, but 
depression is not related to either the onset or progression of CLBP. 
There are two other specific problems with the medical model in CLBP.  Firstly, 
the medical model assumes that prevention or treatment should aim to alter bodily 
functions (for example, by using medications or surgery).   Secondly, the medical model, 
though widely accepted in the developed world, does not account for very real pain in 
patients without physical signs, and may, in fact, assume that the patient is malingering 
(e.g. Ogden (2000)).  
Unlike the medical model, the biopsychosocial model attempts to integrate the 
psychological (the ‗psycho‘) and the environmental (the ‗social‘) elements with the 
biological medical model (the ‗bio‘) (Figure 1) e.g. Engel (1977). The bio factors that 
contribute to CLBP could include structural defects of the vertebrae. The psycho 
contributing factors could include cognitions such as catastrophising (a tendency to think 
the worst), emotions such as fear of movement, and behaviours such as restricting activity. 
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The social aspects include social norms of behaviour, pressures to change behaviour and 
social values on health, social class, and ethnicity. 
The biopsychosocial model for CLBP recognises: 1) the non-specific nature of 
back pain; 2) identifies underlying psychosocial factors; 3) treats those factors with non-
traditional interventions such as behavioural therapy; and 4) empowers patients to take 
responsibility for managing their CLBP with possible frequent recurrence (Nordin et al., 
2006).  
Figure 1: The Biopsychosocial Model of Health and Illness (Ogden, 2000) 
 
 
 
 
Since illness is a consequence of a combination of biological, psychological and 
social factors, the biopsychosocial model assumes that individuals are not passive and thus 
they are not perceived as victims. For example, the recognition that an individual‘s 
behaviour may contribute to their health and illness places more responsibility on the 
individual. The biopsychosocial model suggests that rather than focusing on the biological 
factors alone, the whole individual needs to be treated. Treatment may include, for 
example, behaviour change, focusing on changing an individual‘s beliefs, coping 
strategies, and adherence to medication regimens. Further, unlike the medical model, the 
biopsychosocial model suggests that health and illness are not qualitatively different but 
exist on a continuum, and also that the mind and body interact with and affect each other. 
Finally, under this model, psychological factors are not only consequences of illness but 
may also contribute to its aetiology (see Ogden (2000) for review). 
Bio: 
 Viruses 
 Bacteria 
 Lesions 
Psycho: 
 Behaviour 
 Beliefs 
 Coping 
 Stress 
 Pain 
Social: 
 Class 
 Employment 
 Ethnicity 
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Critics have suggested that the biospsychosocial model remains predominantly 
biomedical and that empirical evidence is needed to establish its theoretical basis (see 
Ogden (2000) for review). However, whilst there may be precise causal pathways, 
complicated psychological theories and approaches continue to play an important role in 
understanding, treating and caring for individuals with CLBP. 
1.5.2 Approaches of CLBP Relief 
Nearly 40% of individuals with back pain in the UK consulted a GP for help, and 
10% visited a complementary therapist (osteopaths, chiropractors, and acupuncturists) 
(The Department of Health Statistics Division, 1999). How to best achieve CLBP relief 
and restoration has been debated for at least 30 years (Chew & May, 1999).  Clinical aims 
include relieving pain, improving functioning, developing coping strategies for pain and 
reducing side effects from medications (Waddell, 1992). There are three main approaches 
to CLBP relief: monotherapies, multidisciplinary therapy, and reductionism (Bogduk, 
2004). 
A monotherapy is a particular single intervention prescribed by a healthcare 
professional (HCP) as sole treatment (Bogduk, 2004). These may range from non-opioid 
analgesic medications (such as paracetamol, non-steroidal anti-inflammatory drugs 
(NSAIDs)), opioid analgesic medications and antidepressants, to physiotherapy, 
chiropractic, osteopathy and back surgery, as well as complementary and alternative 
therapies (such as acupuncture and tai chi). 
Multidisciplinary therapy comprises various combinations of exercises, education, 
and behavioural therapy. Most programs address physical disabilities and patients‘ beliefs 
about their pain and behaviour (Bogduk, 2004). 
     Page 28 of 458 
Reductionism pursues diagnosis of a specific physical/biological cause of CLBP 
with the goal of implementing a target-specific treatment (Bogduk, 2004; Bogduk & 
McGuirk, 2002).  One of the outcomes of this approach is its reliance on surgery as a 
treatment for CLBP.   
Bogduk (2004) presented guidance regarding the management of CLBP which is 
outlined in Figure 2. It should be noted that whilst this guidance provides a good overview 
of CLBP general practice management, it is not exhaustive and there are methods used in 
general practice that are not portrayed in Figure 2 such as magnetic resonance imaging 
(MRI) scans. Further details of the main monotherapies and multidisciplinary therapy are 
provided in sections 1.5.3 and 1.5.4. 
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Figure 2: Guidelines for General Practice Management of CLBP (Bogduk, 2004) 
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Recovery 
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1.5.3 Monotherapies 
Medications for CLBP Relief 
Please note that unless otherwise stated, the information outlined below comes 
from the British National Formulary (British Medical Association & Royal Pharmaceutical 
Society of Great Britain, 2009). 
Non-opioid analgesics used in CLBP relief include paracetamol. Other commonly 
used medications for CLBP are non-steroidal anti-inflammatory drugs (NSAIDs), 
combined analgesics (such as paracetamol with codeine phosphate), skeletal muscle 
relaxants, and opioid analgesic medications (Chou & Huffman, 2007; Cherkin, Wheeler, 
Barlow, & Deyo, 1998; Bernstein, Carey, & Garrett, 2004; Luo, Pietrobon, Curtis, & Hey, 
2004; Luo, Pietrobon, & Hey, 2004). Benzodiazepines, systemic corticosteroids, and 
antidepressant medications can also be used in patients with CLBP (Chou & Huffman, 
2007). 
1) Paracetamol 
Paracetamol is often used for short term pain relief and is not associated with any 
anti-inflammatory effects. Although side effects are rare, they include rashes and blood 
disorders, and following over-dosage, liver damage and possibly renal damage. 
2) NSAIDS 
Other non-opioid analgesics include NSAIDs, also known as non-steroidal anti-
inflammatory medicines (NSAIMs). In single doses, NSAIDs have an effect comparable to 
paracetamol, providing short term pain relief. In regular full dosage, NSAIDs have a 
lasting anti-inflammatory effect and are therefore often used for continuous or regular pain 
associated with inflammation. Pain relief starts shortly after taking an NSAID and a 
complete analgesic effect can be obtained within a week. However, the anti-inflammatory 
     Page 31 of 458 
effect may take up to three weeks to be achieved. NSAIDs tend to cause gastro-intestinal 
effects, nausea, diarrhoea, and possibly bleeding and ulceration. NSAIDs include aspirin, 
ibuprofen, diclofenic, and naproxen. 
3) Opioid Analgesics 
Opioid analgesics are usually used for the relief of moderate to severe pain. If used 
frequently, there is potential for dependence and tolerance. Common side effects reported 
include nausea, vomiting, constipation, and drowsiness. Large doses of opioid analgesics 
may cause respiratory depression and hypotension. Opioid analgesics include morphine, 
buprenorphine, codeine, and fentanyl amongst others. 
4) Skeletal Muscle Relaxants 
Skeletal muscle relaxants are used to alleviate chronic muscle spasm or spasticity 
associated with neurological damage. A major disadvantage is that they cause reduced 
muscle tone, which can ultimately lead to increased disability. Other potential side effects 
include sedation, dizziness, confusion, agitation, disorientation, and visual disorders. 
Skeletal muscle relaxants include baclofen and tizanidine. 
In CLBP, benzodiazepines are also used as muscle relaxants that are usually 
prescribed as anti-anxiety medications. They have to be prescribed in the smallest dosage 
possible to provide an acceptable level of symptom relief due to the potential for 
dependency. Paradoxical effects are experienced by patients and range from talkativeness 
and excitement to aggression and anti-social behaviours. Withdrawal effects may occur up 
to three weeks after stopping a long-acting benzodiazepine and may include insomnia, 
anxiety, loss of appetite and body weight, and tremor. 
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5) Corticosteriods 
Corticosteroids are steroidal anti-inflammatory medications for pain relief that 
come in the form of gels, tablets, and injections (for example, prednisolone). 
Corticosteroids are associated with a number of potential side effects such as sleep 
disturbance, increased appetite, weight gain, and psychological effects including increased 
or decreased energy levels. Other side effects include mania, psychosis, heart failure, 
peptic ulceration, and diabetes. 
6) Antidepressants 
Antidepressants are usually used to help deal with depression including that 
associated with physical illness such as CLBP. It can also be used as a sedative for pain 
relief.  The major classes of antidepressants include selective serotonin reuptake inhibitors 
(SSRIs), as well as tricyclics (TCAs) and associated antidepressants. Examples of SSRIs 
include fluoxetine, paroxetine, escitalopram, citalopram, and sertraline. SSRIs typically 
have fewer side effects than TCAs. However, SSRIs are associated with gastro-intestinal 
side effects such as nausea, vomiting, abdominal pain, diarrhoea, and constipation. There 
are many other potential side effects including decreased sexual functioning and some 
bleeding disorders. Suicidal thoughts have been linked to SSRIs, but to date their causality 
has yet to be established with certainty. 
Compared to conventional tricyclic antidepressants (TCAs) such as amitriptyline, 
TCA related antidepressants are associated with fewer side effects such as dry mouth, and 
constipation. Conventional TCAs are also associated with convulsions, abnormal heart 
rhythms, and heart block. Other side effects associated with TCAs and related anti-
depressants include urinary retention, blurred vision, dizziness, confusion, and sexual 
dysfunction.  
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Physiotherapy for CLBP Relief 
The cause and type of pain affects the type of physiotherapy chosen for CLBP 
relief. Physiotherapy includes advice and early activity, mobilisation or manipulative 
therapy, McKenzie therapy (program of assessment, treatment and prevention strategies 
including exercise), specific stabilisation exercises, general exercise and stretches, 
ergonomic advice, and postural advice (Australian Physiotherapy Association, 2003).  
Chiropractics and Osteopathy 
Chiropractics help individuals with CLBP by manipulating body structures such as 
the spine to relieve symptoms such as pain. Similarly, osteopathy is focused on the 
association between structure and function, with the view that pain and difficulty in 
functioning (even in other parts of the body) are a consequence of problems with structure. 
Osteopaths use manipulative techniques such as massage to relax tense muscles, or 
stretching to improve joint mobility. However, chiropractics are more focused on 
diagnostic procedures such as X-rays, MRI scans, and blood or urine tests (BackCare, 
2008; BackCare, 2004). 
Back Surgery 
Back surgery is usually performed by an orthopaedic surgeon or neurosurgeon. Few 
individuals require back surgery, which is performed in selected individuals who continue 
to experience pain despite taking conventional treatments. There are three main types of 
back surgery: 1) discectomy, which involves removing part of the intervertebral disc; 2) 
decompression techniques, which involve removing any tissue that is compressing the 
nerve; and 3) stabilisation or fusion, which involves the fusion of two or more adjacent 
vertebrae to provide the spine with more stability. Although relatively low risk, several 
problems could occur and and must be weighed before proceeding with back surgery; these 
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include problems associated with anaesthetic medications and the possibility of operator 
error (BackCare, 2004). 
Complementary and Alternative Medicine Therapy for CLBP Relief 
Complementary and alternative (CAM) therapies are sometimes used by 
individuals as an adjunct to conventional therapy to help with CLBP relief. One CAM 
therapy, the Alexander Technique, focuses on balance, posture, and movement. It is based 
on the concept that we function as a whole, and focuses on learning to prevent harmful 
habits which include placing too much tension on one‘s posture and movements or 
tightening muscles too much (BackCare, 2004). Other CAM therapies include 
acupuncture, massage and tai chi (Hart, 2008). 
Other Monotherapies 
There are several other monotherapies available. These include transcutaneous 
electrical nerve stimulation (TENS) whereby electrodes are positioned in areas where 
individuals are experiencing pain. Problems reported with TENS include minor skin 
irritation and dermatitis (Chou & Huffman, 2007; BackCare, 2004). Alternatives include 
electromyographic feedback, which involves teaching individuals with CLBP to control 
the tension in their muscles by receiving feedback regarding the electrical activity of their 
muscles, and practical, physical, and thinking relaxation techniques (BackCare, 2004). 
Further, some individuals with CLBP use lumbar supports, or treatments such as ice or 
heat applications (in the form of gel packs, wheat cushions, body belts, or electric pads) to 
help them temporarily relieve their back pain (BackCare, 2008). 
1.5.4 Multidisciplinary Therapy and Support Groups for CLBP 
Although there is no standard operational definition of multidisciplinary therapy, 
the term usually refers to various combinations of exercises, education, and behavioural 
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therapy. However, one of the main characteristics of multidisciplinary therapy is that it 
addresses physical disabilities, patients‘ beliefs about their pain and resulting behaviour 
(Bogduk, 2004). 
In some cases, patients are referred by their GP to specialist pain clinics that focus 
on the assessment and management of pain, as well as living a fuller life while coping with 
pain. The treatments offered vary and not all hospitals have specialised pain clinics. Often 
there will be a consultant anaesthetist who will prescribe pain medications or give 
injections to manage CLBP. Alternatively, there may be a more multidisciplinary team 
comprising doctors, psychologists, physiotherapists, nurses, occupational therapists and 
others (BackCare, 2006). 
A Pain Management Programme (PMP) is a psychologically based rehabilitative 
treatment for people with CLBP for whom other treatments have not been successful. 
PMPs are often delivered in a group setting with a multidisciplinary approach. PMPs vary 
in approaches. Some focus on educating patients regarding pain, as well as self-
management, coping and living with pain. Others offer CAM therapies (BackCare, 2006). 
In some parts of the UK, patient support groups are run in conjunction with local pain 
clinics, or are affiliated with groups linked to other organisations (BackCare, 2006). Others 
focus on behavioural treatments such as cognitive behavioural therapy to help manage pain 
intensity (Centre for Reviews and Dissemination, 2009). 
1.6 Direct and Indirect Costs Associated with CLBP 
Back pain is associated with enormous costs. These are often broken down in to two 
types. Direct costs are costs associated with the resources expended for healthcare, 
primarily medications and treatments. Such costs can sometimes also include individuals‘ 
out of pocket expenses, or resources from other statutory agencies or voluntary bodies. 
Indirect costs refer to individuals‘ time (or their families‘ time, or society‘s time and cost) 
     Page 36 of 458 
consumed by healthcare. These costs can include work time and productivity losses such as 
lost wages (Drummond et al., 1987). 
In the UK, the total direct healthcare costs for back pain are £1.6 billion per year 
(Maniadakis & Gray, 2000). The National Health Service (NHS) spends more than £1 
billion on back pain related costs; this includes £512 million on hospital costs for back pain 
patients, £141 million on GP consultations for back pain, and £150.6 million on 
physiotherapy treatments for back pain. In private healthcare, £565 million is spent on 
back pain per year (Maniadakis & Gray, 2000). In terms of indirect costs, it is estimated 
that musculoskeletal disorders including back pain cost UK employers between £590 
million and £624 million per year (HMSO, 1997). 
Also, in the UK, nearly five million working days were lost as a result of back pain 
in 2003-2004. These findings were used to calculate that on any single day, 1% of the 
working population are on sick leave due to back problems (HSE, 2005). Further, it has 
been reported that back pain is the second most common reason for long term sick leave in 
most of the UK, and it‘s the most common reason for those in manual labour jobs 
(Department for Work and Pensions, 2002). 
1.7 Summary 
CLBP is widespread, and its treatment is complicated by the fact that its aetiology 
is often unknown.  It is evident that CLBP is a complex condition best considered through 
a model that takes into account the many interconnected physical, psychological and social 
factors associated with the condition.  Despite the numerous treatments available for 
CLBP, it remains burdensome and costly to patients, healthcare systems and society.  
Consequently, it is essential to look at CLBP from the patient‘s perspective.  The main 
focus of this dissertation will be to explore patient satisfaction with two common 
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treatments for CLBP:  medication and physiotherapy. Chapter 2 provides background 
information on the concept of patient satisfaction with treatment. 
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Chapter 2 - An Overview of Treatment Satisfaction and Dissatisfaction  
The aim of this Chapter is to provide an overview of issues pertaining to patient 
satisfaction and dissatisfaction with treatments. Definitions and conceptual issues of 
patient satisfaction with treatment will be considered followed by methodological aspects 
in terms of whether the concept is perceived as a dependent or independent variable, and 
uni-dimensional or multi-dimensional concept. Other methodological considerations 
include designing satisfaction questions, whether questionnaires are generic-, condition-, or 
treatment-specific concept, and issues related to psychometric properties of instruments. 
Other challenges in patient satisfaction measurement as well as factors associated with 
satisfaction and dissatisfaction with treatment will be considered. 
2.1 The Purpose of Investigating Patient Satisfaction or Dissatisfaction 
Exploring patient satisfaction has three main purposes. 1) It can help establish the 
patient‘s perspective of health care services; 2) as a ‗process‘, patient satisfaction can help 
identify problems and help to develop strategies to overcome such issues; and 3) 
satisfaction can be used to evaluate health care  (Sitzia & Wood, 1997). Patient satisfaction 
is important because it provides user input in the planning and assessment of health 
services, and because satisfaction relates to health and illness behaviour. Therefore, 
satisfaction is often perceived as one of the goals of healthcare (Thompson & Sunol, 1995). 
2.2 Definitions of Satisfaction and Dissatisfaction  
Although the term ‗patient satisfaction‘ is widely used, it appears to be rarely 
understood (Sitzia & Wood, 1997), and there is little in the literature to operationally 
define the concept (Rofail, Gray, & Gournay, 2005; Williams, 1994). However, some 
commonly cited definitions view patient satisfaction as an emotional response and 
cognitive appraisal process of aspects of healthcare based on an individual‘s experience. 
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For example, patient satisfaction has been defined as an evaluation that involves ―a 
comparison of the individual’s healthcare experience to a subjective standard‖ (Pascoe, 
1983 p.189).  Similarly, it has been suggested that to convey satisfaction or dissatisfaction 
is an ―attitudinal response‖ to patient‘s opinions about their clinical experiences  (Kane, 
Maciejewski, & Finch, 1997 p. 715). Patient satisfaction has also been defined as 
―affective” and “expressed as an attitude or feeling towards a product such as pleasure or 
displeasure‖ (Ross, Frommelt, Hazelwood, & Chang, 1987 p. 22).  
2.2.1 Patient Satisfaction with Healthcare 
Satisfaction is a subjective rating and thus involves an individual‘s evaluation of 
particular aspects of care (Ware, Snyder, Wright, & Davies, 1983). These include 
interpersonal aspects (features of interaction between healthcare provider and individual 
receiving services, for example, respect and friendliness), technical quality (competence of 
healthcare providers and adherence to standards for diagnosis and treatment), 
accessibility/convenience (factors that impact receiving medical care), continuity 
(maintaining consistency with regard to the healthcare provider or location of care 
received), physical setting (such as how pleasant the atmosphere is), financial 
considerations (factors related to paying for medical services), and efficacy (the results of 
medical care) (Ware et al., 1983). 
Patient satisfaction with health care has also been defined as ―the individual’s 
positive evaluations of distinct dimensions of health care‖ (Linder-Pelz, 1982 p. 580). 
Linder-Pelz‘s definition posits that patient satisfaction is a uni-dimensional concept (a 
single concept) composed of five social-psychological determinants: 1) occurrences (what 
actually happens, or the individual‘s perception of what occurred); 2) value (evaluating the 
health care experience); 3) expectations (beliefs regarding the likelihood that certain 
attributes are linked with an event, and the anticipated outcome of that association); 4) 
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interpersonal encounters (an individual‘s rating of healthcare experience compared to all 
other similar encounters); and 5) entitlement (the belief that one has proper grounds for 
seeking/claiming a particular outcome) (Linder-Pelz, 1982). Sitzia and Wood (1997) 
refined this model further by moving interpersonal encounters and entitlement under the 
expectations heading. Further, whilst patient expectations, values, and perceived 
occurrences were independently associated with patient satisfaction, these variables 
explained less than 10% of the total variance of patient satisfaction (Jackson, Chamberlin, 
& Kroenke, 2001) (see section 2.6 for potential covariates of patient satisfaction).  
Instead of a uni-dimensional concept, Fitzpatrick (1984) proposed three 
independent models of satisfaction  – the need for the familiar, the goals of help seeking 
and the importance of emotional need – each associated with one determinant. ―The need 
for the familiar‖ states that social expectations (such as cultural differences) determine the 
degree of satisfaction. However, a review by Sitzia & Wood (1997) suggested findings 
were ambiguous (e.g. Jain et al., 1985; Madhok, Bhopal, & Ramaiah, 1992). Closer 
examination of the studies they cited suggests that the association between cultural 
differences and satisfaction is not so clear. For example, the Jain et al. study (1985) cited 
by Sitza and Wood that explored attitudes of Asian patients to the delivery of healthcare in 
GP settings suggested that the doctor‘s nationality may be important to some patients. 
However, the results were problematic in that the question asked to assess satisfaction 
(‗have you thought of leaving your present doctor‘) may not have sufficiently addressed 
the issue, and these findings cannot be used as conclusive evidence of an association 
between cultural differences and satisfaction.  
―The goals of help seeking‖ model suggests satisfaction is not the main focus for 
individuals; instead, they seek a solution to their health problems (Fitzpatrick, 1984). 
However, anecdotal evidence suggests that individuals with good health status may be 
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unhappy or dissatisfied, and individuals with poor health status may be happy or satisfied 
(Ross et al., 1987). Further, because patients‘ perceptions about change in health status are 
not usually measured in satisfaction studies (Wensing, Grol, & Smits, 1994), it‘s difficult 
to assess the adequacy of the model. 
―The importance of emotional need‖ is the third model and is based on the 
emotional experience that individuals have both because of uncertainty and anxiety due to 
health problems, as well as the fact that many individuals are only able to assess healthcare 
professionals‘ competency from a non-technical perspective. Consequently, this model 
proposes that individuals judge satisfaction according to affective behaviour and 
communication skills.  According to Sitzia and Wood (1997) evidence for this model 
seems to have emerged in part from Ben-Sira‘s work (1976), in which satisfaction with 
treatment from GPs was strongly related to perceptions of interest and devotion from the 
doctor rather than technical skills or administrative aspects (Ben-Sira, 1976).  
Whilst it is apparent that there have been several attempts to define patient 
satisfaction, the definitions are relatively vague and thus the question of what actually 
constitutes patient satisfaction remains unanswered. Further, the above definitions relate to 
patient satisfaction with healthcare, or aspects of healthcare rather than specific to 
treatment (see section 2.2.2).  
2.2.2 Treatment Satisfaction 
Though there are few definitions of patient satisfaction with treatment, it can be 
defined operationally, as in terms of antipsychotic medication:  ―Treatment acceptability 
(positive orientations towards treatment) and medication insight (self knowledge, 
awareness, and understanding) into the need for medication and its potential side effects‖ 
(Rofail et al., 2005 p. 1068). The operational definition can be reliably and validly 
measured using the Satisfaction With Antipsychotic Medication (SWAM) scale (Rofail et 
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al., 2005). For example, an advisory team agreed that the content of the SWAM scale was 
relevant and important to patient satisfaction with antipsychotic medication, and that the 
scale demonstrated clear face validity. In addition, a number of HCPs who reviewed the 
questionnaire felt that it was useful. The SWAM scale contains two scales, Treatment 
Acceptability and Medication Insight. Both have good internal consistency with 
Cronbach‘s alpha of 0.92 and 0.84 respectively. 
2.3 Conceptual Frameworks and Models of Patient Satisfaction 
There are a number of conceptual frameworks or models of patient satisfaction. 
The most commonly cited in satisfaction studies – a conceptual framework of treatment 
satisfaction, the cognition-affect model of satisfaction, the assimilation-contrast model of 
perceptions, and the zone of tolerance model – are reviewed below. 
2.3.1 A Conceptual Framework of Treatment Satisfaction (Weaver et al., 1997) 
Weaver et al. (1997) proposed a conceptual framework of treatment satisfaction 
(Figure 3) that suggests that treatment satisfaction for a specific condition is a subset of 
general healthcare experience (Weaver et al., 1997). The framework was developed to 
further Pascoe‘s view of patient satisfaction (see section 2.2) (Pascoe & Atkinson, 1983); 
therefore, Weaver et al‘s conceptual framework includes patient characteristics that 
represent patients‘ subjective standards such as expectations, or those that may affect the 
standard such as previous experiences. Weaver et al. (1997) suggest that the framework is 
complimentary to Wilson and Cleary‘s (1995), which focuses on health status. 
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Figure 3: Conceptual Framework of Treatment Satisfaction (Weaver et al., 1997) 
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evaluate care and refer to a handful of patient satisfaction questionnaires and consumer 
satisfaction surveys assess patient satisfaction.  
Weaver et al. (1997) refer to Wilson and Cleary‘s definition of health status, which 
states that as an outcome, health status includes: a) biological and physical factors; b) 
symptom status; c) functional status; d) general health perceptions; and e) overall quality 
of life (Wilson & Cleary, 1995). They propose that ‗satisfaction with outcomes‘ is an 
individual‘s evaluation of those outcomes on, for example, a five-point likert rating scale: 
―poor, fair, good, very good, and excellent‖ (Weaver et al., 1997). 
The second part of Figure 3 considers the ‗treatment experience‘ in parallel to the 
‗general healthcare experience.‘ Patients‘ expectations of treatment, their preferences for a 
particular treatment, and the actual characteristics of treatment all influence the treatment 
experience. The ‗treatment experience‘also includes consultation with the doctor. In this 
model, ‗choice‘ can be either unilateral, involving either the doctor or the patient, or a joint 
decision where patients are involved in treatment decisions by being informed and having 
their preferences taken into consideration. For example, a patient may make a unilateral 
decision to take over-the-counter medications for pain, while another doctor and patient 
might make a joint decision to discontinue a drug regimen based on a mutual discussion of 
side effects and patient preferences.  ‗Results‘ of the ‗treatment experience‘ include 
outcomes such as ‗adherence‘, ‗disease-specific health status‘, and ‗intentions‘. In this 
model, treatment satisfaction is an outcome that is represented by items and domains that 
have an asterisk in Figure 3. Weaver et al. state that the question ‗which treatment do you 
prefer?‘ could form part of a treatment satisfaction measure.  
The conceptual framework of treatment satisfaction provided by Weaver et al. 
(1997) provides a good contribution to this field especially in that it attempts to distinguish 
between ‗satisfaction as an outcome‘ of general healthcare versus ‗treatment satisfaction‘. 
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However, though the framework builds in part on Pascoe‘s conceptualisation of patient 
satisfaction (see section 2.2) and considers the NCQA‘s Member Health Survey, it is 
primarily based on researcher intuition. Further, whilst there is some evidence in the 
literature to support associations between some of the variables and treatment satisfaction 
(e.g. Awad and Feine (1998)) (see also section 2.6), more empirical work is necessary to 
confirm the conceptual framework, including consideration for the potential joint effects of 
the proposed variables on treatment satisfaction.  
In addition, Weaver‘s conceptual framework does not provide a sufficient 
operational definition of treatment satisfaction. Though an indication of the salient 
concepts is provided, whether the conceptual framework is exhaustive and captures all or 
the main important concepts remains questionable. This becomes more evident when 
considering that patients‘ views are often different to clinicians‘ or researchers‘, and are 
formed in different ways (Zandbelt, Smets, Oort, Godfried, & de Haes, 2004).  
Further, it remains unclear whether the salient concepts of treatment satisfaction are 
equally weighted in terms of importance. For example, are treatment characteristics such as 
‗ease/complexity‘ equally as important as ‗discomfort‘ and ‗convenience‘, and is there 
anything else that has not been considered that is equally or even more important during 
the ‗process‘?  
In addition, there is no reference to dissatisfaction with treatment (see section 
2.5.1). Perhaps this was not addressed since the model implies that satisfaction and 
dissatisfaction are on a continuum, with higher patient ratings of the relevant concepts 
representing satisfaction and lower patient evaluations of the salient concepts indicating 
dissatisfaction. This oversight may be reflective of this field in general, in that it focuses on 
positive rather than negative aspects (Markson et al., 2001). Sitzia and Wood (1997) 
explain that such bias may be a consequence of the fact that a preponderance of 
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satisfaction research has emerged from consumerism and is often driven by health services 
research and clinician intuition (Sitzia & Wood, 1997).  
Another consideration relates to expectations, which in this conceptual framework 
are perceived as determinants of the general healthcare experience and also of the 
treatment experience, but are not necessarily included as part of a treatment satisfaction 
questionnaire. As this work notes in section 2.6.4, there are several issues to consider in 
relation to expectations, including ambiguity in defining the concept and the notion that 
there may be different types of expectations (e.g. Stimpson and Webb (1975) and 
Fitzpatrick (1984)). 
2.3.2 Cognition-Affect Model of Satisfaction (Oliver, 1993) 
Oliver (1993) proposed a cognition-affect model of satisfaction (Figure 4) in which 
satisfaction is a result of a comparative process between expectations and attributes 
performance (e.g., perceptions of treatment performance). There is a disconfirmation 
paradigm that suggests that the greater the discrepancy between initial expectations and 
treatment performance, the more apparent the satisfaction or dissatisfaction, depending on 
the direction of the discrepancy. 
Figure 4: Cognition-Affect Model of Satisfaction (Oliver, 1993)  
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The model also indicates a direct link between treatment performance and 
satisfaction. Both positive affect (such as joy and interest) and negative affect (such as 
anger, disgust, and contempt) domains are mediators of satisfaction via treatment 
performance and ‗attribution‘. For example, satisfaction is expected to be higher when 
individuals attribute favourable outcomes to themselves and unfavourable outcomes to 
others (Thompson & Sunol, 1995). In addition, equity is seen as a distinct moderating 
factor on satisfaction, and thus satisfaction is expected to be higher when individuals 
perceive fair treatment (Oliver & Swan, 1989).  
Oliver‘s cognition-affect model of satisfaction is predominantly a theoretical model 
of psychological processes. There is some empirical evidence to suggest that the best 
predictors of satisfaction are dependent on the sample and type of satisfaction. For 
example, Oliver found that ‗disconfirmation‘ was the best predictor for a sample of 
individuals buying cars (based on consumerism), whereas ‗affect‘ was the best predictor 
for those in education attending a course in marketing (Oliver, 1993). However, the model 
has not been empirically tested in its entirety.  
Further, the model assumes that individuals bring with them expectations and have 
an ability and willingness to judge the quality of the relationship (Weaver et al., 1997) 
There is also some debate in the literature with regard to whether expectations are indeed 
related to satisfaction (see section 2.6.4) and, as noted earlier, further research is necessary 
to define the term expectations (e.g. Stimpson and Webb (1975); and Fitzpatrick (1984)).  
Furthermore, whilst the model focuses on psychological processes, it does not 
consider concepts such as convenience, preferences and intentional behaviours such as 
adherence. Indeed, in health care, adherence to treatment appears to depend in part on the 
patient‘s satisfaction with the treatment or medical service received (see section 2.6.10). 
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Also, the question of what actually constitutes patient satisfaction remains unclear. 
For example, the model indicates that expectations are both mediating and moderating 
factors of satisfaction, but satisfaction is a separate concept and what exactly is it and how 
should it be measured are undetermined. 
2.3.3 Assimilation-Contrast Model of Perception (Anderson, 1973) 
Anderson‘s satisfaction model of assimilation-contrast is shown in Figure 5. The 
assimilation effect occurs in cases where perceptions of attribute performance slightly 
differ from initial expectations, and consequently individuals are more likely to displace 
their perceptions towards their expectations. The contrast effect is the opposite, whereby 
individuals start to exaggerate the increasingly large variation between their perceptions 
and expectations (Anderson, 1973; Ross et al., 1987). 
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Figure 5: Assimilation-Contrast Model of Perceptions (Anderson, 1973) 
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expectations and patient satisfaction, and they have yet to be empirically proven in their 
entirety. This limitation means that quantifying patient satisfaction reliably and validly is 
problematic, especially in terms of determining which topics should be covered under the 
umbrella term of ‗treatment satisfaction‘ versus factors that may influence the concept but 
which are perhaps not part of the concept. The ambiguity incurred from operationally 
defining ‗treatment satisfaction‘ leads one to question the validity and reliability of 
instruments used to measure patient satisfaction with treatment, and thus the results 
reported using such instruments. The following sections consider treatment satisfaction 
topics, methodological issues of patient satisfaction with treatment, and factors associated 
with patient satisfaction with treatment. 
2.4 Treatment Satisfaction Topics 
Weaver et al‘s 1997 literature review on treatment satisfaction identified a wide 
range of treatment satisfaction topics in both broad ranges of chronic diseases as well for 
specific conditions (Weaver et al., 1997).  A search on ―treatment satisfaction‖ identified 
19 articles from 1400 abstracts that contained multi-dimensional instruments that measured 
treatment satisfaction (Weaver et al., 1997). Initially, 57 treatment satisfaction topics were 
identified in one or more of the 19 instruments. Of the 57 topics identified, 40 were 
reflective of Weaver et al‘s treatment satisfaction definition and conceptual framework 
(see section 2.3). Closer examination revealed that of the 40 treatment satisfaction topics, 
17 were appropriate across a broad range of chronic diseases such as rheumatoid arthritis 
or coronary heart disease, or to a specific treatment such as insulin-dependent diabetes 
(Table 2). The study also identified other topics that may be appropriate to several 
conditions, such as information about non-medical aspects of the disease such as home 
help, safety, time required to learn to use appliance or undergo treatment, reliability, 
patients‘ sense of participating in treatment, independence, recommendation of the 
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treatment to others, appropriateness, sense of responsibility for treatment, cost of 
treatment, how realistic was treatment, duration of treatment, number of doses required, 
and confidence in accuracy (Weaver et al., 1997). 
Table 2: Treatment Satisfaction Topics Included in One or More of the 19 Instruments 
(Weaver et al., 1997) 
 
Satisfaction Topic 
Number of Times Topic 
Mentioned in one or more of 
the 19 Instruments 
Overall satisfaction with current treatment 9 
Effectiveness or results of treatment 9 
Information about the disease 7 
Discomfort from treatment, including side effects 6 
Design/appearance product 6 
Convenience of treatment 6 
Desire to continue treatment 5 
Ease/bothersomeness of treatment 4 
Information about treatment 4 
Flexibility of treatment e.g. when and where 3 
Operation of appliance in general 3 
Convenience when not in use (e.g. to carry or store) 2 
Patients‘ confidence in ability to use 2 
Which of the treatments is preferred 2 
How easy the treatment is to buy 2 
Satisfaction with plan of care 2 
How fast treatment worked 2 
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Though Weaver et al. (1997) identified topics related to treatment satisfaction, the 
literature review did not establish the importance of the satisfaction topics listed in Table 2. 
They did cite one study in the review that reported that efficacy, safety, how quickly 
treatment works, and side effects were important compared to topics such as ease of 
treatment and cost (Luciani, Osterhaus, & Gutterman, 1995); however, the  Luciana et al. 
(1995) study was specific to migraine therapy, and it‘s unclear whether there are other 
treatment satisfaction topics not captured in this study.  
Further, Weaver et al.‘s (1997) research was based on the factors (domain names) 
of instruments that were reported in published literature. However, there appears to be 
inconsistency in the factors (domain names) and associated items (questions) between 
studies. For example, there is diversity in the number of items in satisfaction instruments 
that contribute to a domain such as  ‗convenience‘;  some use an overall convenience item 
while other instruments measure the various components that may relate to convenience 
often with no rationale for one way or another. Further, factors may be inconsistently 
named or defined. Therefore, further research is required on this topic, with closer 
examination into the items and factors of satisfaction instruments. 
2.5 Methodological Issues of Patient Satisfaction with Treatment 
2.5.1 The Difference between Patient Satisfaction and Dissatisfaction with Treatment 
It should be noted that there are many patient satisfaction studies but far fewer that 
focus on dissatisfaction. They share the common trait that whilst we all know what 
satisfaction or dissatisfaction is, limited conceptual work has been performed to truly 
understand and define the concept. This means that there is even ambiguity regarding 
whether it is the same concept or different. Nevertheless, there seems to be some 
acceptance that they can be seen as on a continuum (Collins & O'Cathain, 2003). There is 
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some evidence to indicate factors associated with dissatisfaction including social class, as 
well as aspects of care such as waiting times, communication, and patient information 
(Sitzia & Wood, 1997).  
2.5.2 A Dependent or Independent Variable 
Patient satisfaction can be viewed as an independent variable that might influence 
one‘s behaviour (Linder-Pelz, 1982) such as adherence, and hence the efficacy of treatment 
(see sections 2.6.9 and 2.6.10). Alternatively, it can be viewed as a dependent variable 
(Linder-Pelz, 1982), whereby patient satisfaction might be influenced by different factors 
such as age, educational background, and previous or current experiences with treatment 
(see sections  2.6.1 to 2.6.11). However, the direction of associations is not always clear, 
and establishing a causal relationship is determined by various factors such as study 
design. For example, patient satisfaction studies are often cross-sectional and are limited in 
controlling environments and potential confounding variables, making it difficult to 
establish a cause and effect relationship.   
Linder-Pelz noted that in either case, researching patient satisfaction as an 
independent or dependent variable aims to provide practical data rather than being 
concerned with building or testing theories (Linder-Pelz, 1982). This still appears to be the 
case. Where theories have been developed, these have rarely been supported entirely by 
empirical data. For example, Weaver et al. (1997) combined the Zone of Tolerance model 
by Parasuraman et al 1991 with the Assimilation-Contrast model by Anderson (1973), but 
as a combined model the theory of satisfaction has not been tested empirically (see section 
2.3). 
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2.5.3 Uni-dimensional Concept and Measurement 
Sections 2.2 and 2.3 point out that defining satisfaction and establishing a 
conceptual model of what constitutes satisfaction is complex. The ambiguity of whether 
satisfaction is a uni-dimensional concept (e.g. Linder-Pelz 1982) that is influenced by 
various factors or a multi-dimensional concept that is also influenced by various factors 
(e.g. Fitzpatrick 1983) has resulted in ambiguity regarding how to measure the concept. 
Adding to the complexity of these issues is whether the components that comprise patient 
satisfaction are themselves multidimensional or uni-dimensional.  Ware et al. noted that 
multi-item scales generally result in greater variability in scores compared to single-item 
measures (Ware et al., 1983). 
In any case, the issue of whether satisfaction is uni- or multi- dimensional may in 
part explain the inconsistency in findings among studies. For example, a systematic 
literature review exploring patient satisfaction with treatments in CLBP showed that 
although the majority of studies indicated that patients are satisfied, there was significant 
diversity among studies in terms of study design and how patient satisfaction was assessed 
(see Chapter 3). 
2.5.4 Methods for Designing Satisfaction Questions 
As is the case for measurement, the question of how to design satisfaction questions 
is complicated by the ambiguity surrounding the subject in general.  The three main 
methods of developing satisfaction questions – qualitative research with input directly 
from patients, adapting existing questionnaires, and using literature and expert opinion to 
create a new measure – are discussed in detail below. 
Although patient satisfaction with treatment is a subjective concept (Ware et al., 
1983), it must be emphasised that the methods employed to develop satisfaction items and 
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questionnaires do not always use information directly from patients (Weaver et al., 1997; 
Bond & Thomas, 1991). For example, only one of 19 studies cited by Weaver et al. (1997) 
in their review asked patients open-ended questions about their choice for a particular 
treatment. This study included both positive and negative reasons, and developed a 
question based on each of the characteristics mentioned by patients. In order to ensure 
comparison of treatments, characteristics that were specific to a particular treatment were 
excluded (Lewis, Bradley, Knight, Boulton, & Ward, 1988). However, Lewis et al. (1998) 
failed to specify which items they excluded on these grounds, and it‘s possible that the 
items that were excluded may have been pertinent to the concept of treatment satisfaction 
from the patient perspective in individuals with insulin-dependent diabetes. 
The importance of qualitative research in the development of questions is 
increasingly recognized as important, not only by researchers, but also by regulators; in 
fact, the FDA has made this a key guideline (Weaver et al., 1997; Aharony & Strasser, 
1993; Food and Drug Association, 2009). Such recommendations and guidance documents 
have resulted in instruments such as the SWAM Scale (Rofail et al., 2005), the Satisfaction 
with Iron Chelation Therapy (SICT) Instrument (Abetz, Baladi, Jones, & Rofail, 2006; 
Rofail et al., 2008),   the Eye Drop Satisfaction Questionnaire (EDSQ) (Nordmann et al., 
2007), and the Alzheimer‘s Disease Caregiver Satisfaction Questionnaire (Abetz et al., 
2009). The qualitative research that emerges from patient interviews or focus groups 
allows reviewers to establish whether topics were omitted during instrument development 
that may have been important to patients. Using information from qualitative research also 
allows developers to check the phrasing of questions to ensure that they are meaningful to 
patients (Weaver et al., 1997).  
Some treatment satisfaction questionnaires have been created by adapting existing 
instruments from the literature (Weaver et al., 1997). While this is a common shortcut, 
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these studies usually don‘t provide sufficient rationale for including an instrument in a 
study. For example, in cases where existing treatment satisfaction questionnaires have been 
used, there is little assurance that the items encompass all of the relevant concepts based on 
rich qualitative data from patients, or whether the recall period is appropriate to patients 
(see for example, Pincus, Vogel, Savage, & Newman, 2000). As a consequence, the chosen 
instrument(s) may have unacknowledged limitations.  For example, if the instrument is not 
discriminative or sensitive to change, this may have implications on the results.  
Satisfaction questions can also be developed using published literature, as well as 
expert opinion or clinical judgement (Rofail et al., 2005; Weaver et al., 1997). For 
example, a recent cross-sectional study was designed to explore satisfaction and subjective 
experiences with treatment using antipsychotic medication in patients with schizophrenia 
(Gray, Rofail, Newey, Allen, & Gournay, 2005). The questionnaire used in the study was 
developed by a researcher identifying concepts in the literature related to patients‘ 
experiences with antipsychotic medication and creating questions to be reviewed by 
healthcare professionals (e.g. psychologist, psychiatric nurse) as well as a patient who was 
taking medication at the time. A draft questionnaire was created and piloted in patients 
who were not included in the main study. This standard method elicited verbal and non-
verbal feedback regarding the clarity of the items, tested patients‘ reactions to the 
questions, and was used to refine the question order and content (Gray et al., 2005). 
Another example used a similar method; this study used a literature review followed by 
cognitively debriefing items with an expert panel composed of clinicians and patients to 
develop the Treatment Satisfaction and Medicines Questionnaire (SATMED-Q) (Ruiz et 
al., 2008).  Some studies have used questionnaires developed specifically for the purpose 
of the study without any validation (Simoens, Lobeau, Verbeke, & van Aerschot, 2009; 
Braig, Beutel, Toepler, & Peter, 2008). 
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2.5.5 Generic and Treatment-Specific Satisfaction Instruments 
There is no ‗gold standard‘ for measuring patient satisfaction with treatments 
(Rofail et al., 2005). However, like other patient-reported outcomes (e.g. health-related 
quality of life), instruments can be categorised as either generic or specific measures.  
Generic measures should be applicable regardless of condition, treatment, sex, age, 
education, socio-economic status or culture  (Fayers & Hays, 2005; Hayes & Morales, 
2001). They are global in content and cover domains relevant to –  in this case – 
satisfaction. The psychometric validity and responsiveness of generic instruments are 
demonstrated in general populations. An example of a generic treatment satisfaction 
questionnaire is the Treatment Satisfaction Questionnaire for Medication (TSQM) 
(Atkinson et al., 2004; Atkinson, Kumar, Cappelleri, & Hass, 2005). 
In contrast, condition-specific instruments are comprehensive and pertinent for the 
target population, and their psychometric validity and responsiveness are demonstrated in 
the target population. In addition to condition-specific instruments, there are also 
treatment-specific instruments (Weaver et al., 1997). Examples of disease and treatment-
specific instruments include the Satisfaction with Iron Chelation Therapy (SICT) 
questionnaire for patients with iron overload, and the SWAM scale for patients with 
schizophrenia receiving antipsychotic medication (Rofail et al., 2008; Rofail et al., 2005). 
2.5.6 Psychometric Properties of Satisfaction Instruments 
Weaver et al.‘s (1997) literature review of treatment satisfaction measurement 
reported that several researchers considered the psychometric properties of satisfaction 
instruments. The main measurement attributes and number of studies were documented, 
and as shown in Table 3, seven studies (out of 19 included in the review) reported the 
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construct validity of satisfaction instruments and 10 documented the responsiveness to 
change over time. 
Table 3: Psychometric Properties from the Instrument Review Criteria by the Medical 
Outcomes Trust Scientific Advisory Committee and the Number of Studies that Assessed 
Psychometric Properties (Weaver et al., 1997) 
Attribute Number of 
Studies* 
I Conceptual and measurement model  
(scale and subscale structure) 
5 
II Reliability 
A. Internal consistency (Cronbach‘s alpha or KR-20) 
B. Reproducibility 
a. Test-retest 
b. Inter-observer (interviewers) 
 
3 
 
3 
0 
III Validity 
- Content (review by laypersons and experts) 
- Construct (logical relationships between measures or 
individuals) 
- Relationship to criterion measure 
 
3 
7 
 
0 
IV Responsiveness or sensitivity to change 10≠ 
V Interpretability (qualitative meaning of the scores) 0 
VI Burden 
1. Respondent 
2. Administrative 
 
18 
0 
VII Alternative forms (administration modes or proxy versions) 0 
VIII Language and/or cultural adaptations (conceptual equivalence, 
linguistic equivalence, and psychometric properties) 
0 
*19 total studies included in Weaver‘s review 
≠ Responsiveness was not measured in a randomised controlled trial in 4 of 10 studies 
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Whilst Weaver et al‘s study was not systematic or exhaustive, Table 3 demonstrates 
that some measurement attributes are not considered during the development and 
psychometric validation of treatment satisfaction questionnaires. Potential gaps are 
apparent for discriminative (known groups) validity and administrative burden. Further, 
whilst Table 3 provides a good overview of the measurement attributes that have been 
considered by researchers in treatment satisfaction, further research is warranted into 
whether the results documented reached pre-defined criteria. For example, of the three 
studies that explored internal consistency, it would be useful to consider how many studies 
achieved Cronbach‘s alpha of ≥ 0.7 (see for example, Kline, 2000), and if relevant, to 
closely examine possible reasons for not reaching the accepted criterion for internal 
consistency.  
2.5.7 Other Challenges in Patient Satisfaction Measurement 
Previous research that assessed patient satisfaction with treatment has generally 
used cross-sectional or longitudinal survey designs using self-report questionnaires to elicit 
information about satisfaction as a secondary or exploratory outcome (see for example 
Table 4 in section 3.4.3). A literature review of patient satisfaction with antipsychotic 
medication found that none of the questionnaires had been used on more than one 
occasion, and there were no studies exploring the clinical utility of the questionnaires or 
the psychometric properties of the measures (Rofail et al., 2005). Further, questionnaires 
differed in the number of items included and the rating scales. Notable examples include 
Helewell et al (1999), who measured patient satisfaction with an antipsychotic (quetiapine) 
using a seven-item questionnaire and a five-point rating scale from ‗very dissatisfied‘ to 
‗very satisfied‘, and Koivumaa Honkanen et al (1999), who used a ten-item questionnaire 
(Helewell, Kalali, Langham, Mckellar, & Awad, 1999; Koivumaa Honkanen, Honkanen, 
Antikainen, Hintikka, & Vinamaki, 1999). Although the latter rated satisfaction from 1 to 
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10, scores were dichotomised as ―satisfied‖ or ―dissatisfied‖ for statistical analysis. Whilst 
collapsing categories into extreme cases can be advantageous in simplifying data for 
presentation or in cases where few observations exist within some categories, it is 
generally not advised. This is because with categorical data (even ordinal data),  it should 
not be assumed that the difference between scores on a scale are the same (for example, 
between ‗satisfied‘ and ‗very satisfied‘ (Collins & O'Cathain, 2003)), and doing this may 
increase the chance of error.    
Further, the study designs often used to measure patient satisfaction (e.g. 
observational or cross-sectional) mean that it is not possible to directly attribute the 
observed outcome to the process of treatment since social, economic, and other factors 
may influence the course of illness (Coulter, 1991). 
2.6 Factors Associated with Satisfaction and Dissatisfaction with Treatment 
There are many factors associated with patient satisfaction including patient 
demographic and clinical/treatment characteristics, information provided, beliefs, patient 
expectations, doctor-patient communication, effectiveness or efficacy of treatment, 
adherence to treatment, and psychological or social factors. These are presented in further 
detail below. 
Rofail et al. (2005) performed a literature search of patient satisfaction with 
antipsychotic medication from January 1980-January 2003, using the key words 
‗satisfaction‘, ‗patient‘, ‗consumer‘, ‗user‘, ‗antipsychotic‘ and ‗treatment‘. A total of 
eighty papers were identified that included the terms ‗patient satisfaction‘ and 
‗antipsychotic medication‘ in the title or abstract. Based on this review, there was no study 
that considered all the factors in the literature associated with patient satisfaction, or even 
identified the key factors associated with satisfaction (Rofail et al., 2005). Thus, further 
 Page 61 of 458 
research is warranted in order to determine the main factors associated with satisfactaion as 
well as the interaction of factors with each other. 
2.6.1 Demographic Characteristics 
Research indicates that patient satisfaction may be associated with patients‘ 
demographic characteristics such as age, ethnicity, education, and socio-economic status. 
For example, one study found that older people are more satisfied with healthcare than 
younger people (Williams, 1994; Hall & Dornan, 1990). However, results on ethnicity and 
patient satisfaction are not so definitive. For example, Pasco and Atkinson (1983) found 
that ‗whites‘ on the whole were more satisfied than ‗non-whites‘ (Pascoe & Atkinson, 
1983). However, in a meta-analysis of published patient satisfaction surveys, ethnic origin 
did not appear to be related to patient satisfaction (Hall & Dornan, 1990). In addition, 
higher degrees of satisfaction are associated with lower levels of education (Hall & 
Dornan, 1990; Anderson & Zimmerman, 1993).  
Note that although patient satisfaction appears to be associated with patient 
demographic characteristics, patients‘ gender has generally not been associated with 
patient satisfaction (Hall & Dornan, 1990; Sitzia & Wood, 1997) and there is a lack of 
literature showing an association of patient satisfaction with socioeconomic status. 
2.6.2 Clinical and Treatment Characteristics 
There are few studies in the literature demonstrating an association between patient 
satisfaction and clinical or treatment characteristics. For example, there is a lack of data 
exploring aspects such as type of medications (e.g. non-opioid analgesics versus opioid 
analgesics), dosage, and frequency of administration. However, there is some evidence to 
suggest that duration of disease, mode of administration of treatment, and whether 
individuals experience side effects from their treatment are associated with patient 
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satisfaction. For example, Lewis et al. (1988) showed a positive association between 
treatment satisfaction and duration of diabetes. In haematology, several studies have 
demonstrated that overall, patients are satisfied and prefer oral-iron chelation therapy (ICT) 
compared to conventional infused-ICT (Cappellini et al., 2007; Vichinsky et al., 2008; 
Payne et al., 2007; Scalone et al., 2008; Rofail et al., 2008). Further, in rheumatology, 
Huskisson et al. (1992) found an association between overall satisfaction and the absence 
of pain and side effects. 
2.6.3 Information and Knowledge 
To date, satisfaction research has not focused extensively on the association of 
satisfaction with patient information and knowledge. However, there is some indirect 
evidence that they might be associated. For example, since information and knowledge 
have been shown to be associated with adherence to medication regimens (Myers & 
Midence, 1998), which is also related to satisfaction (see section 2.6.10), the level of 
information provided regarding treatment could also affect patients‘ level of satisfaction. 
2.6.4 Patient Expectations 
There is some evidence to suggest that expectations are associated with satisfaction, 
the notion being that patients with lower expectations tend to be more satisfied (Sitzia & 
Wood, 1997). For example, patient satisfaction was assessed using a survey with 2- week 
and 3-month follow-up in a general medicine walk-in clinic in the U.S. Findings showed 
that for each assessment, unmet expectations markedly decreased satisfaction (Jackson & 
Kroenke, 1997). 
Further, models of satisfaction (see section 2.3) often refer to expectations 
(Anderson, 1973; Parasuraman et al., 1991; Oliver, 1993; Thompson & Sunol, 1995).  
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A mathematical equation of satisfaction using measurements of an individual‘s 
expectations regarding certain attributes, and the individual‘s appraisal of those attributes 
was proposed (Linder-Pelz, 1982). Satisfaction was the result of meeting or exceeding 
one‘s expectations. However, it has also been demonstrated that expectations have an 
independent influence on patient satisfaction, regardless of whether those expectations 
were fulfilled. This led to the conclusion that the fulfilment of expectations might have 
little to do with reported satisfaction (Linder-Pelz, 1982). 
However, ‗expectations‘ as a concept lacks a standard operational definition and 
there has been little research to establish what constitutes expectations (Stimpson & Webb, 
1975). This is important, since if expectations are part of treatment satisfaction and there is 
general consensus that the concept of expectations is ambiguous and lacks clear definition, 
then the relationship between treatment satisfaction and expectations is questionable.  
Further, as suggested by Fitzpatrick, there is a need to establish whether 
expectations are an identifiable concept (Fitzpatrick, 1984). Also, there are several 
potential confounding variables that may influence the relationship between expectations 
and satisfaction, such as individual‘s values, attitudes, and socio-economic status (Sitzia & 
Wood, 1997). 
Expectations also seem to vary according to knowledge and prior experience, and 
therefore are likely to change rather than remain stable (Fitzpatrick, 1984). In addition, 
patients with no experience of receiving services may not have formed any expectations 
(Williams, 1994) so proposing that expectations may be an underlying mechanism of 
satisfaction is questionable in this instance.  Williams was sceptical of expectations, further 
suggesting that individuals may question the legitimacy of their own expectations in light 
of information from healthcare professionals or complicated treatments (Williams, 1994). 
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For example, one may argue that individuals do not have sufficient knowledge of what to 
expect in aspects such as treatment. 
With regard to research related to patients‘ expectations of treatment for CLBP, 
there have been some interesting findings from a number of studies (see for example, 
Rives & Douglass, 2010; Verbeek, Sengers, Riemens, & Haafkens, 2004; McIntosh & 
Shaw, 2003; Liddle, Baxter, & Gracey, 2007; Yardley et al., 2009). For example, in one 
study (Liddle et al., 2007), key themes and categories related to patients‘ expectations of 
treatment included: individually specific advice and exercises, supervision and follow-up 
to check progress, support and understanding from practitioner, proactive versus passive 
approach, a quick fix, and pain relief. 
Other studies have shown similar findings, and patients with CLBP generally 
expect information and advice regarding back pain management, and their previous 
experiences led them to expect that treatments would be ineffective especially since they 
continue to experience pain and have difficulties with their normal activities (see for 
example, Verbeek et al., 2004; Rhodes, McPhillips-Tangum, & Markham, 1999). 
In another study which explored beliefs contributing to attitudes for an intervention 
(using the Alexander technique and exercise) in low back pain, results showed that patients 
had a number of pre-intervention expectations such as expected outcomes of doing the 
intervention (behavioural beliefs), expected attitudes of others (normative beliefs), and 
expected ability to carry out recommended activities (control beliefs) (Yardley et al., 
2009). In this study, patients experiences post-intervention were also documented and 
themes identified included specific outcomes regarding for example, partial or total pain 
relief, experienced attitudes of others, and experiences of ability to carry out recommended 
activities (Yardley et al., 2009). Patient perceptions and experiences of treatment are 
further considered in section 2.6.5. 
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2.6.5 Patient Perceptions and Experiences of Treatment  
Patients‘ perceptions and experiences with a condition and its treatment also seem 
to be associated with overall treatment satisfaction (see for example, McPhillips-Tangum, 
Cherkin, Rhodes, & Markham, 1998; Glenton, Nilsen, & Carlsen, 2006; Cherkin, Deyo, 
Berg, Bergmann, & Lishner, 1991). For example, with regard to patients experiences, it 
has been reported that patients requiring help for their LBP from primary care physicians 
are often dissatisfied not only with the information and care that they receive, but also their 
treatment (Cherkin et al., 1991). These findings inspired a qualitative study to further 
explore patients‘ subjective experiences and reasons for repeated medical visits in chronic 
back pain (McPhillips-Tangum et al., 1998). Reasons for repeated medical visits included 
having difficulties performing normal activities or experiencing activity limitations and 
increased pain (or ‗flare ups‘). There was a general need for participants to discover the 
cause of the pain, and often participants in the study reported seeking a diagnostic test that 
would help find a physical cause to their underlying pain. Results also indicated that 
participants were frustrated and confused when their questions were unanswered by HCPs 
which was associated with dissatisfaction with the care received. Further, even when 
treatment was delivered, it was sometimes considered unsatisfactory with participants 
often seeking alternative and new types of treatment. The authors suggested that clear and 
confident diagnosis and treatment programmes may help improve patient outcomes such as 
satisfaction (Thomas, 1987), and agreement between the patient and HCP was likely to be 
a stronger predictor of outcomes than clinical measures (Bass, 1986). However, this 
hypothesis warrants further exploration. 
There is a preponderance of literature to document the negative impact and burden 
incurred to patients from CLBP (see for example, Smith & Osborn, 2007; Bacon et al., 
1994; Pain in Europe, 2003; Keeley et al., 2008; Roland et al., 2007; Vlaeyen, Kole-
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Snijders, Boeren, & van Eek, 1995; Woby, Watson, Roach, & Urmston, 2004; Liddle et 
al., 2007). However, there is some evidence to indicate that patients‘ experiences extend 
beyond just presence and intensity of pain, and its impact on every day activities, 
functioning, and level of disability incurred. For example, one qualitative study indicated 
that patients‘ experiences of CLBP included loss of function and impact on their social 
roles, but also included the uncertainty of aetiology and diagnosis, as well as impact on 
their self and identity (Smith & Osborn, 2007). The impact seemed to be worse for patients 
who felt they had a derogatory self image who in turn felt that they directed their negative 
feelings towards others (Smith & Osborn, 2007). 
In another qualitative evaluation of evidence-based information presented in the 
form of a website for back pain sufferers, results showed that individuals were quite 
sceptical of the information presented, and expressed lack of trust with regard to research 
and researchers (Glenton et al., 2006). This was tied to the fact that research evidence 
seemed to be constantly changing, and also that often the researchers disseminated 
conflicting information. It is thought that the lack of trust and confidence in research may 
transition to a similar sense with HCPs and perhaps the healthcare system itself (Glenton et 
al., 2006). Conflicts of interest also appear to be somethingconsidered by patients receiving 
managed care for low back pain (Lo, 1999). For example, patients may question whether 
the tests employed by HCPs are truly not indicative of a CLBP problem or whether the 
HCP is trying to save money on behalf of themselves, their practice, or even the healthcare 
system in general (Lo, 1999). 
Also, a study regarding patients‘ experiences, opinions and expectations for clinical 
management indicated that in general patients had experienced a number of diverse 
treatments that did not work for them (Liddle et al., 2007). Patients valued the advice and 
treatment provided to them, but they often questioned the appropriateness of treatment 
 Page 67 of 458 
especially since a diagnosis was rarely provided yet patients often experienced varying 
degrees of pain and related symptoms. Consequently, patients often do not adhere to 
medication regimens and exercises as recommended by their HCP, and this in turn may 
affect the efficacy of the treatment (Liddle et al., 2007).   
2.6.6 Involvement in Treatment Decisions 
There is some evidence to indicate that lack of involvement in treatment decisions 
is significantly related to treatment dissatisfaction (see for example, Gray et al., 2005).  
This finding suggests that patients‘ perceptions regarding their treatment may be a 
determinant of patient satisfaction. 
2.6.7 Therapeutic Relationship 
A definition of a therapeutic relationship is a connection of trust and rapport 
between a HCP and patient involving: collaboration, empathy from the therapist, as well as 
mutual understanding and respect (Cole & McLean, 2003). The therapeutic relationship is 
sometimes referred to as a ‗helping relationship‘ and the terms are often used 
interchangeably with the ‗therapeutic alliance‘ (Leach, 2005). A definition of a therapeutic 
alliance emphasises active collaboration between a HCP and a patient (Ackermam & 
Hilsenroth, 2003).  
There are various models that have been proposed to describe the therapeutic 
relationship between HCPs and patients. In particular, five main models are often referred 
to: the working alliance, the transferential/countertransferential relationship, the 
developmentally needed relationship, the I-you relationship, and the transpersonal 
relationship (Clarkson, 1990).  
Specifically, the working alliance is considered to develop within the context of a 
business contract between a HCP and patient (such as times, fees, role and limits of 
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responsibility). HCP‘s encourage the development of a working alliance via for example 
active listening, and practice should be indicative of competence and trust to the patient. 
Being part of a working relationship requires that HCP make a good assessment of the 
patient, and that they emphasise that they can commit to helping to the patient. The woking 
alliance is portrayed in terms of bond of mutual understanding regarding what the patient is 
attending for, and reassurance that this is the place to get it (Clarkson, 1990). 
The transferential/countertransferential relationship relates to how past experience 
can distort the way a patient perceives and relates to others. The HCP aims to identify with 
patients when and how they may be distorting their perception of the HCP to develop a 
process from ‗here and now‘ to ‗there and then‘. At the same time, HCPs try to tease out 
countrtransferential responses to the patient with particular attention regarding what could 
be represented to the patient, versus what could be considered by them as a HCP 
(Clarkson, 1990). 
The developmentally needed relationship relates to what the patient may need from 
the treatment that they did not get during their childhood years. In particular, the process of 
empathising in a new way can be considered a way of fulfilling a gap from childhood 
years. It should be noted that the greater the patient‘s needs (i.e. the gap), the more the 
HCP should consider the appropriateness of the therapy, as well as whether other kinds of 
help are also required (Clarkson, 1990). 
The I-you relationship focuses on intimacy and is characterised by the HCP‘s 
openness, the patient‘s openness, and the process between the two. The I-you relationship 
model encourages consideration regarding how HCPs and patients may be blocking 
themselves from intimacy at a specific time in the relationship. Further, intimacy is not 
something that should be demanded (Clarkson, 1990). 
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The fifth model relates to the transpersonal relationship and is the idea that there 
may be something beyond current understanding and which provides a sense of hope. This 
model places emphasis on being aware that the topic of ‗spirituality‘ may emerge from 
time to time during consultations between a HCP and patient, but that the role of the HCP 
should not extend to spiritual guidance (Clarkson, 1990). 
Whilst these five models of the therapeutic relationship are well known within the 
field of psychotherapy, research specific to CLBP has focused more on the dynamics of the 
consultation in the context of the social interaction between HCP and patient (Derebery, 
2003; Lo, 1999). The consultation process usually involves negotiations between HCP and 
patient about the meaning of symptoms, which can determine the outcome of the patient. 
Given that most patients with CLBP experience ‗pain‘, they often consider their pain of 
organic physical nature (rather than psychological) (see for example, Derebery, 2003; 
Chew & May, 1997; Derebery, 2003; Chew & May, 1997). However, in CLBP the 
pathology is not often apparent particularly for non-specific CLBP, and GP‘s need to 
diagnose the patient as an initial step of the consultation process. Consequently, responding 
to and managing patients with CLBP can be difficult (Chew & May, 1997; Derebery, 
2003; Chew & May, 1997; Derebery, 2003), and patients with CLBP are often perceived 
as ―a problem patient and a problem situation‖ (Nordin et al., 2006).  
In a qualitative study conducted in North-West England, when asked about making 
a diagnosis for CLBP one GP mentioned ―...how do you put it? Mechanical, due to bad 
posture, bad working practices, bad sitting, just to bad back care.‖ However, some GPs did 
not report pathology as the primary cause of consultations about CLBP, with one reporting: 
―(the) need for sick notes, any excuse to get money off the tax payer, avoidance of work...‖ 
The mismatch of explanatory models between doctor and patient causes frustration to both 
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patients and GPs resulting in difficulties for GPs regarding whether to adopt a patient- or 
doctor-centred approached (Chew & May, 1997; Chew & May, 1997).  
Further, the back pain may be causing considerable suffering to the patient. This 
may be for a number of reasons such as anxiety about health status, loss of function, or 
even a negative economic impact, which could increase a patient‘s distress levels.  A GP 
could misinterpret such issues as a worse pathology than may be the case, thus leading to 
further testing, referrals, prolonged lost time at work and excessive treatment. This can 
ultimately lead to general patient dissatisfaction (Derebery, 2003).  
In addition, often HCPs inform patients with CLBP to remain active when 
experiencing back pain and that bed rest will make the pain worse (Bogduk, 2004; Roland 
et al., 2007). The benefits of activity include that it will help develop muscles, keep the 
individual supple, give stronger bones, make patients fit and feel good, and releases natural 
chemicals that reduce pain (Roland et al., 2007). However, such key messages that HCP‘s 
disseminate do not fit well with the patient‘s explanatory model of pain especially since 
movement may also induce the pain intensity (Bogduk, 2004). Consequently, patients may 
not adhere to HCPs recommendations and this may in turn impact further on CLBP.  
Other research related to the therapeutic relationship has explored how GP‘s often 
adopt a more autonomous rather than collaborative approach to managing patients with 
CLBP (see for example, MacNeela, Gibbons, McGuire, & Murphy, 2010). Reasons for an 
autonomous approach are in part explained by GP‘s expectations related to uncertainty 
regarding symptoms and doubts related to the possibility that patients are malingering or 
‗faking it‘. Nevertheless, a shared-decision approach is generally recommended (see for 
example, Charles, Gafni, & Whelan, 1999; Heritage & Maynard, 2006; May, 2007). Also, 
whilst GPs are interested in the patient as individuals, their perspective of the patient‘s 
subjective experiences are often quite different to patient‘s actual experience and they 
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generally place less emphasis than patients on the importance of experiences such as anger 
and frustration (see for example, Barry, 2002; Smith & Osborn, 2007). 
It should be noted that there is some evidence to suggest an association between 
aspects of the therapeutic relationship and outcomes such as satisfaction (see for example, 
Leach, 2005; McCaffrey, Pugh, & O'Conner, 2007; Strutt, Shaw, & Leach, 2008; 
Cromarty, 1996). Such aspects include: 
 Patient‘s perception of HCP‘s behaviour and attitude (Cromarty, 1996) 
 Patient‘s perception of HCP‘s competence (effective, thorough, 
knowledgable) (Strutt et al., 2008; Cromarty, 1996)          
 Effective communication skills (see section 2.6.8 also) (Leach, 2005; 
Cromarty, 1996) 
 Establishing good patient rapport including making time for rapport (Leach, 
2005) 
 Building trust and confidence (Leach, 2005)  
 Empathising (caring, reassuring, listening, continuity) (Strutt et al., 2008; 
McCaffrey et al., 2007) 
 Generating a friendly, relaxed and secure atmosphere (Strutt et al., 2008)  
 Manner in which treatment is delivered (such as being gentle and treating 
the root cause) (Strutt et al., 2008) 
 Adequate consultation time (not rushed, short waiting times) (Strutt et al., 
2008; Leach, 2005; Cromarty, 1996; McCaffrey et al., 2007) 
 Adopting a collaborative consultation style (rather than authoritarian, 
technical, or parental) (Leach, 2005) 
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 Information-giving (explanation, advice) (Strutt et al., 2008; Leach, 2005; 
Cromarty, 1996) 
 Level of understanding achieved (Cromarty, 1996) 
 Patient‘s perception of HCP‘s responsiveness (whether the HCP is 
perceived to understand and accept a patient‘s concerns and to provide 
appropriate treatment and care) (Reis et al., 2008) 
Closer examination of empirical studies provides further evidence to support an 
association between the therapeutic relationship and satisfaction or dissatisfaction. For 
example, one study showed a general level of dissatisfaction with conventional treatments 
but particularly with being rushed, not being listened to, and feeling dismissed as a 
complainer (McCaffrey et al., 2007). 
In addition, there are various factors which may increase or worsen the therapeutic 
relationship and consequently, these factors may indirectly contribute to treatment 
satisfaction or dissatisfaction. For example, indications of a good therapeutic relationship 
include increased flow of conversation, disclosure of sensitive information, relaxed body 
language, increased eye contact, and improvements in listening and responding (Leach, 
2005). However, a poor therapeutic relationship may be presented in terms of long periods 
of silence, less conversation or very brief responses, lack of eye contact, and defensive 
body language (Leach, 2005).  
Further, in a study that qualitatively explored what patients think about during their 
consultations (Cromarty, 1996), results showed that patients had a desire for understanding 
and considered the HCP‘s willingness to help, as well as their ability and their available 
time. These findings suggest that patients consider the therapeutic relationship and evaluate 
the adequacy of various aspects which may in turn be related to treatment satisfaction. 
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A similar study explored patients‘ views of the doctor-patient relationship, and 
findings revealed three stages that seem to be related to creating the relationship (Gore & 
Ogden, 1998). The first is ‗developing a relationship‘ and patients appeared to approach 
this in several ways. For example, some patients described knowing instantly that they 
would bode well with the doctor, whilst others described trying out several doctors in the 
practice, or searching for a doctor that would help them with specific requirements. For 
some patients who had been unsure about a new doctor, they tried to overcome their initial 
reservations and were relieved that they had not gone to a different practice too quickly. 
The second stage is ‗validating the relationship‘ where patients seemed to pay particular 
attention to evidence of caring to help determine whether they liked their doctor. For 
example, some patients used these insights as in indication of the doctor‘s future 
behaviour, whilst some compared their doctor with others to consider the value of the 
relationship, whereas some patients generally accepted their doctor. In addition, there 
seemed to be key events that influenced the relationship, such as making a diagnosis, or 
receiving an important treatment. Caring and help during a crisis were also key events, 
whilst some patients described resolving a conflict between themselves and the doctor 
which had resulted in bringing them closer together. Also, accepting dissatisfaction for 
what would otherwise be considered a good relationship was another important aspect and 
included accepting problems with the appointment system, lack of availability, and 
wanting a more caring and listening doctor. The third stage was described as ‗consolidating 
the relationship‘ with the doctor and involves a process of testing and setting boundaries. 
Some patients viewed conflict as necessary, whilst others considered conflict something to 
avoid. Specifically, some patients described exploring the HCP‘s knowledge boundaries, to 
gauge whether the HCP would allow the patients own knowledge to contribute to the 
consultation. Other patients described trying to establish the HCP‘s willingness to allow 
active participation from the patient (Gore & Ogden, 1998).  
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As developing, validating and consolidating a relationship with the HCP is often 
part of the treatment process, it is expected that these aspects may also contribute towards 
treatment satisfaction or dissatisfaction. However, further research is warranted to explore 
this. 
2.6.8 Doctor-Patient Communication 
Evidence suggests that doctor-patient communication is associated with patient 
satisfaction. For example, empathy and active listening are associated with increased 
patient satisfaction, and patients expect confirmation from HCPs that their pain is real 
(Verbeek et al., 2004). However, quantifying doctor-patient communication is problematic 
given the many ways doctors communicate about an individual‘s situation and health 
problems. Some of the most pertinent ways are through partnership building (establishing a 
rapport by empathising and actively listening), asking questions, information exchange, 
encouragement, non-verbal communication, and use of communication aids (Williams, 
1999). The terminology used and various features of verbal communication are also 
important (Williams, 1999). For example, the type of questions that could be asked to 
initiate a response should progress from open to closed questions so that as much 
information as possible is extrapolated from the individual. However, if the questions are 
likely to invoke an emotional response, then objective to subjective questioning may be 
more appropriate (Williams, 1999). Also, an empathetic doctor-patient relationship 
includes the elicitation of feelings, paraphrasing, reflecting, using silence, encouragement, 
and non-verbal behaviour as well as listening to what the patient says and what is not said 
(Williams, 1999). 
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2.6.9 Effectiveness of Treatment 
Effectiveness of treatment is the extent to which treatment does what it is intended 
to do under normal circumstances or in real world settings (Drummond et al., 1987). A 
review by Weaver et al. (1997) (see section 2.4 for details) stated that existing literature is 
inconclusive regarding the relationship between treatment satisfaction and effectiveness of 
treatment (Weaver et al., 1997) due to conflicting evidence. They provided evidence to 
support the link from studies such as Lewis et al., who demonstrated a positive relationship 
between treatment satisfaction and perceived blood glucose control (Lewis et al., 1988), 
and Huskisson et al. who showed an association between overall satisfaction and absence 
of pain and side effects in patients with rheumatoid or osteoarthritis (Huskisson et al., 
1992), versus Castelin and Kerr who did not find such an association in patients with 
cardiac problems (Castelin & Kerr, 1995). 
On reflection, it does not seem to be relevant to examine treatment satisfaction 
covariates between studies on several grounds. Firstly, study designs may differ 
significantly and the way that satisfaction is quantified in one study may not be comparable 
with another.  
Also, one study refers to for example treatment satisfaction in patients with 
diabetes, and another measures satisfaction in patients with cardiac problems. The nature 
of patients is thus very different and whilst there are some similarities with regard to for 
example, that in both cases patients have to live with a continuous medical problem and are 
often advised about their diets, there are also very apparent differences. For example, 
individuals with diabetes may take regular insulin injections whereas people with cardiac 
problems are often faced with taking tablets (they do not take injections or blood sugars), 
and according to the severity of their condition may have to adjust their lifestyle. 
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Consequently, concepts such as treatment satisfaction and efficacy/effectiveness may vary 
significantly by condition. 
2.6.10 Adherence to Treatment 
Few studies have tried to define adherence (for a review see Myers & Midence, 
1998), however, a definition of adherence by Haynes et al. is often cited and states that 
adherence is ―the extent to which a person’s behaviour (in terms of taking medications, 
following diets, or executing lifestyle changes) coincides with medical and health advice‖ 
(Haynes, Taylor, & Sackett, 1979). Recently, a study in 107 patients with β-thalassemia, 
sickle cell disease, or myelodysplastic syndromes taking ICT provided data to support an 
association between satisfaction with ICT and adherence (Rofail et al., 2008). There were 
four independent variables that significantly predicted adherence (R
2
=42.3%):  age, 
perceived effectiveness of ICT, low burden of ICT, and low side effects of ICT (Rofail et 
al., 2008). 
Whilst Rofail et al. (2008) demonstrated an association between treatment 
satisfaction and adherence, it should be noted that the concept of adherence is complex. 
Rofail et al (2008) assessed adherence using three questions. These were, in general, in the 
last four weeks, how often did you: 1) have trouble remembering to take your iron 
chelation therapy?; 2) think about stopping iron chelation therapy; and 3) follow the 
chelation therapy regimen exactly as recommended by your doctor? These questions were 
rigorously developed, emerging from data elicited from in-depth patient interviews refined 
according to patient and clinical expert input (Abetz et al., 2006; Rofail et al., 2008). 
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2.6.11 Psychological States 
Sitzia & Wood (1997) noted that there has been little research into the relationship 
between psychological states (e.g. anxiety) and satisfaction.  Further research into this 
connection is needed. 
2.7 Treatment Satisfaction Definitions, Conceptual Frameworks, Methodological 
Issues and Associated Factors: The Significance to CLBP 
This Chapter included definitions, conceptual frameworks, methodological issues 
and factors associated with treatment satisfaction within a wider context, not specific to 
CLBP which is the focus of this thesis. The rationale for this approach was that there is an 
ever increasing body of literature that pertains to treatment satisfaction in general, and 
which may provide useful insights when exploring the concept to a specific indication such 
as CLBP. For example, Oliver‘s theory of consumer satisfaction (Oliver, 1993) presented 
in section 2.3.2 has frequently been referred to, but is not specific to CLBP. Nevertheless, 
based on this model, it could be inferred that satisfaction or dissatisfaction with treatment 
in CLBP may be a result of the discrepancy between patient expectations and the actual 
patient experience in terms of the performance of the treatment such as whether it worked 
and whether any side effects were incurred etc. 
Similarly, in section 2.2.2 a definition of treatment satisfaction specific to 
antipsychotic medication (Rofail et al., 2005) was provided as well as other more general 
definitions of treatment satisfaction. One of the reasons for this was to demonstrate how 
definitions based on patient input are often richer and more detailed than those based on 
clinical and researcher intuition. In addition, some aspects of satisfaction with 
antipsychotic medication may be relevant to CLBP such as treatment acceptability. 
However, it is important to note that other aspects relevant to antipsychotic medications 
may be less relevant to CLBP. For example, medication insight which is defined as self 
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knowledge, awareness and understanding into the need for medication and its potential 
side effects, is an important concept for patients with schizophrenia receiving antipsychotic 
medication where the nature of the condition includes cognitive impairment and lack of 
insight into their condition. However, medication insight may not be as relevant to patients 
with CLBP where the condition is mainly characterised by severity of pain and associated 
functional impairment. Therefore, whilst an overview of treatment satisfaction in general is 
useful, its relevance in context of CLBP needs careful consideration. Ideally, further 
exploration of the treatment satisfaction literature specific to CLBP and input from patients 
with CLBP is warranted (see Chapter 3 and Chapter 4, respectively).  
2.8 Summary 
In summary, this Chapter outlines the problematic nature of current research into 
treatment satisfaction.  Satisfaction can be viewed as a research problem in terms of 
defining what constitutes treatment satisfaction and establishing appropriate measurement 
of the concept based on reliable and valid instruments. Satisfaction can also be viewed as a 
treatment problem in terms of levels of satisfaction associated with continuing and 
adhering to treatment. It can also be a useful indication of best practice (for example, are 
patients involved in treatment decisions), providing a reference point for clinical practice. 
Findings also suggest that there are numerous factors associated with treatment satisfaction 
including but not limited to demographic, clinical and treatment characteristics, 
information provided, knowledge, beliefs, expectations, doctor-patient communication, and 
effectiveness of treatment. 
Future research should consider existing definitions and frameworks of treatment 
satisfaction but also work to resolve the ambiguities around the concept. A systematic 
review of the literature is warranted that is focused on a particular indication and with 
particular attention to chronic conditions such as CLBP. The review should describe 
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empirical studies that meet pre-specified inclusion criteria with attention to study designs, 
samples, as well as to definitions and conceptual frameworks of treatment satisfaction, and 
attention to the development and psychometric properties of instruments. 
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Chapter 3  - Study I – Treatment Satisfaction and Dissatisfaction in 
Patients with Chronic Low Back Pain: A Systematic Review 
3.1 Introduction 
There are many forms of CLBP treatment that offer varying levels of relief (see 
Chapter 1). Though adherence in CLBP is complex, there are negative consequences to 
non-adherence such as increased healthcare expenditure and social costs including burden 
on carers (Myers & Midence, 1998).  
There is an expanding body of evidence to suggest that increased patient 
satisfaction would increase adherence to recommended treatment regimens (see for 
example, Rofail et al., 2008; Myers & Midence, 1998) (see section 2.6.10).  Treatment 
satisfaction is therefore an important variable to assess as part of routine clinical practice 
and would aid the effective management of patients‘ treatment programmes, as well as 
help to improve and maintain patient well-being. The assessment of treatment satisfaction 
may also be useful in any CLBP survey or clinical trial.  
There are various definitions of satisfaction (see section 2.2). A generally accepted 
definition is that satisfaction or dissatisfaction is an attitude or opinion expressed by 
patients about their clinical experiences (Kane et al., 1997). However, it is controversial 
whether the concept is a multidimensional or a unitary concept. For example, some have 
proposed that satisfaction is a unitary concept influenced by determinants such as values 
(Kane et al., 1997; Sitzia & Wood, 1997), whereas others have suggested that satisfaction 
is multidimensional, comprised of two or more domains (factors), such as ‗treatment 
acceptability‘ and ‗medication insight‘ (Rofail et al., 2005). The focus of this thesis is on 
CLBP, and there is also a need to synthesise the literature on treatment satisfaction within 
this field. 
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3.2 Objectives 
The objective of this systematic review was to explore treatment satisfaction and 
dissatisfaction in patients with CLBP. Specifically, to: 
1. Establish definitions and conceptual frameworks or models of treatment 
satisfaction in CLBP including:  
 Whether treatment satisfaction in CLBP is a uni-dimensional or multi-
dimensional concept. 
 Whether treatment satisfaction in CLBP has been used as a dependent or 
independent variable. 
2. Identify factors associated with treatment satisfaction in patients with CLBP.  
3. Provide an overview of questionnaires available to assess satisfaction or 
dissatisfaction with treatments in CLBP. 
4. Establish the quality of treatment satisfaction studies. 
5. Establish the level of treatment satisfaction in patients with CLBP. 
3.3 Methods 
Using guidelines defined by the University of York NHS Centre for Reviews and 
Dissemination (Centre for Reviews and Dissemination, 2009), a systematic search strategy 
was implemented. In order to ensure as comprehensive and unbiased a search as possible, a 
variety of search methods (both computerised and manual) were implemented. 
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3.3.1 Electronic Databases 
The following five electronic databases were searched:  
 PUBMED (index of medical literature) 
 PsycINFO (index of psychological literature) 
 EMBASE (indexes journals in biomedical and pharmacological literature) 
 CINAHL (Cumulative Index to Nursing and Allied Health Literature) 
 Web of Knowledge 
A key specialist database was also searched:  
 PROQOLID (Patient-Reported Outcomes Quality of Life Instruments 
Database) 
3.3.2 Search Strategy 
A search of published studies between January 1990 and December 2009 was 
conducted using the following keywords: 
 chronic low back pain OR CLBP 
AND 
 treatment OR therapy OR medication OR analgesic OR opioid OR 
physiotherapy OR physical therapy  
AND  
 satisfaction OR dissatisfaction       
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3.3.3 Hand Searching  
The following journals considered to be most relevant to today‘s treatment scenario 
in CLBP and were hand searched separately for October, November and December of 
2009 to identify publications that may not yet have been entered into databases: 
 Pain 
 Physiotherapy   
 SPINE 
3.3.4 Inclusion Criteria 
The inclusion criteria were designed to capture articles that measured treatment 
satisfaction or dissatisfaction in CLBP. To be eligible for inclusion, an article had to 
specify the following in the title or abstracts of articles:  
 patients with CLBP   
 original data describing patient satisfaction and/or dissatisfaction with 
treatments for CLBP 
 empirical quantitative data of patient satisfaction and/or dissatisfaction with 
treatments  
3.3.5 Exclusion Criteria 
 Studies were excluded in the following cases: 
 CLBP was not the primary focus  
 the focus was on a broadly defined LBP patient population (see for example, 
Kalauokalani, Cherkin, Sherman, Koepsell, & Deyo, 2001) 
 Page 84 of 458 
 patients had acute or sub-acute back pain and there was no chronic comparison 
group (see for example, Curtis et al., 2000)  
 data of sub-groups (e.g. acute, sub-acute and chronic patients) were pooled for 
analyses 
 treatment was surgery or other invasive methods such as injections, implantable 
drug delivery systems, or acupuncture (N.B. where the issues related to 
satisfaction/dissatisfaction are likely to extend beyond those related to 
medication and/or physiotherapy e.g. fear of needles, fear of blood or 
puncturing of the skin, concerns about the future related to a non-reversible 
procedure, fear of going under anaesthetic, incidence and severity of side 
effects associated with anaesthetic surgeon‘s competence,  potential 
complications of surgery, attitudes and behaviour of surgeons and nursing staff, 
adequacy of hospital facilities, etc. In addition, treatment with surgery and other 
invasive methods were beyond the scope of this thesis whereby the main focus 
is on medications/physiotherapy and satisfaction with these treatments.) 
 results did not document treatment satisfaction scores 
 results focused on other types of satisfaction or dissatisfaction such as job 
satisfaction, life satisfaction, and marital satisfaction 
 qualitative studies  
 review papers 
 posters 
 letters or commentaries 
 foreign language studies and non-English papers 
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Only studies which met all of the pre-defined inclusion and none of the exclusion 
criteria were included. 
3.3.6 Description of Studies 
Information was extracted about the aim, design and method, treatment or therapy, 
sample size, outcome measures, statistical analysis, and main findings including statistical 
significance. 
3.3.7 Data Synthesis and Analysis 
Studies were qualitatively reviewed with consideration given to methodological 
strengths and weaknesses.  Meta-analysis was not performed since a preliminary review of 
studies revealed that there are limited data and study designs varied too much. 
The quality of the articles was assessed in two parts. The first part used a ‗hierarchy 
of evidence‘. Specifically, studies were categorised according to the attributes of their 
design. An amalgamation of two hierarchies was used, which increases progressively 
downwards (Centre for Reviews and Dissemination, 2009; Greenhalgh, 1997). The 
categorisation of each study was conducted by two independent researchers (DR and a 
trained researcher), and any discrepancies were resolved by discussion. 
The second part involved using a 10-item checklist that was developed for a 
systematic review of patient satisfaction in antipsychotic medications (Walburn, Gray, 
Gournay, Quraishi, & David, 2001) and modified for this review. Originally, the items for 
this checklist were derived from two main sources (Centre for Reviews and Dissemination, 
2009; Greenhalgh, 1997), and focused on variables most often highlighted in critical 
appraisal. The ten items were whether studies had explicit a priori aims, definitions of the 
size of the population under investigation, sample size calculation, justification that sample 
was representative of population, specification of inclusion/exclusion criteria, demographic 
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details, justification of reliable and valid satisfaction instruments, an original questionnaire, 
response/drop-out rates, and discussion about the generalisability of results. 
3.4 Results 
3.4.1 Selection of Studies 
The search strategy produced 722 articles.  Of these, 660 were excluded (reasons 
included search terms not in title or abstract (n=352), non-English abstracts (n=13), and 
duplicates from use of various electronic databases (n=295)). Sixty-two abstracts met the 
inclusion criteria for containing satisfaction data and these were retrieved for more detailed 
evaluation.  Closer examination excluded 36 studies after evaluation of full text because 
they did not meet the pre-specified inclusion and exclusion criteria (see section 3.3.4).  
Figure 6: Flow Diagram of Study Selection Process 
 
 
 
 
 
 
 
 
 
 
3.4.2 Description of Included Articles 
The final list of reviewed articles is presented in Appenidix A.  Table 4 summarises 
the design, participants, treatments/interventions and satisfaction measures used in the 
722 potentially relevant citations identified 
after liberal screening of electronic searches  
660 citations excluded: 352 search 
terms not in title or abstracts / 13 
foreign language abstracts / 295 
duplicate abstracts 
 
62 studies retrieved for 
more detailed evaluation 
36 studies excluded after 
evaluation of full text from 
systematic review (e.g. search 
terms not in results) 
26 relevant studies included in 
systematic review 
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studies described in the included articles. All the studies included in this systematic review 
explored satisfaction in patients with CLBP (see sections 3.4.7 to 3.4.9).  
CLBP was defined in different ways. For example, CLBP was referred to as pain 
lasting ≥ three months or ≥ 3 months constant/intermittent LBP (See for example, 
Licciardone et al., 2003; Barker, Elliott, Sackley, & Fairbank, 2008; Buchner, Zahlten-
Hinguranage, Schiltenwolf, & Neubauer, 2006) or in some instances ≥ 3 months 
continual/recurrent LBP (See for example, Mannion, Muntener, Taimela, & Dvorak, 
1999). However, one study defined CLBP as having had pain for ≥ 6 weeks (Nyiendo, 
Haas, & Goodwin, 2000). As well as duration of chronicity, impact on activities of daily 
living or functioning was a main criteria of inclusion for three studies (Wallace, 
Skowronski, Khanna, Tudor, & Thipphawong, 2007; Buchner, Neubauer, Zahlten-
Hinguranage, & Schiltenwolf, 2007; Carey, Garrett, & Jackman, 2000). For example, one 
study specified that patients must be experiencing disabling symptoms (Carey et al., 2000), 
another required that patients were also on sick leave for six weeks or more (Buchner et al., 
2007), and another that patients had experienced CLBP and activity limitations everyday 
for the last three months (Wallace et al., 2007). There were two studies that also included 
other groups of patients such as neck pain (Buchner et al., 2006) or acute pain (Haas, 
Sharma, & Stano, 2005). These studies were included because the results of each group 
were separate from the CLBP group. However, results on neck pain and acute pain were 
not extrapolated or reported as they are beyond the scope of this review. 
The treatments and interventions studied were diverse (Table 4) and included 
medical/GP care, chiropractic care, osteopathy, physiotherapy, and surgery. For example, 
one study explored the benefits of back school (Shirado et al., 2005) and another focused 
on patients‘ perceptions of yoga (Groessl, Weingart, Aschbacher, Pada, & Baxi, 2008).  
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3.4.3 Quality of Studies  
The quality of studies was mixed.  Study performances as assessed by the checklist ranged 
from 3-7 out of 10 (mean number of lost points was 4.23, indicating an overall low quality 
of studies). The studies performed best for ‗explicit a priori aims‘ (included in all studies), 
followed by ‗inclusion/exclusion of studies‘ (included in 92% of studies).  Only 19% of 
studies provided a sample size calculation to indicate the number of participants required 
to determine significant differences between groups, and only 12% of studies discussed the 
generalisability of results. None of the studies demonstrated that the study sample was 
representative of patients with CLBP Table 5. 
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Table 4: Characteristics of Included CLBP Studies 
Study
*
 Design Participants Treatments/Intervention n Satisfaction Outcome Measures 
Barker 2008 RCT. Patients with CLBP > 3 
months. 
TENS/ FairMed device (to 
deliver sensory discrimination 
training). 
60 Global rating of improvement and satisfaction, the Patient Global 
Impression of Change (PGIC) scale.  
Buchner 2006 Cohort study. Patients with CLBP > 3 
months. 
Multidisciplinary therapy as 
inpatients. 
231 Level of satisfaction with therapy (5-point Likert-type scale: 5 = 
very satisfied; 1 = completely dissatisfied). 
Buchner 2007 Cohort study Patients with CLBP ≥ 3 months 
and sick leave for 6 weeks or 
more. 
Multidisciplinary therapy as 
inpatients. 
405 Level of satisfaction with therapy (5-point Likert-type scale: 5 = 
very satisfied; 1 = completely dissatisfied). 
Buchner 2007 Cohort study. Patients with CLBP ≥ 3 months 
who had sick leave for 6 weeks 
or more. 
Multidisciplinary therapy as 
inpatients. 
387 Level of satisfaction with therapy (5-point Likert-type scale: 5 = 
very satisfied; 1 = completely dissatisfied). 
Carey 2000 Cohort study. Patients with CLBP and 
persistent disabling symptoms 
> 3 months. 
Chiropractic/ medical care. 96 A study specific question administered by telephone about overall 
satisfaction with care over the course of the patient‘s LBP. No 
further details provided. 
Chown 2008 Cohort study.  Patients with CLBP > 3 
months. 
Group exercise/ physiotherapy/ 
osteopathy. 
154 Questions regarding satisfaction with medical treatment on five-
point Likert-type scale. No further details provided. 
Goodwin 2000 Cross-sectional 
survey. 
Patients with CLBP.  Multidisciplinary therapy in 
outpatients. 
105 A patient satisfaction questionnaire was used with 10cm visual 
analogue scales to assess relative satisfaction with the individual 
components of the rehabilitation programme. The questions 
covered the introduction, understanding back pain, pain theories, 
sleep and beds, gym, hydrotherapy, part of a group, physical 
abilities, organisation, and staff. A score of 10 represented the 
most positive view towards that question, and scores less than 7 
depicted areas of dissatisfaction. 
Groess 2008 Cohort study.  Veteran patients with CLBP > 
6 months attending a clinical 
yoga program. 
Clinical yoga program. 49 Patients rated health benefits received from the yoga program, 
their yoga instructor, and the ease of participation on 0-10 visual 
analogue scales (0 being the worst and 10 indicating more 
satisfaction). 
Haas 2005 Cohort study. Patients with a primary 
complaint of CLBP of 
mechanical origin. 
Chiropractic / medical care. 837 Patient satisfaction was evaluated on a 100-point scale, with 
higher scores indicating greater patient satisfaction. 
 Page 90 of 458 
Study
*
 Design Participants Treatments/Intervention n Satisfaction Outcome Measures 
Hazard 1994 Cohort study. Patients with CLBP, minimum 
4 months work loss from back 
pain and absence of a clear, 
surgically correctable lesion. 
Functional restoration and 
behavioural support. 
90 Global treatment satisfaction questions. Scales ranged from 
0=least satisfaction to 10=most satisfaction. No further details 
provided. 
Holm 2003 Before-and-after 
study. 
Patients with CLBP. None specified. [Possible 
enrolment into an RCT to 
compare conservative 
treatment and spinal infusion]. 
42 Back satisfaction was measured using a single question designed 
to measure patients‘ overall back disability today.It was designed 
originally for a study to evaluate patients after shoulder surgery. 
Katz 2005 RCT. Patients with CLBP ≥ 3 months 
or more. 
Bupropion sustained release 
(anti-depressant medication) / 
placebo. 
60 Global satisfaction with pain relief item using Likert-type scale 
responses (1=very dissatisfied, 2=dissatisfied, 3=neither 
dissatisfied nor satisfied, 4=satisfied, 5=very satisfied). 
Licciardone 
2003 
RCT. Patients with >3 months of 
constant or intermittent, non-
specific CLBP. 
Osteopathic manipulative 
treatment / chiropractic 
manipulation / no intervention 
control group who continued 
their usual care. 
91 Global satisfaction question using Likert-type scale responses. 
Higher scores represent less satisfaction with back care. No 
further details provided. 
Macario 2008 Before-and-after 
study. 
Patients with chronic 
discogenic LBP > 12 weeks 
Spinal decompression using 
DRX9000 
94 Global satisfaction question: ‗How satisfied were you with 
DRX9000 treatment?‘ Response scale ranged from 0=Not 
satisfied to 10 very satisfied. 
Mannion 1999 RCT. Patients with >3 months of 
continual or recurrent episodes 
of CLBP. 
Physiotherapy / muscle 
reconditioning using training 
devices / low-impact aerobics. 
148 Study-specific questionnaire exploring patient satisfaction with 
therapy. Items were: 1) ‗Happy with group to which randomised‘, 
2) ‗Impression changed during therapy‘, 3) ‗Enjoyed coming to 
therapy‘, 4) ‗Recommend therapy to others with similar 
problems, 5) ‗Continue with this therapy if given the chance‘, 6) 
‗Therapist competence‘, 7) 8) Therapist friendliness‘, 9) 
‗Therapist advice in performing everyday tasks‘, and 10) 
Therapist interest in patient and their back problems‘. 
Responses involved various Likert-type scales ranging from 1 to 
5 (e.g. 1 = disappointed, 3=indifferent, 5=satisfied, or 
1=worsened, 3=unchanged, 5=improved). 
Molinari 2001 Cohort study. Servicemen with CLBP history 
≥ 1 year. 
Instrumented posterior lumbar 
interbody fusion surgery / non-
operant treatment. 
14
†
 Three satisfaction questions scored on a 16-point scale with 15 
representing maximum satisfaction and 0 representing total 
dissatisfaction. Scores totalled to provide an overall procedure 
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Study
*
 Design Participants Treatments/Intervention n Satisfaction Outcome Measures 
satisfaction score. No further details provided. 
Niemisto 2005 RCT. Patients with CLBP (with or 
without sciatica). 
Multidisciplinary 
(chiropractic/exercise/GP)  
/ GP care. 
204 Satisfaction with care. No further details provided. 
Norris 2008 RCT. Patients with CLBP > 3 months 
under the care of a private 
physiotherapy company. 
Integrated back stability 
programme / control.  
59 Eight study specific questions explored patients experience and 
includuing an item: ‗Taking into account all your daily activities, 
your level of pain, and your functional impairment, do you 
consider that your current state is satisfactory?‘ Responses 
involved marking a line between a 7-point bipolar rating scales. A 
score of 7 indicated the maximum positive experience, a score of 
1 the maximum negative, and a score of 4.5 indicated a neither 
positive nor negative experience. 
Nyiendo 2001  Cohort study. Patients with CLBP > 6 weeks. Chiropractic / medical care. 835 The Cherkin and MacCornack satisfaction questionnaire (Cherkin 
& MacCornack, 1989) administered by telephone and mailed at 
follow-up. Items covered: Doctor‘s concern, doctor‘s confidence 
and patient‘s confidence. The response scale ranged: ‗very 
satisfied‘, ‗satisfied‘, ‗neutral‘, ‗dissatisfied‘ and ‗very 
dissatisfied‘. 
Nyiendo 2000 Cohort study. Patients with recurrent CLBP ≥ 
6 weeks. 
Chiropractic / medical care. 138 Nine-question telephone interview modelled on the Cherkin and 
MacCornack satisfaction questionnaire (Cherkin & MacCornack, 
1989) and a study specific mailed questionnaire for follow-up. 
Items included patient‘s assessment of physician‘s concern, 
patient‘s impression of physician‘s confidence, and patient‘s own 
level of comfort, scored on a scale of 1=strongly disagree to 5= 
strongly agree. Satisfaction with information, treatment and 
overall medical care were scored on a scale of 1 = very satisfied 
to 5 = very dissatisfied. 
Pincus 2000 Before-and-after 
study. 
Patients with CLBP > 3 
months. 
GP / osteopath. 60 Adapted questionnaire used to assess patient satisfaction among 
the chronically ill (Linn & Greenfield, 1982). Three subscales 
were included: 1) competence (training, diagnosis, thoroughness 
in examination and tests, planning treatment), 2) quality of care 
(personal relationships, listening, caring), and 3) efficacy 
(improvement in health, reduction in symptoms). Each subscale 
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Study
*
 Design Participants Treatments/Intervention n Satisfaction Outcome Measures 
was measured on a 7-point scale, with anchors (extremely 
dissatisfied/extremely satisfied). A score of global satisfaction 
with back-pain management was also obtained. 
Rainville 1997 Cohort study. Patients with CLBP > 4 
months. 
Exercise and spine 
rehabilitation. 
192 Patient satisfaction was assessed with a 10-item questionnaire 
covering scheduling, business services, physician services, 
therapist services, team-work, communication, education, home 
exercise instruction, quality of care, and effectiveness of care. 
Responses ranged from 1=excellent, 2=very good, 3=good, 
4=fair, and 5=poor. Responses to the 10 questions were totaled. 
Shirado 2005 Cohort study. Patients with CLBP > 4 months 
who attended a low back 
school. 
Back school – 
multidisciplinary team. 
182 Global satisfaction question using 4 response categories: very 
satisfied, satisfied, not satisfied and not disappointed (equal), 
unsatisfied. 
Smeets 2006 RCT. Patients with non-specific 
CLBP > 3 months. 
Active physical treatment / 
cognitive-behavioural therapy / 
combined treatment / waiting 
list control group. 
223 Treatment satisfaction was measured by using a 100mm visual 
analogue scale for the overall treatment provided to the patient.  
Torstensen 
1998 
RCT. Patients with CLBP sick-listed 
for more than 8 weeks and less 
than 52 weeks. 
Medical exercise therapy / 
conventional physiotherapy / 
ordinary activity level. 
208 Treatment satisfaction questions rated on a 4-point scale: 
1=completely satisfied, 2=partly satisfied, 3=not satisfied and 
4=dissatisfied. No further details provided. 
Wallace 2009 Cross-sectional 
survey. 
Patients with CLBP and 
activity limitations every day 
for the previous 3 months. 
None specified. 624 Six dichotomous (yes/no) questions were used to assess patients‘ 
satisfaction with their most recent provider for CLBP. The 
questions were: 1) ‗Were you satisfied with your contact with the 
doctor or practitioner?‘ 2) Did you have an adequate explanation 
of your problem?‘ 3)  ‗Did you feel he/she was concerned about 
you?‘ 4) ‗Did you feel he/she understood what was bothering 
you?‘ 5) Did the doctor or practitioner spend enough time with 
you?‘ 6) Would you want to see the same doctor or practitioner 
the next time you see a practitioner for your back problem?‘ 
Patients who gave affirmative answers to all six questions were 
identified as ‗satisfied‘ with their last visit (dichotomous 
dependent variable of satisfied or not satisfied). 
*
Only first author reported; † n for comparative group/s not included; RCT: Randomised controlled trial. 
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Table 5: Quality of Included CLBP Studies 
 
Study
*
 Explicit 
a priori 
aims 
Definition of 
population 
under 
investigation 
Sample 
size 
calculation 
Justification 
that sample is 
representative 
of population 
Inclusion/ 
exclusion 
criteria 
Demographic 
details 
Justification 
of reliable/ 
valid 
satisfaction 
instruments 
Original 
item/ 
questionnaire 
Response/ 
dropout 
rate  
specified 
Discussion of 
generalisability 
Total Score
**
 
Barker 
2008 
+ + + - + + + - + - 7/10 
Buchner 
2006 
+ + - - + + + - - - 5/10 
Buchner 
2007 
+ + - - + + - 
+ + - 6/10 
Buchner 
2007 
+ + - - + + + - + - 6/10 
Carey 1998 + + - - + + - + + - 6/10 
Chown 
2008 
+ + - - + + + + + - 7/10 
Goodwin 
2000 
+ + - - + + - + - - 5/10 
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Study
*
 Explicit 
a priori 
aims 
Definition of 
population 
under 
investigation 
Sample 
size 
calculation 
Justification 
that sample is 
representative 
of population 
Inclusion/ 
exclusion 
criteria 
Demographic 
details 
Justification 
of reliable/ 
valid 
satisfaction 
instruments 
Original 
item/ 
questionnaire 
Response/ 
dropout 
rate  
specified 
Discussion of 
generalisability 
Total Score
**
 
Groessi 
2008 
+ + - - - + + + + - 6/10 
Haas 2005 + + - - + + + - + + 6/10 
Hazard 
1994 
+ - - - + + - + + - 5/10 
Holm 2003 + - - - + + + - + - 5/10 
Katz 2005 + + + - + + + - + - 7/10 
Licciardone 
2003 
+ - - - + + - + + + 6/10 
Macario 
2008 
+ + + - + + - + + - 7/10 
Mannion 
1999 
+ - - - + + - + + - 5/10 
Molinari 
2001 
+ + - - + - - - - - 3/10 
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Study
*
 Explicit 
a priori 
aims 
Definition of 
population 
under 
investigation 
Sample 
size 
calculation 
Justification 
that sample is 
representative 
of population 
Inclusion/ 
exclusion 
criteria 
Demographic 
details 
Justification 
of reliable/ 
valid 
satisfaction 
instruments 
Original 
item/ 
questionnaire 
Response/ 
dropout 
rate  
specified 
Discussion of 
generalisability 
Total Score
**
 
Niemisto 
2005 
+ + - - + + + - - - 5/10 
Norris 
2008 
+ + - - + - + + - - 5/10 
Nyiendo 
2001 
+ + - - + - + - + - 5/10 
Nyiendo 
2000 
+ - - - + + - + + - 5/10 
Pincus 
2000 
+ + - - + + + - - + 6/10 
Rainville 
1997 
+ - - - + + - + + - 5/10 
Shirado 
2005 
+ + - - + + + + + - 7/10 
Smeets 
2006 
+ + + - + + - + + - 7/10 
Torstensen + + + - + + - + + - 7/10 
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Study
*
 Explicit 
a priori 
aims 
Definition of 
population 
under 
investigation 
Sample 
size 
calculation 
Justification 
that sample is 
representative 
of population 
Inclusion/ 
exclusion 
criteria 
Demographic 
details 
Justification 
of reliable/ 
valid 
satisfaction 
instruments 
Original 
item/ 
questionnaire 
Response/ 
dropout 
rate  
specified 
Discussion of 
generalisability 
Total Score
**
 
1998 
Wallace 
2009 
+ + - - + + - + + - 6/10 
TOTAL 26/26 20/26 5/26 0/26 24/26 21/26 13/26 16/26 19/26 3/26 - 
 
 
*
Only first author reported    + Present - Absent 
**
If study met all criteria, total score 10 points 
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3.4.4 Design 
The majority of studies were longitudinal cohort designs (39%, n=10) (Buchner, 
Neubauer, Zahlten-Hinguranage, & Schiltenwolf, 2007; Carey et al., 2000; Groessl et al., 
2008; Haas et al., 2005; Hazard, Haugh, Green, & Jones, 1994; Molinari & Gerlinger, 
2001; Nyiendo et al., 2000; Nyiendo, Haas, Goldberg, & Sexton, 2001; Rainville, Sobel, 
Hartigan, & Wright, 1997; Shirado et al., 2005). Others were randomised controlled trials 
(31%, n=8) (Barker et al., 2008; Katz, Pennella-Vaughan, Hetzel, Kanazi, & Dworkin, 
2005; Licciardone et al., 2003; Mannion et al., 1999; Niemisto et al., 2005; Norris & 
Matthews, 2008; Smeets et al., 2006; Torstensen et al., 1998), before and after studies (See 
for example, Macario, Richmond, Auster, & Pergolizzi, 2008) and cross-sectional surveys 
(See for example, Wallace, 2009). 
3.4.5 Samples 
All but one study specified the definition or diagnostic criteria used for CLBP 
(Nyiendo et al., 2001), but the criteria used to select CLBP populations varied. One 
potential consequence of small differences in diagnostic criteria is large differences in 
selected populations. 
3.4.6 Descriptive and Inferential Statistical Analyses 
All the studies included in this review used both descriptive and inferential 
statistics for statistical analyses. Descriptive statistics are concerned with the presentation, 
organisation, and summarisation of data (Norman & Streiner, 1994). Common descriptive 
statistics used in patient satisfaction with treatments in CLBP studies included measures of 
central tendency such as mean, median, and mode, and measures of dispersion such as 
range, minimum, maximum, and standard deviation.  
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Inferential statistics enable generalisation from a sample of data to a larger group of 
individuals (Norman & Streiner, 1994). Common inferential statistics used in patient 
satisfaction with treatments in CLBP studies included regression analyses (See for 
example,Mannion et al., 1999), analysis of variance (See for example, Licciardone et al., 
2003; Mannion et al., 1999; Nyiendo et al., 2001),  and chi
2
 test (See for example, 
Licciardone et al., 2003). 
3.4.7 Definitions and Conceptual Frameworks of Patient Satisfaction with Treatments 
in CLBP 
Of the 26 studies included in this systematic review, none operationally defined 
patient satisfaction or dissatisfaction with treatments in CLBP, or proposed a conceptual 
framework or model of what comprises patient satisfaction with treatments. Often, there 
appeared to be no distinction between satisfaction and dissatisfaction, and the way that 
satisfaction and dissatisfaction were measured generally implied equality between the 
concepts. Further, none of the studies stated how the concepts were used, although 
sometimes this could be inferred. For example, no study discussed whether satisfaction 
was considered an independent or dependent variable, and studies did not state whether the 
concept was perceived as uni-dimensional or multidimensional but this information could 
be extrapolated from closer observation of the measures used or statistical analyses.  
3.4.8 Questionnaires Used to Measure Patient Satisfaction with Treatment in CLBP 
All 26 studies reported satisfaction data from patients‘ perspectives, all using a 
patient-reported assessment. There were three studies that used a telephone interview 
which may have influenced results because for example, even with pre-specified responses 
it required interpretation of responses for coding (Nyiendo et al., 2000; Nyiendo et al., 
2001; Carey et al., 2000).  
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Based on the findings of this systematic review, there is no consensus or ‗gold 
standard‘ for measuring treatment satisfaction or dissatisfaction in CLBP.  The Cherkin 
and McCornack Satisfaction Questionnaire was used in 8% of studies (n=2) (Nyiendo et 
al., 2000; Nyiendo et al., 2001). This instrument covers aspects relevant to patients‘ 
satisfaction with care and contains 11 items (see section 3.4.9).  In addition, one study 
(Pincus et al., 2000) adapted a 27-item osteopathic and GP management satisfaction 
questionnaire originally developed by Linn & Greenfield (1982). One important 
consideration is that the adapted 27-item questionnaire was originally developed in patients 
with chronic illness and further details are not provided regarding for example, types of 
chronic illness and number of patients, if any, with CLBP which is the focus of this thesis. 
Whilst there are some similarities between patients with CLBP and those with other 
chronic indications (such as that they may both experience pain which may cause some 
form of disability), there may be key differences. For example, someone with chronic pain 
induced from having for example, cancer, may have a very different experience of pain, or 
may rationalise their pain and any limitations they experience in the context of survival, 
whereas an individual with CLBP may not face issues related to survival and therefore may 
perceive their pain and its impact on daily activities very differently.  
In addition, five studies used study specific questionnaires (Carey et al., 2000; 
Goodwin & Goodwin, 2000; Mannion et al., 1999; Molinari & Gerlinger, 2001; Rainville 
et al., 1997). See Table 4 for details on the content of satisfaction items or factors. In 
general, these study-specific questionnaires measured satisfaction with various components 
of treatment such aspects of the therapeutic relationship or a particular rehabilitation 
programme. Also, the content was usually unidimensional measurement and so many 
aspects of treatment satisfaction related to the focus of this thesis were omitted such as 
satisfaction with the treatment process (e.g. involvement in treatment decisions), and often 
minimal details were provided. 
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Further, satisfaction assessments differed in the number of items included, and the 
rating scales. Notable examples include studies that measured patient satisfaction modelled 
on the Cherkin & MacCornack satisfaction questionnaire and a 5-point Likert-type scale 
(Nyiendo et al., 2000; Nyiendo et al., 2001), and 13 studies that used a single global 
satisfaction item of various kind (Barker et al., 2008; Buchner et al., 2006; Buchner et al., 
2007; Buchner et al., 2007; Barker et al., 2008; Hazard et al., 1994; Holm, Friis, Storheim, 
& Brox, 2003; Katz et al., 2005; Licciardone et al., 2003; Macario et al., 2008; Shirado et 
al., 2005; Smeets et al., 2006; Torstensen et al., 1998). Closer examination of the global 
satisfaction items revealed the diversity between studies using satisfaction ratings, since 
they focused on different aspects of CLBP and its treatment. For example, one global 
satisfaction rating was specific to pain relief (Katz et al., 2005) while another measured 
back satisfaction (Holm et al., 2003).  
In fact, this potential problem was not just limited to global satisfaction ratings and 
CLBP studies appear to assess satisfaction with many different aspects ranging from pain 
relief (Katz et al., 2005), back satisfaction (Holm et al., 2003), satisfaction with the 
rehabilitation programme (Goodwin & Goodwin, 2000), satisfaction with therapy 
(Buchner et al., 2006; Buchner et al., 2007; Buchner et al., 2007; Mannion et al., 1999), 
and satisfaction with care (Carey et al., 2000). This makes comparisons between studies 
particularly difficult. 
In addition, the response scales also varied for global satisfaction assessments from 
5-point Likert-type scales (See for example, Buchner et al., 2006; Buchner et al., 2007; 
Buchner et al., 2007), to scales that ranged from 0-10 or 0-100 (See for example, Groessl et 
al., 2008; Haas et al., 2005) where higher scores indicate a level of satisfaction. Some 
global satisfaction assessments had 4 categorical options such as ‗very satisfied‘, 
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‗satisfied‘, ‗not satisfied and not disappointed‘, and ‗unsatisfied‘ (See for example, Shirado 
et al., 2005).  
Comparing satisfaction results across these 26 studies is complicated because the 
studies did not focus on satisfaction and because the design of the studies and measurement 
of satisfaction varied so greatly.  However, some key points did emerge when the 
satisfaction results were compared, as shown in Table 6.  Most studies reported a positive 
level of satisfaction. Nevertheless, it is not apparent from this review whether these 
positive results were a true reflection of patients‘ scores or if some have ceiling effect 
(perhaps a consequence of the way studies measured satisfaction). Also, in general, 
chiropractic care appeared to be favoured by patients over medical care (Nyiendo et al., 
2001; Nyiendo et al., 2000).  
It should be noted that whilst there are numerous global ratings of satisfaction items 
used in CLBP studies, these generally require patients to average their opinion of for 
example, ‗satisfaction with therapy‘ into one single question at each timepoint. Chapter 2 
demonstrates the various aspects that may be related to patient satisfaction with treatment 
(e.g. information/knowledge provided, involvement in treatment decisions, therapeutic 
relationship, patient perceptions and experiences with treatment etc.) and therefore the 
appropriateness of global ratings could be questionable depending on the intended purpose. 
For example, can patients truly average all of that information into a single item, and if 
they can, is there consistency between patients in terms of what they consider in making 
their global evaluation? Whilst global ratings are brief and easily administered, the 
inconsistency incurred when patients make their assessments possibly based on different 
criteria,  may ultimately impact on reproducibility of scores (Feinstein, 1987). In addition, 
global ratings of satisfaction are subject to ceiling effects and can disguise or hide aspects 
of dissatisfaction (Lebow, 1974; Locker & Dunt, 1978). Further, global ratings are 
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generally known to be less informative than for example, disease-specific or treatment-
specific questionnaires which are multidimensional (Locker & Dunt, 1978; Hudak & 
Wright, 2000). Consequently, global rating assessments are sometimes used to aid 
interpretation.  This notion is documented in the FDA PRO guidance which recommends 
the use of global ratings in general (not specific to treatment satisfaction) to help 
interpretation by the definition of responders (Food and Drug Association, 2009). 
Therefore, although a global rating of treatment satisfaction may in general not be suitable 
as an only assessment, it may be helpful in some studies in addition to other measures to 
aid interpretation of results. 
Table 6: Patient Satisfaction Data in Included CLBP Studies 
Study
*
 Positive (+) Satisfaction Data Neutral (0) 
Satisfaction Data 
Negative (-) Satisfaction 
Data 
Barker 
2008 
In the FairMed group, 27% of patients 
stated that they were more able to 
cope with pain at 3weeks; in the 
TENS group, it was 45%.  
73% of the FairMed 
participants stated no 
change in their ability 
to cope with pain 
compared to 44% in the 
TENS group. 
11% of TENS group 
participants stated that 
they were less able to cope 
with pain at 3 weeks. 
Buchner 
2006 
  Using a 5-point Likert 
scale, the mean 
satisfaction with therapy 
score for patients with 
CLBP was 2.85 (SD ± 
1.61). 
Buchner 
2007 
 Using a 5-point Likert-
type scale, satisfaction 
with therapy scores 
between the three age 
groups ranged from 
3.10 to 3.48 (SD ± 1.43 
to 1.58) at 6 month 
follow-up.Results 
between different age 
groups were not 
statistically significant. 
 
Buchner 
2007 
 Using a 5-point Likert-
type scale, satisfaction 
with therapy scores 
between the three 
groups of chronicity 
ranged from 3.13 to 
3.45 (SD ± 1.40 to 
1.58) at 6 month 
follow-up. Results 
between groups of 
chronicity were not 
statistically significant. 
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Study
*
 Positive (+) Satisfaction Data Neutral (0) 
Satisfaction Data 
Negative (-) Satisfaction 
Data 
Carey 2000 At 22 months, patients were asked 
about their overall satisfaction with 
care. Care was rated as ‗very good‘  
or ‗excellent‘ by 25% of patients with 
unremiting CLBP compared to 38% 
of those with remitting CLBP. 
  
Chown 
2008 
Results on the 5-point Likert-type 
scale were collapsed. At baseline, the 
majority of patients were 
‗somewhat/very satisfied‘ with group 
exercise, physiotherapy and 
osteopathy: 39%, 42%, and 40% , 
respectively. The proportion of 
patients stating ‗somewhat satisfied‘ 
or ‗very satisfied‘ with overall 
medical treatment increased for all 
treatment groups (group 
exercise/physiotherapy/ osteopathy) 
between baseline and 6 weeks. 63%, 
79%, 87%, respectively. 
  
Goodwin 
2000 
The following elements of the 
programme scored positively - above 
7 on 0-10 VAS scales: the 
introduction, understanding back pain, 
pain theories, open discussion about 
pain, ergonomics, exercise principles, 
stress and relaxation, gym, 
hydrotherapy, part of a group, 
physical abilities, psychological 
abilities, staff and organisation. 
 The following elements 
scored negatively - below 
7 on 0-10 VAS scales: 
healthy back video, sleep 
and beds, and mentoring. 
Groessl 
2008 
On VAS scales of 0-10, mean scores 
for the health benefits received from 
the yoga program, the yoga instructor, 
and the ease of participation were 
5.97, 9.09, and 6.03, with higher 
scores indicating more satisfaction. 
  
Haas 2005 On a scale of 0-100, results indicated 
that patients with CLBP receiving 
chiropractic care had significantly 
higher patient satisfaction than 
patients receiving medical care: mean 
86.4 SD 19.9 vs. mean 71.3 SD 22.7, 
respectively, p<0.01. 
  
Katz 2005 On a scale of 1 to, satisfaction with 
pain relief was 3.43 (SD 1.06) for 
patients receiving bupropion 
compared to 2.78 (SD 1.07) for 
patients receiving placebo. This 
difference reached statistical 
significance.  
  
Licciardone 
2003 
Both osteopathic manipulative 
treatment (p=0.001) and sham 
manipulation (p=0.02) participants 
reported significantly greater 
satisfaction with their back care than 
the no intervention control 
participants. 
 
 
  
 
Macario 
2008 
On a scale of 0 to 10, mean 
satisfaction scores with DRX9000 
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Study
*
 Positive (+) Satisfaction Data Neutral (0) 
Satisfaction Data 
Negative (-) Satisfaction 
Data 
treatment (for spinal decompression) 
was 8.55 (median 9, range 5 to 10). 
Mannion 
1999 
The majority of the patients declared 
their satisfaction on hearing which 
group they had been assigned to, and 
few of them changed their impression 
for the worse during the course of the 
treatment. This was observed for all 
three groups.  
  
Molinari 
2001
†
 
The non-operative group had an 
average satisfaction score of 9.6 of 15 
(SD 2.8). The operative group had an 
average satisfaction score of 13.9 of 
15 (SD 1.8). The difference in 
satisfaction scores between the groups 
reached statistical significance. 
  
Niemisto 
2005 
At 2 years, the combination group 
(receiving combined manipulation, 
stabilising exercises and physician 
consultation) had higher satisfaction 
with care compared to the 
consultation group. 
  
Norris 
2008 
Mean values of all patient satisfaction 
questions showed positive experience 
(>4.5 points). 
  
Nyiendo 
2001 
There was a sharp contrast favouring 
chiropractic in the proportion of 
patients that reported satisfaction with 
care at 1 year; the trend was apparent 
on all 10 satisfaction questions 
(p<0.0001). Differences between 
chiropractic and medical care were 
found in patients‘ confidence that the 
treatment was working (36% vs. 74%) 
and in the proportion of patients who 
would see a physician of the same 
type in the future for a CLBP problem 
(61% vs. 83%). For both groups, 
patients were least satisfied with 
‗sufficient information provided about 
the cause of their pain‘ (40% vs. 
73%).  
  
Nyiendo 
2000 
Satisfaction was higher for patients 
attending chiropractors than medical 
physicians. In particular, patients 
expressed greater satisfaction 
regarding information on treatment 
program provided, and overall 
medical care. 
  
Pincus 
2000 
Levels of satisfaction were high (for 
competence, quality of care, and 
efficacy) for GP management and 
osteopath; however, there were 
significantly higher scores for 
satisfaction with osteopathic treatment 
compared to GP treatment in the same 
surgery.  
  
Rainville 
1997 
Satisfaction scores were analysed 
according to types of compensation 
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Study
*
 Positive (+) Satisfaction Data Neutral (0) 
Satisfaction Data 
Negative (-) Satisfaction 
Data 
involvement (e.g. patients receiving 
Workers‘ Compensation, Social 
Securuity Disability, or private 
disability policy benefits). Where 
items scores ranged from 1to 10 
(excellent to poor), mean item and 
total satisfaction scores were similar 
between those with and without 
compensation involvement (16.4 and 
16.7, respectively). 
Shirado 
2005 
Eighty-five patients (48.6%) were 
satisfied with the back school 12 
months after enrollment. Fifty-eight 
patients (33.1%) were satisfied. 
Twenty patients 
(11.4%) were not 
satisfied/not 
disappointed (equal) 
with the back school 12 
months after 
enrolment. 
Twelve patients (6.9%) 
were 
unsatisfied/disappointed 
with the back school 12 
months after enrolment.  
Smeets 
2006 
Satisfaction scores for three different 
percentiles of the baseline Roland and 
Morris Disability Questionnaire 
(RMDQ) were presented. Satisfaction 
was significantly higher in the active 
physical therapy group compared to 
the waiting list control group when 
the patient had a lower level of 
functional limitations at pre-
treatment. For the ninetieth percentile 
score (RMDQ = 19) this difference 
was not significant. CBT and 
combined therapy showed a 
significantly higher level of 
satisfaction compared to the waiting 
list group, and the higher the baseline 
RMDQ-score, the greater this 
difference became. No differences 
were evident between CT and CBT.  
  
Torstensen 
1998 
A total of 34.2% (26 patients) in the 
medical exercise therapy group 
(MET), 32.2% (19 patients) in the 
conventional physiotherapy (CP) 
group, and 6 patients 9.5% (6 
patients) in the ordinary activity level 
group were ‗completey satisfied‘ with 
their treatment. Many patients were 
‗satisfied‘ with their treatment: 28 in 
the MET group, 21 in the CP group, 
and 24 in the ordinary activity group. 
There were 9 patients 
in the MET group, 14 
in the CP group, and 25 
in the ordinary activity 
group were ‗partly 
satisfied‘ with their 
treatment. 
There were 4 patients in 
the MET group, 5 in the 
CP group, and 8 in the 
ordinary activity group 
who were ‗dissatisfied‘ 
with their treatment. 
Wallace 
2009 
Atotal of 69% of the sample was 
completely satisfied with all elements 
of their care and 63% did not intend 
to seek care from another health-care 
provider. 
  
Number of 
studies 
21/24 5/24 5/24 
*
Only first author reported 
N.B. Hazard 2001/Holm 2003 are not included since papers document 
correlations/associations only. 
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3.4.9 An Overview of the Cherkin and MacCornack Questionnaire  
As mentioned previously, the Cherkin and MacCornack questionnaire has been 
used in two out of 26 CLBP studies and therefore warrants further exploration (see section 
3.4.8). On closer examination of the development paper (Cherkin et al., 1991), the 
questionnaire contains 11 items and was compiled to measure patient satisfaction with care 
for LBP rather than treatment satisfaction for CLBP. Firstly, the nature of patient 
satisfaction with care is a much broader and all-encompassing concept than treatment 
satisfaction (see sections 2.2.1 and 2.2.2). Also, patients with LBP include those with 
acute, subacute, and chronic pain (see section 1.1). Those with for example acute pain may 
have very different experiences compared to those with chronic pain both in terms of the 
clinical nature of their pain and its impact on daily functioning, as well as the management 
of pain (Grichnik & Ferrante, 1991), and therefore aspects of treatment satisfaction could 
also be very different. For example, acute pain is often incurred by a specific injury or 
disease, whereas, chronic pain may or may not emerge as a consequence of an injury and is 
often related to psychological states. Consequently, the treatment for acute pain is usually 
to target the underlying cause whereas chronic pain often requires a multidisciplinary 
approach (see section 1.5). 
The Cherkin and MacCornack questionnaire was administered by telephone two to 
four weeks after patient‘s back pain visit. The process involved the interviewer reading 17 
statements to patients about the care they had received from their physician. This method is 
not ideal given the potential bias that could be incurred in for example the way that 
statements are read to patients, as well as social desireability bias due to  patient‘s desire to 
please the interviewer (Sitzia & Wood, 1997).  
The items of the questionnaire covered information adequacy, physician caring, and 
technical quality of care, and were developed based on another study which indicated 
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family physician‘s and chiropractor‘s perceptions regarding patients concerns about care 
(Cherkin & MacCornack, 1989). Therefore, the items were developed based on clinical 
expert opinion rather than patient‘s perceptions. Whilst the family physicians and 
chiropractors may have been involved in the day-to-day management of patients with LBP 
and therefore well informed of the daily challanges patients may face, developing a 
questionnaire informed by HCPs rather than patients (or perhaps both) may have resulted 
in missing important concepts.   
Also, as mentioned in section 2.5.4 the qualitative research that emerges from 
patient interviews or focus groups allows reviewers to establish whether topics were 
omitted during instrument development that may have been important to patients. Using 
information from patient qualitative research also allows developers to check the phrasing 
of questions to ensure that they are meaningful to patients (Weaver et al., 1997). However, 
this level of information was not documented in the development paper of the Cherkin and 
MacCornack Questionnaire. 
In the development paper there are also no details given regarding the actual 
questions asked to family physicians, or how item generation was actually performed. 
Also, it appears that that there were no cognitive debriefing exercises or pilot testing to 
establish whether patients truly understood what was required of them from each question. 
Cognitive debriefing would have provided further support for the face and content validity 
of the questionnaire and allowed an opportunity to pilot test the questionnaire including 
generating evidence to support that the response options are meaningful to patients and 
suitable for each item.   
Item responses were on a Likert-Type scale from ‗strongly agree‘ to ‗strongly 
disagree‘. Factor analysis was performed which yielded three subscales labelled: 
Information, Caring, and Effectiveness. However, the development paper does not 
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document the percentage of variance that each factor contributed. Also, there is no clear 
indication of why three factors were extrapolated (for example, there is no scree plot or 
descriptive information to show the eigenvalues), and the factor loading matrix is not 
presented.  
In addition, whilst Chronbach‘s alpha was performed for three subscales and results 
exceeded Nunnally‘s threshold of 0.70, and the construct validity of the scales were 
explored by correlating the scale scores with variables one would expect to be associated 
with patient satisfaction (all of which were statistically significant), the psychometric 
properties were not explored any further e.g. discriminant validity and test-retest reliability. 
In addition, there was no attempt to show that the questionnaire was sensitive to change 
over time.  
With the above in mind, whilst the Cherkin and MacCornack Questionnaire has 
been used in clinical practice to inform treatment decision making for chiropractic care in 
patients with LBP, there is insufficient evidence from the development paper to support its 
utility and adequacy as a measure of treatment satisfaction in patients with CLBP receiving 
medication and/or physiotherapy.  
3.4.10 Factors Associated with Patient Satisfaction 
Four studies documented how satisfaction was related to other concepts (Hazard et 
al., 1994; Wallace et al., 2007; Nyiendo et al., 2001; Pincus et al., 2000). Factors 
associated with satisfaction included: 
 pain (Hazard et al., 1994) 
 disability (Hazard et al., 1994) 
 age (Pincus et al., 2000) 
 employment status (Hazard et al., 1994) 
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 narcotic use (Wallace et al., 2007) 
 doctor type (Nyiendo et al., 2001) 
One study also reported factors that did not seem to be associated with satisfaction 
(Pincus et al., 2000). These were: osteopath‘s competence, quality of care, efficacy, and 
number of appointments, demographic characteristics (sex, work status, and ethnicity), and 
psychological factors (depression, anxiety and coping style). However, there were mixed 
results between studies. For example, whilst Hazard (1994) found an association between 
satisfaction and pain/disability, Pincus (2000) found no association between satisfaction 
and symptoms including duration, pain intensity and disability. 
3.5 Discussion  
3.5.1 Summary 
The last Chapter provides an overview of patient satisfaction and dissatisfaction in 
general. In this Chapter, this study investigated patient satisfaction and dissatisfaction with 
treatments for CLBP. There were five specific objectives discussed below.  
The first objective was to establish definitions and conceptual frameworks or 
models of satisfaction and dissatisfaction with treatments in CLBP, including whether 
satisfaction was a uni-dimensional or multi-dimensional concept, and whether it had been 
used as a dependent or independent variable. Results indicated that there are few data in 
the literature concerned with patients‘ satisfaction with treatments for CLBP.  Of the 
studies that exist, none focused on operationally defining the concept or establishing 
whether the concept is uni-dimensional or multi-dimensional. Consequently, there is a 
need to establish conceptually what patient satisfaction and dissatisfaction with treatments 
in CLBP is and how it relates to other concepts such as adherence.  
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The second objective of this study was to identify factors associated with treatment 
satisfaction or dissatisfaction in CLBP. Whilst there were some associations identified, 
there were mixed results between studies. For example, whilst Hazard (1994) found an 
association between satisfaction and pain/disability, Pincus (2000) found no association 
between satisfaction and symptoms including duration, pain intensity and disability. 
Therefore, further research is warranted to establish with greater certainity factors 
associated with the treatment satisfaction or dissatisfaction. 
The third objective was to provide an overview of questionnaires used to measure 
treatment satisfaction or dissatisfaction. The Cherkin and MacCornack questionnaire was 
the most popular satisfaction assessment having been used in 2 out of 26 studies (8%). 
However, none of the studies including those who used the Cherkin and MacCornack 
Satisfaction questionnaire, provided rationale for its utility. Further, although the domain 
coverage and content of questionnaires were often briefly described, the psychometric 
properties of the instruments used were not documented. Thus it is questionable whether 
the studies were really assessing treatment satisfaction in CLBP or some other concept.  
The Cherkin and MacCornack questionnaire had been used in two studies. Closer 
reflection of the questionnaire indicated that it was developed to measure patient 
satisfaction with family physician and chiropractic care in LBP rather than treatment 
satisfaction in CLBP. Further, it was developed using clinical expert opinion rather than 
patient input and there was no information regarding how the items of the questionnaire 
were developed. The questionnaire had not been cognitively debriefed or piloted with 
patients. Further, whilst there was some attempt to perform factor analysis of the items of 
the questionnaire, the information in the papers was insufficient to establish the 
appropriateness of the analyses and decisions made. Moreover, whilst there was some 
evidence of internal consistency and concurrent validity, there were no details regarding 
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discriminant validity, test-retest reliability or sensitivity to change over time. Since no 
comprehensive and well developed instrument measuring treatment satisfaction in patients 
with CLBP could be found in the literature, there is a need to construct and validate one 
whose items are developed using rich qualitative interviews with patients with CLBP, with 
explicit details regarding the open-ended questions posed to patients, how the qualitative 
analyses were performed, and then cognitively debriefing the questionnaire in patients with 
CLBP. Following this, psychometric testing should be performed to confirm that 
questionnaire is truly measuring treatment satisfaction. 
The fourth objective was to establish the quality of satisfaction studies. The designs 
used varied from the lower levels of the hierarchy of evidence, such as cohort studies, to 
the higher levels, such as double blind prospective randomised controlled trials (RCTs).  
While such longitudinal designs could be used to assess, for example, change in 
satisfaction scores over time, such data were rarely reported.  When testing the clinical 
efficacy of treatment, several factors should be considered. Amongst the most important to 
patients are pain and functional impairment which are often primary and secondary 
endpoints in studies. The limited satisfaction data may in part demonstrate a lower priority 
placed on the patient‘s perspective. However, assessing treatment satisfaction as a 
supportive endpoint is also important given that it is associated with adherence to 
treatment, which in turn is likely to impact efficacy and therefore pain and functional 
impairment.  Further, the mixed quality of studies makes comparisons and generalisations 
problematic.  
Finally, the fifth objective was to establish the level of patient satisfaction or 
dissatistfaction with treatments in CLBP. What data there are to examine patient 
satisfaction with treatments in CLBP, illustrate predominantly positive but some negative 
attitudes towards treatment.  The positive finding of the majority of studies suggests that 
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such studies may be susceptible to the Hawthorne effect, since often data collection was 
within a clinical setting. Therefore, participants may have responded in a way they hoped 
would give them a preferred image in the eyes of the researcher.  Future research should 
implement strategies to minimise such biases, such as conducting the study in a non-
clinical setting, or being interviewed by an independent researcher who is not informed of 
the primary aims of the study, thereby enabling a more ‗real‘ measure of patient 
satisfaction. 
This systematic review suggests that there appears to have been no conscious 
efforts to distinguish between satisfaction and dissatisfaction, and to date the way that 
satisfaction and dissatisfaction have been measured generally imply equality between the 
concepts. However, these issues warrant further exploration based on rich qualitative data 
that emerge from in-depth interviews with patients who have CLBP, as well as clinician 
and researcher insights. In addition, there is a need to develop a valid and reliable measure 
of satisfaction with treatments in CLBP that is also based on rich qualitative data from in-
depth patient interviews.  Using this valid measure, further research could test hypotheses 
regarding factors associated with patient satisfaction and dissatisfaction.  
3.5.2 Strengths and Limitations 
It is important to acknowledge that the findings of this literature review are based 
predominantly on published studies found by searching electronic databases, such as 
PUBMED and PsycINFO, as well as from selective hand searches. Other instruments that 
measure patient satisfaction with treatment in CLBP may exist, and which were not part of 
this review. 
Further, meta-analyses could not be performed in this literature review due to 
insufficient data and the diversity of study designs. However, the literature review was 
conducted systematically; the inability to perform meta-analyses does not diminish the 
 Page 113 of 458 
robustness of the interpretation of the findings and the recommendations made. Thus, this 
literature review has fulfilled its purpose in providing an overview of treatment satisfaction 
and dissatisfaction in CLBP including consensus around satisfaction definitions, and 
whether good questionnaires exist to quantify the concept. 
3.5.3 Conclusions 
It is important to comprehensively assess patients‘ satisfaction with treatment in 
both routine clinical practice and CLBP clinical trials and surveys.  Current instruments are 
not based on an operational definition of what constitutes patient satisfaction with 
treatment or a conceptual framework that clarifies relationships among the complex set of 
factors associated with this concept. Though the well-regarded Cherkin and McCormack 
Satisfaction Questionnaire has been used in two studies to assess satisfaction with overall 
care and treatment, the studies did not justify its use as a measure nor did they define 
patient satisfaction. Further, in cases where assessment tools have been used, the 
psychometric properties have rarely been reported and documented as they relate to 
patients with CLBP.   
The findings of this systematic literature review highlight the need to develop an 
instrument specific to patient satisfaction with treatments in CLBP, that is based on a 
standard operational definition and a conceptual framework, and that has good 
psychometric properties. As outlined in Chapters 4-6, development and psychometric 
validation of such an instrument is currently underway.  
Quantifying patient satisfaction allows health professionals to target aspects of 
patients‘ treatment that distress them (such as experiencing side effects), and therefore may 
assist in the improvement and maintenance of the patient‘s health.  Moreover, analysing 
patient satisfaction with medication could indicate if best practice is being carried out 
(such as whether patients feel involved in treatment decisions, or if side effects are 
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effectively managed by healthcare professionals) and provide a point of reference for 
clinical practice and future research. Finally, by reliably and validly measuring patient 
satisfaction and dissatisfaction with treatments in CLBP, analyses can be performed to 
explore how the concept is related to other concepts such as health-related quality of life 
and adherence to treatment regimens. 
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Chapter 4 - Study II – Treatment Satisfaction and Dissatisfaction in 
Patients with Chronic Low Back Pain: A Qualitative Study 
The initial objectives of this study were to explore patients‘ subjective experiences 
with CLBP and its treatments, and their satisfaction and dissatisfaction with treatments. 
The researcher (DR) also planned to use the rich qualitative data extrapolated from 
interviews to develop a new instrument to assess satisfaction and dissatisfaction with 
treatment (medication and physiotherapy) for CLBP relief (see Chapter 5). 
4.1 Introduction 
The ultimate objective of the study was to obtain rich qualitative data to develop a 
disease-specific (CLBP) questionnaire that measures patient satisfaction and dissatisfaction 
with treatments (medication and/or physiotherapy). With this in mind, the purpose of the 
semi-structured interviews was to gain insight into and understand the subjective 
experiences of patients with CLBP receiving treatment (medication and/or physiotherapy) 
naturalistically –   that is, to collect qualitative data based on spontaneous responses to 
open-ended questions rather than using pre-specified codes, summaries, or probes (Willig, 
2001).  
There are a number of different methods of sampling for qualitative research; these 
include convenience samples (the least rigorous method, also known as accidental 
sampling), theoretical sampling (Marshall, 1996) whereby ideally, the process of data 
collection and conceptualisation in qualitative research continues until ‗saturated‘, that is, 
new data does not add to the developing theory (Guest, Bunce, & Johnson, 2006), and 
purposive sampling (also known as judgement sample), which is the most common. In 
qualitative research, purposive sampling is intended to enhance understandings of 
experiences encountered by individuals or a particular group of individuals. With 
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purposive sampling, the intention is to select particular cases (e.g. individuals or groups) 
that provide the best insights to help address the research question (Devers & Frankel, 
2000). There are many different strategies that can be employed for purposive sampling 
including but not limited to extreme case sampling (using cases that are rich in detail 
because they are unusual or specific in some way), maximum variation sampling (captures 
key themes across participant variations such as individuals of different age, gender, and 
employment), and homogenous sampling (identifies a small sample with similar traits to 
describe a group of individuals in detail such as patients with CLBP) (Collins, 
Onwuegbuzie, & Qun, 2006).  
4.1.1 Method of Analysis 
There are several methods that could be used to analyse qualitative data including, 
but not limited to, interpretive phenomenological analysis (IPA), discourse analysis, 
grounded theory, and thematic analysis. The most appropriate method is dependent on 
several factors but should be informed by the research question (Willig, 2001).  If the 
primary purpose of this research had been to gain insight into patients‘ psychological 
worlds, then IPA would have been considered. Similarly, if the primary purpose of this 
study had been to explore the basic social processes, then grounded theory may have been 
used (Willig, 2001). 
However, in this study, thematic analysis (Braun & Clarke, 2006),  a widely-used 
qualitative analytic method that is increasingly being used in health-related research, was 
deemed the most appropriate method.  Thematic analysis allows an analyst to find repeated 
patterns of meanings (themes) in a dataset. Whilst other qualitative methods also allow the 
identification of themes in a dataset, in this case, the primary purpose of the interviews was 
to use the data to develop a questionnaire. Further, thematic analysis is useful to establish a 
rich thematic description of the entire dataset, so that predominant themes can be 
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identified. It is also a particularly useful technique when working with individuals whose 
views on a topic are unknown, and can help generate unanticipated insights. Indeed, 
Chapter 3 revealed a paucity of understanding in current literature about the concept of 
patient satisfaction or dissatisfaction with treatments in CLBP.  
Various factors influence findings using thematic analysis, including the research 
questions asked, whether an inductive or theoretical approach is adopted, the rationale for 
semantic or latent levels of coding, and the epistemological positioning (i.e., an 
essentialist/realist versus constructionist approach) (Braun & Clarke, 2006; Willig, 2001). 
Thematic analysis has six key stages (Braun & Clarke, 2006). These key stages can occur 
one after the other and data can be collected before analysis begins, although thematic 
analysis can equally be used when data collection and analysis occur simultaneously. The 
key stages are familiarising yourself with your data, generating initial codes, searching for 
themes, reviewing themes, defining and naming themes, and producing the report. 
Stage 1: Familiarising yourself with the data 
 Transcribing the data, reading and re-reading the data, recording initial ideas. 
Stage 2: Generating initial codes 
 Systematically coding interesting features of the data in the entire data set, collating 
data relevant to each code. 
Stage 3: Searching for themes 
 Establishing codes into themes, gathering all data relevant to each potential theme. 
Stage 4: Reviewing themes 
 Checking whether the themes work in relation to the coded extracts and the entire 
dataset, generating thematic ‗map‘ of the analysis.  
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Stage 5: Defining and naming themes 
 Reviewing the analysis to refine the specifics of each theme and considering the 
overall story that the analysis tells, generating clear definitions and names for each 
theme. 
Stage 6: Producing the report 
 Selecting compelling extract examples, final analysis of selected extracts, referring 
to the research question and existing literature, producing a report of the analysis. 
  At this juncture, it‘s important to note some key points.  Because qualitative 
research aims to elicit rich contextual information based on in-depth methods (usually) 
using small sample sizes, it  has often been criticised by quantitative researchers for not 
being able to generalise findings from a representative statistical sample to the wider 
population from which the sample was drawn (Willig, 2001). However, the goal of 
qualitative methods are not to make claims about trends or provide information about 
prevalence and statistical distribution (Willig, 2001). Rather, qualitative methods often 
make analytical generalisations (Miles & Huberman, 1994) allowing insights in terms of 
description and explanation of a specific case and consideration for how selected cases fit 
within general constructs (Curtis, Gesler, Smith, & Washburn, 2000). Further, qualitative 
research is typically concerned with internal generalisability which is the extent to which 
conclusions drawn are generalisable within the particular setting or group studied rather 
than external generalisability which is moving beyond the group, setting or context 
(Maxwell, 1992) (see section 4.1.2). 
It is also important to recognise that even within a realist paradigm that is 
predominantly data driven, reflexivity during the research process and findings (i.e. to 
reflect on one‘s own standpoint in relation to the concept of interest) helps demonstrate the 
potential influence on the validity of the research (see section 4.5.2). 
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4.1.2 Validation 
The ‗correctness‘ or ‗precision‘ of interpretation is key to the validity of qualitative 
research. This includes establishing whether the interpretations  truly represent the features 
of a particular case (internal validity), and whether the concepts are applicable to other 
groups within the population (external validity) (Ritchie & Lewis, 2003). 
Establishing internal validity is achieved in several ways. For example, thematic 
analysis is a six-step process (see 4.1.1) that involves a ‗constant comparative process‘ 
(Silverman, 2000). Usually, the thematic analysis is also supported and verified by two 
experienced researchers to confirm consensus in the interpretation. In addition, qualitative 
research usually supports its validity by citing verbatim quotations to support the analyses 
(Willig, 2001). Quotations are provided for many themes throughout the analyses to 
illustrate and support linkages or explanations. 
External validity is often considered in terms of triangulation, which involves 
different ways of looking at the same concept. The literature recommends different forms 
of triangulation, including multiple analysis using different analysts, triangulation using 
different qualitative methods (e.g. face-to-face in-depth interviews versus focus groups), 
and ‗methods triangulation‘ (Banister, Burman, Parker, Taylor, & Tindall, 1999). ‗Methods 
triangulation‘ is common and relies on generating data via alternative quantitative analysis. 
This study was intended as the basis for quantitative analysis. The study reported in 
Chapter 6 will serve for triangulation and validation of the themes and concepts that 
emerge from the current study. 
An alternative method for establishing whether the themes and concepts identified 
are applicable to other groups within the population (external validity) is through 
respondent validation, or taking the research evidence back to the participants. Because 
this method would have required additional time from the participating patients, this was 
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judged unfeasible and unnecessary given that triangulation was planned to validate the 
observations from this study. 
4.2 Objectives 
The specific objectives of this study were to: 
 Interview  patients with CLBP who take medication and/or receive physiotherapy 
for CLBP relief in order to explore patients‘ subjective experiences with treatment 
including their satisfaction and/or dissatisfaction with various aspects of their 
treatment 
 Collect rich quantitative data in order to design a questionnaire to assess 
satisfaction and dissatisfaction with treatments (medications and physiotherapy) in 
CLBP   
4.3 Methods 
Ethical approval was obtained from Stockport Ethics Research Committee 
(Ref:06/Q1401/41). The approval letter is in Appendix B. 
4.3.1 Participants 
Ten patients with CLBP participated and varied in age from 45 to 55 years (mean 
age 50 years). There were 8 women and 2 men. Patients were recruited from one NHS 
Trust in the North of England (Stepping Hill Hospital) via physiotherapists.  
In this qualitative study, purposive sampling was performed using a homogenous 
sampling strategy whereby patients attending a pain clinic and/or receiving physiotherapy 
for CLBP were screened. They were considered eligible if they met all of the inclusion 
criteria and none of the exclusion criteria, which were pre-specified on a screening script 
(Appendix C). The inclusion criteria were:  
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 Patient diagnosed with CLBP (defined as pain lasting longer than 12 weeks, 
affecting the lower back, between the bottom of the ribs and top of the legs);  
 Patient was receiving treatment for CLBP, or advised by their doctor to do so;  
 Patient was 18 years or older;  
 Patient was able to understand and communicate in English.  
The exclusion criteria were:  
 Patient had known cognitive impairment;  
 Patient had a case-note diagnosis of co-morbid learning disabilities;  
 Patient was currently using alcohol or illegal drugs;  
 Patient had brain injury or any other organic disorder. 
4.3.2  Interview Agenda  
A semi-structured interview agenda was developed for patients with CLBP 
receiving treatment based on information from literature reviews and discussions with 
HCPs from a variety of backgrounds (including an extended scope physiotherapist in the 
orthopaedic clinic, a GP, physiotherapists, psychologists, and nurses). The interview 
agenda contained open questions but probes were designed in cases where patients 
provided very little or no response to questions. This method has been commonly cited in 
studies (Willig, 2001). 
Ultimately, the content of the interview agenda was based on two independent 
researcher‘s opinions (DR and LM) according to the research question, and was designed 
to start with general questions and to move onto more personal matters when rapport had 
been established. With this in mind, the interview started with a short introduction 
regarding the content of the interview itself, explaining the areas that would be discussed 
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and reassuring participants about confidentiality. The interview agenda was organised into 
four main sections relating to the main topics of interest. These ranged from (1) general 
discussion about demographic, clinical, and treatment details to more specific discussions 
about (2) CLBP, (3) treatments for CLBP relief, and (4) their opinions regarding 
satisfaction and dissatisfaction with treatments for CLBP relief. 
The questions were formulated following careful consideration of alternative 
versions before the interview. Questions were descriptive, structural (to identify categories 
and frameworks of meaning from the patient perspective), and evaluative (for example, 
establishing feelings about CLBP and its treatment) (Spradley, 1979). In sections 2 – 4 of 
the interview guide, patients were asked several open-ended questions covering topics such 
as ‗what does pain mean to you?‘, ‗what does CLBP mean to you?‘, ‗What does the term 
‗chronic‘ mean to you?‘ and ‗what is the cause of your CLBP?‘ Questions also explored 
symptoms of CLBP.  A number of discussion prompts were provided for each section, 
relating to issues such as duration, frequency and impact of CLBP  
In addition, patients answered open-ended questions about their expectations of 
treatment, why they take treatment and their involvement in treatment decisions, as well as 
questions about adherence to medication and exercise regimens, and what ‗satisfaction‘ 
and ‗dissatisfaction‘ with treatments meant to them.  
The interview agenda was piloted with three CLBP patients who were receiving 
treatment for CLBP relief. The results of the first pilot test showed that some of the 
questions needed to be repositioned within the interview guide to facilitate the flow of the 
interview. For example, the questions relating to CLBP and chronicity were reorganised so 
that patients were asked ―What does ‗pain‘ mean to you?‖ first, followed by ―What does 
‗CLBP‘ mean to you?‖ and then ―What does the term ‗chronic‘ mean to you?‖ 
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These subtle changes were implemented for a second pilot test (n=2), where results 
indicated that there was some overlap in the questions being asked.  While some 
overlapping questions were retained, since the researchers felt that some slightly different 
questions might elicit different responses from different patients, the interview agenda was 
further refined to minimise duplication of discussion topics and ensure that if a topic was 
discussed spontaneously earlier in the interview, it was not probed later. These changes 
helped limit the interview to a manageable length for both patient and interviewer.   
A third pilot test was performed with these changes implemented (n=2), and results 
indicated that the guide could elicit spontaneous responses from patients related to the 
topics of interest and within a reasonable timeframe (45 minutes).  
The final interview agenda included questions about CLBP, questions exploring 
experiences with treatments for CLBP relief, and opinions regarding satisfaction and 
dissatisfaction with treatments for CLBP relief (Appendix F). If patients did not have 
experience with a particular type of treatment (e.g. injection therapies) then questions 
relating to that treatment were skipped. The questions ‗do you ever experience CLBP?‘, 
‗how long have you experience CLBP?‘ and ‗are you currently taking any medication for 
your CLBP?‘ were used as warm ups and lead-ins to the interview. This was followed by 
questions such as ‗what does ‗pain‘ mean to you?, ‗what does ‗CLBP‘ mean to you?‘ and 
‗what symptoms do you experience from your CLBP?‘, to more treatment-specific 
questions such as ‗why do you take treatment for CLBP?‘, ‗do you feel involved in 
treatment decisions?‘, followed by ‗please describe what taking medication for CLBP 
involves on a daily basis from your perspective‘. Satisfaction-specific questions included 
‗what does satisfaction with treatment mean to you?‘, ‗what does dissatisfaction with 
treatment mean to you?‘ and ‗are you satisfied with your treatment for CLBP?‘ The 
interview ended with a general closing question, ‗are there any other points that you would 
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like to mention in relation to our discussions on treatment(s) for CLBP relief, its impact on 
your life, satisfaction, or adherence?‘ Questions about patient demographic characteristics 
were also included as part of the interview agenda. 
4.3.3 Other Study Documents 
Information and consent forms were developed for the patient interviews (see 
Appendix D and E, respectively). These contained information about the purpose and 
conduct of study, confidentiality, the purpose of the study results, and ethical approval. 
Contact details were also provided should the HCP‘s or patients have any questions or 
problems.  
4.3.4 Procedure 
A non-probabilistic, purposive sampling approach was used. The Head of the 
Physiotherapy Department systematically screened patients attending the outpatient 
department according to a pre-specified screening script that included the inclusion and 
exclusion criteria (Appendix C). A trained researcher performed all patient interviews 
(DR). At the start of the interview, patients were given a patient information sheet and 
consent form to sign (Appendix D and E). They were assured of their anonymity and were 
informed that they had the right to withdraw at any time. They were also informed that any 
decision to do so would not affect the treatment and care that they receive in any way. 
Once the patient was comfortable, the tape recorder was switched on and they were asked 
to repeat their consent to participate for recording purposes. 
The interviews lasted between 40 and 75 minutes, depending on how much each 
patient wanted to say. The interviewer was female and all interviews were conducted in an 
enclosed office within Stepping Hill Hospital to ensure confidentiality. All patients were 
asked identical questions in the same sequence, but the interviewer probed inductively on 
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key responses, and probes were used only if a patient‘s response to the initial question did 
not cover certain topics of interest. All interviews were audio-taped and transcribed 
verbatim by the researcher to allow greater familiarity with the data prior to analyses. A 
tracking form was used to ensure the data generated from a specific interview was 
identifiable via patient identification numbers, thus ensuring anonymity. This tracking 
form was stored on a password-protected laptop computer. 
Thematic analysis was supported and verified by two experienced researchers who 
confirmed consensus in the interpretation. There were two occasions where the analyses 
were discussed and interpretations amended as necessary. Any discrepancies were resolved 
via discussion until consensus was obtained between the researchers (see section 4.3.5). By 
example, whether anxiety and depression were separate independent themes or sub-themes 
of emotions. 
4.3.5 Data Analysis 
A number was assigned to every patient in the order in which interviews were 
conducted. The data were transcribed verbatim by DR, and the transcripts were checked 
against the tapes for accuracy. Data were managed using an Excel spreadsheet and 
ATLAS.ti 6 software, which is qualitative data analysis software. ATLAS.ti allows the 
researcher to locate, code, and annotate findings in datasets, to weigh and evaluate their 
importance, and to develop visual representations of associations between themes.  
Each data item in each transcript was studied repeatedly and given equal attention 
during the coding process, which was thorough, inclusive and as comprehensive as 
possible. The coding process was performed without trying to fit data into a pre-existing 
coding frame. Rather, the relevant extracts from the dataset were collated to form themes. 
Themes were then checked against each other and also against the original dataset to 
ensure that they were coherent, consistent, and distinctive. The process was predominantly 
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inductive in that the themes identified were strongly linked to the data themselves, and thus 
data-driven. Also, the themes were semantic themes in that they were identified within the 
explicit or surface meanings of the data, and the researcher was not looking for anything 
beyond what a patient said. As themes were identified, there was gradual progression from 
description, where the data were organised and summarised into patterns, to an 
interpretative process that theorised about the significance of the patterns as well as their 
broader meanings and implications, often in relation to previous research. The extracts 
were also checked to ensure that they matched the analytic claims. As recommended by 
Braun and Clarke (2006), during the analysis process, the researcher continually 
considered whether the analysis told a convincing and well-organised story about the data 
and the topic.  
 Throughout the analysis process, issues regarding various aspects of the process 
itself required defining and refining. For example, a theme was considered a level of 
patterned response related to the research question. The researcher was flexible and used 
their judgement as necessary. Other issues that were considered throughout the process 
included consideration regarding the epistemology which was an essentialist/realism 
positioning in that a general unidirectional relationship was assumed between meaning, 
experience, and language. The analysis process is outlined in Table 7. 
Table 7: Process of Analysis 
DR transcribed interviews and read through each interview transcript to generate codes 
relating to CLBP, treatments for CLBP, and aspects related to satisfaction and/or 
dissatisfaction with treatments for CLBP. 
DR read and compared the codes to identify themes within these such as the ‗impact of 
CLBP and its treatment‘, and ‗satisfaction with treatment‘. 
Quotes relating to each theme were assembled. DR and two experienced researchers 
independently reviewed these and discussed definitions of themes and the data within 
these. During this process, some changes were implemented to definitions.  
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DR re-coded all transcripts for these themes.  
DR coded for sub-themes within themes. For example, sub-themes of ‗impact of CLBP 
and its treatment‘ included ‗physical functioning‘, ‗emotional impact‘, ‗confidence‘, 
‗self-esteem‘, ‗sleep‘, and ‗relationships‘. Examples of sub-themes of ‗satisfaction with 
treatment‘ included ‗efficacy‘, ‗side effects from medications‘, ‗health-related quality of 
life‘, ‗preferences‘, ‗convenience‘, ‗adherence‘, ‗information provided‘, and ‗involvement 
in treatment decisions‘. 
The process of coding for sub-themes included developing a conceptual model of CLBP 
and treatments for CLBP relief (Figure 7) as well as a thematic map of treatment 
satisfaction from patients‘ perspective (Figure 8). This process involved shifting themes 
to sub-themes and vice-versa within Figure 7 and Figure 8. 
Tables of data extracts and quotes representing the themes were generated in Excel. In 
addition, questions for a new questionnaire to measure satisfaction/dissatisfaction with 
treatments for CLBP relief were developed and tabulated to corresponding themes. 
DR and an experienced researcher examined Figure 7 and Figure 8 to gain understanding 
of themes and sub-themes and agree on the main issues. The tables documenting the 
items generated for the newly-developed questionnaire were also examined. 
Disagreements were discussed and amendments were made as necessary. 
4.3.6 Sampling and Saturation 
Since there are few guidelines regarding non-probablistic sampling, purposive 
sampling was established inductively, and the sample size relied on a ‗saturation‘ 
approach, which is the point at which no new information or themes are identified from 
interviews (Guest et al., 2006). Thus, the first seven interviews were compared with the 
last three interviews to examine whether saturation had been achieved in the overall 
sample of patients with CLBP receiving treatment. 
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4.4 Results  
4.4.1 Demographic Characteristics 
Patients‘ ages ranged from 45 to 55 years. The overall mean age was 50 years. 
There were eight women and two men. The majority of patients had no qualifications 
(n=7), two had O-levels, and one was a qualified nurse. Nine patients were unemployed, 
one was phased back to work and was working part-time as a staff nurse. All patients 
reported that their work was limited by their CLBP. 
Various symptoms were recorded on patients‘ case notes, including pain in lower 
back; numbness in back; constant ache and intense pain; lack of strength in back; and 
unable to walk long distances. Duration since first diagnosis varied from six months to 30 
years. 
Patients were receiving a number of different medications for CLBP relief 
including non-opioid analgesics (such as paracetamol or cocodamol) (n=6), NSAIDs 
(ibuprofen or diclofenic) (n=7), opioid analgesics (codeine or dihydrocodeine) (n=4), 
benzodiazepines (diazepam) (n=3), and tricyclic antidepressants (amitriptiline) (n=3). Most 
were taking these medications as required. Side effects reported in patients‘ case notes 
included dizziness, dysphagia, nausea, and dysarthria. 
In addition to taking medications for CLBP relief, all patients were seen and 
assessed individually by a physiotherapist and if they were demonstrating yellow flags (a 
belief that pain meant damage or harm, they were fear-avoiding and tending to be very 
passive in treatment) they were invited to attend the back programme. The back 
programme consisted of eight sessions (twice weekly) comprised of education regarding 
the causes of back pain, posture and positioning, and pacing, as well as exercises, and 
relaxation techniques. 
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4.4.2 Patients’ Subjective Experiences with CLBP and its Treatment 
The following themes were extrapolated from the data until the data was saturated 
and no more themes emerged. Common words used by patients with CLBP to describe 
their CLBP included ―slicing‖, ―twinge‖, ―pins and needles‖, ―stabbing‖, ―numbness‖, 
―swelling‖ and ―burning‖.  The duration, severity, and tolerability of CLBP were very 
prominent topics during discussions with patients. 
A central theme that emerged from the interviews was the impact of CLBP and its 
treatments on patients. Particularly interesting was how widely CLBP impact on patients‘ 
daily lives varied. The impact ranged from physical functioning and social functioning to 
influences on appearance, emotions, mood, self-esteem, confidence, sleep, relationships, 
and sex. Figure 7 provides a proposed conceptual model of CLBP and its treatments from 
the patient perspective.  
Physical Impact 
Physical functioning was a particular burden to patients, who not only described 
problems with standing up or standing all day but also difficulties with standing after only 
five minutes. Other issues with physical functioning included difficulties bending down, 
leaning over, and sitting still. Being able to function normally and carry out everyday 
activities were important to patients. 
 “Standing during the day is very difficult especially after five minutes” (ID01). 
 “I couldn’t even walk let alone go to the pharmacist...” (ID03). 
 “I am still hoping to get back to normal. You know at some stage I will be fully 
functioning, and go back to work, and just do normal things like everybody else” 
(ID04). 
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Social Functioning 
Social functioning was also described as an aspect of their lives that had changed 
and was impaired due to their back pain. Many patients noted that they were more socially 
active before being affected by CLBP.   They explained that they can‘t partake in physical 
sport or socialise in the evening. On the rare occasions that they do go out, they go more to 
watch than to participate in various events. One patient explained how even going to the 
cinema or for a meal was problematic because the chairs are uncomfortable. 
 “I can’t do indoor bowling and ballroom dancing. If I go out I just sit. For example 
I go to watch the dancing. I still go where I would normally go but I don’t do it. 
Even when I felt better I didn’t go out because I didn’t feel right, so just stayed in” 
(ID10). 
Although generally patients with CLBP described a negative impact on their social 
functioning, one patient described how they could still do the things they used to do: 
 “I’ve been involved in the church and that has helped me a lot, and I walk a dog 
with a friend. And I go to a choir still” (ID03). 
Appearance 
Patients described problems with maintaining their apprearance, with one 
explaining that they did not have the same interest, and another describing the pragmatic 
problems she encounters with trying to do her hair. 
 “Well just look at my hair! I can’t do my hair because it hurts my back trying to do 
it. Every time I try it catches right in the middle of my back” (ID02). 
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Emotions 
The impact of CLBP on emotions was important for patients and ranged from 
feeling embarrassed about the pain to unhappy, sad or depressed. One patient said it was 
particularly hard to be positive at work. 
Anxiety and worry about the uncertainty of the future and fear of movement were other 
emotions patients referred to in relation to their CLBP. 
 “I was anxious because I wanted to go back to work and I couldn’t because I knew 
I wasn’t fit enough” (ID09). 
 “I’m scared to do too much to set the pain off” (ID02). 
Patients described being in a bad mood, and specifically referred to being annoyed by 
having to stop and rest. They were particularly frustrated at not being able to do what they 
wanted to, or by comparing their current condition to how they were before they had 
CLBP. Being irritable and miserable were also negative consequences of having CLBP. 
 “I’ve been fed up, frustrated and cross. Miserable but not desperate” (IDO2). 
 “Irritability, and frustration because I was quite fit before. Also, I can’t do what I 
used to do” (ID03). 
Self Esteem 
Self esteem and confidence were other aspects that patients felt were compromised 
due to their CLBP. In relation to self-esteem, one patient described struggling to get 
acknowledged at work due to CLBP and suggested that this had affected self esteem. 
 “I was struggling to get acknowledged so that didn’t do anything for my self esteem 
anymore” (ID03). 
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Confidence 
Closer examination of the issues related to confidence reveal that patients talked a 
lot about how uncertain they were of themselves, and particularly how cautious having 
CLBP has made them. 
 “I never do anything without thinking about how I’m going to do it, even the 
ironing” (ID02). 
Discussions also centred on lack of self confidence and how that was related to what 
they felt or what they could do. 
 “It knocks your confidence so much and I don’t feel the same about yourself” 
(ID10). 
Sleep 
Patients with CLBP discussed how the quality of their sleep was negatively 
impacted, and noted that waking up in the night due to the back pain was a problem, as 
well as difficulties sleeping or trying to get back to sleep. 
 “Generally not sleeping well and something always aches in my back in the 
morning. But it doesn’t last all day (ID07). 
Relationships  
Relationships were a sensitive issue, but patients noted that their partners were 
frustrated by the CLBP, did not always show empathy, or could not understand the pain 
and impact of the back pain experienced. Relationships impacted by CLBP include those 
with partners, siblings, parents, and work colleagues. Further, some individuals with CLBP 
were concerned about bothering others who were close to them since they had their own 
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problems, and one patient explained how sometimes they didn‘t want anyone near them 
because of the back pain. 
  “I was beginning to think that everybody was thinking I was just playing on it, 
including my husband” (ID03). 
 “My mum and my dad are nearly 90 years, and they have their own problems. So 
whenever they ask me I just say I am fine. Because they have their own problems” 
(ID04). 
 “I think there were times when it does affect you so much that you don’t want any 
one near you, you don’t want to know” (ID05). 
Sex Life 
During discussions, some patients tried to justify lack of sex as a consequence of 
age and characterised it as an old habit that has phased out over time.  
  “I don’t know but my wife has noticed that probably my sex life has been affected 
because I hardly do it anymore because of the pain and all the surroundings that 
goes with it” (ID04). 
 “You can forget sex with my back. When you get to my age there’s no one nice 
anyway” (ID02). 
Factors Associated with CLBP 
Some patients discussed issues related to the diagnosis of CLBP, with some indicating that 
their condition had gone undiagnosed and others suggesting they had been misdiagnosed 
or, in some, cases even indirectly accused of malingering. 
  “Because I was misdiagnosed, I was treated for being depressed for quite a while 
actually, I mean, that’s always bothered me” (ID05). 
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 “When they got the diagnosis wrong then that was quite stressful” (ID09). 
 “The doctors don’t have a clue. Because they didn’t have it they don’t know. The 
doctor said we need to get you back to work. That made me feel as if he thought I 
was faking it” (ID01). 
Trust and Confidence in Clinicians 
Some patients reported concerns about trust and confidence in clinicians in 
identifying their CLBP. 
 “I saw two locums at open clinics and they haven’t a clue and so I didn’t trust the 
clinicians” (ID01). 
Work 
Patients talked about how impaired physical functioning limited their ability to 
work, and how absence at work resulted in changes that they didn‘t want to happen and 
that almost hindered their career. 
  “I can’t get through my work because I physically can’t keep going” (ID01). 
 “I had 8 weeks off work and when I got back they change my job.  I didn’t want 
them to change my job. It was all arranged previously, I had sponsorship, 
training…I had plans and they all got changed” (ID02). 
Coping 
Some patients briefly mentioned that their back pain resulted in an inability to cope 
and said that either one has to put up with the pain or to find some way of dealing with it. 
 “Pain means to me that it makes you feel miserable, not able to cope, and gets 
things out of perspective” (ID02). 
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 “You either put up with it or find a way of coping with it” (ID03). 
Locus of Control 
The majority of patients with CLBP described an external locus of control, 
expressing the belief that the problem of back pain was for health professionals; one 
patient suggested that the health professionals know best and they [the patient] are 
ignorant. 
 “I just leave it to them. My problem is in their hands and I leave it up to them to 
come up with a solution” (ID04). 
 “They know what’s best for me. I’m ignorant” (ID02). 
Fear of Dependency 
Patients explained that they were taking or had taken various treatment options to 
try and help them with their CLBP. Most commonly mentioned were non-opioid analgesic 
medications such as paracetamol or NSAIDs on an as-required basis. Other medications 
included opioid analgesics and anti-depressants. There was a general reluctance to take 
medication regularly and patients expressed concerns about dependency. Some patients 
described not taking their medication as recommended by their doctors due to fear of 
dependency and tolerance. 
 “I am worried about dependency. I don’t want to rely on them” (ID04). 
 “I only use it when it gets particularly bad. And as I said I take some pain killers 
and hope for the best really. Because I don’t want to rely on tablets all my life” 
(ID09). 
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Side Effects of Medication 
A main consequence of taking medications for CLBP relief was negative side 
effects. Many patients referred to feeling spaced out, and one described not knowing what 
time of year it was. Other descriptions of side effects included feeling light-headed, dopey, 
unaware of things, and like a zombie. Some patients said that the side effects were 
intolerable and made them stop taking their medication or alter the amount of medication 
they took. Others said that regularly taking medication resulted in feeling out of control 
and negatively impacted their quality of life. 
 “The medicines made me not know if it was Christmas or Easter” (ID02). 
 “You get zombified if you take them all the time. You don’t feel in control” (ID05). 
 “I decided not to take them because I was dopey all the time and I didn’t have any 
quality of life or anything” (ID08). 
Other medication side effects cited included loss of appetite, difficulty getting to sleep, 
and gastric side effects such as heart burn and stomach ache. Clearly, the bother associated 
with side effects varied among patients, but it clearly affected their ability to perform 
everyday activities.  
 “They upset my stomach. I get a lot of heart burn, a lot of horrendous hear burn” 
(ID07). 
 “The side effects are gastric” (ID03). 
Information about Side Effects 
Another key theme related to treatment was information about side effects. Patients 
claimed that no one had informed them of the possible side effects of taking CLBP 
medication. 
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 “I made a decision not to take them unless I was absolutely desperate. No one 
explained to me how drugs make you feel. I couldn’t eat breakfast, and I was 
unable to sleep anytime after 2pm. Diazapam is habit forming and I was afraid of 
that” (ID02). 
Effectiveness of Medication 
The primary reason for taking medication was to end the back pain and feel better 
again.  Effectiveness of medication was important to patients, who expressed concerns that 
the treatment was not working but instead contributing towards the problems they were 
experiencing. 
 “I take treatment to make me feel better and get right again” (ID01). 
 “Treatment not working, not helping, hindering. Causing more discomfort” (ID03). 
4.4.3 Satisfaction and Dissatisfaction with Treatments for CLBP Relief 
In addition to understanding patients‘ subjective experiences with CLBP and 
treatments for CLBP relief, the purpose of the in-depth interviews was to also explore the 
concept of satisfaction and dissatisfaction with treatment from the patient perspective. 
Figure 8 provides a thematic map of the key themes that were associated with the concept 
of satisfaction or dissatisfaction with treatment (medications and physiotherapy).  
Satisfaction with Treatments for CLBP Relief 
Generally, satisfaction with treatment is positive aspects of treatment where 
patients described being happy or pleased with treatment. One patient in particular stated 
that they were satisfied with their treatment since receiving the correct diagnosis. In 
addition, the majority of patients referred to satisfaction with treatment as maintaining 
 Page 138 of 458 
general health, being able to return to normal functioning or at least being able to do 
everyday activities and work as they were once able to do.  
 “Satisfaction with treatment means you are satisfied with the treatment you receive 
and you’re happy with it” (ID02). 
 “Well satisfaction with treatment is having everything that you want and being 
happy, healthy and something like that” (ID05). 
 “Satisfaction with treatment means when I am 100% satisfied with my body. Like I 
said because the pain has been there a long time, and it’s probably going to be 
there for the rest of my life. So, satisfaction to me is just, going back to work, 
feeling fit, I can do daily things, you know daily activities. It doesn’t have to be 
something extreme. You know I’m not going to do a bungee jump or something like 
that, I don’t expect to do something like that. My satisfaction is just going about 
doing my daily life as normal as possible” (ID04). 
Dissatisfaction with Treatments for CLBP Relief 
Patients often referred to dissatisfaction with treatment in terms of treatment not 
being efficacious, in other words, the treatment is unable to stop or minimise their back 
pain so that they can return to normal functioning and continue everyday activities or 
work. In this respect, the negative impact that back pain has had on health-related quality 
of life seems to be particularly related to dissatisfaction with treatment, but especially 
reduced physical and social functioning. If the treatment was not working, causing 
discomfort, or hindering them, then this was also related to dissatisfaction. For example, 
patients referred to experiencing side effects and finding the side effects intolerable or 
unbearable, sometimes to the extent that they have to stop taking the medication. These 
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aspects of treatment were all associated with dissatisfaction.  The inconvenience of taking 
medication was also a key factor. 
Lack of information about back pain, its treatments and potential consequences 
were also components of dissatisfaction with treatment. Not feeling involved in treatment 
decisions, lack of trust and confidence in healthcare professionals, being misdiagnosed or 
undiagnosed, feeling that healthcare professionals were not listening to them, and the 
general feeling that healthcare professionals were not empathetic about their CLBP were 
also all associated with dissatisfaction with treatment. 
 “The side effects would affect my satisfaction. Everybody in my class come off the 
medications because you don’t feel right. I don’t like the tablets because I am not 
as ill without them” (ID01). 
 “Not being listened to. Long waiting lists to get seen to things. Long referral 
processes. Treatment not working, not helping, hindering. Causing more 
discomfort. Like the physio would make me feel worse, for four days I was in pain 
afterwards. So at the time it wasn’t helping. It was causing me more pain than I 
arrived with” (ID03).   
 “I never felt involved. I trust them now they know” (ID02). 
 “No one explained to me how drugs make you feel” (ID08). 
 “Dissatisfaction with treatment would mean if you didn’t get the time or if the 
treatment wasn’t appropriate or inconvenient, if their attitude wasn’t good. If your 
left waiting too long or if they weren’t interested and just going through the 
motions” (ID10). 
Having to pay for treatment privately due to long referral and waiting times was a 
contributing factor for one patient with CLBP. 
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 “I mean I paid privately to get treatment purely because you know the waiting list 
was so long that I would have ended ten times as worse before I would have got 
some treatment” (ID05). 
In addition, closer examination of the discussions that took place in interviews reveal 
that satisfaction or dissatisfaction with treatments for CLBP relief were part of a much 
bigger concept  – satisfaction with healthcare — which seemed to encompass referral 
times, waiting times, general communication about treatments, as well as a sense of 
empathy from HCPs. 
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Figure 7: Conceptual Model of Chronic Low Back Pain and Treatment 
 Page 142 of 458 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Thematic Map of Satisfaction/Dissatisfaction with Treatment for CLBP Relief from 
Patients‘ Perspective 
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4.4.4 A Summary of Data Driven Themes 
Table 8 and Table 9 respectively provide summaries of data driven themes and sub-
themes associated with patients‘ subjective experiences of treatment for CLBP relief and 
their satisfaction and dissatisfaction with treatments for CLBP relief. 
Table 8: Summary of Data Driven Themes and Sub-Themes Associated with Patients‘ 
Subjective Experiences with Treatment for CLBP Relief 
Impact of CLBP and its treatments (medication and physiotherapy) 
Pain  Duration 
 Severity 
 Tolerability 
Symptoms  Slicing 
 Twinge 
 Pins and needles 
 Stabbing 
 Numbness 
 Swelling 
 Burning 
Physical  Functioning 
 Activities of daily living 
Social  Functioning 
Emotional  Anxiety 
 Fear of movement 
 Worry 
 Uncertainty of the future 
 Depression 
 Motivation 
 Embarrassment 
 Annoyance 
 Frustration 
 Irritability 
 Miserable 
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Impact of CLBP and its treatments (medication and physiotherapy) 
Confidence  Cautious 
 Lack of confidence 
Sleep  Quality 
 Difficulty 
 Awake 
Tiredness  
Relationships  
Sex life  
Distress  
Self esteem  
 
Table 9: Summary of Data Driven Themes and Sub-Themes Associated with Satisfaction 
and Dissatisfaction with Treatments for CLBP  
Satisfaction and Dissatisfaction with Treatments for CLBP  
Pain   
Symptoms  
Effectiveness  Removes or minimises pain 
 Return to normal functioning and can perform 
activities of daily living 
 How fast treatment works 
Side effects  Incidence 
 How much of a problem they are 
Health-related quality of life 
(see Table 8) 
 Physical functioning / ADLs 
 Social functioning 
 General health 
 Emotions 
 Distress 
 Self esteem 
 Confidence 
 Tiredness 
 Sleep 
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Satisfaction and Dissatisfaction with Treatments for CLBP  
 Relationships 
 Sex life 
Preferences  Mode of administration (tablet, capsule...) 
 Taste of medication 
Convenience  
Information provided  About the causes of back pain 
 Possible side effects of medications 
Adherence as recommended 
by HCPs 
 Medication regimens 
 Exercises 
Involvement in treatment 
decisions 
 
Diagnosis  Undiagnosed 
 Misdiagnosed 
Trust and confidence in 
HCPs 
 
Communication with HCPs  Level of empathy 
 Active listening 
Satisfaction with healthcare  Private/NHS 
 Referral times 
 Waiting times 
 
4.5 Discussion  
The findings of this study suggest that satisfaction and dissatisfaction with treatments 
is a multidimensional concept and provide some support for a model similar to 
Fitzpatrick‘s (1984) ‗multidimensional‘ perception of satisfaction. When exploring the 
concept of satisfaction with treatment (medication and/or physiotherapy) in patients with 
CLBP, patients‘ responses to open-ended questions generally described positive aspects of 
treatment, such as receiving the correct diagnosis, and being ‗happy‘ or ‗pleased‘ with 
treatment. Maintaining general health and returning to normal functioning such as carrying 
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out everyday activities or going to work are very important concepts that form part of 
satisfaction with treatment.   
Patients were even more descriptive about dissatisfaction with treatment, which was 
generally perceived as the opposite of satisfaction with treatment and thus supports the 
view that satisfaction and dissatisfaction are on a continuum (Collins & O'Cathain, 2003). 
Dissatisfaction includes negative aspects of treatment such as being misdiagnosed or 
undiagnosed, a lack of trust and confidence in clinicians, lack of information (about back 
pain, its treatments, and potential consequences of treatment). Communication by 
healthcare professionals is important, and dissatisfaction with treatment seems to also be 
related to perceived lack of empathy and lack of active listening by HCPs to the patient.  
These findings are consistent with those of a systematic review which cited aspects 
of treatment for back pain about which patients have expectations or express satisfaction in 
qualitative studies (Verbeek et al., 2004). Like this study, Verbeek et al found that 
associated treatment aspects included ‗diagnoses/finding cause of pain‘ where patients 
stated that there wasn‘t really an initial diagnosis and clinicians weren‘t really certain what 
was going on. ‗Confidence based relationship‘ was another aspect of treatment where 
patients reported lack of  faith in their HCPs. ‗Information/instructions‘ was key, since 
patients reported that they needed more knowledge and direction regarding what to do. 
Verbeek et al. (2004) findings regarding communication with HCPs and listening are also 
confirmed in this study.  
Limited efficacy of treatment is a major theme of dissatisfaction with treatment.  
Patients report dissatisfaction when treatment doesn‘t succeed in removing or minimising 
the back pain and does not enable the patient to return to normal functioning, thus limiting 
their HRQoL. These results are consistent with Lewis, Bradley, Knight, Boulton, and Ward 
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(1988), whose results demonstrated an association between treatment satisfaction and 
efficacy/effectiveness in terms of perceived glucose control in diabetes.  
In this study, experiencing intolerable side effects were also an important theme 
related to dissatisfaction with treatment. These findings are in line with Huskisson et al., 
(1992), who found that overall satisfaction was associated with absence of pain and side 
effects in rheumatoid arthritis.  
This study also revealed that convenience of treatment regimens and the mismatch of 
medication compared to patient preferences in terms of for example mode of 
administration were also associated with the concept. Dissatisfaction was also associated 
with non-adherence to treatment regimens as recommended by doctors. These results are 
supported by previous research which indicated that patients with iron overload receiving 
infused iron chelation therapy were less satisfied than those receiving oral iron chelation 
therapy, and that satisfaction with iron chelation therapy was significantly associated with 
never thinking about stopping chelation therapy (a proxy for adherence) (see for example, 
Rofail et al., 2008; Cappellini et al., 2007; Payne et al., 2007). However, it should be noted 
that the direction of the association between satisfaction and adherence warrants further 
exploration since it‘s not clear whether treatment satisfaction as an independent variable 
influences adherence to medication regimens, or whether it is adherence as an independent 
variable that influences satisfaction and dissatisfaction with treatment. The role of efficacy 
and other concepts in the associations also require further exploration. 
Findings from these in-depth interviews also suggest that patients are perhaps not as 
satisfied with their treatment as they may initially indicate. For example, the majority of 
patients indicated that they were satisfied with their treatments for CLBP relief. However, 
further discussion revealed that patients still experienced CLBP and that this appeared to 
significantly impact their everyday lives in terms of physical functioning, activities of daily 
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living, emotional impact, social functioning, and relationships. These findings come as no 
surprise, since another study reported similar results in patients receiving antipsychotic 
medications (see for example, Gray et al., 2005).  
The findings from this study provide support for other CLBP studies, such as with 
regard to patients‘ actual experiences of CLBP and its treatment in terms of intensity of 
pain and impact on quality of life which is well documented in the literature (see for 
example, Roland et al., 2007; Keeley et al., 2008; Pain in Europe, 2003). Further, the 
actual experiences patients report in this study are similar to other CLBP studies that have 
used a qualitative approach. For example, patients with CLBP seem to describe their 
experiences of treatment regarding limited efficacy and this is similar to patients‘ 
descriptions of failed treatment approaches (Liddle et al., 2007), and also patients in this 
study describe lack of trust and confidence in clinicians which is similar to another study 
which showed lack of trust in research, and researchers and possibly also HCPs (Glenton et 
al., 2006). 
Unexpectedly, expectations were mentioned by only one patient in this study in 
relation to satisfaction with treatment. Closer examination of the interview transcript and 
the discussions between the interviewer and the patient revealed that the patient did not 
mention expectations spontaneously in response to any of the open-ended questions. In 
light of this and given that it was only mentioned briefly by one patient in response to 
being probed by the interviewer, expectations were not added to the final thematic map of 
satisfaction and dissatisfaction with treatments in CLBP. Further research to test this 
decision is warranted. The literature on expectations and satisfaction is ambiguous (see 
section 2.6.4). Although several studies suggest expectations are related to satisfaction with 
treatment (Jackson & Kroenke, 1997; Sitzia & Wood, 1997), expectations, like 
satisfaction, lacks an operational definition and there is a lack of consensus opinion 
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regarding what constitutes patient expectations. Further, some researchers have questioned 
patients‘ abilities to form an opinion of what to expect from treatment, especially if they 
are treatment-naive or have not received health services before (Williams, 1994). With this 
in mind, the relationship between satisfaction and expectations requires further exploration.  
Despite this, it is important to acknowledge that there are a number of studies that 
qualitatively document LBP patients‘ expectations from treatment (Liddle et al., 2007; 
McIntosh & Shaw, 2003; Rives & Douglass, 2010; Verbeek et al., 2004; Yardley et al., 
2009).  On reflection, one of the possible reasons why expectations did not emerge as a 
major theme in this study may be due to the questions in the interview guide which focused 
more on patients overall experiences and the notion of satisfaction and dissatisfaction. For 
example, a closer examination of Liddle et al. (2007) shows that they asked a number of 
open questions related to patients‘ expectations during the focus groups. For example, 
‗what are your expectations from treatment?‘ and ‗how did you decide if your expectations 
are met or not?‘  Therefore future studies could consider defining the concepts of 
satisfaction and dissatisfaction further as they relate to expectations and the extent to which 
they have been met. Future studies should pay particular attention to the questions put to 
patients. 
Finally, it is apparent from this study that satisfaction and dissatisfaction with 
treatment is part of a larger concept of satisfaction with healthcare; such findings support 
Weaver et al.‘s (1997) treatment satisfaction conceptual framework. However, evidence 
from this study reveals that the boundaries between the two concepts are not explicit to 
patients, and further research is warranted to establish empirical evidence to support the 
concepts and their association.  
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4.5.1 Strengths and Limitations 
Some strengths and limitations of this study warrant comment. We can assume a 
certain degree of patient homogeneity because a homogenous sampling strategy was used, 
and thus patients were chosen based on some common criteria; in this case they were 
patients with CLBP taking medication and/or receiving physiotherapy to help them with 
their back pain problems. Further, the more similar the patients were in their experience as 
it related to the research concept of interest, the sooner it can be expected to reach 
saturation (Guest et al., 2006). In this study, the similarities appeared to be sufficient to 
produce a fairly exhaustive dataset within ten interviews. 
The results of this study cannot be generalised to patients‘ receiving physiotherapy 
alone, as all patients were taking medication and a few had mentioned that they were using 
other methods to help them with their back pain. Also, whilst the data that emerged from 
this study was based on robust methods and thus the findings can stand alone, it is 
important to re-emphasise that the main purpose of this study was to use the data to 
develop a questionnaire (see Chapter 5).  
Furthermore, there were a few concepts such as ‗the motivation to continue taking 
medication‘ and ‗flexibility of taking treatment if you are travelling‘  appear  in the 
satisfaction literature (see Weaver et al., 1997) but did not emerge as key themes in this 
study. One reason for this may be that the sample was not diverse enough, or that these 
concepts are not specific to patients with CLBP receiving medication and/or 
physiotherapy. Note, though, that the satisfaction topics identified in Weaver et al., (1997) 
were found in a comprehensive literature review rather than the in-depth patient interviews 
used in this study that are recommended for development of conceptual models and 
questionnaires (see for example, Acquadro et al., 2003; Food and Drug Association, 2009). 
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In addition, it should be noted that there appears to be some overlap between the 
conceptual model of CLBP and its treatments and the thematic map of satisfaction and 
dissatisfaction with treatments for CLBP, and the proposed associations within each are 
not definite causal links. Thus, further empirical work is necessary to test the validity and 
reliability of the proposed conceptual model and thematic map. The conceptual model and 
thematic map do not show which concepts are more important than others and further 
studies should explore this question as well. 
One aspect requiring further consideration is that the use of a purposive 
homogenous sampling strategy may in part explain a sample comprised of mainly females, 
of narrow age range and occupational background.  Thus, additional studies could explore 
subgroups and identify thematic variability within a sample to establish the cohesiveness of 
themes/subthemes and its association to sample heterogeneity. Further, studies using other 
purposive sampling strategies could be considered and may provide alternative insights 
into patients‘ subjective experiences. For example, maximum variation sampling could 
help to establish central themes across patient variations such as patients with CLBP of 
different ages, or those with different occupational backgrounds. Alternatively, extreme 
case sampling could help consider patients‘ subjective experiences or the concept of 
treatment satisfaction in cases which are unusual or special in some way. For example, one 
might expect that patients with CLBP who were misdiagnosed or undiagnosed on several 
occasions are likely to have different experiences. 
It is important to acknowledge that the interview guide contained some closed 
questions that resulted in yes or no answers, and which were then followed up by, if yes, 
why, or if no, why not? Whilst such questions make it easy for patients to answer, the 
control of the interview generally remains with the interviewer and such questions may 
limit the detail and richness of data or result in shorter answers compared to open 
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questions. Open questions usually provide the interviewees with control of the 
conversation, and encourage patients to think and reflect as well as provide opinions and 
feelings. Also, they are often considered more objective and less leading than closed 
questions.  
Finally, to ensure confidentiality and for the convenience of patients, the interviews 
were performed in an enclosed office within Stepping Hill Hospital. However, whilst the 
room was quiet thus helping to facilitate discussions, it is rather official, and not the most 
relaxing and comfortable of environments. Consequently, such an environment may not 
necessarily help to get the most out of patients in terms of detailed discussions. Other 
environments such as interviewing in their home settings may be considered more 
comfortable for some patients. If the interviews were performed in patients‘ homes then 
some patients may have felt that the information provided to the interviewer was private 
compared to a hospital setting where they may consciously or unconsciously associate the 
interview questions with the environment and ultimately health professionals. Given that 
the interview topics centred on treatment satisfaction, this may have affected the results. 
For example, patients may have tried to provide more favourable responses.  On the other 
hand, some patients may feel that interviews performed at home are less private especially 
if family or friends are about, which may in turn also affect the results. Further research 
could explore patients‘ subjective experiences and the notion of treatment satisfaction in 
CLBP using more open-ended questions and in different environments.   
4.5.2 Reflexivity 
Reflexivity refers to the self awareness researchers have in terms of how they may 
influence the research conducted (Willig, 2001). Generally, all the interviews went very 
well. Patients were keen to talk about their experiences with CLBP. However, on 
reflection, during the first interview, as an enthusiastic researcher, I wrote many notes to 
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help later to support the interpretation of the data that would emerge from the transcripts. 
Gradually I became aware of the fact that as an interviewer, the process of writing notes 
reinforced the patient to talk more and taking notes was distracting them as they were more 
focused on giving the answer they thought they should give or checking what I had written 
was correct. Consequently, I modified my approach for all other interviews and wrote 
notes only in cases where it was absolutely necessary.  
Also, I was surprised to find that expectations as a concept had not emerged as a 
theme during the data driven process. I revisited the data at a later date to check and found 
one instance when a patient had talked about how satisfaction was related to their 
expectations. However, revisiting the audio-tapes of the interview and closer examination 
of the transcripts indicated that the patient was actually responding to being probed by me 
as the interviewer. Since the theme had not emerged during the original analysis, it was not 
included but this incident made me aware of how researcher‘s pre-conceptions can affect 
interpretation. 
These experiences and reflexivity made me more aware, and as a consequence the 
research process was an even richer experience. 
4.6 Conclusion 
The main purpose of the interviews was to explore CLBP patients‘ subjective 
experiences with treatment including their satisfaction and/or dissatisfaction with various 
aspects of their treatment. A conceptual model of CLBP was developed to show how 
widely CLBP impacts on patients‘ daily lives. The impact ranged from physical 
functioning and social functioning to influences on appearance, emotions, mood, self-
esteem, confidence, sleep, relationships, and sex. 
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A thematic map of satisfaction and dissatisfaction was also developed. Satisfaction 
was related to being ‗happy‘ or ‗pleased‘, maintaining general health and normal 
functioning. If the treatment was not working, causing discomfort, or negatively affecting 
their health-related quality of life then this was related to dissatisfaction. The 
inconvenience of taking medication, lack of information, not feeling involved in treatment 
decisions, lack of trust and confidence in healthcare professionals, being misdiagnosed or 
undiagnosed, and feeling healthcare professionals were not listening were key factors. 
Findings suggest satisfaction and dissatisfaction with treatments is a 
multidimensional concept. Further research should consider all key components.  
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Chapter 5 - Development and Cognitive Debriefing of the CLBP 
Treatment Satisfaction and Dissatisfaction Questionnaire 
This Chapter documents the development and cognitive testing of the CLBP 
Treatment Satisfaction Questionnaire. There are two parts to this Chapter. The first 
describes the development process and includes details of how the items (questions) and 
response options of the questionnaire were generated. The second part covers cognitive 
debriefing to generate evidence to support the face and content validity of the 
questionnaire. 
Part I: Development  
5.1 Introduction 
Results from the systematic review described in Chapter 3 revealed a need to 
develop a valid and reliable measure of treatment satisfaction and dissatisfaction that is 
based on rich qualitative data from in-depth interviews with patients with CLBP. Chapter 4 
presents results of a qualitative study exploring subjective experiences in patients with 
CLBP receiving treatment, based on face-to-face semi-structured interviews. This is part I 
of Chapter 5 and documents the development of the CLBP Treatment Satisfaction 
Questionnaire, including a description of the outcome of the item generation process.  
The content of a questionnaire is highly dependent on the item generation method, 
which can include a review of the literature and interviews or focus groups with HCPs 
and/or patients. There is some evidence to suggest that methods such as focus groups using 
clinicians do not generate as many items as those with patients. Further, as a method of 
item generation, clinician focus groups or interviews do not usually identify any new items 
compared to patient focus groups or interviews (Rat et al., 2007).  This is perhaps not 
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surprising since clinicians may be best observers of behaviours whereas patients are able to 
describe their subjective experiences (Streiner & Norman, 1999).  
Since capturing important and relevant concepts from patients‘ perspectives will 
increase the sensitivity of the instrument, data saturation is important at this stage. Further, 
ensuring item generation is performed accurately is critical since no statistics can 
compensate for poorly worded items, ambiguous or irrelevant concepts, or missing 
relevant concepts (Streiner & Norman, 1999). Ideally, items should be generated by 
avoiding double-barrelled questions, jargon, and value-laden words (Streiner & Norman, 
1999). 
5.2 Objectives 
The objective of this part of the study was to use information from in-depth patient 
interviews to develop items for a questionnaire to measure treatment satisfaction and 
dissatisfaction with treatments in patients with CLBP. 
5.3 Methods  
Details of participants, interview agenda, procedure, saturation, and data analysis are 
presented in section 4.3. For each theme and sub-theme associated with treatment 
satisfaction or dissatisfaction in patients with CLBP that emerged from the data driven 
thematic analysis (see Chapter 4), patient quotes were examined and items (questions) 
formulated. The open-ended questions asked during the patient interviews ensured all 
relevant concepts were covered. The first draft of the instrument was developed. The items 
of the questionnaire and the hypothesized domains were created following thematic 
analyses, and a close examination of how patients conceptually understood their 
experience of CLBP, symptoms and impact, as well as satisfaction and dissatisfaction with 
treatment (medication and/or physiotherapy). During the item generation process, 
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researchers avoided leading questions, double-barrelled questions, jargon, and value-laden 
words that may prejudice the patients and lead them to answer inaccurately (Streiner & 
Norman, 1999). In addition, items were kept short as possible (Oppenheim, 1992). Also, 
some terms used in the questionnaire were defined to ensure that all patients understood 
the term in the same way. 
A simplified measure of gobbledygook (SMOG) formula that gives a readability 
level for written material was used to test for readability (McLaughlin, 1969). Readability 
is an attempt to match the reading level of written material to the "reading with 
understanding" level of the reader (McLaughlin, 1969). 
5.4 Results 
5.4.1 Item Generation 
The emergent themes of the interviews (see section 4.4) were organized into a 
manageable format of six broad categories. These were: ‗Information Provided to You 
About Back Pain and Treatment‘, ‗About Your Medical Care‘, ‗Your Health‗, ‗Beliefs 
About Your Back Pain Medication‘, ‗Side Effects from Back Pain Medication‘, 
‗Satisfaction with Treatments for Back Pain‘.  The items that were developed related to 
these six broad categories, but there were also some items which did not easily fit within 
the categories but were related to how much pain the patient experienced, or their 
preferences for mode of administration. 
The purpose of the section ‗Information Provided to You About Back Pain and 
Treatment‘ was to gain insight into how much information patients would have liked to 
receive about their condition or injury, the causes of their back pain, and their back pain 
medications, including potential side effects of back pain medications. This section also 
assesses how much information patients would have liked about the treatment options 
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available (other than medications), as well as posture and positioning, goal setting (setting 
tasks to do), pacing (taking things gradually), and exercise. 
The section ‗About Your Medical Care‘ was developed to find out about patients 
beliefs regarding whether they thoughts doctors knew what was wrong with them, as well 
as their beliefs regarding whether they felt involved in treatment decisions, and whether 
they had been misdiagnosed. 
The purpose of the section ‗Your Health and Well-Being‘ was to ascertain to what 
extent patients felt their back pain interfered with regular activities, physical functioning, 
confidence, appearance, mood, relationships, and sleep. For example, questions relating to 
regular daily activities explored the extent to which patients felt they spent less time on 
tasks than they would have liked to, how much they were limited in the tasks that they 
could do, whether they stopped everyday tasks (including work), and whether they went 
out of the home.  
The section related to ‗Beliefs About Your Back Pain Treatments‘ explored the 
extent to which patients agreed or disagreed that their back pain medication was helpful, 
prevented future problems, enabled them to be independent (carry out everyday activities), 
and made them feel out of control. This section also explored whether patients altered the 
amount of medication they took, whether they set realistic goals, remembered to do their 
exercises, and paced their activities. 
The purpose of the ‗Side Effects from Back Pain Medication‘ section was to 
establish whether patients experienced side effects from their back pain medication, and if 
so, to what extent each side effect was a problem. Side effects included loss of appetite, 
weight gain, inability to concentrate, drowsiness, nausea, constipation, diarrhoea, stomach 
aches, heartburn, and inability to sleep. 
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The ‗Satisfaction with Treatments for Back Pain‘ section explored the extent to 
which patients were satisfied or dissatisfied with the communication with their doctor 
regarding back pain medication, the information provided about the possible side effects 
from back pain medication, the form of administration of back pain medication (e.g. tablet, 
injection, patch), the amount of medication prescribed, as well as the way doctors had dealt 
with the side effects of back pain medication. 
  Space was also provided at the end of the questionnaire so that patients could 
express any opinions or additional comments, which would bring to attention important 
concepts not captured by existing items or response options. Findings by Williams and 
Calnan (1991) indicated that specific questions and those of a qualitative nature are more 
likely to elicit responses reflecting dissatisfaction and therefore reduce response bias.  
It should be noted that as indicated above, the questionnaire covered a variety of 
concepts (e.g. quality of life, mood, physical functioning, and adherence). The rationale to 
include all these in a satisfaction questionnaire (rather than using different instruments to 
assess these) was driven in part by results from the patient interviews but also, from a 
practical perspective, it allowed a more standardised assessment across the concepts with 
regard to, for example, the instructions and response format. This was expected to help 
minimise the burden to patients and increase the likelihood of obtaining a complete 
meaningful dataset to measure treatment satisfaction in CLBP. Given that the various 
concepts were measured in a consistent manner, the data collected was then considered 
suitable for exploratory factor analyses to consider a total score of treatment satisfaction or 
various principal components. 
The items of the questionnaire varied in terms of direction and were usually 
developed using the same language that patients had used. Consequently, since CLBP was 
generally described by patients negatively, for example, in terms of limiting their physical 
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abilities, the direction of the items of the questionnaire was generally more negatively than 
positively worded. All items were written in the first person. The draft of the questionnaire 
contained 113 initial items. The questionnaire had a SMOG grade of 11, suggesting 
patients do not need college education to understand the questionnaire. 
5.4.2 Recall Period  
The majority of items referred to patients‘ experiences (such as those that relate to 
the impact of back pain and its treatment on patients‘ lives or the experience of side effects 
from treatments) and usually stared with the stem, ‗During the last 7 days…‘ The rationale 
for using a 7-day recall period was to avoid the problem of being influenced by a good day 
or a bad day; a longer than 7-day recall period has the potential to increase measurement 
error via recall bias. In addition, a 7-day recall period was deemed appropriate given the 
nature of CLBP, as well as its treatment and management, as patients with CLBP often 
visit a HCP such as a physiotherapist once a week. This rationale is in line with a recent 
published article that suggests that recall can be influenced by characteristics of the 
recalled concept (e.g. attributes and complexity), as well as by the context or meaning of 
the recalled concept (e.g. patient experience and mood) (Stull, Leidy, Parasuraman, & 
Chassany, 2009). 
However, there were some questions where a 7-day recall period did not apply 
including questions related to the amount of information that a patient would have liked to 
have received about the causes of their back pain, their back pain medication, and potential 
side effects. In addition, items related to initial diagnosis and involvement in treatment 
decisions did not specify a recall period since the timeframe for each patient may have 
varied significantly from around 12 weeks (or 3 months) to several years. Further, all 
attitudinal or belief related items such as satisfaction and dissatisfaction items or how 
helpful they perceive medication to be were developed to assess patients‘ current opinions, 
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since retrospective assessment of satisfaction and/or dissatisfaction was considered too 
complex for patients and likely to generate inaccurate responses. 
5.4.3 Response Options 
The majority of items were measured on a 5-point Likert scale, which is the most 
widely used standard response option for survey research (Likert, 1932). For example, 
response options to items in to the ‗Health and Well-Being‘ section ranged from 1 (‗all of 
the time‘) to 5 (‗none of the time‘).  Response options to satisfaction items ranged from 1 
(‗very satisfied‘) to 5 (‗very dissatisfied‘). A Likert-type scale allows for non forced-choice 
answers so that respondents can answer neutrally (Guy & Norvell, 1977). Furthermore, 
Likert-type scales are more valid than forced-choice scales because they reduce consenting 
response bias, and are therefore considered more reliable (Ray, 1990). 
5.4.4 Instructions 
Because this is a self-administered questionnaire, there was an introductory section 
included to set the scene and explain to patients how they should read and answer the 
questionnaire. Specifically, the instructions stated ―This questionnaire asks for your views 
about your back pain and your treatment. Please read the following statements carefully 
and then place a circle around the most appropriate number that applies to you.‖ 
5.4.5 Draft Conceptual Framework 
A conceptual framework outlines the relationships between the various aspects of 
the concepts being measured in a questionnaire and demonstrates hypothesised domains 
(factors) (Food and Drug Association, 2009).  In the case of the satisfaction questionnaire, 
the conceptual framework shows how the items that were generated from patient 
interviews relate to each other and whether they can be summarized by factors or sub-
concepts.  It also demonstrates how the sub-concepts are linked to the overall concept of 
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‗satisfaction‘. The draft conceptual framework that was used to group items in draft 
versions of the satisfaction questionnaire is illustrated below Figure 9. 
This conceptual framework categorised items according to Information Provided 
about Back Pain and Treatment, About Medical Care, About Health, Beliefs About Back 
Pain Treatment, Side Effects from Back Pain Medication, and Satisfaction with Treatments 
for Back Pain. However, it is important to note that items could be grouped in other ways 
or can be studied as individual items, as in the case of the side effects related to CLBP 
medications.  Further, please note that patients were encouraged to talk about their 
experiences regardless of the proposed categorisation. 
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Figure 9: Draft Conceptual Framework of the Treatment Satisfaction and Dissatisfaction 
Questionnaire 
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4.3a. I planned before I did things 
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5.5 Discussion 
The aim of this part of the study was to develop a draft questionnaire to measure 
satisfaction or dissatisfaction with treatments (medication and/or physiotherapy) for CLBP 
relief from patients‘ perspective. Items were generated from in-depth patient interviews 
based on data driven thematic analysis (see Chapter 4). The draft questionnaire had six 
broad categories: ‗Information Provided to You About Back Pain and Treatment‘, ‗About 
Your Medical Care‘, ‗Your Health‗, ‗Beliefs About Your Back Pain Medication‘, ‗Side 
Effects from Back Pain Medication‘, and ‗Satisfaction with Treatments for Back Pain‘.  In 
addition to questions in these six broad categories, there were some items which seemed 
independent but were related to how much pain the patient experienced or their preferences 
for a particular mode of administration (e.g. tablet, injection etc.).  
Whilst a SMOG grade 11 was obtained, suggesting patients do not need college 
education to understand the questionnaire, cognitive debriefing interviews are required to 
establish with greater certainty the face and content validity of the draft questionnaire, and 
to ensure that patients truly understand the questions. 
Further, it should be noted that the draft questionnaire is long and contains 113 items. 
This means that it is subject to fatigue and burden to patients during completion, which 
may affect the responses they provide to questions. Despite this limitation, item reduction 
was not implemented at this stage since all the concepts included were deemed important 
from the patients‘ perspective and derived as a consequence of data driven thematic 
analysis. This is in line with recent papers that suggest that patient-reported questionnaires 
should be developed in this way (Turner et al., 2007). Section 5.7 of this Chapter discusses 
the cognitive debriefing interviews that were performed and in Chapter 6 factor analysis 
and reliability and validity testing are described. Following the latter, items could be 
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removed from the total scoring algorithm or deleted from the entire questionnaire if 
statistically they do not perform adequately and if closer reflections of the qualitative 
analyses support such decisions.  
The majority of items that referred to patients experiences had a 7-day recall period 
(‗During the last 7 days…‘).  Some items related to concepts like ‗initial diagnosis‘ where 
the recall period may vary significantly between patients (from around 12 weeks to several 
years) or ‗involvement in treatment decisions‘ where the aim of data collection was to 
understand the extent to which patients felt involved in treatment decisions, did not have 
specific recall periods. Further, all attitudinal or belief related items, such as satisfaction 
and dissatisfaction items, were developed to assess patients‘ current opinions since 
retrospective assessment of satisfaction and/or dissatisfaction was considered too complex 
for patients and likely to generate inaccurate responses.  
It should be noted that a mixed recall period is not ideal and could be confusing to 
patients. The decision to retain this approach was based on the principle that patients‘ 
evaluations of their experience during the reference period is what matters most, rather 
than the accuracy of recall of every single experience leading to that judgment. Also, any 
response process relies on cognitive processing and to some extent on memory, and even 
‗current state‘ is open to interpretation. In any case, the draft questionnaire will be further 
tested during cognitive debriefing interviews with particular attention to the recall period 
of items. 
Also, based on the item generation process, a proposed conceptual framework was 
developed to present a graphical representation of the hypothesized associations between 
the items of the questionnaire and the potential domains (factors). This warrants further 
testing. 
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5.6 Conclusion 
The CLBP Treatment Satisfaction Questionnaire captures concepts relevant to 
patients. Its face and content validity requires testing using a cognitive debriefing exercise 
(see Part II). 
Part II: Cognitive Debriefing 
5.7 Introduction 
During patient-reported questionnaire development, it is important to ensure that the 
items are based on rich qualitative data that ideally emerged from in-depth patient 
interviews or focus groups (Turner et al., 2007). Further, achieving saturation during this 
first step provides evidence that the concept one purports to measure is comprehensive and 
captures all the relevant aspects from patients who describe their subjective experiences 
with the condition and treatment of interest. The outcome of part I of this Chapter was a 
draft questionnaire to measure satisfaction and dissatisfaction with treatments (medication 
and/or physiotherapy) for CLBP relief (Appendix H).  
The next step was to ensure that the items and response options that comprise the 
draft questionnaire are truly understood by patients with CLBP receiving treatment, and 
that the questionnaire is relevant to them. It should be emphasised that the focus is 
ensuring that patients understand the concepts and items rather than saturation. Cognitive 
debriefing interviews allow us to test for relevance and comprehension, including whether 
the questionnaire has face and content validity (Turner et al., 2007). Face validity is 
whether the questionnaire appears to measure what it purports to measure, and content 
validity is whether the questionnaire contains all the relevant items and concepts related to 
the phenomenon of interest, in this case satisfaction or dissatisfaction with treatment 
(Oppenheim, 1992). 
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5.8 Objectives 
The main objective of this part of the study was to perform face and content 
validation of the items developed to measure satisfaction and dissatisfaction with 
treatments for CLBP relief. The ultimate aim was to produce a version of the questionnaire 
that was clear, comprehensive, and relevant. 
5.9 Method 
The questionnaire was scrutinised by colleagues and potential users of the 
information generated by the questionnaire (for example, 2 psychologists and 2 
physiotherapists and a nurse working with patients with CLBP). Additionally, before 
carrying out the main study, a cross-section of patients who met the inclusion criteria and 
none of the exclusion criteria participated in a cognitive debriefing exercise to establish the 
face and content validity of the questionnaire (see section 5.9.1).  These patients were 
different to those who participated in part I. 
5.9.1 Participants 
Ten patients with CLBP participated and varied in age from 32 to 58 years (mean 
age 46 years). There were six women and four men. Patients were recruited from one NHS 
Trust in the North of England (Stepping Hill Hospital) via physiotherapists.  
Purposive sampling was performed where patients attending a pain clinic and/or 
receiving physiotherapy were screened. They were considered eligible if they met all of the 
inclusion criteria and none of the exclusion criteria which were pre-specified on a 
screening script (Appendix C). Please note these were criteria as the initial interviews. The 
inclusion criteria were:  
 Patient diagnosed with CLBP (pain lasting longer than 12 weeks, affecting the 
lower back, between the bottom of the ribs and top of the legs); 
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 Patient was receiving treatment for CLBP, or advised by their doctor to do so;  
 Patient was 18 years or older;  
 Patient was able to understand and communicate in English.  
The exclusion criteria were:  
 Patient had known cognitive impairment;  
 Patient had a case-note diagnosis of co-morbid learning disabilities;  
 Patient was currently using alcohol or illegal drugs;  
 Patient had brain injury or any other organic disorder. 
5.9.2 Interview Agenda 
A cognitive debriefing interview agenda was developed for patients with CLBP 
receiving treatment and was partly informed by knowledge from the in-depth semi-
structured patient interviews (see Chapter 4), as well as the draft questionnaire. The 
content of the interview agenda was decided upon based on two independent researchers‘ 
opinions according to the research question, and was designed as much as possible move 
from general questions to more specific questions when rapport had been established.  
The first step involved asking patients an open-ended question, ‗what does 
satisfaction with treatment mean to you?‘, followed by another open question,  ‗what does 
dissatisfaction mean to you?‘ Patients then completed the draft questionnaire to familiarise 
themselves with the instructions, items, and response options. Next, the interview explored 
patients‘ general impressions of the questionnaire, including general feelings about ease or 
difficulty understanding the questionnaire, opinions about the instructions and length of the 
instructions, what they thought of the length of the questionnaire, and whether anything 
needed to be added or deleted. Outpatients were also asked whether there were any 
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questions that were unclear and what they thought of the layout. This section also enquired 
about the appropriateness of the response options to the questions and the relevance of the 
recall period in terms of how far back patients were thinking when answering the 
questions.  
Following the general impressions section, more specific questions were asked 
regarding each aspect of the questionnaire, including the title, instructions, the statement 
before the items, and each item. These specific questions were ‗Did you have difficulty 
understanding the question?‘, ‗What does it mean to you?‘, ‗Is it relevant to your 
situation?‘, ‗How would you have worded the question?‘, and ‗Are the response choices 
clear and consistent with the question?‘ At the end of the cognitive debriefing agenda, 
patients were asked whether there were any questions or areas missing from the 
questionnaire. 
5.9.3 Procedure 
The Head of the Physiotherapy Department at Stepping Hill Hospital agreed to 
identify physiotherapists in their team who could help to recruit patients into the study 
according to the screening script. The physiotherapists who agreed to help were briefed 
regarding the purpose of the study and the inclusion/exclusion criteria for recruitment of 
patients (see Appendix C). If patients met all of the inclusion criteria and none of the 
exclusion criteria, they were informed by the physiotherapist that a study was taking place 
to explore their experiences with CLBP and their opinions about a questionnaire. Patients 
who were interested were provided with an information sheet and completed a consent 
form (see Appendix D and E). An interview date and time was then arranged. 
At the start of the interview, patients were briefed and consent forms were obtained 
from patients. They were assured anonymity and were informed that they had the right to 
withdraw at any time. They were also informed that any decision to withdraw would not 
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affect the treatment and care that they receive in any way. Once the patient was 
comfortable, the tape recorder was switched on and they were asked to repeat their consent 
to participate for recording purposes. Patients then responded to some questions before 
being asked to complete the draft questionnaire so that they were familiar with it. Any 
problems or questions incurred during completion or observed by the interviewer were 
recorded. Then the cognitive debriefing interview continued according to the interview 
agenda (see section 5.9.2). 
The interviews lasted between 35 and 60 minutes, depending on how much each 
patient wanted to say. The interviewer was female and all interviews were conducted in an 
enclosed office at Stepping Hill Hospital to ensure confidentiality. All patients were asked 
identical questions in the same sequence, but the interviewer probed inductively on key 
responses, and probes were asked only if a patient‘s response to the initial question did not 
cover certain topics of interest. 
All interviews were audio-taped and transcribed verbatim by the researcher to allow 
greater familiarity with the data prior to analyses. A tracking form was used to ensure the 
data generated from a specific interview was identifiable via patient identification numbers 
thus ensuring anonymity. The tracking form was stored on a password protected laptop 
computer. 
5.9.4 Analysis of Cognitive Debriefing Interviews 
Transcripts were analysed in-depth and quotes were arranged using an Excel 
spreadsheet into appropriate sections relating to satisfaction or dissatisfaction with 
treatment, general impressions of the draft questionnaire (overall opinion, length of 
questionnaire, instructions, items, recall period, and response options), as well as details 
relating to cognitive debriefing of each aspect of the questionnaire (for example, the title, 
instructions, and items). 
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5.10 Results 
5.10.1 Demographic Characteristics 
Ages ranged from 32 to 58 years. The overall mean age was 46 years. There were 
six women and four men. The majority of patients had no qualifications (n=8), and two had 
O-levels. Eight patients were unemployed, and two worked part time. All patients reported 
that their work was limited by their CLBP. 
Symptoms recorded on patients‘ case notes included pain in lower back; numbness 
in back; constant ache and intense pain; lack of strength in back; and unable to walk long 
distances. Duration since first diagnosis varied from four months to 34 years. 
Patients were receiving a number of different medications for CLBP relief, 
including non-opioid analgesics (such as paracetamol or cocodamol) (n=8), NSAIDs 
(ibuprofen, diclofenic, or naproxen) (n=9), opioid analgesics (codeine or dihydrocodeine) 
(n=3), benzodiazepines (diazepam) (n=3), and tricyclic antidepressants (amitriptiline) 
(n=1). Most were taking these medications as required. Side effects reported in patients‘ 
case notes included loss of appetite, nausea, and constipation. In addition to taking 
medications for CLBP relief, all patients were seeing a physiotherapist regularly. 
5.10.2 Satisfaction and Dissatisfaction with Treatments for CLBP Relief 
When asked ‗what does satisfaction with treatment mean to you?‘ patients with 
CLBP described positive opinions of treatment such as being ‗pleased‘ and ‗content‘ with 
the treatment. Patients described getting rid of the pain. They also mentioned that for them 
to be satisfied, the medication needs to work quickly, and they need to be able to continue 
with their everyday activities such as going to work or doing housework. Satisfaction with 
treatment was also associated with good communication with HCPs such as doctors and 
physiotherapists, and being provided with information regarding treatment options and the 
 Page 174 of 458 
potential consequences of medication such as side effects. It was important to patients that 
their HCP or a family member such as a partner was taking their complaints about back 
pain seriously. Experiencing side effects influenced the level of satisfaction with treatment. 
When asked ‗what does dissatisfaction with treatment mean to you?‘ all patients 
said that it was the opposite of satisfaction with treatment and referred to negative aspects 
of treatment. Patients talked about their medication not working, experiencing constant 
pain, and this impacting their lives in terms of what they could do every day. Some patients 
mentioned that they had become extremely cautious about everything that they did, and 
had lost self confidence. Others talked of how it had affected their self esteem, appearance, 
and their relationship with their partners. Being misdiagnosed or undiagnosed for a 
significant time contributed to dissatisfaction with treatment. Experiencing side effects and 
the extent to which those side effects were a problem to patients were also associated with 
dissatisfaction. 
5.10.3 General Impressions of the Draft Questionnaire 
To help establish the usability of the draft questionnaire, patients with CLBP were 
asked their opinions about its coverage and format. Patients were asked to complete the 
draft version of the questionnaire first.  
Overall, the majority of patients were positive about the questionnaire and reported 
that it was ―helpful‖ and ―relevant‖. One patient (ID09) stated, ―These questions are good. 
I have never been asked these questions in 20 years!‖ Another patient (ID06) mentioned 
that although it was quite long, they didn‘t mind it because it was related to their problems. 
When asked if there was anything missing from the questionnaire, patients did not 
contribute any additional suggestions. 
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In terms of the length of the questionnaire, one patient (ID03) suggested making the 
questionnaire shorter, and another two patients stated it was too long (ID04; ID07). 
However, another patient (ID05) stated the length of the questionnaire was ―just right‖. 
Therefore, the questionnaire was reviewed for overlapping items. For example, ‗I felt I 
gained weight‘ was deleted from the ‗Health‘ section of the questionnaire because ‗weight 
gain‘ was already an item in the ‗Side Effects from Back Pain Medication‘ section, and 
based on informal discussions with HCPs it was felt that weight gain was more a 
consequence of the medication than of the back pain.  
Generally, the instructions of the draft questionnaire were well understood. 
However, one patient (ID03) stated it would be helpful to explain in the instructions why 
the questionnaire focuses on ‗7 days‘ rather than ‗since your diagnosis‘ or ‗since the start 
of treatment‘. Another patient (ID02) stated that they thought the questionnaire was in 
relation to their physiotherapy class. Consequently, treatment was operationally defined in 
the instructions to specify ‗medication and/or physiotherapy‘. 
With regard to the recall period of 7 days, one patient (ID02) mentioned that they 
felt the recall period was too short and that they wanted to review all the time that had 
passed since their CLBP diagnosis. However, this change was not implemented since there 
is some evidence to suggest recall bias and measurement error are associated with longer 
recall periods (Stull et al., 2009). 
Further, all the patients reported that the response options were relevant to the 
questions. However, one patient (ID01) stated that it may be useful to include ‗not 
applicable‘ responses for some items, such as those relating to oral, injection or patch 
treatments. With this in mind, ‗not applicable‘ options were added to the draft 
questionnaire for items such as whether the back pain interfered with relationships, since 
not all patients may have a partner or family. However, the ‗not applicable‘ option was not 
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added to items associated with mode of administration because those items were preceded 
by answering questions regarding how back pain medication is administered (oral, 
injections, patch) and then requiring patients to complete only the sections that apply to 
them. 
5.10.4 Cognitive Debriefing Items  
A total of 26 items were deleted since they overlapped with other items in the 
questionnaire, and one item was modified following face and content validation (Table 10). 
For example, the item ‗How much back pain have you had in the last 24 hours?‘ was 
deleted to minimise the number of questions and duplication, and also because patients‘ 
responses did not vary compared to the question ‗How much back pain do you have right 
now?‘ which was retained.  
One patient (ID01) suggested  changing ‗1 week‘ to ‗7 days‘ to make the 
questionnaire more consistent. Thus, the item ‗How much back pain have you had in the 
last week?‘ was modified to ‗How much back pain have you had in the last 7 days?‘ 
Another patient (ID03) recommended that the section ‗Symptoms of Back Pain‘ 
with items such as ‗Pain in back‘, ‗Pain in legs‘, ‗Pins and needles‘, ‗Numbness‘ and 
‗Stiffness‘ were too similar to the section ‗About Your Back Pain‘. Consequently, these 
items were deleted since closer examination of the qualitative data that emerged from 
Chapter 5 indicated that patients described pain as the main symptom, and the location or 
description of pain was not mentioned as important in terms of the concept of satisfaction 
or dissatisfaction with treatment. 
Discussing the item ‗I stopped doing sports‘, two patients (ID04; ID07) stated that 
they never did any sports in the first place. Thus this item was deleted because it was not 
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necessarily relevant to everyone and the concept of not being able to do sports could be 
captured by other items, such as ‗I stopped doing my everyday tasks‘.  
Another patient (ID05) mentioned that the item ‗I felt depressed‘ was too similar to 
‗I felt life was not worth living‘. Consequently, ‗I felt depressed‘ was deleted, as this could 
still be captured by ‗I felt life was not worth living‘. 
In addition, the items ‗I did not sleep well‘ and ‗It was difficult to get comfortable 
to get to sleep‘ were both deleted since three patients (ID04; ID08; ID10) indicated that 
these were too similar to the item ‗Inability to sleep‘ in the Side Effects from Back Pain 
Medication section. 
One patient (ID10) mentioned that all items relating to relationships were only 
relevant if you have a partner; another patient (ID01) similarly critiqued the item ‗I could 
not relax with my partner‘. These statements reinforced the decision to include ‗not 
applicable‘ to the response options for items relating to relationships.  
Further, the items ‗My partner was frustrated‘, ‗My partner felt guilty‘, and ‗My 
partner treated me as fragile‘ were deleted because three patients (ID01; ID03; ID10) 
stated that their partner‘s feelings had nothing to do with CLBP. These items were also 
deleted because the draft questionnaire was intended to capture patients‘ subjective 
experiences, and on reflection these items were proxies (the patient was reporting on behalf 
of their partner) and thus results may not have been accurate. Also, the item ‗I tried not to 
worry my family‘ was deleted because one patient stated that this was the same as ‗I did 
not want to burden others with my problems‘. 
The section ‗About Your Current Medication‘ was reworded to ‗Beliefs About 
Your Back Pain Medication‘, as one patient (ID06) said that this section was more about 
beliefs and therefore should say so.  
 Page 178 of 458 
Also, in relation to the section ‗How satisfied or dissatisfied are you with the 
following...‘ and the item ‗the care provided for my back pain‘, one patient (ID07) stated 
that the term care was too generic and could relate to hospital care, GP, physiotherapy, 
help at home, or other types of care.  In line with the patient‘s suggestion, this item was 
deleted because it was too broad. 
Table 10: Summary of Deletions and Modifications to Draft Questionnaire Following Face 
and Content Validation 
Original Item Modified /Deleted Rationale for Change 
1c. How much back pain have you 
had in the last 24 hours? 
Deleted Overlapped with 1b. How much back pain 
do you have right now? 
2a. Pain in back Deleted Pain is the main symptom and the location 
or description is not important in relation to 
satisfaction or dissatisfaction with 
treatment. 
2b. Pain in legs Deleted 
2c. Pins and needles Deleted 
2d. Numbness Deleted 
2e. Stiffness Deleted 
4j. Injections Deleted Item was considered not essential and not 
relevant to many patients. 
5.1d. I stopped doing tasks I 
wanted to do 
Deleted Overlapped with 4.1c. I stopped doing my 
everyday tasks. 
5.1e. I stopped doing sports Deleted Not relevant to all patients and overlaps 
with 4.1c. I stopped doing my everyday 
tasks. 
5.2a. I went to work Deleted Not relevant to all patients and overlaps 
with 4.1c. I stopped doing my everyday 
tasks. 
Also, physical limitations can refer to 
walking or bending and this overlaps with 
other items e.g. 5.3a. I was able to do 
physical activities. 
5.2b. I was unable to work due to 
my physical limitations 
Deleted 
5.2c. It was difficult to be positive 
at work 
Deleted 
5.6a. I felt I gained weight Deleted Overlapped with 7b. Weight gain. 
5.7.e I was annoyed Deleted Overlapped with 5.7c. I was frustrated. 
5.7i. I felt depressed Deleted Overlapped with 5.7h. I felt life was not 
worth living. 
 
5.8a. I did not sleep well Deleted Overlapped with 7j. Inability to sleep. 
5.8b. It was difficult to get 
comfortable to get to sleep 
Deleted 
5.9b.I was interested in 
relationships 
Deleted Overlapped with 5.9a. I did not want anyone 
near me. 
5.9d.I tried not to worry my 
family 
Deleted Overlapped with 5.9c. I did not want to 
burden others with my problems. 
5.9f. I did not have sex Modified Reworded positively: ‗I was sexually active‘ 
5.9h. My partner was frustrated Deleted Feelings about partners are not necessarily 
linked to CLBP. Also, draft questionnaire 
intended to measure patients‘ subjective 
experiences rather than a proxy for partners. 
5.9i. My partner felt guilty Deleted 
5.9j. My partner treated me as 
fragile 
Deleted 
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Original Item Modified /Deleted Rationale for Change 
5.9k. People around me were 
sympathetic 
Deleted Overlapped with 5.9m. People around me 
did not understand. 
8a. The care provided for my back 
pain. 
Deleted Care was considered too broad and covers 
for example, hospital, GP, physiotherapy, 
help at home. 
8b.The communication between 
myself and health professionals 
regarding my back pain 
medication 
Modified ‗Healthcare professional‘ replaced with 
‗doctor‘ because they prescribe the 
medication. 
8c. The information provided 
about the treatment options 
Deleted Overlapped with 4c. Treatment options 
available (apart from back pain medication). 
8g. The amount of time taken to 
take my back pain medication 
Deleted Not meaningful since the time taken for 
most medications are minimal. 
 
5.10.5 Revised Questionnaire and Conceptual Framework 
Following the modifications outlined in Table 10, the questionnaire and conceptual 
frameworks were revised (Appendix J and K). 
5.11 Discussion 
The cognitive debriefing interviews demonstrated that patients liked this 
questionnaire because it was relevant to them. The majority of items were well understood 
and appropriate to patients with CLBP receiving treatment. Twenty-six items were deleted, 
the main reason being that they overlapped with other items in the questionnaire that were 
more appropriate. When asked if there was anything missing from the questionnaire, all of 
the patients stated that there was nothing missing, and none contributed anything additional 
beyond what was already in the questionnaire. However, there were a few minor 
modifications to either operationally define treatment, clarify the recall period, or to be 
more specific in the section titles. The deletion of items and minor modifications were 
implemented to form a revised draft questionnaire (see Appendix J). 
However, it should be emphasised that although the items of the questionnaire were 
reviewed for overlap and some minor modifications implemented, further changes to 
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shorten the draft questionnaire were not implemented since item reduction should follow 
factor analysis as well as reliability and validity testing.  
Further, one patient thought the recall period should extend beyond 7 days, but this 
was not implemented because there is some evidence to suggest that long recall periods are 
subject to recall bias and are more likely to incur measurement error (Stull et al., 2009). It 
should be noted that Chapter 6 presents the main study where the revised questionnaire is 
implemented over time. For patients recruited from a physiotherapy clinic, data was 
collected during the first week of treatment (day 1 to 7), second week of treatment (day 8 
to 14), and six weeks from the start of treatment (day 33 to 42). 
Also, a 7-day recall period was not used for some items in the questionnaire since it 
was not considered appropriate. For example, retrospective assessment of satisfaction or 
dissatisfaction items was considered too complex for patients. Indeed, this was in line with 
a comment from a patient with CLBP who stated that 7 days was not long enough for them 
to report their satisfaction with treatment. One point for consideration is that whilst the 7-
day recall period was included for some sections but not others, it‘s possible that some 
patients may miss this subtlety and this could have some impact on results. 
5.12 Conclusion 
The CLBP Treatment Satisfaction Questionnaire has good face and content 
validity. Patients find the items very relevant, and understand the questions and associated 
response options. The recall period is also relevant to patients in the context of CLBP. 
Psychometric validation is necessary to establish the factor structure and scoring method, 
as well as explore whether the questionnaire has discriminative validity and reliability (see 
Chapter 6). 
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Chapter 6 - Study III: Psychometric Testing of the Treatment 
Satisfaction and Dissatisfaction Questionnaire 
6.1 Introduction 
Chapter 5 documents the development and face and content validity of the CLBP 
Treatment Satisfaction Questionnaire. This Chapter explores the psychometric properties 
of the questionnaire in terms of validity and reliability. 
Instrument validity is concerned with the extent to which the questionnaire is 
measuring what it purports to measure (British Psychological Society Steering Committee 
on Test Standards, 1999). When testing the validity of an instrument, it is important to 
know the content of the questionnaire, the purpose the questionnaire is intended for and the 
type of validity being applied (Oppenheim, 1992).  If a test is not reliable, it is unlikely to 
be valid. There are different types of validity, including but not limited to face and content 
validity (which is demonstrated in part II of Chapter 5), construct validity, concurrent 
validity, clinical validity, and discriminant validity. It‘s not necessary to assess all types of 
validity, but the methods chosen should be based on the project objectives, resources, and 
needs. The statistical methods for testing validity and the reasons for using these methods 
in the present study are outlined below (section 6.3.8). 
Reliability is often referred to in terms of consistency or repeatability (Kline, 2000). 
The British Psychological Society (BPS) Steering Committee on Test Standards refers to 
reliability as ―the extent to which the outcome of a test remains unaffected by irrelevant 
variations in the conditions and procedures of testing‖ (British Psychological Society 
Steering Committee on Test Standards, 1992). The BPS Steering Committee also state that 
reliability reflects accuracy and precision (British Psychological Society Steering 
Committee on Test Standards, 1999). There are various types of reliability, including but 
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not limited to internal consistency and test-retest reliability. The statistical methods for 
measuring reliability and rationale for these methods in this study are provided in section 
6.3.8. 
6.2 Objectives 
The main objective of this part of the study was to explore the psychometric 
properties of the CLBP Treatment Satisfaction Questionnaire. The ultimate aim was to 
produce a reliable and valid version of the questionnaire. The second objective was to 
construct a framework to make sense of factors associated with treatment satisfaction in 
CLBP. 
6.3 Methods 
6.3.1 Study Design 
This study was a longitudinal study that involved collected data from the same 
sample at three timepoints (Table 11). The rationale for a longitudinal design was that it 
enabled a large number of patients to be compared at the same time, provided data that was 
sufficient to enable an exploration of the factor structure(s) of the questionnaire (The 
CLBP Treatment Satisfaction Questionnaire), as well as allowing exploration of test-retest 
reliability, and responsiveness to change over time.  
For patients recruited from physiotherapy clinics, the week 1 assessment was prior 
to the first consultation, week 2 was the first follow-up (varied between day 8 and day 14), 
and week 6 was the last, end of study (EOS) assessment (varied between day 33 and 42). 
For patients recruited from the Back Show in London, there were no follow-ups and of 
those patients who were receiving physiotherapy in this group, patients may have had more 
than one consultation at baseline. 
 Page 183 of 458 
Table 11: Schedule of Assessments 
Questionnaires Week 1 – 
Baseline 
[prior to 1st 
consultation] 
Week 2 – 1st 
Follow-up 
[Day 8 – 14] 
Week 6 – EOS 
[Day 33 - 42] 
Demographic & clinical details x   
Satisfaction x x x 
Change question  x x 
Adherence x x x 
SF-36 x x x 
PETS x x x 
McGill PAIN x x x 
Roland & Morris x x x 
6.3.2 Participants 
Two-hundred and fifty participants took part in the study and presented with CLBP 
as their primary complaint. All participants were above 21 years of age, ranging from 21 to 
77 years, with a mean of 47.86 years. 173 (70%) participants were female. Participants 
were recruited by a researcher (DR) at the Back Show in London in October 2008, or were 
consecutive referrals from an Extended Scope Practitioner (ESP) to a physiotherapist or a 
pain clinic.  Participants were included in the study if they fulfilled all of the following 
criteria: 
 Had a diagnosis of CLBP (defined as pain lasting longer than 12 weeks, affecting 
the lower back, between the bottom of the ribs and tops of the legs); 
 Were receiving treatment for CLBP (medication and/or physiotherapy), or had been 
advised by their doctor to do so; 
 Were able to understand and communicate in English; 
Participants were excluded if they had any one of the following: 
 Known cognitive impairment; 
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 Case note diagnosis of co-morbid learning disabilities; 
 Were abusing alcohol or taking illegal drugs; 
 Had brain injury or any other organic disorder. 
6.3.3 Sample Size 
As there is no formal method to estimate sample size, in order to conduct an 
exploratory factor analysis, the generally accepted rule of 3 participants for every item was 
employed (Mundform, Shaw, & Ke, 2005).  
There were 77 items to be included in the exploratory factor analysis, and therefore 
it was estimated that 231 (77x3) patients was an acceptable sample size. This figure was in 
line with Comrey and Lee (1992) who stated that a sample size of 200 was ―fair‖, 300 
―good‖ and 500 ―very good‖. 
6.3.4 The CLBP Treatment Satisfaction Questionnaire 
All participants completed the revised CLBP Treatment Satisfaction questionnaire 
which had been developed specifically for this study and consists of 87 items. Seventy-
seven items were included in the validation study.  The remaining items provided 
additional qualitative information and were therefore not included in the PCA.  
6.3.5 Other Patient-Reported Outcome Instruments  
The following other patient-reported instruments were completed by participants: 
The Adherence Questionnaire (Horne, 1997); The Short Form 36 Item Health Survey 
(Ware & Sherbourne, 1992); The Problematic Experiences of Therapy Scale (Yardley & 
Kirby, 2006); The McGill Pain Questionnaire (Melzack, 1987); and the Roland and Morris 
Disability Questionnaire (Roland & Morris, 1983) (see Appendix M to Q). The main 
reason these questionnaires were included were because together they covered the main 
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topics of interest that emerged from the patient interviews in Chapter 5, and which would 
allow various psychometric testing of the CLBP Treatment Satisfaction Questionnaire to 
be performed.  
The Adherence Questionnaire (Horne, 1997) 
The adherence questionnaire contains the following five items which were analysed 
independently because there was little evidence of reliability and validity: 1) I forget to 
take my medicines; 2) I alter the dose of my medicines; 3) I stop taking my medicines for a 
while; 4) I decided to miss a dose; and 5) I take less than instructed. All items are rated on 
the following scale: always, often, sometimes, rarely, and never. 
The Short Form 36-Item Health Survey (Ware & Sherbourne, 1992)  
The Short Form 36 Item Health Survey (SF-36) version is a self-administered 
questionnaire that contains 36 items comprising eight domains: Physical Functioning (10 
items); Role Limitation due to Physical Health Problems (4 items); Bodily Pain (2 items); 
General Health Perceptions (5 items); Vitality (4 items); Social Functioning (2 items); Role 
Limitations due to Emotional Problems (3 items); and General Mental Health (5 items). 
There are also Physical and Mental Component Summary scores. There is an additional 
single item giving information on health change over the past year. The response options 
for items vary between items. For example, some items have a dichotomous response 
option (yes or no), some have three response options (yes limited a lot, yes limited a little, 
and no not limited at all), and others are on a 5-point Likert scale (all of the time, most of 
the time, a good bit of the time, some of the time, and a little of the time). Item scores for 
each domain are coded, summed and transformed to a scale from 0 (worst possible health 
state measured by the questionnaire) to 100 (best possible health state). The higher values 
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indicate a better evaluation of health. The SF-36 is well-documented in terms of reliability 
and validity (see for example, Ware & Sherbourne, 1992). 
Problematic Experiences of Therapy Scale (Yardley & Kirby, 2006) 
The Problematic Experiences of Therapy Scale (PETS) is a self-administered 
questionnaire composed of 12 items forming four domains: Symptoms too severe or 
aggravated by therapy (3 items); Uncertainty about how to carry out the treatment (2 
items); Doubts about treatment efficacy (3 items); and Practical problems (such as lack of 
time or opportunity, forgetting) (4 items). All items are scored on a scale of 1-5, with 1 = 
disagree strongly and 5 = agree strongly.  The subscales are calculated by adding the 
relevant items together and dividing by the number of items in that subscale. High scores 
indicate problematic experiences with therapy. There is evidence to support good 
reliability and validity of the PETS (Yardley & Kirby, 2006). 
The Short-Form McGill Pain Questionnaire (Melzack, 1987) 
The Short-Form McGill Pain Questionnaire (SF-MPQ) comprises three sections. 
The first section contains a list of 15 words used to describe pain. Eleven of the 15 words 
are sensory descriptors and the other four are affective descriptors. Patients rate their pain 
on each descriptor as ‗none‘, ‗mild‘, ‗moderate‘, or ‗severe‘.  The second section is a 10cm 
visual analogue scale (VAS) with the term ‗no pain‘ and ‗worst possible pain‘ as anchors 
at either end. The third section consists of a Present Pain Intensity Scale (PPI). The PPI 
contains six terms to describe the level of pain. The Short-Form McGill Pain Questionnaire 
yields five scores: a sensory score, an affective score, a total score (sensory and affective), 
a VAS score, and a PPI score. The good psychometric properties of the SF-MPQ are 
presented in Melzack (1987). 
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The Roland and Morris Disability Questionnaire (Roland & Morris, 1983) 
The Roland and Morris Disability Questionnaire (RMDQ) contains 24 statements 
that people with back pain could use to describe themselves. Patients are required to mark 
0 for false or 1 for true to indicate statements that best describe them on the day of 
completion. The RMDQ is scored by adding the number of items checked. Scores range 
from 0 to 24, with higher scores indicating greater disability. There are several papers 
providing evidence to support the reliability and validity of the RMDQ (see for example, 
Kuijer, Dijkstra, Goeken, Groothoff, & Geertzen, 2004; Stratford, Binkley, & Riddle, 
2000).  
The Change Item 
At follow-up, patients were asked the following question to establish the degree of 
change in their health that could then be used to define patients as improved, stable, or 
worsened: ‗Compared to the way you felt at the start of this study, please rate the degree of 
change in your health on the following scale: very much worse, moderately worse, a little 
worse, about the same, a little better, moderately better, very much better.‘   
Demographic and Clinical Details 
Patients answered questions on demographic characteristics and clinical history 
including  gender, age, work status, number of working days lost due to CLBP in the last 4 
weeks, date of first diagnosis, present medication details and other treatments they were 
currently taking to help them with their CLBP. These questions were developed so that the 
data obtained could be compared to UK national statistics to the greatest extent possible.  
6.3.6 Data Collection Procedure 
Ethical approval was granted for the protocol by North Manchester Research Ethics 
Committee (REC reference number 07/Q1406/50). Although random sampling was 
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preferential, this approach was impracticable because a list of all the patients could not be 
obtained. Therefore, the method of selection employed was purposive sampling because 
patients were identified from specific locations according to pre-specified 
inclusion/exclusion criteria and for the intention of collecting data on patients with CLBP. 
Specifically, the patient sample was recruited from ESPs and physiotherapists at 
Stepping Hill Hospital, Tameside Hospital, Kingsgate Medical Centre, and Hyde 
Physiotherapy Clinic. The researcher (DR) informed the ESPs and physiotherapists in each 
hospital or clinic about the survey and gained their support. An email was sent to ESPs and 
physiotherapists informing them of the aims and procedure of the survey, together with 
contact details of the researcher involved, so that any queries could be dealt with directly.  
Information and consent forms (Appendix L), a demographic and clinical details 
form, and the battery of questionnaires (Appendix M to Q) were prepared as survey packs 
for each hospital and pain clinic. A tracking form was developed to maintain anonymity by 
assigning each participating site an ID number and listing the ID numbers allocated for 
each participating patient. The census for each participating site was arranged so that 
immediately after the researcher visited (to provide survey packs) the physiotherapists 
would issue the packs and then ensure that every patient who attended was given the 
opportunity to participate. The researcher explained the procedure at the time of the visit 
and clarified any concerns raised by the teams. 
Physiotherapists were asked to distribute a survey pack to every patient on their 
caseload who met the inclusion criteria and none of the exclusion criteria (See section 
6.3.2). If a patient refused to participate, physiotherapists were asked to offer the survey 
pack to the next patient on their caseload until they had no more survey packs. Written 
informed consent was obtained from all patients and confirmed by physiotherapists. 
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Patients attending a consultation with an ESP who were subsequently referred to 
visit a physiotherapist or attend a pain clinic were screened using the pre-specified 
inclusion/exclusion criteria prior to their first appointment with a physiotherapist or 
attendance at a pain clinic. Those meeting all of the inclusion criteria and none of the 
exclusion criteria were invited to participate in the study. After one week, follow up calls 
were made to each head of physiotherapy departments or pain clinics to ensure everything 
was in place and address any questions that may have emerged. Additionally, a thank you 
letter was sent to all those who had assisted in the facilitation of the survey. 
For patients attending physiotherapy or pain clinics in the North West of England, 
those who agreed completed the survey during their second visit, one week later, and again 
at week six (see Figure 10) 
Patients with CLBP were also recruited from the Back Show in London (October 
2008), as well as support groups run by charities. For those attending the Back Show,  
announcements were made throughout each day inviting people who have back pain to 
visit the Brunel University stand to help with ongoing research. At the stand, patients were 
screened by trained researchers (DR and a researcher trained by DR) according to the pre-
specified screening script (Appendix C), and people who met all of the inclusion criteria 
and none of the exclusion criteria were invited to participate. Each person with CLBP who 
met the criteria were provided with an information sheet (Appendix L) informing them of 
the purpose of the study, and those who wished to take part were asked to sign the consent 
form (Appendix E). 
Patients were then individually asked to complete a battery of questionnaires that 
were presented as a survey pack (see sections 6.3.4 and 6.3.5). Patients recruited from the 
Back Show did not participate in follow-up assessments.  
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As the completed survey sheets and clinical details forms were received, the 
information was entered on a Statistical Package for Social Scientists database (SPSS, 
version 13) and the consent forms were filed. The requirements of the Data Protection Act 
were considered at all times. Descriptive and inferential statistics were conducted. 
Interpretation of results preceded writing up and disseminating the findings, including to 
all patients who wished to receive feedback and to all physiotherapists and team leaders. 
6.3.7 Analysis Methods 
Description of Variables, Normality, and Outliers 
Nominal and ordinal variables (such as ‗In general, how do you rate your health?‘) 
were described by the number of patients and the percentage for each response category. 
Continuous variables (such as the VAS) were described by presenting the frequency, mean, 
standard deviation, standard error, median, minimum, maximum, and number of missing 
data.  
Normality refers to the extent to which the distribution of scores appears ‗normal‘, 
i.e., the degree to which the data represents a symmetrical, bell-shaped curve, with the 
greatest frequency of scores in the middle, and smaller frequencies towards the extremes 
(Pallant, 2001).  It should be noted that patient-reported outcomes data is frequently non-
normal, and despite this parametric tests are often used because they are robust to non-
normality and are more powerful than non-parametric tests. For this reason parametric tests 
were employed, but the normality of the data was explored using the Kolmogorov-Smirnov 
statistic to understand the data. A non-significant result (significance value of >0.05) is 
indicative of ‗normal‘ distribution of scores. The actual shapes of the distribution were also 
observed using histograms, as well as the inspection of Normal-Q-Q Plots, Detrended 
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Normal Q-Q Plots, and box plots. This information was considered in parallel to 
descriptive statistics such as the mean, 5% trimmed mean, skeweness, and kurtosis.  
Software, Statistical Tests, and Level of Significance 
All data were analysed using the Statistical Package for Social Scientists (SPSS) 
version 13. Scoring of all questionnaires except the Satisfaction questionnaire were 
performed as per the instructions of the developers of those questionnaires.  For the 
Satisfaction questionnaire, scoring was determined during the factor-analyses. Principal 
Components Analysis (PCA) with varimax rotation was performed in order to explore the 
construct of the instrument (ordinal items) (see section 6.4.4).  
For all statistical tests, a threshold of 0.05 was used for statistical significance 
unless otherwise specified, and all hypotheses were two-tailed. No adjustment on threshold 
p-values for multiplicity was performed as the analyses were exploratory in nature. 
Therefore, the p-values were presented as an indication of trend. 
6.3.8 Statistical Analysis Plan 
Study Populations 
In order to analyse the psychometric properties of the CLBP Treatment Satisfaction 
Questionnaire, three population groups were defined. The ‗validation‘ population included 
patients with exploitable satisfaction questionnaires at week 1 - baseline. All cross 
sectional analyses were performed on the ‗validation‘ population. The ‗test-retest‘ 
population included patients with both baseline and week 2 CLBP Treatment Satisfaction 
Questionnaires. Test-retest analyses were performed on this population. The 
‗responsiveness‘ population included patients with both baseline and week 6 CLBP 
Treatment Satisfaction Questionnaires. Responsiveness to change over time was performed 
on this population. 
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Summary Report 
The response rate was reported and the following were described for the overall 
sample: 
 Number of CLBP Treatment Satisfaction questionnaires, the Adherence 
Questionnaire, the Problems with Therapy questionnaire, The McGill Pain 
Questionnaire; and the Roland and Morris Functional Disability Questionnaire, 
for each time point (baseline, week 2, and week 6) 
 Number of patients selected when analysing the construct of the scale 
(‗validation‘ population) 
 Number of patients selected for the test-retest analyses 
 Number of patients selected for the responsiveness analyses 
Description of Responses to CLBP Treatment Satisfaction Questionnaire 
A description of patients‘ responses on each of the items of the CLBP Treatment 
Satisfaction Questionnaire was performed for the total sample at baseline. 
 Item Recoding  
Not applicable responses were relevant to items on relationships and problems with 
side effects. For the relationship items, participants were asked ‗during the last 7 days, to 
what extent has your back pain interfered with your relationships?‘ This section comprised 
seven items such as ‗I did not want anyone near me‘, with the following response options 
and raw scores: 
1 = all of the time 
2 = most of the time 
3 = some of the time 
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4 = a little of the time 
5 = none of the time 
6 = not applicable 
The PCA ultimately is based on the correlation between items and requires that 
items be coded on a continuous scale. ‗Not applicable‘ options are not suitable as part of a 
continuous scale. Further, the PCA can be performed on complete cases, i.e. only for those 
participants who answered all of the items. Therefore, in order to retain sufficient sample 
size for the purpose of the PCA, those answering ‗not applicable‘ were re-assigned to the 
‗none of the time‘ category. The rationale being that relationship items would not be 
relevant to those who answered ‗not applicable‘, presumably because they did not have a 
partner or were not sexually active etc. Consequently, a raw score of 6 for ‗not applicable‘ 
was re-assigned a score of 5 representing ‗none of the time‘. 
Similarly, for the problems with side effects items, participants were asked 
‗Because of your back pain medication, in the last 7 days how much of a problem were the 
following‘. This section comprised 7 items such as ‗loss of appetite‘, or ‗weight gain‘ with 
the following response options and raw scores: 
1 = not a problem 
2= a little bit of a problem 
3 = a problem 
4 = a big problem 
5 = a severe problem 
6 = not applicable 
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For the same reasons as those outlined above, those answering ‗not applicable‘ 
were re-assigned to the ‗not a problem‘ category. The rationale for this being, those who 
answered ‗not applicable‘ either did not experience the side effect or did not notice it 
sufficient to report it was a problem to them and therefore there is no impact to patients. In 
this case, a raw score of 6 was reassigned a score of 1.  
It should be emphasised that only ‗not applicable‘ responses related to relationships 
and problems with side effects items were re-assigned another code because there was a 
clear rationale to do so (as outlined above), and this method is sometimes referred to as 
‗smart imputation‘. For the remaining items, no such imputation was performed because 
there was no clear rationale to do so. 
For the purpose of calculating domain scores, items that were negatively worded 
were rescored in a positive direction in order to match the other items in a scale, and to 
ensure that all items provided consistent information (i.e. a higher score indicating a higher 
level of satisfaction or related concept). The reverse scored items were 3c, 4.1e, 4.2d, 4.3a, 
5.1f, 6.2a – 6.2c, 7a – 7j, and 8a – 8e. Items that represented non-scaled values (for 
example, missing or not applicable) were not included in the reverse scoring or the 
computation of subscale scores. 
 Exploratory Analysis of the Construct Validity of the CLBP Treatment Satisfaction 
Questionnaire and Item Reduction 
The construct validity of a questionnaire refers to the underlying theoretical 
concepts that correspond to a set of related items (variables) (Kline, 2000). There are 
various analytical methods that can be used to assess the construct validity of a 
questionnaire, the most common of which is broadly referred to as factor analysis (FA) 
(Tabachnick & Fidell, 2001). Although FA and PCA often produce similar results (Pallant, 
2001), in this study PCA was used as a type of exploratory factor analysis using orthogonal 
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(varimax) rotation to make sense of the complex factors associated with satisfaction, and to 
observe relationships between the items of the instrument. The rationale for this analytic 
method included that the ultimate aim was to obtain an empirical summary of the dataset 
rather than a theoretical solution that is not confounded by unique and error variability 
(Tabachnick & Fidell, 2001). Also, PCA is often the preferred method and is documented 
as ‗psychometrically sound‘. It is a simpler mathematical solution than FA, and often 
limits potential problems related to ambiguous factors (Stevens, 1996; Abbott et al., 2005).  
For PCA, there are two issues to consider when determining whether a dataset is 
suitable. The first relates to sample size. As there is no formal method to estimate sample 
size, in order to conduct an exploratory factor analysis, the generally accepted rule of 3 to 
10 participants for every item was employed (see for example, Tabachnick & Fidell, 2001; 
Mundform et al., 2005) (see section 6.3.3). The other main issue relates to the strength of 
the correlations between the items (variables). If there are few correlations above 0.3, then 
factor analysis may not be suitable. In addition, Bartlett‘s test of sphericity (Bartlett, 1954) 
and Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy (Kaiser, 1970; Kaiser, 
1974) are tests to help assess the factorability of the data (Pallant, 2001). Both were used in 
this study; the Bartlett‘s test should be significant (p<0.05), and the KMO (which ranges 
from 0 to 1) should be at least 0.6 for good factor analysis (Tabachnick & Fidell, 2001).  
Also, as mentioned earlier, there are a number of factor extraction techniques 
(methods used to establish a small number of factors to represent related variables) 
including PCA, principal factors, image factoring, maximum likelihood factoring, alpha 
factoring, unweighted least squares, and generalized least squares. PCA is the most 
common of these (Pallant, 2001). An exploratory approach is recommended whereby the 
number of factors extracted that best describes the underlying relationships among 
variables is determined by the researcher, and involves compromising in terms of finding 
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as few factors as possible as well as explaining as much of the variance as possible 
(Tabachnick & Fidell, 2001). Kaiser‘s criterion (also known as the eigenvalue rule) and 
observation of Catell‘s scree test (Cattell, 1966) were used to facilitate decision making 
regarding the number of factors to retain. 
Following factor extraction, factors are ‗rotated‘ to aid interpretation either via 
‗orthogonal‘ (uncorrelated) or ‗oblique‘ (correlated) rotation. Often both provide similar 
factor solutions when correlations between the variables are clearly defined; however, it 
has been reported that orthogonal rotation provides outputs that are easier to interpret but 
assumes that the factors are independent and unrelated (Tabachnick & Fidell, 2001). Also, 
it should be noted that there are various types of orthogonal and oblique rotation. The most 
commonly used orthogonal technique is varimax (reduces the number of variables with 
high loadings on each factor) and the most used oblique technique is direct oblimin. In this 
study, varimax rotation was used as it is the most common approach. Further, item 
reduction was performed according to poor item-factor loadings (correlation). 
 
 Psychometric Testing of the CLBP Treatment Satisfaction Questionnaire 
The following analyses were performed for the validation sample: internal 
consistency, concurrent validity, and discriminant validity. In addition, test-retest 
reliability was performed on the test-retest sample (all those who completed the CLBP 
Treatment Satisfaction Questionnaire at baseline and week 2), and responsiveness to 
change over time was performed on the responsiveness sample. Analyses are detailed 
below. 
1) Internal Consistency  
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Internal consistency reliability refers to the degree to which a group of items (for 
example, in a factor) are measuring the same underlying concept (Hays & Hayashi, 1990). 
There are various statistical methods that can be used to calculate the internal consistency 
of a scale; the most common is the Cronbach‘s alpha coefficient (Cronbach, 1951), which 
was used in this study. Cronbach‘s alpha scores provide an average correlation amongst the 
items within a scale. Scores range from 0 to 1 and the alpha should be at least 0.7 to be 
acceptable (British Psychological Society Steering Committee on Test Standards, 1995).  It 
should be noted that Cronbach‘s alpha scores are sensitive to the number of items in a 
scale, with fewer items associated with lower Cronbach‘s alpha scores (Kline, 2000). 
Therefore, in scales with a small number of items, a slightly lower criterion of acceptability 
of about 0.6 can be adopted (Kline, 2000). 
2) Concurrent Validity 
Concurrent validity is defined as the extent to which a questionnaire concurs with 
other measures that quantify the same concept (Kline, 2000). To explore concurrent 
validity, correlations are often calculated between the scales which measure the same 
concepts, often with scores of ≥ 0.40 considered acceptable  (see for example, Rofail et al., 
2008).  
In this study, concurrent validity was assessed by examining correlations between 
the relevant domains of the SF-36 that measure health concepts, as well as relevant 
domains of the PETS that are similar to the domains of the CLBP Treatment Satisfaction 
Questionnaire.  Since HRQoL may be associated with Satisfaction (see for example, 
Innocenti et al., 2005), it is expected that there will be correlations between all of the SF-
36 domains with all of the domains of the CLBP Treatment Satisfaction Questionnaire. But 
in particular, moderate correlations are expected between the SF-36 and the Burden of 
Back Pain domain. In addition, moderate correlations are expected between the Symptoms 
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too severe or aggravated by therapy domain of the PETS and the Problems with Side 
Effects domain of the CLBP Treatment Satisfaction Questionnaire, as well as between the 
Problems due to uncertainty or doubts about the therapy and practical problems domains of 
the PETS with the Adherence to Physiotherapy domain of the CLBP Treatment 
Satisfaction Questionnaire. Further moderate correlations are also expected between the 
PETS domains and both the Information about Back Pain and Treatment domain as well as 
the Satisfaction with the Treatment Process domain of the CLBP Treatment Satisfaction 
Questionnaire. When interpreting results, correlations were considered negligible if <0.20, 
small if ≥ 0.20 and <0.40, moderate if ≥ 0.40 and < 0.70, and large if ≥ 0.70.   
3) Discriminant Validity 
Discriminant validity refers to the ability of a questionnaire to discriminate between 
groups known to differ, for example, in their clinical severity or some other parameter. 
There are various statistical methods that can be used to demonstrate discriminant validity 
including correlating the questionnaire scores with clinical parameters, or describing mean 
scores according to such parameters and using statistical tests to test for differences 
between groups. 
In this study, discriminant validity was assessed by exploring the mean domain 
scores of the CLBP Treatment Satisfaction Questionnaire according to how patients rated 
their health (e.g. excellent, very good, etc.), how much pain they had right now, and how 
much pain patients had had in the last 7 days (See sections 6.3.4 and 6.3.5).  
4) Test-Retest Reliability 
Test-retest reliability refers to the extent to which the two administrations of the 
same questionnaire to the same group of participants provide consistent results (Guyatt, 
Deyo, & Charlson, 1989). It is often assessed in stable patients, usually defined as those 
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who report ‗no change‘ in their condition based on a response to clinicians‘ assessments or 
the patient global impression (PGI) of improvement on a six or seven-point ordinal scale at 
the second assessment (see for example, Deyo, Diehr, & Patrick, 1991). 
To explore test-retest reliability, a visual description of a correlation can be 
developed as a scatter plot where scores for two variables from the same participants are 
plotted with one variable on the X-axis and the other variable on the Y-axis. In addition, 
the Pearson‘s correlation coefficient is usually used for continuous measures in test-retest 
reliability and captures the degree of linearity between two variables (i.e. the perfect 
relationship between two variables) (Schuck, 2004). However, some researchers have 
critiqued the Pearson‘s correlation for not providing an accurate measure of reliability 
because it does not detect systematic error. That is, it does not measure ―identity of 
measurement pairs‖ (Schuck, 2004). This is one of the common reasons why the Intraclass 
Correlation Coefficient (ICC) is often used as an alternative assessment of reproducibility 
(Deyo et al., 1991). It should be noted that there is much discussion in the literature 
regarding computing and interpreting ICC (for details see for example, Schuck, 2004; 
Deyo et al., 1991; Shrout & Fleiss, 1979). 
Scores range from -1 to +1 with higher scores (for Pearson‘s r and ICC) indicating 
greater agreement between the two assessments and therefore greater reliability. As a 
general rule of thumb, correlation coefficients surpassing the criterion of 0.70 indicate a 
high level of consistency between the scores at the two time points. The correlations can 
also be squared to provide a percentage of agreement between the two scores (Kline, 
2000). Further, if the correlation reliably differs from zero, the r-value will be statistically 
significant (i.e., does not result from a chance occurrence). Such findings imply that if the 
same variables were measured on another set of similar subjects, a similar correlation 
would result (Kline, 2000).  
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In this study, test-retest reliability was explored by performing scatter plots, 
Pearson‘s correlation coefficients and ICC. For ICC, two-way mixed effects models were 
performed where people effects were random and measures effects fixed, with single 
measures of absolute agreement because systematic differences among levels of ratings 
were considered relevant. 
5) Responsiveness to Change over Time 
Responsiveness refers to how sensitive the questionnaire is over time (Kline, 2000) 
and is the ability of a measure to reflect underlying change (Guyatt et al., 1989). It is often 
assessed in patients who have improved or worsened, as defined by clinician assessments 
of improvement or the PGI (see test-retest reliability above). For responsiveness, mean 
domain questionnaire scores are usually considered according to patients in the ‗improved‘ 
group or the ‗worsened‘ group, and then differences  between groups are compared to zero 
using appropriate statistical tests (e.g. ANOVAs) (see for example, Rofail et al., 2008). ES 
is often calculated to determine the magnitude of the differences and categorised as small 
(0.2), moderate (0.5), or large (0.8) (Cohen, 1977).  
In this study, responsiveness of the CLBP Treatment Satisfaction Questionnaire 
was assessed using the responsiveness sample. Specifically, the change scores between 
baseline and week 6 were calculated for three subgroups of patients (worsened, stable, and 
improved as defined by the PGI of health) but only improved and worsened patients were 
used for responsiveness analysis.  
6) Exploring Factors Associated with the CLBP Treatment Satisfaction Questionnaire 
Since this study collected data on a number of different variables, this provided an 
opportunity to further explore how well demographic, treatment, and pain variables predict 
the various components of treatment satisfaction in CLBP, how much variance can be 
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explained by the predictors, and to establish which variables are the best predictors. 
Therefore, Standard Multiple Linear Regressions were used whereby the domains of the 
CLBP Treatment Satisfaction Questionnaire were the dependent variables and the 
following independent variables were entered into each model: gender, age, ethnicity, 
academic qualifications, whether patients had time off work in the last four weeks, whether 
patients were taking opioid analgesics, whether patients were taking non-opioid analgesics, 
whether patients experience side effects, pain severity in the last seven days, and the 
McGill Total Score. 
6.4 Results 
6.4.1 Response Rate and Summary Report 
Of the 485 questionnaires distributed, 249 questionnaires were returned (124 from 
individuals from the Back Show, 59 from physiotherapists in hospitals, 51 from pain 
clinics, 7 from charities, and 8 unknown). This is a 51.3% response rate.  
The number of documents received at baseline, week 2, and week 6 are presented 
in Table 12. Among the 249 patients included in the study, all patients returned the CLBP 
Treatment Satisfaction Questionnaire, and of those one was not evaluable. Therefore, 248 
patients were included in the ‗validation‘ population. The ‗test-retest‘ population had 35 
patients, and the ‗responsiveness‘ population contained 31 patients. 
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Figure 10: Flow Diagram of Participants Included in the Study at Baseline and Follow-up 
Baseline: 
 
 
 
 
First follow-up: 
 
 
 
Second follow-up: 
 
Eligible consulting participants n= 485 
Consent n=249 Non-consent n= 236 
Questionnaires n=248 
Non-response n=104 Response n=35 
Questionnaires n=35 
Questionnaires n=30 
Non-response n=4 Response n=31 
Clinical sites* 
Back Show n=124 
Hyde n=13 
Macclesfield n=5 
Tameside n=30 
Stepping Hill n=11 
Kingsgate n=51 
Charities n=7 
* Missing data n=8 
Excludes participants from Back 
Show, Macclesfield, charities, & 
Corus group  
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Table 12: Number of Documents Received at Baseline, Week 2, and Week 6 
 Baseline Week 2 Week 6 
 Physio Pain 
Clinics 
Charities Back 
Show 
NC Total Physio Pain 
Clinics 
Charities Back 
Show 
NC Total Physio Pain 
Clinics 
Charities Back 
Show 
NC Total 
Demographic 
form 
59 44 7 119 8 237 Not applicable Not applicable 
CLBP 
Treatment 
Satisfaction  
59 51 7 124 8 249 18 17 0 0 0 35 12 19 0 0 0 31 
Adherence  54 39 7 91 6 197 15 15 0 0 0 30 8 17 0 0 0 25 
SF-36 55 28 7 101 7 198 18 17 0 0 0 35 12 17 0 0 0 29 
PETS 26 9 6 51 4 96 17 16 0 0 0 33 12 17 0 0 0 29 
McGill PAIN 51 23 7 98 6 185 17 16 0 0 0 33 12 17 0 0 0 29 
RMDQ 52 25 7 98 5 187 18 16 0 0 0 34 12 17 0 0 0 29 
NC - Not classified 
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6.4.2 Description of Sample at Baseline 
Socio-demographic Characteristics 
Socio-demographic characteristics are presented in Table 13 by subgroups for the 
overall sample, and compared to data obtained from the Office of Population Censuses and 
Survey (OPCS) regarding the prevalence of back pain in Great Britain (The Department of 
Health Statistics Division, 1999). The overall sample included a greater proportion of 
women to men (73.0% and 27.0%, respectively). The mean age of the overall sample was 
47.9 years (21-77 years).  Two hundred and eight (88.5%) participants were Caucasian or 
white. With regard to academic qualifications, 108 (49.3%) completed ‗other‘ to indicate 
having for example a diploma. A further 73 (33.3%) had GCSE or O levels, and another 27 
(12.3%) had A levels. Only 11 (5.0%) reported having no qualifications. One hundred and 
seven (45.1%) were working full-time, 61 (25.7%) were working part-time, and 64 
(27.0%) were unemployed. Five participants (2.1%) were economically inactive (e.g., 
retired or student). Of the overall sample, 168 (70.9%) participants aged 16 to 64 years 
were employed in the 4 weeks prior to the first assessment. In this age group, 70 (41.9%) 
had taken time off work during that period due to back pain. Further, 69 (29.1%) 
participants aged 16 – 64 years who were not in employment in the preceding four weeks 
were asked why they were not employed. Seventy-three (37.3%) reported back pain as a 
reason; 11 (5.6%) reported other health problems; 104 (53.3%) stated other problems not 
related to their health; and 7 (3.6%) didn‘t want a job. The mean duration of time off work 
was 5.02 days (SD=9.52) and range from no days to 31 days.  
The mean duration since being diagnosed with CLBP was 138.3 months (SD=154.3 
months) and ranged from 3 to 552 months. This translates into a mean duration of 11.5 
years (SD=12.9 years) ranging from 3 months to 46 years. 
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Although there were similarities observed in socio-demographic characteristics 
between subgroups (e.g. participants recruited from physiotherapy departments compared 
to those from pain clinics or charities) there were also differences. For example, the age of 
participants appeared to be higher in the charities and pain clinics than the physiotherapy 
and Back Show groups. Specifically, there were 5 out of 7 patients (71.4%) in the 55-64 
age group for charities, 24 patients in the 45-54 age group (54.6%) from the pain clinic 
group, and 22 (37.9%) and 44 (38.9%) patients in the 25-44 age group from the 
physiotherapy and Back Show groups respectively. Also, whilst the majority of patients 
were Caucasian or white in all groups, there was a slightly higher proportion of patients 
from the Back Show who were non-white; twenty-one (17%) compared to 3 in the 
physiotherapy group (5.1%), 2 from the pain clinic group (4.8%), and none from the 
charities. Similarly, whilst the majority of patient‘s highest qualifications were GCSE or 
O-levels in the physiotherapy and Pain Clinic groups (41.5% and 53.8%, respectively), the 
majority of patients from the Back Show had ‗other‘ qualifications (63.7%) and those from 
the charity group had a range of qualifications (e.g. 33.3% had GCSE/O-levels, another 
33.3% had A Levels, and another 33.3% had other qualifications). With regard to work 
status, the majority of patients from the physiotherapy, Pain Clinic and Back Show groups 
were in full-time employment (39.0%, 50.0%, and 47.9%, respectively) compared to those 
in the charity group, where the majority were unemployed (85.7%). Comparisons between 
subgroups according to categorical socio-demographic characteristics reached statistical 
significance (p<0.05 level) using Chi
2
 and Fisher‘s Exact Tests. 
Further, the total sample was broadly comparable to the national average provided 
by the OPCS (The Department of Health Statistics Division, 1999). However, notable 
differences between the data sets were apparent in gender (more women than men in this 
study compared to OPCS study), age (more patients in the 16-24 age group in the OPCS 
study compared to this study), and reasons why patients were not employed (more patients 
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in this study reported back problems or other problems getting a job as reasons for not 
being employed compared to the OPCS study) (Table 13). 
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Table 13: Socio-demographic Characteristics of Patients who completed the Satisfaction Questionnaire in Comparison with Data Presented from the OPCS 
(1998) Regarding the Prevalence of Back Pain in Great Britain 
 Recruitment Sites
*
 for This Study OPCS Study
**
 
 Physiotherapy 
Completed 
questionnaires 
(n=59) 
Pain Clinics 
Completed 
questionnaires (n=51) 
Charities 
Completed 
questionnaires (n=7)
 
 
Back Show  
Completed 
questionnaires (n=124)
 
 
Total 
Completed 
questionnaires 
(n=248) 
Completed 
questionnaires 
(n=5,549) 
 Number 
(n) 
Percent 
(%) 
Number (n) Percent 
(%) 
Number (n) Percent 
(%) 
Number (n) Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Percent (%) 
Gender (MD
†
=11) 
Chi
2
 p = 0.11 
           
Male 14 23.7 18 40.9 0 0 31 26.1 64 27.0 40 
Female 45 76.3 26 59.1 7 100 88 74.0 173 73.0 41 
Age (MD
§
=18)
  
Fisher‘s p not available
††
 
           
16-24 4 6.9 0 0 0 0 2 1.8 6 2.6 31 
25-44 22 37.9 13 29.6 0 0 44 38.9 86 37.4 39 
45-54 12 20.7 24 54.6 2 28.6 28 24.8 66 28.7 39 
55-64 11 19.0 5 11.4 5 71.4 28 24.8 49 21.3 31 
65 and over 9 15.5 2 4.5 0 0 11 9.7 23 10.0 39 
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 Recruitment Sites
*
 for This Study OPCS Study
**
 
 Physiotherapy 
Completed 
questionnaires 
(n=59) 
Pain Clinics 
Completed 
questionnaires (n=51) 
Charities 
Completed 
questionnaires (n=7)
 
 
Back Show  
Completed 
questionnaires (n=124)
 
 
Total 
Completed 
questionnaires 
(n=248) 
Completed 
questionnaires 
(n=5,549) 
 Number 
(n) 
Percent 
(%) 
Number (n) Percent 
(%) 
Number (n) Percent 
(%) 
Number (n) Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Percent (%) 
Ethnicity (MD
§
=13)
  
Fisher‘s p < 0.05 
           
White 56 94.9 40 95.2 7 100 98 82.4 208 88.5 Data not  
available Non-white 3 5.1 2 4.8 0 0 21 17.7 27 11.5 
Qualifications (MD
§
=29)
  
Fisher‘s p < 0.0005 
           
GCSE/ O levels 22 41.5 21 53.8 2 33.3 24 21.2 73 33.3 Data not  
available A level or higher 7 13.2 4 10.3 2 33.3 14 12.4 27 12.3 
Other 18 34.0 12 30.8 2 33.3 72 63.7 108 49.3 
None 6 11.3 2 5.1 0 0 3 2.7 11 5.0 
Employment (MD
§
=11)
  
Fisher‘s p = 0.06 
           
Working part time 11 18.6 13 29.5 0 0 36 30.3 61 25.7 Data not  
Available Working full time 23 39.0 22 50.0 1 14.3 57 47.9 107 45.1 
Unemployed 21 35.6 8 18.1 6 85.7 26 21.8 64 27.0 
Economically inactive 4 6.8 1 2.3 0 0 0 0 5 2.1 
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 Recruitment Sites
*
 for This Study OPCS Study
**
 
 Physiotherapy 
Completed 
questionnaires 
(n=59) 
Pain Clinics 
Completed 
questionnaires (n=51) 
Charities 
Completed 
questionnaires (n=7)
 
 
Back Show  
Completed 
questionnaires (n=124)
 
 
Total 
Completed 
questionnaires 
(n=248) 
Completed 
questionnaires 
(n=5,549) 
 Number 
(n) 
Percent 
(%) 
Number (n) Percent 
(%) 
Number (n) Percent 
(%) 
Number (n) Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Percent (%) 
Whether patients 16-64 years 
who were employed had time 
off due to CLBP (MD
§
=21)
  
Fisher‘s p < 0.005 
           
Employed in preceding 4 
weeks 
34 57.6 35 79.5 1 14.3  93 78.2 168 70.9 63 
Days off due to back pain 14 41.2 15 42.9 1 100 38 41.3 70 41.9 5 
No days off 20 58.8 20 57.1 0 0 54 58.7 97 58.1 60 
Not employed 25 42.4 9 20.5 6 85.7 26 22.8 69 29.1 34 
Reasons not employed 
(MD=53)
  
Fisher‘s p = 0.08 
           
Back pain 14 35.9 16 44.4 1 33.3 37 33.9 73 37.3 13 
Other health problems 4 10.3 0 0 2 66.7 5 4.6 11 5.6 24 
Other problems getting a job 20 51.3 19 52.8 0 0 62 56.9 104 53.3 24 
Didn‘t want a job 1 2.6 1 2.8 0 0 5 4.6 7 3.6 46 
 
*
Some cases were not classified by recruitment site; 
**
Percentage of general population with back pain for at least one day in the last 12 months 
†
MD: Missing data indicated for total sample; 
††
Fishers Exact Test could not be calculated due to computational resources 
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Short Form McGill Pain Scores  
 At baseline, the mean sensory score was 12.01 (SD = 7.64, n=182), the mean 
affective score was 3.06 (SD = 3.28, n = 185), the mean total score was 15.02 (SD = 10.04, 
n=182), and the mean VAS score was 58.87 (SD = 23.85, n=110). Six (3.3%) patients 
reported ‗no pain‘, 31 (16.9%) described their present pain as ‗mild‘, 90 (49.2%) as 
‗discomforting‘, 31 (16.9%) as ‗distressing‘, 21 (11.5%) as ‗horrible, and 4 (2.2%) as 
‗excruciating‘. The present pain index mean score was 2.23 (SD = 1.04, n = 183). 
Roland and Morris Disability Questionnaire Scores 
At baseline, the mean RMDQ score was 11.47 (SD = 5.92) and ranged from 0 – 23 
(n=179).  
SF-36 Scores 
At baseline, CLBP patients had significantly lower HRQoL scores than U.K. age-
matched norms particularly for Role Functioning due to Physical Limitations, and Vitality 
(Figure 11). Mean point differences between study scores and age-matched norms ranged 
from 11.32 for Mental Health to 45.30 for Role Functioning due to Physical Limitations. 
Since 3 to 5 point differences are considered clinically meaningful (Kosinski, Zhao, & 
Dedhiya, 2000; Samsa, Edelman, & Rothman, 1999), these results indicate that patients 
with CLBP in this study had clinically significant HRQoL impairment. 
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Figure 11: Study Participants‘ SF-36 Domain Scores (Mean Age = 47.8 years) Compared 
with U.K. Age-Matched Norms 
 
PF=Physical Functioning; RP=Role Functioning due to Physical Limitations; BP=Bodily Pain; GH=General 
Health; VT=Vitality; SF=Social Functioning; RE=Role Functioning due to Emotional Limitations; 
MH=Mental Health. 
Treatment Characteristics 
Participants in this study were on a range of medications to help them with their 
CLBP (Table 14). The majority were taking non-opioid analgesics (n=174, 87.9%) or 
NSAIDs (n=123, 62.1%), followed by paracetamol (n=63, 31.8%).  
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Table 14: Type of Medications Taken by Patients with CLBP Included in this Study 
Type of Medication
*
 Number (n) Percent (%) 
Non-opioid analgesics 174 87.9 
Paracetamol 63 31.8 
Compound analgesics 55 27.8 
NSAIDs 123 62.1 
Opioid analgesics 43 21.7 
Skeletal muscle relaxants 22 11.1 
Benzodiazapines 10 4.0 
Corticosteroids 16 8.1 
Anti-epileptic 18 13.3 
Antidepressants 20 10.1 
*
Patients with CLBP may have reported more than one medication for CLBP relief. 
In addition, the majority of patients (n=156, 65%) reported that they experience 
side effects from their back pain medication. Figure 12 below, illustrates the prevalence of 
side effects amongst patients; the most common reported were ‗inability to sleep‘, 
affecting 108 (45.4%) patients, followed by ‗drowsiness‘ with 106 patients (44.4%), and 
then ‗inability to concentrate‘, experienced by 101 patients (42.6%). The least common 
type of side effect experienced was ‗diarrhoea‘, affecting 50 patients (20.9%). Note that 
many patients on CLBP medication experience more than one side effect.  
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Figure 12: The Prevalence of Side Effects from CLBP Medication
*
 
 
*
Patients with CLBP may have reported more than one side effect 
Adherence to Medications 
In response to the statement ‗I forget to take my medicines‘, 8 (4.0%) stated 
‗always‘, 8 (4.0%) stated ‗often‘, 56 (28.1%) reported ‗sometimes‘, 51 (26.7%) answered 
‗rarely‘, and 68 (35.6%) reported ‗never‘. Further, although 58 (29.1%) answered ‗never‘ 
to the statement ‗I alter the dose of my medicines‘ and 29 (14.6%) reported ‗rarely‘, 69 
(34.7%) reported ‗sometimes‘, 25 (12.6%) stated ‗often‘, and 10 (5%) said ‗always‘. Also, 
whilst 73 (36.9%) stated ‗sometimes‘ they stopped taking medicines for a while, 21 
(10.6%) reported ‗often‘ 8 (4.0%) stated ‗always‘, 19 (8.6%) reported ‗rarely‘ and a further 
69 (34.8%) answered ‗never‘. Moreover, although the majority (n=63, 32.6%) responded 
‗sometimes‘ they decided to miss a dose, 33 (17.1%) said ‗often‘, 7 (3.6%) reported 
‗always‘, 23 (11.9%) stated ‗rarely‘ and 59 (30.6%) answered ‗never‘. In addition, in 
response to ‗I take less than instructed‘, whilst 55 (27.8%) reported ‗never‘ and a further 
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28 (14.1%) mentioned ‗rarely‘, the majority 70 (35.4%) reported ‗sometimes‘, 24 (12.1%) 
stated ‗often‘, and 14 (7.1%) answered ‗always‘.  
Other Types of Monotherapies 
Many participants included in this study were also taking other types of treatment 
to help them with their CLBP. For example, 79 (40.3%) were using physiotherapy, 40 
(20.2%) were attending a pain management programme, and 17 (8.6%) were receiving 
osteopathy. Other types of treatment that patients were taking included acupuncture (n=10, 
5.1%), massage (n=2, 1%), and TENS (n=1, 0.5%). 
6.4.3 Description of Responses on the CLBP Treatment Satisfaction Items 
Detailed results concerning the description of responses to the CLBP treatment 
satisfaction items are presented in Appendix R. Results are provided by recruitment site 
(physiotherapy, pain clinic, charities, and the Back Show) and for the total sample. The 
distribution of responses to each of the items did not seem to vary according to recruitment 
site.  
General (Items 1a to 1c) 
Many participants reported their health was ‗good‘ (n=96, 40.3%). Participants 
rated the level of pain right now, and in the last 7 days, from 1 (no pain) to 10 (worst pain 
possible). The majority indicated a level of pain of between 4 and 8 (n=175, 73.6%; and 
n=176, 73.6%, respectively).  
Information about Back Pain and Its Treatment (Items 2a to 2i) 
The majority of participants reported that they would like ‗more‘ or ‗a bit more‘ 
information about their condition or injury (n=150, 61.9%), the causes of their back pain 
(n=151, 62.9%), back pain medications (n=142, 59%), and the potential side effects of 
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back pain medications (n=140, 58.1%). The majority also reported they would like ‗more‘ 
or ‗a bit more‘ information about the treatment options available (apart from back pain 
medication) (n=164, 68.9%), goal setting (setting tasks to do) (n=140, 58.6%), posture and 
positioning (n=154, 64.2%), pacing (taking things gradually) (n=129, 53.5%), and exercise 
(n=139, 57.7%). Very few participants (between 3 and 8) reported that they would have 
liked to have ‗a little less‘ information or ‗none‘.  
About Your Medical Care (Items 3a to 3c) 
Although many of participants reported that they ‗disagree‘ or ‗strongly disagree‘ 
with the statement ‗my doctors did not know what was wrong with me (n=91, 38%), one 
third reported that they ‗agree‘ or ‗strongly agree‘ (n=83, 34.8%). Similarly, whilst the 
majority stated they ‗disagree‘ or strongly disagree‘ with the statement ‗I was 
misdiagnosed‘ (n=121, 50.9%), nearly a quarter agreed or strongly agreed (n=55, 23.1%). 
Further, over half responded ‗disagree‘ or ‗strongly disagree‘ to the statement, ‗I was 
involved in treatment decisions‘. Details are provided in Table 32 in Appendix R. 
Impact of Back Pain on Regular Activities (Items 4.1a-4.1e) 
The majority of participants responded ‗most of the time‘ or ‗some of the time‘ to 
the statements ‗I spent less time on tasks than I would have liked to‘ (n=145, 60.7%), and 
‗I was limited in the type of tasks that I could do‘ (n=135, 56.7%). Similarly, many 
responded ‗some of the time‘ or ‗most of the time‘ to the item ‗I stopped doing everyday 
tasks‘ (n=107, 45.5%), although a third reported ‗none of the time‘ (n=73, 31.1%). Whilst 
a small proportion of participants answered ‗all of the time‘ to the item ‗I was unable to 
work‘ (n=31, 13.5%), and many answered ‗most of the time‘, ‗some of the time‘ or ‗a bit 
of the time‘ (n=89, 38.9%), the majority stated ‗none of the time‘ (n=109, 47.6%). Further, 
although nearly one fifth of participants answered ‗none of the time‘ to ‗I went out of the 
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home‘ (n=41, 17.4%), many reported ‗a little of the time‘ or ‗some of the time‘ (n=103, 
43.8%). Details are provided in Table 33 in Appendix R). 
Impact of Back Pain on Physical Functioning (Items 4.2a-4.2e) 
Whilst the majority of participants responded ‗none of the time‘ to ‗I was unable to 
walk‘ (n=116, 50.7%), ‗I had poor balance‘ (n=98, 41.2%), and ‗I leaned on one side‘ 
(n=82, 35.0%), there were many who reported that at least ‗a little of the time‘ back pain 
interfered with walking ability, balance, and posture. Back pain also interfered with 
participants‘ ability to bend down, with a few responding ‗none of the time‘ to ‗I could 
bend down‘ (n=26, 11%), and over a quarter answering ‗all of the time‘ or ‗most of the 
time‘ to ‗It was difficult to keep standing‘ (n=66, 27.5%). Details are provided in Table 34 
in Appendix R. 
Impact of Back Pain on Confidence (Items 4.3a-4.3f) 
Whilst a few participants responded ‗none of the time‘ to ‗I planned before I did 
things‘ (n=47, 19.7%) and ‗I was cautious in everything I did‘ (n=32, 13.6%), the majority 
responded at least ‗a little of the time‘. Similarly, whilst many answered ‗none of the time‘ 
to ‗I had low beliefs in my abilities‘ (n=85, 35.9%), ‗I was scared to do too much‘ (n=58, 
24.4%), and ‗I had low self esteem (n=97, 40.8%), the majority answered at least ‗a little 
of the time‘. Moreover, in response to ‗I felt uncertain of the future‘, although a third 
reported ‗none of the time‘, approximately a third said ‗most of the time‘ or ‗all of the 
time‘ (n=69, 28.7%), and the remaining reported ‗a little of the time‘ or ‗some of the time‘ 
(n=91, 37.9%). Details are provided in Table 35 in Appendix R. 
Impact of Back Pain on Appearance (Items 4.4a to 4.4e) 
The majority of participants reported ‗none of the time‘ to ‗I was unable to 
brush/comb my hair (n=179, 75.8%), ‗I had difficulty getting dressed (n=115, 48.1%), ‗I 
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slouched‘ (n=70, 29.2%), ‗I was not interested in my appearance‘ (n=134, 56.3%), and ‗I 
was embarrassed about my image‘ (n=132, 56.2%). However, the remaining reported at 
least ‗a little of the time‘. Details are provided in Table 36 in Appendix R. 
Impact of Back Pain on Mood (Items 4.5a to 4.5h) 
The majority of participants answered ‗some of the time‘ to ‗I was irritable‘ (n=79, 
33.3%), ‗I was frustrated‘ (n=74, 31.1%), ‗I was tired‘ (n=77, 32.2%), and ‗I did not want 
to do anything‘ (n=65, 27.2%). Further, whilst the majority answered ‗none of the time‘ to 
‗I was sad‘ (n=78, 33.5%), ‗I was worried‘ (n=74, 34%), ‗I could not cope with the pain‘ 
(n=84, 35.1%), and ‗I felt life was not worth living‘ (n=164, 69.2%), the remaining 
responded at least ‗a little of the time‘. Details are provided in Table 37 in Appendix R. 
Impact of Back Pain on Relationships (Items 5.1a to 5.1g) 
Overall, the majority of participants answered ‗some of the time‘ or ‗most of the 
time‘ in response to ‗I did not want to burden others with my problems‘ (n=101, 50.3%). 
Although, many responded ‗none of the time‘ to ‗I did not want anyone near me‘ (n=72, 
39.6%), ‗I could not relax with my partner‘ (n=61, 35.5%), and ‗People thought I was 
faking my back pain‘ (n=100, 52.4%), the remaining reported at least ‗a little of the time‘. 
Further, whilst the majority responded ‗all of the time‘ or ‗most of the time‘ to ‗I was 
sexually active‘ (n=92, 59.0%), a smaller proportion reported ‗some of the time‘ (n=49, 
31.4%), and nearly 10% answered ‗a little of the time‘ or ‗none of the time‘ (n=15, 9.6%). 
In addition, although the majorityanswered ‗none of the time‘ to ‗sex was very 
uncomfortable‘ (n=47, 34.6%), one fifth stated ‗most of the time‘ or ‗all of the time‘ 
(n=30, 22%), and the remaining stated ‗some of the time‘ or ‗most of the time‘ (n=59, 
43.4%). Details are provided in Table 38 in Appendix R. 
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Impact of Back Pain on Sleep (Items 5.2a to 5.2c) 
The majority of participants indicated that back pain had interfered with their sleep, 
with most reporting ‗some of the time‘ or ‗most of the time‘ to ‗I tossed and turned in my 
sleep‘ (n=135, 56.5%), and ‗I woke up in the night‘ (n=124, 51.9%). Further, in response 
to ‗I had an ache in my back when I woke‘, many answered ‗all of the time‘ (n=95, 
39.7%), and the majority reported ‗some of the time‘ or ‗most of the time‘ (n=105, 44%). 
Details are provided in Table 39 in Appendix R. 
Beliefs about Back Pain Medications (Items 6.1a to 6.1e) 
Although a large number of participants responded ‗disagree‘ or ‗strongly disagree‘ to ‗my 
back pain medication is helpful to me (n=125, 54.8%), the majority agreed or strongly 
agreed in response to ‗my back pain medication prevents future problems‘ (n=113, 49.6%). 
However, the majority also answered ‗disagree‘ or ‗strongly disagree‘ to ‗my back pain 
medication helps me to be independent‘ (n=95, 42%). Further, only a small proportion of 
patients answered ‗agree‘ to ‗by taking back pain medication, I felt out of control‘ (n=32, 
13.9%); one fifth were ‗not sure‘ (n=50, 21.7%), and the remaining answered ‗disagree‘ or 
‗strongly disagree‘ (n=136, 59.1%). In addition, the majority agreed that they altered the 
amount of back pain medication they took (n=89, 39.6%). Details are provided in Table 40 
in Appendix R. 
Adherence to Physiotherapy (Items 6.2a to 6.2c) 
The majority of participants reported ‗disagree‘ in response to ‗I set realistic goals‘ 
n=121, 51.5%), ‗I remembered to do my exercises‘ (n=100, 42.9%), and ‗I paced my 
activities‘ (n=138, 58.7%). Details are provided in Table 41 in Appendix R. 
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Problems with Side Effects (Items 7a to 7j) 
Of those who reported experiencing side effects, the majority stated they were ‗a 
big problem‘ or ‗a severe problem‘ for ‗loss of appetite‘ (n=57, 82.6%), ‗weight gain‘ 
(n=38, 43.6%), ‗inability to concentrate‘ (n=53, 75.5%), ‗drowsiness‘ (n=62, 59.6%), 
‗nausea‘ (n=43, 63.2%), ‗constipation‘ (n=53, 59.6%), ‗diarrhoea‘ (n=35, 68.6%), 
‗stomach aches‘ (n=40, 58.8%), ‗heartburn‘ (n=50, 63.3%), and ‗inability to sleep‘ (n=42, 
38.5%). Details are provided in Table 42 in Appendix R. 
Satisfaction with Treatment for Back Pain (Items 8a to 8e) 
Most participants reported being ‗dissatisfied‘ or ‗very dissatisfied‘ for the 
following items: ‗the communication between my doctor and I regarding my back pain 
medication‘ (n=117, 50.9%), ‗the information provided about the possible side effects from 
my back pain medication‘ (n=84, 37%), ‗the form of administration (e.g. tablet, injection, 
patch) of my back pain medication‘ (n=119, 54.1%), ‗the amount of medication 
prescribed‘ (n=114, 51.1%), and ‗the way doctors have dealt with the side effects of my 
back pain medication‘ (n=77, 34.8%). Details are provided in Table 43 in Appendix R. 
Oral Medication Characteristics (Items 9.Aa to 9.Ac) 
Whilst the majority of participants disagreed or strongly disagreed in response to 
‗my oral medication is difficult to swallow‘ (n=151, 70.9%), and ‗my oral medication 
leaves an unpleasant taste in my mouth‘ (n=137, 65.6%), the majority reported ‗agree‘ or 
‗strongly agree‘ to ‗my oral medication doesn‘t work quickly‘ (n=66, 32.2%). 
6.4.4 Construct Validity of the CLBP Treatment Satisfaction Instrument 
The suitability of data was assessed before performing a PCA. After recoding ‗not 
applicable‘ scores for items related to relationships and problems with side effects (see 
section 6.3.8), and deleting cases of missing data (n=39), a PCA was performed on the 
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resulting sample (n=209). A review of the correlation matrix indicated the presence of 
many coefficients of 0.3 and above. The KMO value was 0.76, exceeding the 
recommended value of 0.60 (Kaiser, 1970; Kaiser, 1974). Also, the Bartlett‘s Test of 
Sphericity (Bartlett, 1954) reached statistical significance (p <0.0001). Consequently, the 
data were considered appropriate for PCA analysis. 
This was conducted on the collected data and 19 principal axis factors were initially 
extracted with eigenvalues greater than one. Table 15 shows the eigenvalues, percentage of 
variance, and cumulative variance for the 19 factors. Closer observation of Table 15 
showed a major difference in the size of the eigenvalue after the seventh factor suggesting 
that only seven factors should be orthogonally rotated.  These explain 52.0% of the 
systematic covariance between the 77 items. Although this leaves 48.0% of the variance 
remaining, Cattell‘s Scree Test (Cattell, 1966), as shown in Figure 13, confirms that seven 
factors are powerful enough to explain any of the covariance among the 77 items that form 
the questionnaire.  
Table 15: Initial Statistics for a Principle Components Analysis of the 77-item Satisfaction 
Questionnaire: Eigenvalue, Variances and Cumulative Variance for the first 19 factors 
Factor Eigenvalue Pct of. Var. Cum. Pct. 
1 16.71 21.71 21.71 
2 6.22 8.08 29.79 
3 4.34 5.63 35.42 
4 3.80 4.93 40.35 
5 3.50 4.55 44.90 
6 3.31 4.30 49.20 
7 2.12 2.76 51.96 
8 1.97 2.56 54.52 
9 1.86 2.41 56.92 
10 1.78 2.32 59.24 
11 1.63 2.12 61.36 
12 1.53 1.99 63.35 
13 1.38 1.79 65.14 
14 1.30 1.68 66.82 
15 1.24 1.61 68.43 
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Factor Eigenvalue Pct of. Var. Cum. Pct. 
16 1.20 1.55 69.98 
17 1.11 1.45 71.43 
18 1.11 1.44 72.87 
19 1.05 1.37 74.24 
 
Figure 13: Factor Scree Plot of Eigenvalue for the 77-item Satisfaction Questionnaire 
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The seven-factor solution was further investigated to determine the actual item 
loadings for each factor. A Varimax-Rotation Principle Components Analysis with 25 
iterations was carried out as the factors were considered independent (unrelated). The 
findings of this analysis are presented in Table 16 with the factor loadings matrix for the 
seven factors. Varimax rotation was chosen because it selects the factors that do not 
correlate strongly (orthogonal rotation). The internal correlation of the seven factors was 
.60. However, eight item of the 77 item questionnaire did not load onto any of the factors. 
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These were ‗I could bend down‘, ‗I went out of my home‘, ‗I was involved in treatment 
decisions‘, ‗I was misdiagnosed‘, ‗My back pain medication is helpful to me‘, ‗My back 
pain medication enables me to be independent‘, ‗I had an ache in my back when I woke‘ 
and ‗I altered the amount of back pain medication I took‘.  
Table 16: A Factor Loading Matrix Using Varimax-Rotated PCA for the 77-item 
Questionnaire 
 Factors 
Satisfaction Items 1 2 3 4 5 6 7 
4.5a I was sad .82       
4.3d I was scared to do too much .81       
4.3c I had low beliefs in everything I did .80       
4.3f I felt uncertain of the future .79       
4.5h I was worried .76       
4.5c I was frustrated .75       
4.3e I had low self esteem .74       
4.5f I could not cope with the pain .69       
4.3b I was cautious in everything I did .69       
4.5b I was irritable .69       
4.1c I stopped everyday tasks .67       
4.5e I did not want to do anything .66       
4.3a I planned before I did things .66       
4.5g I felt life was not worth living .65       
4.4d I was not interested in my 
appearance 
.64       
4.1b I was limited in the type of tasks I 
can do 
.62       
4.4c I had difficulty getting dressed .61       
4.4a I slouched .61       
4.1a I spent less time on tasks than I 
would have liked to 
.61       
4.4e I was embarrassed about my image .60       
4.2e It was difficult to keep standing .60       
4.5d I was tired .59       
4.2b I had poor balance .55       
4.2c I leaned on one side .54       
4.4b I was unable to brush/comb my hair .51       
4.2a I was unable to walk .50       
4.1d I was unable to work .47       
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 Factors 
Satisfaction Items 1 2 3 4 5 6 7 
7f Constipation  .76      
7c Inability to concentrate  .75      
7j Inability to sleep  .75      
7e Nausea  .74      
7d Drowsiness  .73      
7h Stomach aches  .72      
7b Weight gain  .64      
7g Diarrhoea  .60      
7i Heartburn   .57      
7a Loss of appetite  .57      
5.2a I tossed and turned in my sleep  .50      
5.2b I woke up in the night  .46      
2f Information about posture and 
positioning 
  .81     
2e Information about treatment options 
available (apart from back pain 
medication) 
  .79     
2b Information about the cause of my 
back pain 
  .77     
2a Information about my condition or 
injury 
  .75     
2i Information about exercise   .75     
2h Information about pacing (taking 
things gradually) 
  .72     
2g Information about goal setting 
(setting tasks to do) 
  .71     
2d Information about the potential side 
effects of back pain medications 
  .68     
2c Information about back pain 
medications 
  .67     
3a My doctors did not know what was 
wrong with me 
  .53     
8b Satisfaction with the information 
provided about the possible side 
effects from my back pain 
medication 
   .79    
8e Satisfaction with the way doctors 
have dealt with the side effects of 
back pain medication 
   .76    
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 Factors 
Satisfaction Items 1 2 3 4 5 6 7 
8c Satisfaction with the form of 
administration of back pain 
medication 
   .75    
8d Satisfaction with the amount of 
medication prescribed 
   .72    
8a Satisfaction with the 
communication between my doctor 
and I regarding back pain 
medication 
   .61    
5.1d People around me did not 
understand my back pain  
    .75   
5.1e People thought I was faking my 
back pain 
    .73   
5.1c I could not relax with my partner     .72   
5.1g Sex was very uncomfortable     .71   
5.1a I did not want anyone near me     .66   
5.1f I was sexually active      .64   
5.1b I did not want to burden others with 
my problems  
    .58   
9Ab My oral back pain medication 
leaves an unpleasant taste in my 
mouth 
     .72  
9Aa My oral medication is difficult to 
swallow 
     .69  
6.1b My back pain medication prevents 
future problems 
     .63  
9Ac My oral back pain medication does 
not work quickly 
     .55  
6.1d By taking medication, I felt out of 
control 
     .55  
6.2b I remembered to do my exercises       .75 
6.2c I paced my activities       .74 
6.2a I set realistic goals       .72 
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Labelling the Extracted Factors 
After a careful review of the content of the original variables, each of the seven 
factors was given a label to reflect the items related to that factor. By referring to the 
questionnaire (see Appendix J) inference was made from the relevant items to determine 
the nature of the seven factors for measuring treatment satisfaction. For each of the factors, 
examples of items are provided and the interpretations made stated. 
Factor one with an eigenvalue of 16.71 accounted for 21.7% of the variance and 
consisted of 27 items with loadings ranging from .43 to .82. Generally, it has been 
accepted that the first factor usually has moderate loadings, ranging from approximately .3 
to .7 (Kline, 2000). The items in this factor, such as 4.5a ‗I was sad‘; 4.3b ‗I was cautious 
in everything I did‘; 4.3a ‗I planned before I did things‘; 4.4.e ‗I was embarrassed about 
my image‘; 4.2e ‗It was difficult to keep standing‘; and 4.1d ‗I was unable to work‘, all 
reflect the burden of back pain, and are thus labelled ‗Burden of Back Pain‘. 
Factor two with eigenvalue of 6.22 accounted for 8.1% of the variance and 
consisted of 12 items with loadings ranging from .46 to .76. The items in this factor, such 
as 7f ‗constipation‘; 7e ‗nausea‘; 7h ‗stomach aches‘; 7g ‗diarrhoea‘; 7a ‗loss of appetite‘; 
and 7j ‗inability to sleep‘ all reflect problems encountered with side effects, and are thus 
labelled ‗Problems with Side Effects of Back Pain Medication‘. 
Factor three with an eigenvalue of 4.34 accounted for 5.6% of the variance and 
consisted of 10 items with loadings ranging from .53 to .81. The items in this factor, 2f 
‗Information about posture and positioning‘; 2e ‗Information about treatment options 
available (apart from back pain medication)‘; 2b ‗Information about the cause of my back 
pain‘; 2c ‗Information about back pain medication‘; 2d ‗Information about the potential 
side effects of back pain medication‘; and 3a ‗My doctors did not know what was wrong 
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with me‘,  all reflect information and knowledge about back pain and treatment, and are 
thus labelled ‗Information About Back Pain and Treatment‘. 
The fourth factor with an eigenvalue of 3.80 accounted for 4.9% of the variance 
and consisted of 5 items with loadings ranging from .61 to .79. The items in this factor, 8b 
‗Satisfaction with the information provided about the possible side effects from back pain 
medication‘; 8e ‗Satisfaction with the way doctors have dealt with the side effects of back 
pain medication‘; 8d ‗Satisfaction with the amount of medication prescribed‘; and 8a 
‗Satisfaction with the communication between my doctor and I regarding back pain 
medication‘  all reflect satisfaction with medical processes such as the information 
provided, the amount of medication prescribed, the way doctors have dealt with side 
effects as well as communication between the doctor and patient, and are thus labelled 
‗Satisfaction with the Back Pain Treatment Process‘. 
Factor five with an eigenvalue of 3.50 accounted for 4.6% of the variance and 
consisted of 7 items, with loadings ranging from .58 to .75. The items in this factor, 5.1d 
‗People around me did not understand my back pain‘; 5.1e ‗People thought I was faking 
my back pain‘; 5.1c ‗I could not relax with my partner‘; 5.1a ‗I did not want anyone near 
me‘; 5.1b ‗I did not want to burden others with my problems‘, all reflect aspects of 
relationships with others, and are thus labelled ‗Impact of Back Pain on Relationships‘. 
The sixth factor with an eigenvalue of 3.31 accounted for 4.3% of the variance and 
consisted of 5 items with loadings ranging from .55 to .72. The items in this factor, 9Ab 
‗My back pain medication leaves an unpleasant taste in my mouth‘; 9Aa ‗My back pain 
medication is difficult to swallow‘; 6.1b ‗My back pain medication prevents future 
problems‘; and 9Ac ‗My back pain medication does not work quickly‘, all reflect patients' 
acceptability of back pain medication in terms of convenience and the ease of 
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administration, preference in terms of the taste of medication, and how quickly the 
medication works, and are thus labelled ‗Back Pain Medication Acceptability‘. 
The seventh factor with an eigenvalue of 2.12 accounted for 2.8% of the variance. 
It consisted of 3 items with loadings ranging from .72 to .75. The items in this factor, 6.2b 
‗I remembered to do my exercises‘; 6.2c ‗I paced my activities‘; and 6.2a ‗I set realistic 
goals‘, all reflect adherence behaviours related to physiotherapy regimens, and are thus 
labelled ‗Adherence to Physiotherapy‘. 
6.4.5 Internal Consistency  
To investigate the internal consistency of the re-formulated questionnaire (69 items 
remained after PCA), Cronbach‘s alpha was calculated for each of the seven factors. The 
results of the final Chronbach‘s alpha solutions are summarised in Table 17. 
Table 17: Cronbach‘s Alpha for the CLBP Treatment Satisfaction Questionnaire Domains: 
Internal Consistency 
CLBP Treatment Satisfaction 
Questionnaire Domains 
Number of Items Cronbach’s alpha 
Burden of Back Pain  27 0.94 
Problems with Side Effects 10 0.89 
Information Provided About Back 
Pain and Treatment 
10 0.91 
Satisfaction with the Treatment 
Process 
5 0.85 
Impact of Back Pain and 
Treatment on Relationships 
7 0.84 
Back Pain Medication 
Acceptability 
3 0.75 
Adherence to Physiotherapy 3 0.79 
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6.4.6 Tests for Normality and Outliers 
The Kolmogorov-Smirnov statistic was significant for all domains, indicating that 
the data were non-normal. Inspection of the shape of the distribution revealed bimodal or 
occasional multi-modal distributions (e.g. the Burden of Back Pain) and skewness and 
kurtosis were observed. However, closer observation of the descriptive statistics indicated 
that the skewness and kurtosis values were well below the threshold of 4.0 considered 
generally acceptable, and therefore the data does not deviate from the mean significantly 
enough to warrant transformation of scores. Further, all scores fell within the expected 
ranges and whilst there were some outliers, attention to the 5% trimmed mean compared to 
the mean indicated small differences. See Appendix S for normality and outlier tests. 
Given the above, and because parametric tests are more powerful than non-parametric tests 
and are generally robust to non-normality, parametric tests were performed for the 
remaining analyses. 
6.4.7 Concurrent Validity 
Table 18 provides evidence to support the concurrent validity of the CLBP 
Treatment Satisfaction Questionnaire. In general, there were low to moderate correlations 
with both the SF-36 (r=0.003 to 0.76) and the PETS (r= -0.11 to -0.61).  
As expected, the Burden of Back Pain and the Impact of Back Pain on 
Relationships domain of the CLBP Treatment Satisfaction Questionnaire indicated 
statistically significant moderate correlations with the HRQoL domains of the SF-36: 
r=0.49 to 0.66, p<0.0001, r=0.42 to 0.64, p<0.0001, respectively. There were also low to 
moderate correlations between the Problems with Side Effects domain of the CLBP 
Treatment Satisfaction Questionnaire and the SF-36: r=0.30 to 0.76, some of which 
reached statistical significance at the p<0.0001 or p<0.05 levels.  
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Further, there were low to moderate statistically significant correlations between 
the Adherence to Physiotherapy domain of the CLBP Treatment Satisfaction Questionnaire 
and all domains of the PETS: r= -0.37 to -0.51, p<0.0001. Closer examination of Table 18 
also indicates similar findings between the PETS and the following domains of the CLBP 
Treatment Satisfaction Questionnaire: Information about Back Pain and its Treatment (r= -
.38 to -0.54, p<0.0001), and the Satisfaction with Treatment Process (r= -0.30 to -0.48, 
p<0.0001). The Impact of Back Pain on Relationships domain of the CLBP Treatment 
Satisfaction Questionnaire was also statistically significantly (p<0.0001) correlated with 
the PETS domains (with the exception of the Practical Problems): r= 0.44 to 0.45.  
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Table 18: Pearson‘s Correlations between the Domains of the CLBP Treatment Satisfaction Questionnaire with the SF-36 and PETS Domains: Concurrent 
Validity 
 
Burden of Back 
Pain  
Problems with 
Side Effects 
Information about 
Back Pain and 
Treatment 
Satisfaction with 
the Treatment 
Process 
Impact of Back Pain 
on Relationships 
Back Pain 
Medication 
Acceptability 
Adherence to 
Physiotherapy 
SF-36        
Physical Functioning 0.57** n=162 0.36  n=29 0.09     n=174 -0.24* n=170 0.42** n=71 0.01  n=157 0.08    n=177 
Role-Physical 0.55** n=167 0.31    n=28 0.19*  n=181 -0.10    n=175 0.49** n=73 0.11  n=162 -0.11  n=183 
Bodily Pain 0.63** n=163 0.37    n=28 0.08    n=175 -0.05  n=169 0.52** n=71  0.00  n=157 0.02   n=178 
General Health 0.49** n=170 0.76**n=29 0.04    n=180 -0.01  n=174 0.37** n=73 0.13  n=161 0.17* n=183 
Vitality 0.58** n=168 0.51**n=29 0.17* n=181 -0.01  n=175 0.59** n=73 0.16* n=164 0.16* n=184 
Social Functioning 0.66** n=168 0.58**n=29 0.15* n-181 0.04   n=175 0.55** n=73 0.09   n=162 0.04  n=184 
Mental Health 0.58** n=168 0.37    n=29 0.08    n=180 -0.10  n=174 0.62** n=73  0.18* n=161 0.06  n=183 
Role Emotional 0.63** n=164 0.30    n=28 0.12    n=176 -0.01  n=170 0.64** n=71 0.07   n=159 0.10  n=179 
PETS        
Symptoms too severe 
or aggravated by 
therapy 
-0.37**n=83 -0.48  n=14 -0.38** n=90 -0.30**n=87 -0.44**n=41 -0.12 n=80 -0.48** n=93 
Uncertainty about 
how to carry out the 
treatment 
-0.24* n=80 -0.13  n=14 -0.43** n=86 -0.38**n=83 
 
-0.44** n=40 -0.11 n=76 -0.37** n=89 
Doubts about 
treatment efficacy 
-0.21  n=81 -0.47  n=14 -0.54**  n=88 -0.46** n=85  -0.45** n=41 -0.02 n=78  -0.41** n=91 
Practical Problems -0.16  n=80 -0.61*n=14 -0.40**  n=88 -0.48** n=85 -0.29     n=41 -0.12 n=78 -0.51** n=91 
*p<0.05; ** p<0.0001 
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6.4.8 Description of Baseline CLBP Treatment Satisfaction Domain Scores 
Table 19 provides summary statistics for baseline scores of the CLBP Treatment 
Satisfaction Questionnaire domains. 
Table 19: Summary Statistics of the CLBP Treatment Satisfaction Questionnaire 
 n Mean SD 
Burden of Back Pain 227 96.8 20.9 
Problems with Side 
Effects 
32 38.8 8.2 
Information About Back 
Pain and Its Treatment 
223 21.4 7.2 
Satisfaction with 
Treatment Process 
217 16.3 4.1 
Impact of Back Pain on 
Relationships 
99 23.8 6.1 
Adherence to 
Physiotherapy 
232 10.9 2.6 
Back Pain Medication 
Acceptability 
205 10.4 2.6 
6.4.9 Discriminant Validity 
Table 20 and Table 21 provide evidence to support the discriminative validity of 
the CLBP Treatment Satisfaction Questionnaire.  One-way between-groups ANOVAs 
were performed to describe and compare the distribution of scores according to the 
following variables related to clinical severity: 
 Patients‘ rating of health 
 Level of pain in the last 7 days 
 Level of pain right now 
‗How do you rate your health‘ had five response options: excellent, very good, good, 
fair, and poor. There were statistically significant differences at the p<0.05 level in 
CLBP Treatment Satisfaction Scores for the following domains: Burden of Back Pain 
[F(4, 198)=10.60, p<0.0001]; Problems with Side Effects [F(3, 28)=8.49, p<0.0001]; and 
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Impact of Back Pain on Relationships [F(4, 91)=8.00, p<0.0001]. The effect sizes, 
calculated using eta squared, were 0.18, 0.48, and 0.26, respectively. There was also a 
trend towards significance for the Back Pain Medication Acceptability domain [F(4, 
197)=2.24, p=0.07] with an effect size of 0.04. However, mean differences for the 
following domains did not reach statistical significance: Information about Back Pain 
and Its Treatment, Satisfaction with the Treatment Process, and Adherence to 
Physiotherapy. 
Table 20: Comparison of CLBP Treatment Satisfaction Domain Scores at Baseline 
According to How Patients Rate Their Health: Discriminative Validity 
  How do you rate your health? 
  n Mean SD 
Burden of Back 
Pain  
Excellent 5 87.40 26.11 
Very good 56 105.43 19.29 
Good 83 100.00 19.18 
Fair 51 85.45 18.81 
Poor  8 75.50 17.01 
Problems with Side 
Effects 
Excellent 0 - - 
Very good 5 48.00 2.00 
Good 13 39.92 5.75 
Fair 11 37.00 6.97 
Poor  3 25.67 9.81 
Information about 
Back Pain and Its 
Treatment 
Excellent 5 19.80 7.01 
Very good 58 21.14 7.73 
Good 91 22.31 7.24 
Fair 56 21.23 6.68 
Poor  9 15.56 7.04 
Satisfaction with 
the Treatment 
Process 
Excellent 3 13.67 3.21 
Very good 59 16.15 4.41 
Good 86 16.77 3.51 
Fair 56 16.25 4.42 
Poor  10 14.10 4.09 
Impact of Back 
Pain on 
Relationships 
Excellent 5 21.80 4.09 
Very good 20 27.45 5.39 
Good 42 25.57 5.61 
Fair 23 20.09 4.94 
Poor  6 18.17 5.91 
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  How do you rate your health? 
  n Mean SD 
Back Pain 
Medication 
Acceptability 
Excellent 3 10.33 1.53 
Very good 52 11.17 2.87 
Good 83 10.41 2.27 
Fair 54 9.94 2.77 
Poor  10 9.10 2.28 
 
Adherence to 
Physiotherapy 
Excellent 5 12.00 1.41 
Very good 60 11.27 3.21 
Good 90 10.81 2.26 
Fair 62 10.79 2.33 
Poor  10 9.40 3.60 
- No data available  
 
Level of pain in the last 7 days and level of pain right now were originally scored 
on a scale of 1 to 10. However, to obtain sufficient sample size and minimise the number 
of groups for comparison, patients‘ responses were grouped to create five categories: 1-
2, 3-4, 5-6, 7-8, and 9-10.   
For both level of pain in the last 7 days, and level of pain right now, there were 
statistically significant differences at the p<0.05 level in the following CLBP Treatment 
Satisfaction domains: Burden of Back Pain ( [F(4,199)=12.39, p<0.0001] and 
[F(4,198)=11.89, p<0.0001], respectively); Impact of Back Pain on Relationships 
([F(4,90)=2.93, p<0.05] and [F(4,89)=3.35, p<0.01]). Back Pain Medication 
Acceptability was also statistically significant for level of pain in the last 7 days, and 
there was a trend towards significance for level of pain right now [F(4,198)=2.87, 
p<0.02] and [F(4,197)=2.16, p=0.07). Effect sizes using eta squared ranged from 0.01 to 
0.30. 
For pain in the last 7 days, there were also statistically significant differences for 
Problems with Side Effects [F(4,27)=2.96, p<0.05] and Satisfaction with the Treatment 
Process [F(4,209)=2.98, p=0.20], with effect sizes ranging from 0.05 to 0.30. However, 
mean differences did not reach statistical significance for level of pain right now, and 
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mean differences for Adherence to Physiotherapy did not reach statistical significance 
for either clinical severity variable. 
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Table 21: Comparison of CLBP Treatment Satisfaction Questionnaire Scores at Baseline According to Pain in the Last 7 days, and Pain Right Now: 
Discriminative Validity 
  Pain in the Last 7 days Pain Right Now 
  n Mean SD n Mean SD 
Burden of Back 
Pain 
1-2 15 121.13 15.38 26 111.38 20.84 
3-4 46 104.52 18.51 53 101.11 19.32 
5-6 55 96.82 20.70 61 99.38 19.87 
7-8 66 89.62 18.43 57 84.04 17.40 
9-10 22 85.36 19.47 6 83.67 12.96 
Problems with 
Side Effects 
1-2 1 37.00 - 1 37.00 - 
3-4 2 37.00 2.83 9 36.44 11.98 
5-6 7 45.86 4.49 8 41.75 6.14 
7-8 19 35.68 8.54 13 38.62 6.70 
9-10 3 44.33 2.08 1 42.00 - 
Information 
about Back 
Pain and Its 
Treatment 
1-2 16 22.94 8.83 29 22.28 7.61 
3-4 44 20.41 6.28 54 20.06 6.72 
5-6 61 20.97 7.49 66 23.18 7.80 
7-8 74 21.99 7.50 63 20.21 6.85 
9-10 25 22.16 6.55 7 22.57 7.02 
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  Pain in the Last 7 days Pain Right Now 
  n Mean SD n Mean SD 
Satisfaction 
with Treatment 
Process 
1-2 14 17.64 5.08 27 17.67 4.44 
3-4 41 15.61 3.08 51 15.96 3.26 
5-6 58 15.83 3.66 62 15.74 4.07 
7-8 77 16.18 4.52 67 16.33 4.44 
9-10 25 18.60 3.64 7 18.57 3.51 
Impact of Back 
Pain on 
Relationships 
1-2 10 28.60 5.30 16 26.94 6.55 
3-4 23 25.48 5.62 27 24.59 6.00 
5-6 25 23.24 6.42 27 24.19 6.95 
7-8 27 21.82 6.07 21 20.19 3.09 
9-10 10 23.50 5.15 3 25.67 4.51 
Adherence to 
Physiotherapy 
1-2 15 12.07 3.81 30 11.03 3.59 
3-4 47 10.89 2.27 55 11.04 2.33 
5-6 64 10.89 2.56 67 10.54 2.74 
7-8 80 10.81 2.59 69 10.97 2.33 
9-10 22 10.54 2.69 6 11.80 1.60 
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  Pain in the Last 7 days Pain Right Now 
  n Mean SD n Mean SD 
Back Pain 
Medication 
Acceptability 
1-2 12 10.42 3.18 23 11.35 2.93 
3-4 37 10.05 2.91 49 10.12 2.84 
5-6 55 10.93 2.80 58 10.86 2.56 
7-8 74 9.84 2.36 64 9.84 2.31 
9-10 25 11.52 1.71 8 10.63 1.19 
- Not applicable 
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6.4.10 Test-Retest Reliability 
Thirty-four participants completed the satisfaction questionnaire at baseline and 
week 2. Of these, 17 (50%) were considered stable because they responded ‗about the 
same‘ to the Patient Global Impression (PGI) question ‗Compared to the way you felt at 
the start of the study, please rate the degree of change in your health?‘ The other 17 
indicated their health had improved with 8 (23.5%) answering ‗a little better‘, 5 (14.7%) 
‗moderately better‘, and 4 (11.8%) ‗very much better‘. Since test-retest assumes no 
change in health status, the analyses focused on the 17 patients who were defined as 
stable. Reliability data for the 17 stable patients are shown in Table 22 and Table 23. 
Table 22: CLBP Treatment Satisfaction Questionnaire Test-Retest Reliability in Stable 
Patients who Responded ‗no change‘ on the Patient Global Impression (PGI) of Health: 
Paired t-tests Between Baseline and Week 2 
  Baseline Week 2 t-test p-value 
CLBP Treatment 
Satisfaction Domain 
n Mean SD Mean SD   
Burden of Back Pain  14 102.64 16.68 105.71 13.61 -0.97 p=0.35 
Problems with Side 
Effects 
Not relevant 
Information About Back 
Pain and Treatment 
13 22.15 7.12 33.31 13.09 -3.75 p≤0.005** 
Satisfaction with 
Treatment Process 
15 16.20 3.19 16.53 2.92 -0.54 p=0.60 
Impact of Back Pain on 
Relationships 
- - - - - - - 
Back Pain Medication 
Acceptability 
15 10.40 2.29 11.06 3.43 -0.89 p=0.39 
Adherence to 
Physiotherapy 
15 11.46 1.96 12.60 1.18 -2.24 p≤0.05* 
- Sample size too small to calculate               *p≤0.05; ** p≤0.005 
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Table 23: Test-Retest Reliability between Baseline and Week 2 as Assessed Using 
Pearson‘s and Intraclass Correlation Coefficients for Stable Patients who Responded 
‗about the same‘ on the Patient Global Impression (PGI) of Health 
CLBP 
Treatment 
Satisfaction 
Domain 
Stable Patients who responded ‘about the same’ on the PGI between baseline and 
week 2 
n Pearson’s r p-
value 
% of 
agreement
§
 
ICC
≠
 p -value % of 
agreement
§
 
Burden of Back 
Pain  
14 0.71 0.004 50.4 0.70 p≤0.01** 49.0 
Problems with 
Side Effects 
- - - - - - - 
Information 
About Back Pain 
and its 
Treatment 
13 0.58 0.04 33.6 0.32 p≤0.05* 10.2 
Satisfaction with 
Treatment 
Process 
15 0.70 0.004 0.49 0.71 p≤0.001*** 50.4 
Impact of Back 
Pain on 
Relationships 
- - - - - - - 
Back Pain 
Medication 
Acceptability 
15 0.55 0.03 30.3 0.51 p≤0.05* 26.0 
Adherence to 
Physiotherapy 
15 0.30 0.274 0.09 0.22 p=0.16 4.8 
≠
Two way mixed effects model were people are random and measures are fixed  
§Correlation coefficient squared 
*p≤0.05; **p≤0.01; *** p≤0.001 
 
Table 22 indicates that mean differences between baseline and week 2 were small 
and all domains of the CLBP Treatment Satisfaction questionnaire did not reach 
statistical significance with the exception of Information Provided about Back Pain and 
its Treatment, and Adherence to Physiotherapy. 
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Table 23 shows that ICC correlations between baseline and week 2 were 0.70 and above 
for the Burden of Back Pain domain and the Satisfaction with Treatment Process domain 
(p<0.05). With the exception of the Adherence to Physiotherapy domain (ICC = 0.22), 
all other ICC correlations reached statistical significance and ranged from 0.32 to 0.51.  
Pearson‘s correlation coefficients ranged from 0.30 to 0.71 and were also statistically 
significant for all domains except the Adherence to Physiotherapy domain. 
6.4.11  Responsiveness to Change over Time 
Responsiveness for all domains of the CLBP Treatment Satisfaction questionnaire was 
calculated except the Problems with Side Effects and the Impact of Back Pain and 
Treatment on Relationships domains, where sample sizes were too small. Results 
presented in Table 24  show responsiveness data for the remaining domains.  Mean change 
scores were positive for the improved group for all domains, and statistical significance 
was achieved for all domains except the Satisfaction with Treatment Process and the 
Medication Acceptability domains (p values for t-test p ≤ 0.05). Effect sizes were 
calculated for all significant results and findings showed that the magnitude of the 
differences were often moderate to large, ranging from -0.36 to -0.73. 
Table 24: Description and Comparison of the Changes in CLBP Treatment Satisfaction Questionnaire 
between Baseline and Week 6: Responsiveness 
   Baseline Week 6 t-test p-value ES
†
 
CLBP 
Treatment 
Satisfaction 
Domain 
Status of 
Patients 
n Mean SD Mean SD    
Burden of 
Back Pain  
MD 2 109.50 10.61 118.00 2.83 -0.97 p=0.54  
Worsened - - - - - - - - 
Stable 4 101.25 21.93 97.25 6.34  p=0.69  
Improved 13 102.15 23.97 118.62 17.54  p≤0.05* -0.36 
Problems 
with Side 
Effects 
MD   
Not calculated due to small sample sizes between groups 
 
Worsened  
Stable  
Improved  
Information MD 2 20.50 3.54 36.00 4.24 -3.75 p=0.22  
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   Baseline Week 6 t-test p-value ES
†
 
CLBP 
Treatment 
Satisfaction 
Domain 
Status of 
Patients 
n Mean SD Mean SD    
About Back 
Pain and 
Treatment 
Worsened - - - - - - - - 
Stable 5 23.40 3.65 35.40 13.57  p=0.12  
Improved 16 24.50 6.44 42.50 10.09  p≤0.0001*** -0.73 
Satisfaction 
with 
Treatment 
Process 
MD 2 18.50 0.71 13.00 4.24 -0.54 p=0.27  
Worsened - - - - - - - - 
Stable 5 17.20 2.82 17.21 2.20  p=1.00  
Improved 11 17.60 4.22 18.50 3.71  p=0.15  
Impact of 
Back Pain on 
Relationships 
MD   
Not calculated due to small sample sizes between groups 
 
Worsened  
Stable  
Improved  
Back Pain 
Medication 
Acceptability 
MD 2 11.00 1.41 9.00 4.24 -0.89 p=0.71  
Worsened - - - - - - - - 
Stable 6 10.83 3.06 11.67 2.16  p=0.22  
Improved 11 11.45 2.62 12.09 1.79  p=0.40  
Adherence to 
Physio-
therapy 
MD 2 11.00 1.41 12.50 3.54 -2.24 p=0.74  
Worsened - - - - - - - - 
Stable 6 11.50 2.26 11.17 1.33  p=0.80  
Improved 16 11.25 2.52 13.19 1.38  p≤0.01** -0.41 
*p≤0.05; ** p≤0.01; ***p<0.0001    †ES Effect size only calculated where statistical significance observed 
 
6.4.12  Exploring Factors Associated with the CLBP Treatment Satisfaction 
Questionnaire 
Standard Multiple Linear Regression was used. The assumptions of multiple 
linear regression were tested for and results indicate that they were met (see Appendix 
T). Specifically, examination of the collinearity diagnostic values for the predictor 
variables was quite respectable (ranging from .54 to .92). Inspection of the Normal 
Probability Plot of the standardised residuals show the points generally lie in a 
reasonably straight diagonal line from bottom left to top right, suggesting no major 
deviations from normality. The scatterplot of the standardised residuals shows that 
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residuals are roughly rectangularly distributed with most of the scores concentrated in 
the centre, again suggesting no major deviations from normality. 
Each multiple regression model included the following variables: gender, age, 
ethnicity, academic qualifications, whether patients had time off work in the last four 
weeks, whether patients were taking opioid analgesics, whether patients were taking 
non-opioid analgesics, whether patients experience side effects, pain severity in the last 
seven days, and the McGill Total Score. The models reached statistical significance for 
all domains except the Problems with Side Effects and Medication Acceptability 
domain. 
Multiple Linear Regressions of Variables on Burden of Back Pain  
Adjusted R
2
 indicated that the model explained 53% of the variance in Burden of 
Back Pain. Of the variables, the McGill Total score made the largest unique contribution 
(beta = -.36) although time off work (beta = .29), pain severity in the last seven days 
(beta = -.27), duration since diagnosis (beta = -.22), and ethnicity (beta = -.20) also make 
significant contributions (see Table 25 for summary of Beta coefficients, significance 
levels, partial correlations and unique variance). 
Table 25: Standard Multiple Regression of Gender, Age, Ethnicity, Academic 
Qualifications, Time off Work in the Last 4 weeks, Duration since Diagnosis, Opioid 
Analgesics, Side Effects, and Pain Severity in the Last 7 days on Burden of Back Pain  
Predictor variable Beta 
coefficients 
Partial 
correlation 
Unique 
variance 
t-value p-value 
Gender .05 .06 .04 .5
0 
0.62 
Age .09 .12 .08 .9
9 
0.33 
Ethnicity -.20 -.28 -.18 -2.31 0.02 
Academic qualifications .13 .19 .12 1.50 0.14 
Time off work in the last 4 
weeks 
.29 .38 .26 3.28 0.002 
Duration since diagnosis -.22 -.28 -.18 -2.27 0.03 
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Predictor variable Beta 
coefficients 
Partial 
correlation 
Unique 
variance 
t-value p-value 
Opioid analgesics -.16 -.21 -.13 -1.69 0.10 
Non-opioid analgesics -.04 -.06 -.04 -.49 0.63 
Side Effects .03 .04 .03 .32 0.75 
Pain Severity in last 7 days -.27 -.32 -.21 -2.65 0.01 
Involvement in treatment 
decisions 
.08 .12 .08 .99 0.33 
McGill Total Score -.36 -.36 -.25 -3.11 0.003 
R
2
 = .61, Adjusted R
2
 =.53, p≤0.0001 
 
Multiple Linear Regression of Variables on Information About Back Pain and 
Treatments 
Adjusted R
2
 indicated that the model explained 26% of the variance of 
Information about Back Pain and Treatments. Of the variables, involvement in treatment 
decisions made the largest unique contribution (beta = .56) although academic 
qualifications also makes significant contributions (beta = -.27) (see Table 26 for 
summary of Beta coefficients, significance levels, partial correlations and unique 
variance). 
Table 26: Standard Multiple Regression of Gender, Age, Ethnicity, Academic 
Qualifications, Time off Work in the Last 4 weeks, Duration since Diagnosis, Opioid 
Analgesics, Side Effects, and Pain Severity in the Last 7 days on Information Provided 
About Back Pain and Treatment 
Predictor variable Beta 
coefficients 
Partial 
correlation 
Unique 
variance 
t-value p-value 
Gender .09 .09 .074 .75 0.45 
Age -.10 -.10 .08 -.81 0.42 
Ethnicity -.02 -.02 -0.16 -.16 0.87 
Academic qualifications -.27 -.31 -.26 -2.65 0.01 
Time off work in the last 4 
weeks 
.11 .13 .10 1.04 0.30 
Duration since diagnosis .14 .15 .12 1.22 0.23 
Opioid analgesics .02 .03 .02 .21 0.84 
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Predictor variable Beta 
coefficients 
Partial 
correlation 
Unique 
variance 
t-value p-value 
Non-opioid analgesics .03 .04 .03 .28 0.78 
Side Effects -.07 -.07 -.06 -.58 0.57 
Pain Severity in last 7 days -.04 -.04 -.03 -.31 0.75 
Involvement in treatment 
decisions 
.56 .56 .53 5.39 0.0001 
McGill Total Score .16 .15 .12 1.25 0.22 
R
2
 = .38, Adjusted R
2
 =.26, p≤0.001 
 
Multiple Linear Regression of Variables on Satisfaction with the Treatment Process 
Adjusted R
2
 indicated that the model explained 16% of the variance in 
Satisfaction with the Treatment Process. Of the variables, involvement in treatment 
decisions made the largest significant unique contribution (beta = .38). There was a trend 
towards significance for the variable whether patients were taking opioid analgesics 
(beta = -.23) (see Table 27 for summary of Beta coefficients, significance levels, partial 
correlations and unique variance). 
Table 27: Standard Multiple Regression of Gender, Age, Ethnicity, Academic 
Qualifications, Time off Work in the Last 4 weeks, Duration since Diagnosis, Opioid 
Analgesics, Side Effects, and Pain Severity in the Last 7 days on Satisfaction with 
Treatment Process 
Predictor variable Beta 
coefficients 
Partial 
correlation 
Unique 
variance 
t-value p-value 
Gender .09 .10 .08 .76 0.45 
Age .14 .14 .12 1.11 0.27 
Ethnicity -.15 -.16 -.14 -1.30 0.20 
Academic qualifications -.02 -.03 -.02 -.22 0.83 
Time off work in the last 4 
weeks 
-.02 -.02 -.02 -.16 0.87 
Duration since diagnosis .20 .20 .17 1.60 0.11 
Opioid analgesics -.23 -.21 -.18 -1.74 0.09 
Non-opioid analgesics -.07 -.08 -.06 -.60 0.55 
Side Effects .21 .21 .18 1.70 0.09 
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Predictor variable Beta 
coefficients 
Partial 
correlation 
Unique 
variance 
t-value p-value 
Pain Severity in last 7 days .12 .11 .09 .89 0.38 
Involvement in treatment 
decisions 
.38 .39 .36 3.39 0.001 
McGill Total Score -.02 -.02 -.02 -.14 0.89 
R
2
= .29, Adjusted R
2
 =.16, p≤0.05 
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Multiple Linear Regressions of Variables on Adherence to Physiotherapy 
Adjusted R
2
 indicated that the model explained 14% of the variance in Adherence 
to Physiotherapy. Of the variables, ethnicity makes the largest significant unique 
contribution (beta = -.23). There were trends towards significance for the variables 
duration since diagnosis (beta = -.24), whether patients were taking opioid analgesics 
(beta = -.22), and whether patients are taking non-opioid analgesics (beta = -.21) (see 
Table 28 for summary of Beta coefficients, significance levels, partial correlations and 
unique variance). 
Table 28: Standard Multiple Regression of Gender, Age, Ethnicity, Academic 
Qualifications, Time off Work in the Last 4 weeks, Duration since Diagnosis, Opioid 
Analgesics, Side Effects, and Pain Severity in the Last 7 days on Adherence to 
Physiotherapy  
Predictor variable Beta 
coefficients 
Partial 
correlation 
Unique 
variance 
t-value p-value 
Gender -.04 -.04 -.03 -.30 0.76 
Age .11 .11 .09 .89 0.38 
Ethnicity -.23 -.24 -.21 -1.97 0.05 
Academic qualifications -.03 -.04 -.03 -.31 0.76 
Time off work in the last 4 
weeks 
.17 .18 .15 1.45 0.15 
Duration since diagnosis .24 .23 .21 1.93 0.06 
Opioid analgesics -.22 -.21 -.18 -1.74 0.09 
Non-opioid analgesics -.21 -.21 -.19 -1.77 0.08 
Side Effects .12 .12 .10 .98 0.33 
Pain Severity in last 7 days -.21 -.19 -.16 -1.55 0.13 
Involvement in treatment 
decisions 
-.01 -.01 -.10 -.09 0.93 
McGill Total Score .22 .19 .17 1.60 0.12 
R
2
 = .27, Adjusted R
2
 =.14, p≤0.05 
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Multiple Linear Regressions of Variables on Impact of Back Pain and Treatment on 
Relationships 
Adjusted R
2
 indicated that the model explained 39% of the variance in Impact of 
Back Pain and Treatment on Relationships. Of the variables, whether patients are taking 
opioid analgesics (beta = -.75) made the largest unique contribution (beta = -.36) 
although age (beta =.58), whether patients are taking non-opioid analgesics (beta = -.47), 
duration since diagnosis (beta = -.47), and academic qualifications (beta = .34) also make 
statistically significant contributions (see Table 25 for summary of Beta coefficients, 
significance levels, partial correlations and unique variance). 
Table 29: Standard Multiple Regression of Gender, Age, Ethnicity, Academic 
Qualifications, Time off Work in the Last 4 weeks, Duration since Diagnosis, Opioid 
Analgesics, Side Effects, and Pain Severity in the Last 7 days on Impact of Back Pain on 
Relationships  
Predictor variable Beta 
coefficients 
Partial 
correlation 
Unique 
variance 
t-value p-value 
Gender .01 .01 .10 .06 0.95 
Age .58 .52 .38 2.79 0.01 
Ethnicity -.24 -.30 -.19 -1.43 0.17 
Academic qualifications .34 .42 .23 2.13 0.05 
Time off work in the last 4 
weeks 
.15 .19 .12 .87 0.40 
Duration since diagnosis -.47 -.46 -.32 -2.38 0.03 
Opioid analgesics -.75 -.55 -.41 -3.02 0.01 
Non-opioid analgesics -.47 -.47 -.33 -2.45 0.02 
Side Effects .11 .10 .06 .47 0.64 
Pain Severity in last 7 days -.25 -.27 -.17 -1.27 0.22 
Involvement in treatment 
decisions 
-.12 -.15 -.10 -.71 0.49 
McGill Total Score -.14 -.16 -.10 -.75 0.46 
R
2
 = .61, Adjusted R
2
 =.39, p≤0.05 
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6.4.13 Summary of Results 
The main objective of this part of the study was to explore the psychometric 
properties of the CLBP Treatment Satisfaction Questionnaire. The results provide some 
evidence to support the reliability and validity of the instrument, and are summarised 
briefly below: 
 A PCA analysis resulted in seven main factors that explained 52% of the total 
variance. The factors were labelled  
o ‗Burden of Back Pain‘ 
o ‗Problems with Side Effects of Back Pain Medication‘  
o ‗Information About Back Pain and Treatment‘ 
o ‗Satisfaction with the Back Pain Treatment Process‘ 
o ‗Impact of Back Pain on Relationships‘  
o ‗Back Pain Medication Acceptability‘  
o ‗Adherence to Physiotherapy‘ 
 Internal consistency for each domain was good; Cronbach‘s alpha ranged 
from 0.79 for ‗Adherence to Physiotherapy‘ to 0.94 for ‗Burden of Back 
Pain‘.  
 There was evidence of concurrent validity, with low to moderate correlations 
between the CLBP Satisfaction Question and both the SF-36 (r=0.003 to 
0.76) and the PETS (r= -0.11 to -0.61).  
 There was evidence of discriminative validity of the CLBP Treatment 
Satisfaction Questionnaire with distribution of scores according to the 
following variables related to clinical severity: 
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o Patients‘ rating of health 
o Level of pain in the last 7 days 
o Level of pain right now 
 Test-retest reliability requires further testing.  
o Whilst the sample size was very small (n=17), mean differences 
between baseline and week 2 were small and all domains of the CLBP 
Treatment Satisfaction questionnaire did not reach statistical 
significance with the exception of Information Provided about Back 
Pain and its Treatment, and Adherence to Physiotherapy.  
o ICC correlations between baseline and week 2 were 0.70 and above 
for the ‗Burden of Back Pain‘ domain and the ‗Satisfaction with 
Treatment Process‘ domain. However, ICCs could not be calculated 
due to insufficient sample sizes for Problems with Side Effects and 
Impact of Back Pain on Relationships. Further, ICCs were poor for 
the remaining domains: Information about Back Pain and its 
Treatment, Medication Acceptability, Adherence to Physiotherapy.  
 Responsiveness was demonstrated for all domains except the ‗Problems with 
Side Effects‘ and the ‗Impact of Back Pain and Treatment on Relationships‘ 
domains where sample sizes were too small to perform tests. 
 Multiple linear regressions showed various clinical and demographic factors 
associated with the principal components of the CLBP Treatment Satisfaction 
Questionnaire. Specifically: 
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o 53% of the variance of ‗Burden of Back Pain‘ was explained by the 
McGill Total Score, Time off work in the last 4 weeks, pain severity, 
duration since diagnosis and ethnicity. 
o 26% of the variance of ‗Information About Back Pain and Treatment‘ 
was explained by involvement in treatment decisions and academic 
qualifications. 
o 16% of the variance of ‗Satisfaction with the Treatment Process‘ was 
explained by involvement in treatment decisions. 
o 14% of the variance of ‗Adherence to Physiotherapy‘ was explained 
by ethnicity. 
o 39% of the variance of ‗Impact of Back Pain and Treatment on 
Relationships‘ was explained by whether patients take opioids, 
whether patients take non-opioids to help them with their problems, 
duration since diagnosis, and academic qualifications. 
6.5 Discussion 
6.5.1 Overview of Study Objectives 
The purpose of this part of the study was two-fold. The first aim was to test the 
psychometric properties of the CLBP Treatment Satisfaction Instrument. In particular, 
the aims were to explore the construct validity, internal consistency, concurrent validity, 
discriminative validity, test-retest reliability, and responsiveness.  
The second aim was to construct a framework to make sense of the complex set of 
factors associated with treatment satisfaction in CLBP. In particular, the aim was to 
explore the predictors of the principal components of the CLBP Treatment Satisfaction 
Questionnaire to understand how well demographic, treatment, and pain variables predict 
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the various components of treatment satisfaction in CLBP, how much variance can be 
explained by the predictors, and to establish which variables are the best predictors. 
6.5.2 Summary of Main Findings 
With regard to the first aim of this study, the study found some evidence to 
support the reliability and validity of the CLBP Treatment Satisfaction Questionnaire. A 
PCA analysis resulted in seven main factors that explained 52% of the total variance. 
The factors were labelled ‗Burden of Back Pain‘, ‗Problems with Side Effects of Back 
Pain Medication‘, ‗Information About Back Pain and Treatment‘, ‗Satisfaction with the 
Back Pain Treatment Process‘, ‗Impact of Back Pain on Relationships‘, ‗Back Pain 
Medication Acceptability‘, and ‗Adherence to Physiotherapy‘. Internal consistency for 
each domain was good, supporting that items within each domain are measuring the 
same concept. 
Following construct validity and internal consistency analyses, the final CLBP 
Treatment Satisfaction Questionnaire was scored so that high scores on each of the 
domains indicated positive outcomes associated with treatment satisfaction. Scores were 
generally non-normal, with some bimodal and multimodal distributions observed.  
Statistical tests in this study supported the discriminative validity of the domains 
of the CLBP Treatment Satisfaction Questionnaire. For example, with the exception of 
‗Information Provided about Back Pain and Treatment‘ and ‗Adherence to 
Physiotherapy‘, all domains of the CLBP Treatment Satisfaction Questionnaire were 
able to discriminate between levels of pain in the last 7 days, with lower pain scores 
associated with more positive outcomes. For example, with higher levels of pain, lower 
scores were observed for ‗Burden of Back Pain‘, indicating significant negative impact 
on patients‘ regular activities. Similarly, the higher the pain, the lower the scores were 
for ‗Impact of Back Pain and Treatment on Relationships‘, indicating that back pain 
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interferes with patients‘ relationships.  In addition, all domains except ‗Information 
Provided about Back Pain‘ were able to discriminate according to levels of pain in the 
last 7 days. 
In terms of test-retest reliability, although the sample size was well below the 
recommended 100 (Kline, 2000) for stable patients who completed the questionnaire at 
baseline and week 2, results provide some evidence to support the reproducibility of 
some of the CLBP Treatment Satisfaction Questionnaire. Specifically, mean differences 
between baseline and week 2 were small for all domains of the CLBP Treatment 
Satisfaction Questionnaire and did not reach statistical significance. The exceptions were 
for the ‗Information about Back Pain and Treatment‘ and ‗Adherence to Physiotherapy‘ 
domains.   
Further, test-retest reliability refers to the extent to which the two administrations 
of the same questionnaire to the same group of patients provide consistent results 
(Guyatt et al., 1989).  Pearson‘s correlation coefficients provided some evidence to 
support agreement between the two assessments for some domains (i.e. ‗Burden of Back 
Pain‘, and ‗Satisfaction with the Treatment Process‘). Since Pearson‘s correlation 
coefficients cannot detect systematic error (Deyo et al., 1991; Schuck, 2004), ICCs were 
also calculated using a two-way mixed effects model where people were random and 
measures were fixed, with an absolute agreement definition and single measures reported 
between baseline and week 2. ICCs were 0.70 and above for ‗Burden of Back Pain‘ and 
the ‗Satisfaction with Treatment Process‘ domains, indicating some confidence in test-
retest reliability (Kline, 2000). With the exception of ‗Adherence to Physiotherapy‘ 
domain (ICC=0.22), all other ICC correlations that were tested reached statistical 
significance and ranged from 0.32 to 0.71. However, it should be noted that ICCs were 
poor for ‗Information about Back Pain and Treatment‘, ‗Medication Acceptability‘, and 
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‗Adherence to Physiotherapy‘. Given these findings and the small sample sizes, further 
testing is required in a larger sample size of stable patients to ascertain with greater 
certainty the test-retest reliability of the CLBP Treatment Satisfaction Questionnaire, and 
particularly for the ‗Problems with Side Effects‘ and the ‗Impact of Back Pain on 
Relationships‘ domains which could not be explored due to the small sample sizes.  
Scores were sensitive to change over time between baseline and week 6, 
providing some evidence of responsiveness. Mean scores between baseline and week 6 
were positive for the improved group for all domains and statistical significance was 
achieved for all domains except the ‗Satisfaction with Treatment Process‘ and the 
‗Medication Acceptability‘ domains. Effect sizes were moderate to large, ranging from -
0.36 to -0.73. It should be noted that responsiveness could not be explored for ‗Problems 
with Side Effects‘ and ‗Impact on Relationships‘ where sample sizes were too small. 
With regard to the second aim, standard MLRs were performed on the principal 
components of the CLBP Treatment Satisfaction Questionnaire. The assumptions of 
MLR were tested and met. All models were significant except for ‗Problems with Side 
Effects‘ and ‗Medication Acceptability‘. The following variables explained 53% of the 
variance of the ‗Burden of Back Pain‘ domain: McGill Total pain score, time off in the 
last four weeks, pain severity in the last 7 days, duration of CLBP since diagnosis, and 
ethnicity. These findings are not surprising since the burden of back pain and whether 
patients can go about their regular activities will be related to how much pain they are 
experiencing. Interestingly, ethnicity was associated with Burden of Back Pain.  
A different set of variables also explained 39% of the variance of the ‗Impact of 
Back Pain and Treatment on Relationships‘ domain: whether patients take opioid 
analgesics, age, whether patients take non-opioid analgesics, duration of CLBP since 
diagnosis, and academic qualifications. Again, these finding are not unexpected and 
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these associations seem relatively intuitive. For example, the Relationships domain 
contains items associated with whether patients are sexually active and whether they find 
sex uncomfortable, and one would expect that if individuals experience CLBP then these 
aspects may be affected. On reflection, during the in-depth patient interviews (see 
Chapter 4), one patient stated: “I don’t know but my wife has noticed that probably my 
sex life has been affected because I hardly do it anymore because of the pain and all the 
surroundings that goes with it” (ID04). Also, age may be associated with whether 
patients have a partner and the desire for sex. Indeed, during in-depth patient interviews, 
another patient stated “You can forget sex with my back. When you get to my age there’s 
no one nice anyway” (ID02). 
A total of 26% of the variance of ‗Information about Back Pain and Treatment‘ 
was explained by the factors involvement in treatment decisions and academic 
qualifications. Again, these findings seem to be logical in that if patients feel involved in 
treatment decisions, then they are likely to be informed about their condition and (for 
example) the treatment options available to them. Also, it seems intuitive that the degree 
of academic qualifications is associated with how much information patients would have 
liked about various aspects of their condition and treatment.  
Involvement in treatment decisions was also a significant predictor of 
‗Satisfaction with Treatment Process‘ domain, which, together with whether patients 
take opioids, explained 16% of the total variance. Further, there were four factors that 
predicted Adherence to Physiotherapy: ethnicity, duration of CLBP since diagnosis, 
whether patients take opioids, and whether patients take non-opioids. Together, these 
explained 14% of the total variance of Adherence to Physiotherapy. 
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6.5.3 Baseline Sample Characteristics  
The mean age of the overall sample at baseline was 47.9 years and included a 
greater proportion of women to men. Unfortunately, national UK statistics were not 
available for patients with CLBP, and OPCS data suggests that the prevalence of back 
pain (defined as pain for at least one day in the last year, i.e. acute or sub-acute) is 
similar between males and females (The Department of Health Statistics Division, 1999). 
It is possible that the transition from acute or sub-acute back pain to CLBP is more 
prevalent in women than men; this hypothesis requires further testing using empirical 
data. Another possibility is that women are perhaps more likely to participate than men. 
Again, future research is warranted to explore this further, since establishing the 
proportion of males and female non-responders could be useful.    
Although there were similarities observed in socio-demographic characteristics 
between subgroups (e.g. participants recruited from physiotherapy departments 
compared to those from pain clinics or charities) there were also some differences. For 
example, the age of participants from charities and pain clinics was higher than the 
physiotherapy and Back Show groups. This result is not surprising, since people 
attending pain clinics are often referred by an ESP and have already tried physiotherapy 
and/or other treatment methods, or have psychological barriers concerning pain; 
therefore, there is a tendency for them to be older. Patients from the Back Show were 
generally more mobile and therefore may be younger. 
Also, whilst the majority of patients were Caucasian or white in all groups, there 
was a slightly higher proportion of patients from the Back Show who were non-white. 
Since the Back Show was held in London where there is a higher proportion of ethnic 
minority groups compared to the Northern England recruitment sites, this is 
unsurprising.   
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Comparisons between subgroups according to socio-demographic characteristics 
reached statistical significance for ethnicity, academic qualifications, employment, and 
whether patients 16-64 years who were employed had time off work due to CLBP. These 
findings suggest that the characteristics of the subgroups are not homogenous. Whilst it 
could be inferred that the data from the subgroups should not be pooled, nevertheless 
samples were pooled in order to obtain sufficient sample for psychometric testing. 
Further, pooling samples allowed an increase in the variability of the level of pain 
reported by patients, which was particularly important for the purpose of this study. 
The sample used in this study was broadly comparable to the national average as 
reported by the OPCS (The Department of Health Statistics Division, 1999); therefore, it 
can be inferred that findings from this study are representative of patients with CLBP 
and can be generalised to the wider population. However, some differences between the 
data sets are apparent in gender (more women than men in this study compared to OPCS 
study), age (more patients in the 16-24 age group in the OPCS study compared to this 
study), whether patients who were employed had time off due to back pain (more 
patients in this study who had time off due to their back pain than in the OPCS study), 
and reasons why patients were not employed (more patients in this study reported back 
problems or other problems getting a job as reasons for not being employed compared to 
the OPCS study). These differences may be explained by the fact that the OPCS study 
(which was the only national average data available at the time) was primarily calculated 
based on the percentage of general population with back pain at least one day in the last 
12 months, whereas this study was focused on patients with CLBP defined as pain 
lasting for at least three months.  
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6.5.4 Baseline Scores of Validated Instruments 
Results using the SF-36 suggest that at baseline patients with CLBP in this study 
had significantly lower HRQoL scores than U.K. age-matched norms (see section 6.4.2). 
These findings were particularly prominent across HRQoL domains, and mean point 
differences between study scores and age-matched norms ranged from 11.32 for Mental 
Health to 45.3 for Role Functioning due to Physical Limitations. Since 3 to 5 point 
differences are considered clinically meaningful (see for example, Kosinski et al., 2000; 
Samsa et al., 1999), these results indicate that patients with CLBP in this study had 
clinically significant impairment in HRQoL domains compared to U.K. age-matched 
norms. This is supported by RMDQ scores, which indicated that patients experienced 
moderate disability due to their CLBP.  
These findings point towards a need for continued support and care for patients 
with CLBP, with particular attention to how CLBP impacts patients‘ HRQoL in terms of 
Role Functioning, Social Functioning, Physical Functioning, Vitality, and General 
Health.  
Further, results from this quantitative study suggested that patients do not adhere 
to the medication regimens recommended by their doctors (see section 6.4.2). These 
findings are in line with (Myers & Midence, 1998). Non-adherence may be a result of 
lack of awareness, knowledge, understanding by patients regarding how medication can 
help with everyday activities, and misunderstanding about the potential for dependence 
or other side effects (Myers & Midence, 1998).  
Regarding pain scores, results indicated inconsistencies in scores between 
measures of pain, which may in part be explained by the fact that the sensory and 
affective scores of the SF MPQ are calculated by summing various items that belong to 
each subscale, whereas the VAS establishes patients‘ experience of pain in a single item. 
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Whilst there is evidence to support the validity and reliability of both methods, there is 
no clear consensus in the literature regarding which pain score is the best indicator, and 
further research is warranted to establish this. 
6.5.5 Overview of Responses to CLBP Treatment Satisfaction Items  
The description of scores for the CLBP Treatment Satisfaction items showed the 
significant and diverse impact of CLBP and its treatment on patients‘ lives (see section 
6.4.3). For example, of those patients who experienced side effects, the majority reported 
that they were a big problem or a severe problem. In addition, most patients stated that 
they disagreed or strongly disagreed that their medication was helpful. When asked 
questions about satisfaction or dissatisfaction with the treatment process, overall most 
patients reported that they were ‗dissatisfied‘ or ‗very dissatisfied‘, specifically with the 
communication with their doctor regarding back pain medication, as well as with the 
information provided about the possible side effects incurred from back pain medication, 
the form of administration (e.g. tablet, patch, etc.), the amount of medication prescribed, 
and the way side effects were dealt with by their doctor. With regard to medication 
acceptability, although the majority disagreed that their back pain medication was 
difficult to swallow or left an unpleasant taste in their mouth, the majority ‗agreed‘ that 
their back medication does not work quickly. Furthermore, the majority ‗disagreed‘ that 
they set realistic goals, they paced their activities, and remembered to do their exercises. 
These findings suggest that medication management and physiotherapy regimens 
need to be more patient focused. Actively listening and empathising with patients may 
help contribute towards more positive satisfaction ratings, as well as asking patients 
whether they experience side effects and how much of a problem they are to them, to 
help make them feel more involved in the treatment process and ultimately facilitate 
doctor-patient communication. 
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6.5.6 Construct Validity of the CLBP Treatment Satisfaction Questionnaire 
The PCA produced seven factors (Burden of Back Pain, Problems with Side 
Effects of Back Pain Medication, Information Provided about Back Pain and Treatment, 
Satisfaction with the Back Pain Treatment Process, Impact of Back Pain and Treatment 
on Relationships, Adherence to Physiotherapy, and Back Pain Medication Acceptability) 
which accounted for 52% of the systematic covariance of the items. Eight-items did not 
load on any of the seven factors: ‗I was misdiagnosed‘, ‗I was not involved in treatment 
decisions‘, ‗I went out of the home‘, ‗I could bend down‘, ‗I had an ache in my back 
when I woke‘, ‗My back pain medication is helpful to me‘, ‗my back pain medication 
enables me to be independent‘, and ‗I altered the amount of back pain medication I 
took‘. Closer examination of the qualitative data and themes that emerged from in-depth 
interviews with patients (see section 4.4.2) suggests that these items are important to 
patients. Therefore, they were not deleted but do not form part of the seven domain 
scores of the questionnaire, and thus are analysed separately. Whilst data from this study 
showed a clear factor structure, further research is warranted to confirm with greater 
certainty the construct validity of the CLBP Treatment Satisfaction Instrument, and also 
whether the eight items that did not load on to any of the domains of the instrument 
should be retained.  
Whilst a very clear factor structure was observed, additional testing using another 
sample of patients with CLBP is warranted to confirm these findings.   
Further, as noted earlier, the PCA is ultimately based on the correlation between 
items and requires that items be coded on a continuous scale. Because ‗not applicable‘ 
options are not suitable as part of a continuous scale and the PCA can be performed on 
complete cases, i.e. only for those participants who answered all of the items, in order to 
retain sufficient sample size for the purpose of the PCA, those answering ‗not 
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applicable‘ to relationship items were re-assigned to the ‗none of the time‘ category. The 
rationale being that relationship items would not be relevant to those who answered ‗not 
applicable‘, presumably because they did not have a partner or were not sexually active 
etc. Consequently, a raw score of 6 for ‗not applicable‘ was re-assigned a score of 5 
representing ‗none of the time‘. 
Similarly, for the problems with side effects items, participants were asked 
‗Because of your back pain medication, in the last 7 days how much of a problem were 
the following‘. This section comprised 7 items such as ‗loss of appetite‘, or ‗weight gain‘ 
and how much of a problem the side effect was, was rated from 1 not a problem, to 5 a 
severe problem. Those answering ‗not applicable‘ because they did not have the side 
effect were re-assigned to the ‗not a problem‘ category. 
In practical terms, including and re-assigning the ‗not applicable‘ group means 
for example, those participants who did not have the symptom and those who had the 
symptom but it was not a problem, were grouped together. One implication is that this 
will have affected the distribution of scores by inflating the number of participant at one 
end of the scale (‗not a problem‘/‘none of the time). This may have led to a more skewed 
distribution of the answers. 
Whilst this is not ideal for psychometric testing such as discriminant analyses 
where one needs sufficient distribution of scores to help establish whether there are 
differences between groups, such scoring is not expected to impact significantly on the 
PCA results where sample size and the strength of relationship among the items are the 
main issues for consideration (Pallant, 2001) – and this is why this scoring was specific 
to the PCA analyses. 
Having scored the questionnaire in this way, the overall sample that the PCA was 
performed on was 209 participants. According to Comrey and Lee (1992) this overall 
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sample size is considered ‗fair‘ for PCA. However, it should be noted that with 77 items 
included in the PCA and using a ratio of 3 participants per item, the overall sample size 
of 209 falls slightly short of the required 231 estimated sample size (see section 6.4.4).  
The possible implication of this outcome is that factors obtained from small datasets do 
not generalise as well as those derived from larger samples (Pallant, 2001)and therefore 
further PCA could be performed using a larger sample size and with particular attention 
to meaningful missing data such as ‗not applicable‘.  
Another possible implication is that by re-assigning raw scores from ‗not 
applicable‘ category to either ‗none of the time‘ or ‗not a problem‘ according to the item, 
it‘s possible that the outcome may have been to underestimate the actual impact which 
may have been greater if they had had a partner or experienced the side effect.  But as 
mentioned previously, if this ‗smart imputation‘ had not been performed then the sample 
would have been very small and not appropriate for PCA.  
Further, if PCA had been performed for all participants who had a partner or 
experienced a side effect, then there may be a question of generalisability since then the 
results of the PCA would be only valid for people with a partner and who experienced 
side effects.  This would be a very restrictive population as people with CLBP have a 
range of experiences some with or without partners and some with or without side 
effects from medication. Consequently, the rationale for ‗smart imputation‘ on items 
related to relationships or problems with side effects was considered appropriate. 
With regard to the consequences of ‗smart imputation‘ for PCA, it is likely to 
have had limited impact on the results. However, one possibility is that the imputation 
may have, in part, caused the creation of the grouping of items into a single factor but as 
the imputation was only performed on one end of the scale, this alone, is not likely to 
explain that all these items loaded on a single factor. Nevertheless, in light of this 
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possibility, future research could try to confirm the factor structure of the CLBP 
Treatment Satisfaction questionnaire, especially for these domains (i.e. Impact on 
Relationships and Problems with Side Effects) using methods such as exploratory and 
confirmatory factor analyses. 
Further, whilst there is justification for performing ‗smart imputation‘ for items 
related to relationships and problems with side effects, and such a method is considered 
meaningful and appropriate, an alternative approach for future research could be to 
perform the PCA on all participants by deleting the two domain‘s items entirely, and to 
later do additional analysis on the subgroup to examine how the domains fit into the 
structure in that subgroup. In this way, the applicable domain results generalize to the 
entire population, and the additional domain results apply to the applicable subset of the 
population. 
 Nevertheless, the methods used in this study are considered appropriate and 
meaningful, and results from patient interviews as well as informal discussions with 
clinicians suggested that treatment satisfaction in CLBP was in part related to the impact 
on relationships and the problems with side effects encountered by patients, thus 
providing further support for the approach taken. 
6.5.7 Internal Consistency 
All seven domains of the questionnaire had satisfactory internal consistency, 
exceeding Nunnally‘s threshold of 0.70 (Nunnally, 1978). These findings suggest that 
the items which comprise each domain are related to each other and point towards the 
conclusion that the items within each domain are indeed measuring the same concepts. 
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6.5.8 Tests for Normality and Outliers 
The data were generally non-normal and there were some bimodal and 
multimodal distributions observed. This is not surprising since the data in this study 
emerged from patient reports, and the majority of data that come from behavioural 
sciences are frequently non-normally distributed (see for example, Micceri, 1989). 
Another possible explanation for non-normality is that patients were recruited from 
diverse types of sites. Therefore, it‘s feasible that if these groups were considered 
separately, then scores may appear normally distributed. However, the data were pooled 
so that sufficient sample size was obtained to explore the main purpose of the study: 
establishing the factor structure of the CLBP Treatment Satisfaction questionnaire. 
Future research could stratify the data by sub-groups (e.g. considering scores by 
recruitment site or treatment, etc.). In addition, some of the questions may have been too 
easy or too difficult for patients with CLBP to respond to, resulting in some floor or 
ceiling effects. (Examples include some of the physical functioning related items such as 
‗I was unable to work‘, ‗I leaned on one side‘ and ‗I had poor balance‘ and all the 
appearance items: ‗I was unable to brush/comb my hair‘, ‗I had difficulty getting 
dressed‘, ‗I slouched‘, ‗I was not interested in my appearance‘, and ‗I was embarrassed 
about my image‘.) The skeweness, indicative of floor and ceiling effects, suggests 
patients performed extremely well or very badly on items. Implications include the 
systematic under estimation or over estimation of scores, which may lead to an inability 
to distinguish between groups or even the incorrect classification of individuals into 
groups. With this in mind, whilst all items underwent a rigorous development and 
cognitive debriefing process (see Chapter 5), further research research with patients 
regarding the content and appropriateness is necessary to establish whether these items 
should be retained in the CLBP Treatment Satisfaction Questionnaire or whether the 
wording of these items needs to be revised. 
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Despite observations of non-normality, generally the deviations from the means 
were minimal and skewness and kurtosis scores were well below an acceptable 4.0, 
indicating that transformation of scores is not required. In addition, the scores were all 
within the expected ranges, and any outliers did not significantly impact the mean 
because comparisons to the 5% trimmed mean showed that there were only small 
differences.  
However, it should be noted that the use of parametric tests on non-normal data 
can cause problems with the interpretation of results. Namely, there is a chance of 
incurring a type I error (rejecting the null hypothesis when it is true) or type II error 
(accepting the null hypothesis when it is false). Thus, observed differences between 
groups should be considered exploratory and further testing is warranted to establish the 
reliability of the results.  
6.5.9 Concurrent Validity 
Low to moderate correlations were observed between the domains of the CLBP 
Treatment Satisfaction Instrument and both the SF-36 HRQoL measure and the PETS, 
indicating concurrent validity, i.e., that the instruments are measuring similar but 
different concepts. These findings are partly supportive of what was expected in that the 
Burden of Back Pain domain shows significant and moderate correlations with the SF-
36. Unexpectedly, the Impact on Relationships domain and the Problems with Side 
Effects domains also showed significant moderate correlations with the SF-36. This may 
in part be explained by the fact that although the domains are not measuring exactly the 
same concepts they are probably related, for example, it is clinically intuitive that 
Problems with Side Effects would be related to HRQoL. 
In addition, as expected the following domains of the CLBP Treatment 
Satisfaction Questionnaire were significantly and moderately correlated with the PETS 
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domains: Information about Back Pain and Treatment, Satisfaction with the Treatment 
Process domain, and Adherence to Physiotherapy domains. 
However, it should be noted that the sample sizes for the Problems with Side 
Effects domain were small. The reason for this is because patients may not have 
experienced a side effect at baseline and therefore a score could not be calculated for that 
domain. Similarly, the sample sizes for the relationships domain were also small and the 
reason for this is that some patients answered ‗not applicable‘ to these questions 
presumably because they did not have a partner. The small sample sizes for these 
domains suggest less confidence in the results obtained for concurrent validity and 
therefore require further testing. Further, given the small sample sizes for these domains, 
alternative scoring algorithms should be considered in the future. For example, with 
regard to the Problems with Side Effects domain, it may be more meaningful to analyse 
each item individually in terms of frequency (whether the patient experienced the side 
effect) and then how much of a problem it was to them. However, there are other 
analytical methods that could be considered such as cluster analysis (which would 
organise the data according to common observations or homogenous cases) or multiple 
regression analyses to consider whether experiencing a particular side effect predicts the 
likelihood of adhering to for example medication regimens.  
6.5.10 Description of Baseline CLBP Treatment Satisfaction Domain Scores 
Based on the validation of the CLBP Treatment Satisfaction Questionnaire, 
descriptive statistics of domain scores were calculated and summarised. To aid 
interpretation, the mean score for each domain was divided by the total number of items 
for that domain, and since a score of 5 represents satisfaction/positive outcomes for all 
items in a domain, a mean of 3.5 or more suggests most patients were satisfied/had 
positive outcomes with most or all items in the domain. 
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Results suggest that patients were experiencing burden from their back pain some 
of the time and also that back pain impacted on their relationships some of the time. For 
those who experienced side effects, these presented as a problem. Overall, patients in this 
study wanted a bit more information about their back pain and its treatment, and results 
suggested that they were neither satisfied nor dissatisfied with the treatment process.  
Further, patients were not sure about adherence to physiotherapy such as whether they 
set realistic goals and paced their activities.  
These results are consistent with recent literature which demonstrates similar 
findings (see for example, Cherkin et al., 1991; McPhillips-Tangum et al., 1998) (see 
section 2.6.5). The implications of these findings suggest potential unmet needs for 
patients with CLBP in the UK. Therefore, HCPs can actively target the various 
components to help alleviate symptoms and the burden incurred to patients. This is 
expected to improve associated outcomes such as satisfaction and adherence.    
6.5.11 Discriminative Validity 
Whilst there was evidence to support the discriminant validity of the CLBP 
Treatment Satisfaction Questionnaire, the domains Information about Back Pain and 
Treatment and Adherence to Physiotherapy did not reach statistical significance in 
discriminating between levels of pain. One possible explanation for this is that these 
items and the overall Information about Back Pain score may not necessarily be 
associated with how much pain patients have had in the last 7 days. Similarly, the 
Adherence to Physiotherapy domain assesses the degree to which patients agree or 
disagree that they set realistic goals, remember to do exercises, and pace activities; these 
may also not necessarily be associated with pain in the last 7 days.  
Burden of Back Pain, and Impact of Back Pain and Treatment on Relationships 
were able to significantly discriminate according to levels of pain right now, and how 
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patients rate their health.  Whilst these results provide further evidence for the 
discriminative validity of the CLBP Treatment Satisfaction Questionnaire, some 
domains did not significantly discriminate according to levels of pain right now and how 
patients rate their health. One possible reason for this is that patients rating of health and 
pain right now may not have captured sufficient spread of scores (e.g. patients may not 
have been experiencing pain at the time they completed the questionnaires). Further 
research could explore other variables that may better reflect the discriminative validity 
of the CLBP Treatment Satisfaction Questionnaire, for example. pain in the last 24-
hours. 
Moreover, it should be noted that the Levene‘s test of homogeneity of variance 
for Impact of Back Pain and Treatment on Relationships with level of pain right now 
reached statistical significance, suggesting that the variances between the groups were 
not the same. Similarly, the Levene‘s test reached statistical significance for Problems 
with Side Effects of Back Pain Medication with pain in the last seven days, as well as 
with how patients rate their health. These results indicate violation of one of the 
assumptions of the ANOVA test used in this study to assess differences between groups 
for discriminative validity. Future research could explore the discriminative validity of 
these domains using modified procedures that do not assume equality of variance if 
necessary. 
6.5.12 Test-Retest Reliability 
Change between baseline and week 2 scores for all domains tested of the CLBP 
Relief Treatment Satisfaction Questionnaire did not reach statistical significance for all 
domains except Information About Back Pain and Treatment, and Adherence to 
Physiotherapy. These results are not surprising, since the test-retest sample was 
composed of patients who had been referred by an ESP to physiotherapy or a pain clinic. 
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Such patients would have completed the baseline assessment prior to their first 
consultation with the physiotherapist, and then their second assessment approximately 1 
week later.  During this time, the physiotherapist or pain specialist would have educated 
them about good back care and provided information about their condition, treatment 
options, posture and positioning, and the importance of remembering to do their 
exercises, setting realistic goals, and pacing activities. Therefore, given this patient 
group, change in scores on the Information about Back Pain and Treatment and 
Adherence to Physiotherapy domains are expected.  
Note that test-retest reliability could not be calculated for the Problems with Side 
Effects of Medication domain since sample sizes were far too small, with only two 
patients reporting problems with the same side effects at baseline and at week 2. Again, 
this is not surprising since the experience of symptoms and side effects is highly variable 
and can change within hours or days (Stull et al., 2009). 
Whilst some evidence for test-retest reliability was demonstrated for some 
domains, it is important to acknowledge that inconsistencies may be due to the person, 
the instrument, or the context, and there are various factors that may contribute to 
distorting results. One such factor is the sample size. Samples should be representative of 
the target population and comprise at least 100 participants (Kline, 2000). Unfortunately, 
such a sample size was not feasible in this study where the majority of patients were 
recruited from the Back Show in London and follow-up was not possible. Further, the 
test-retest sample was originally 35, of which only 17 were classified stable based on the 
fact they reported their health was ‗about the same‘ since the start of the study.  
In addition, timing between the two assessments is often debated, with some 
recommending a three-month period of test-retest reliability (Kline, 2000), and others 
suggesting a much shorter time difference between the experience and the rating of an 
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experience in order to minimise the difficulty as well as increase precision and accuracy 
of recall (Stull et al., 2009). The concern with shorter recall periods relates to exposure to 
recall bias in which patients may remember their responses on the first assessment and 
learning effects may be observed. This may have been the case for statistically 
significant mean differences that were observed between baseline and Week 2 for 
Information about Back Pain and Adherence to Physiotherapy; the effect observed may 
be a result of real differences between the two assessments or to error such as learning or 
fatigue effects.  
In this study, the rationales for assessing test-retest reliability between baseline 
and week 2 were two-fold. First, since follow-up patients were recruited from 
physiotherapy and pain clinics, assessments had to be scheduled around appointments 
with minimal interruption to the daily treatment and care of patients. Thus, having 
patients complete the first assessment at the clinic prior to their first consultation and 
again whilst they waited for their second consultation seemed most appropriate. Second, 
test-retest reliability scores assume that patients‘ health status remains unchanged and 
ideally that patients are not receiving treatment (Kline, 2000). Thus, a one-week time 
difference at the very start of physiotherapy or attendance to a pain clinic was considered 
appropriate because it was anticipated that patients‘ CLBP would not have changed over 
this time.  However, even with assessment of patients at baseline and week 2 based on 
clearly defined rationale, variability between the time points for assessments per 
individual was incurred, with some having the second assessment at day 8 since start of 
study and some as late as day 12 or 13. Furthermore, although CLBP is defined as pain 
lasting 3 months or longer, the intensity of the pain may vary by day or even by hour. In 
addition, it was recognised that patients would be taking medication to help with their 
pain on an as required basis and naturally would have started physiotherapy 
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consultations or attendance to the pain clinic, so these factors may have confounded 
results.  
One other possible reason for distortion of test-retest reliability is that there is a 
problem with the scales or in accurately recording the results. Alternatively, patients‘ 
psychological states may have contributed to variability in the percentage of agreements 
between baseline and week 2, especially since depression and anxiety are associated risk 
factors of CLBP (see section 1.4). Further, as with administering any type of 
questionnaire, environmental factors may also have influenced individual responses and 
contributed to inconsistencies. For example, noise and interruptions during assessments, 
personal factors the individual may have encountered such as problems at work or stress, 
as well as possible life changes that may have occurred for individuals between baseline 
and week 2. 
Nevertheless, despite all these potential confounding variables, this study 
provides some evidence of test-retest reliability for Burden of Back Pain and Satisfaction 
with the Treatment Process domains based on a small sample size. However, future 
studies should explore test-retest reliability for all domains using a larger sample size 
(ideally 100 or more) and especially for those domains not tested in this study such as 
Problems with Side Effects and Impact of Back Pain on Relationships, or where ICCs 
were poor such as for Adherence to Physiotherapy. 
6.5.13 Responsiveness 
The findings from this study suggest that some of the CLBP Treatment 
Satisfaction domains are sensitive to change over time. Specifically, mean changes 
between baseline and week 6 were positive for the improved group for all domains tested 
(note sample sizes were too small to test Problems with Side Effects of Back Pain 
Medication and Impact of Back Pain and Treatment on Relationships domains). 
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Statistical significance was reached for all domains except the Satisfaction with Back 
Pain Treatment Process and the Medication Acceptability domains. Lack of statistical 
significance may in part be explained by the small sample sizes. Although there were 31 
patients who completed satisfaction data at baseline and at week 6, the number of those 
classified as ‗improved‘ ranged from 11 to 16.  These small sample sizes occurred 
because exploring sensitivity to change over time was not the main purpose of this study 
and follow-up was only implemented in a small subgroup of patients (those recruited 
from physiotherapy and pain clinics or hospitals). Further research could explore 
responsiveness of the CLBP Treatment Satisfaction Questionnaire with larger sample 
sizes to determine whether these differences are statistically significant. 
Where statistical significance was obtained, effect sizes were calculated to 
establish the magnitude of the difference. Effect sizes ranged from -0.36 for the Burden 
of Back Pain domain to -0.73 for the Information Provided About Back Pain and 
Treatment domain. According to Cohen (1977), these effect sizes generally show 
moderate to large change, suggesting that the differences that occurred between baseline 
and end of study for these patients were clinically meaningful.  
6.5.14 Factors Associated with Treatment Satisfaction in Patients with CLBP 
Significance was reached for all MLR models except the Problems with Side 
Effects of Back Pain Medication and the Medication Acceptability domain. One possible 
reason for non-significance was the sample size, which was only 32 for the Problems 
with Side Effects of Back Pain Medication domain. Further research should explore 
predictors of these variables using larger sample sizes. 
In addition, the exploratory analyses using the CLBP Treatment Satisfaction 
Questionnaire, which is based on patient‘s subjective experiences, have shown that there 
are several related factors. Whilst these factors can be considered by HCPs to tailor 
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medication management and physiotherapy programmes, further research is warranted to 
confirm with greater certainty, associations between pain, demographic/treatment 
variables and treatment satisfaction in CLBP. For example, in this study, patients were 
asked to describe which category best describes their ethnic origin from the following 
options: White, Black, Asian or Other. On reflection, ethnicity was measured in a rather 
crude way and this is a weakness of the study. A more acceptable way for future studies 
is to use a commonly used classification such as the 17 categories of ethnic origin based 
on the UK census (Office for national statistics, 2001). 
Further, for the purpose of standard MLR and due to the low numbers for some 
categories, the results were then collapsed. For example, with regard to ethnicity, 
categories were collapsed into white and non-white. This approach is often used in cases 
where there are insufficient numbers in each cell (Amponsah-Afuwape, Myers, & 
Newman, 2002). Consequently, the sample size was 208 for white and 27 for the non-
white group. It is important to acknowledge that the sample size can have an effect on 
tests of statistical significance. For example, Allison (Allison, 1999) states: ―With a 
sample of 60 people, a correlation has to be at least .25 (in magnitude) to be significantly 
different from zero (at the 0.5 level). With a sample of 10,000 people, any correlation 
larger than 0.2 will be statistically significant.‖ However, what constitutes a large or 
small sample is ambiguous. Whilst the overall larger sample size is considered adequate 
for standard MLR (Tabachnick & Fidell, 2001), it may in part be contributing to the 
significance of the mean differences.  
Closer examination of the data reveals that the mean differences and SDs 
between the white and non-white group are small, and this is confirmed by small ES. In 
line with Allison‘s recommendations, whilst such statistical significant coefficients and 
ES should be taken seriously, the non-significant outputs in other standard MLRs 
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performed in this study are weak evidence for the absence of an effect (Allison, 1999). 
Thus further research is recommended to explore the role of ethnicity on treatment 
satisfaction in CLBP, with greater consideration regarding the measurement of ethnic 
origin. 
Further, the MLRs performed should be considered exploratory in that there was 
no attempt to adjust for multiple testing. Therefore, further research is needed to 
replicate these findings using a different dataset. Other studies could also consider 
stratifying the data according to these key predictor variables to establish the direction of 
the associations or explore mediating and moderating factors. 
6.5.15 Response Rate  
Of the 485 questionnaires despatched, 249 were returned, representing a 51.3% 
response rate. There is little in the literature as a bench mark of what constitutes an 
‗acceptable‘ response rate for treatment satisfaction studies, based on good rationale and 
empirical evidence  (Sitzia & Wood, 1998). However, a systematic review of 210 studies 
from 1994 that explored response rates in patient satisfaction research indicated that 
response rates range between 25% to 98% (Sitzia & Wood, 1998). These findings 
suggest that the response rate for this study is satisfactory. Further, the response rate can 
be deemed acceptable given that the main aims of this study were to test the 
psychometric properties of the newly developed questionnaire and explore factors 
associated with treatment satisfaction in CLBP, where the issue is more a case of 
whether sufficient sample size has been obtained and whether associations between 
various factors would be different in larger populations, rather than describing 
satisfaction levels and establishing whether the satisfaction level is dissimilar to larger 
populations (Sitzia & Wood, 1998).  
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Also, whilst the response rate shows that 48.7% did not respond, the 51.3% 
response rate can be considered reasonable given the diverse recruitment sites employed. 
For example, examination of response rates by recruitment sites reveals that there was a 
higher response rate for individuals from the Back Show compared to those recruited 
from physiotherapy departments or attending pain clinics. This is unsurprising since 
people attending the Back Show are inclined to be interested in understanding their back 
pain and therefore more willing to participate in CLBP research. Further, pain clinics are 
designed to tackle psychological barriers associated with CLBP (e.g. managing stress 
from work, dealing with relationship problems, unemployment etc.), so it may be that 
patients from pain clinics were less motivated to participate in research. Further, 
recruitment at the Back Show involved two full-time dedicated researchers (DR and a 
trained researcher) whose primary role and purpose was to invite individuals who met all 
of the inclusion and none of the exclusion criteria to take part; therefore, personal contact 
with researchers may help explain the higher response rate obtained from Back Show 
participants (Sitzia & Wood, 1998; see for example, Sitzia & Wood, 1997 for details 
regarding social desirability effects). 
The non-response rate may partially be accounted for by the fact that this was an 
unfunded study. In most cases, HCPs agreed to support the study as a ‗gesture of good 
will‘, but may not have prioritised recruitment due to the competing factors of busy 
clinics, other commitments, etc.    
Another possible explanation for non-response is that even though the patient 
information sheet emphasised that patients‘ participation would in no way affect the 
treatment and care they receive, patients may have been reluctant to take part, especially 
since this study focuses on treatment satisfaction. Alternatively, it may be that only 
satisfied patients took part, or perhaps those with ‗worse‘ health states did not want to 
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take part, or even that responders and non-responders differed according to demographic 
or clinical characteristics. Further research could attempt to explore such differences in 
patients with CLBP participating in treatment satisfaction research.  
6.5.16 Study Strengths and Limitations 
Study III has several strengths. It uses an instrument that was developed based on 
extensive qualitative research from in-depth interviews with patients who have CLBP. 
Therefore, the instrument captures sensitive issues relevant to these patients as they 
pertain to treatment satisfaction. The items and response options underwent rigorous 
cognitive debriefing to ensure that patients understood what was being asked of them 
and to rectify any ambiguity in format or wording. It then follows that the instrument 
demonstrates some evidence of reliability, validity and responsiveness. Using this 
instrument to quantify treatment satisfaction according to seven domains (Burden of 
Back Pain, Information Provided about Back Pain and Treatment, Impact of Back Pain 
and Treatment on Relationships, Problems with Side Effects of Back Pain Medication, 
Satisfaction with the Back Pain Treatment Process, Adherence to Physiotherapy, and 
Medication Acceptability), it was then possible to explore potential factors that may 
predict treatment satisfaction with CLBP, and results were insightful. However, it is 
essential that they be interpreted with an understanding of the current limitations of the 
data and methodological considerations. 
Firstly, the sample is representative of people with CLBP who are in receipt of 
services or who attended the Back Show in London in 2008. That is, people were invited 
and agreed to participate and therefore the data obtained is based on those who are 
receiving treatment, who are more likely to adhere to their medication regimes and have 
a level of satisfaction with their back pain medication. There is insufficient 
understanding of CLBP treatment and satisfaction issues in the general population. 
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Future research should investigate satisfaction and subjective experiences with back pain 
medications and physiotherapy between patients who adhere and those who do not 
adhere to their medication regimes. 
Also, as with surveys in general, it is difficult to ensure consistency amongst the 
sample. Whilst every attempt was made to operationally define terms used in the CLBP 
Treatment Satisfaction Questionnaire, not everyone will have understood or responded to 
the items in a way that is consistent with everyone else. 
Some of the questions required that the responses be categorised for meaningful 
use (for example, the response options to the item ‗Compared to the way you felt at the 
start of the study, please rate the degree of change in your health on the following scale: 
very much worse, moderately worse, a little worse, about the same, a little better, 
moderately better, very much better, were collapsed‘ to ‗worse‘, ‗stable‘ and 
‗improved‘). Because of this, it is inevitable that some of the responses were lost. 
Also, there was no control for the Hawthorne effect (obtaining positive outcomes 
from patients as a result of being made to feel important as part of the research). 
Consequently, HCPs‘ involvement and interest in the distribution of survey packs that 
contain a measure of patients‘ satisfaction with their back pain medication and/or 
physiotherapy may have led patients to give more positive ratings. However, a number 
of HCPs were involved in the distribution of this survey, and this bias would have been 
minimised. 
The response rate was 51.3%, as discussed in section 6.5.2. It should be noted 
that the follow-up groups are significantly smaller than the cross-sectional groups. Part 
of this can be explained by the fact that follow-up was only pursued in physiotherapy, 
pain clinic and hospital settings. Much of the sample was recruited from the Back Show, 
where follow-up was not feasible. Nevertheless, there were 35 patients at week 2 and 31 
patients at week 6. Such sample sizes mean that the results should be interpreted with 
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caution and should be considered exploratory; there is a need to further explore test-
retest reliability and responsiveness of the CLBP Treatment Satisfaction Questionnaire. 
As the study was based on patients‘ self reports, there were issues such as recall 
bias and respondent honesty. Some items referred to previous experiences with treatment 
and retrospective items are open to bias through distortions of memory, which might 
have affected the accuracy of the reporting (Stull et al., 2009). However, attempts were 
made to standardise responses and ensure that, for example, people with a case-note 
diagnosis of learning disabilities were excluded from the study.  
This study has reported on the influence of one factor such as ethnic origin and 
its effect on patients‘ satisfaction. However, isolation of factors is pragmatically 
impossible due to their inter-relation. Therefore, there are always potential confounders 
and it becomes difficult to differentiate between whether factors are moderators or 
mediators.  
Further, ethnic origin was measured rather crudely and this is a weakness of the 
study. Patients were asked to describe which category best describes their ethnic origin 
from the following options: White, Black, Asian or other. Future studies should consider 
use of a commonly used classification such as the 17 categories of ethnic origin based on 
the UK census (Office for national statistics, 2001) (see section 6.5.14 for further 
discussion).  
6.6 Conclusions 
This study provides some evidence to support the reliability and validity of the 
CLBP Relief Treatment Satisfaction Questionnaire that provides insight into patients‘ 
experiences of back pain and treatment. It is a useful instrument for future longitudinal 
studies and may be helpful in clinical practice to facilitate treatment decision making. 
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Further testing is warranted to confirm the psychometric properties of the instrument. In 
particular, further research should consider the test-retest reliability of the instrument in a 
larger sample size. 
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Chapter 7- Discussion 
7.1 Overview of Research 
The aim of the research presented in this thesis was to develop an instrument to 
measure treatment satisfaction and dissatisfaction in patients with CLBP that is 
supported by evidence of reliability and validity. In pursuing this aim, the thesis had 
three objectives: 
1. To establish the research performed to date in the field of treatment 
satisfaction in CLBP. 
2. To explore patients‘ subjective experiences with CLBP and its treatments, as 
well as satisfaction and dissatisfaction with treatments. 
3. To develop a new instrument to measure treatment satisfaction in CLBP, and 
to explore its psychometric properties. 
This Chapter summarises for each of these objectives the main findings, strengths 
and limitations of the studies, and possible future directions. Findings suggest treatment 
satisfaction and dissatisfaction in CLBP can be viewed on a continuum, which as a 
dependent variable involves a multi-dimensional appraisal process of the following 
domains: ‗Information Provided about Back Pain and Treatment; ‗Burden of Back Pain‘; 
‗Impact of Back Pain and Treatment on Relationships‘; ‗Satisfaction with the Back 
PainTreatment Process‘; ‗Problems with Side Effects of Back Pain Medication‘; 
‗Adherence to Physiotherapy‘; and ‗Medication Acceptability‘. Furthermore, there was 
some evidence to suggest that these factors were significantly associated with various 
patient and clinical characteristics. ‗Information about Back Pain and Treatment‘ was 
significantly associated with involvement in treatment decisions and academic 
qualifications. ‗Burden of Back Pain‘ was related to pain as measured by the total score 
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of the McGill Pain Questionnaire, pain severity in the last seven days, whether patients 
took time off from work in the last four weeks due to back problems, duration since 
CLBP diagnosis, and ethnicity. ‗Impact of Back Pain and Treatment on Relationships‘ 
was significantly associated with whether patients took non-opioid and opioids, duration 
since CLBP diagnosis, and academic qualifications. ‗Satisfaction with the Back Pain 
Treatment Process‘ was significantly related to involvement in treatment decisions and 
whether patients took opioids. ‗Adherence to Physiotherapy‘ was significantly linked to 
ethnicity, duration since CLBP diagnosis, and whether patients took opioids.  
More studies are required to confirm these findings using the validated 
instrument. However, the CLBP treatment satisfaction questionnaire can be used to help 
identify aspects of treatment that may require change, as well as to help with the 
planning of new medications or physiotherapy programmes. 
In addition, more theoretical and empirical research is needed to develop a 
shorter instrument for use in clinical practice that can help identify aspects of treatment 
in CLBP that may require change. The shorter version of the instrument might also be 
used to establish the association with adherence, and could be used to screen for patients 
who may not be adherent, thereby facilitating treatment decision making and medication 
management. 
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7.2 Objective 1  
To establish research performed to date in the field of treatment satisfaction in 
CLBP 
Systematic Review: Satisfaction and Dissatisfaction with Treatments for 
CLBP 
Main Findings 
 Twenty-six studies were included in the review that investigated treatment 
satisfaction and dissatisfaction in CLBP.  
o Of these, none of the studies operationally defined the term treatment 
satisfaction or dissatisfaction in CLBP, or proposed a conceptual 
framework or model to help visually represent and theoretically 
understand what comprises the concepts of interest. 
o None of the studies specified whether treatment satisfaction and 
dissatisfaction was considered an independent or dependent variable, 
or whether it was uni-dimensional or multi-dimensional.   
 All but one of the 26 studies reported satisfaction data from the patient‘s 
perspective. The one study that didn‘t used a telephone interview method.  
 The satisfaction outcome measures of PRO studies were diverse and differed 
in the number of items included and the rating scale. 
o For example, two studies by the same author used the Cherkin and 
MacCornack satisfaction questionnaire, which has a 5-point Likert 
response scale (Nyiendo et al., 2000; Nyiendo et al., 2001) and others 
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used a global satisfaction item (See for example, Buchner et al., 2006; 
Licciardone et al., 2003).  
o Even the global satisfaction items had diverse foci; for example, one 
study used a global satisfaction rating that focused on pain relief (Katz 
et al., 2005), while another measured back satisfaction (Holm et al., 
2003). 
o Response scales also varied from 5-point Likert-type scales (See for 
example, Buchner et al., 2006; Buchner et al., 2007; Buchner et al., 
2007), visual analogue scales that ranged from 0 to 10 or 0 to 100 
(See for example, Groessl et al., 2008; Haas et al., 2005), or scales 
with four options (extremely satisfied, satisfied, neutral, and 
extremely dissatisfied) (See for example, Shirado et al., 2005). 
o The Cherkin and MacCornack questionnaire was the only multi-item 
questionnaire used. However, the items of the questionnaire were 
developed retrospectively in 1991, based on focus groups with 
patients who mainly had CLBP but also based on clinical judgement. 
The questionnaire could not be obtained for closer examination of the 
content, and there were few data regarding the validation of the 
instrument. 
 There were also various methodological limitations within the 26 studies 
which may have led to bias and therefore restricted the generalisation of 
results. 
o For example, the criteria for patients with CLBP varied between 
studies. Sometimes CLBP was referred to as pain lasting ≥ three 
months or ≥ 3 months constant/intermittent LBP (See for example, 
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Licciardone et al., 2003; Barker et al., 2008; Buchner et al., 2006) or 
in some instances ≥ 3 months continual/recurrent LBP (See for 
example, Mannion et al., 1999). However, one study defined CLBP as 
having had pain for ≥ 6 weeks (Nyiendo et al., 2000). 
Strengths 
The main strength of the systematic review was that it synthesised evidence from 
the literature specific to treatment satisfaction and CLBP.  
Limitations 
The main limitation of the review was that the findings were based 
predominantly on published literature identified via electronic databases and 
some hand searches. 
Future research 
 More studies are needed to establish what treatment satisfaction and 
dissatisfaction means to patients with CLBP. 
 A new instrument is required to measure treatment satisfaction and 
dissatisfaction in patients with CLBP. This instrument should be based on 
patients‘ opinions and subjective experiences, and should be validated 
psychometrically in the population of interest. 
 Page 284 of 458 
 
7.3 Objective 2 
To explore patients subjective experiences with CLBP and its treatments, as well 
as satisfaction and dissatisfaction with treatments. 
Qualitative Study: Satisfaction and Dissatisfaction with Treatments in 
Patients with CLBP 
Main Findings 
 Thematic analysis of in-depth interviews with CLBP patients about their 
subjective experiences with treatment (medications and physiotherapy) 
found the following main themes and sub-themes: 
o Pain (duration, severity, and tolerability) 
o Symptoms (slicing, twinge, pins and needles, stabbing, numbness, 
swelling, and burning) 
o Physical (functioning and activities of daily living) 
o Social functioning 
o Emotional (anxiety, fear of movement, worry, uncertainty about 
the future, depression, motivation, embarrassment, annoyment, 
frustration, irritability, misery) 
o Confidence (lack of confidence, cautious) 
o Sleep (quality, difficulty, awake) 
o Tiredness 
o Relationships 
o Sex life 
o Self esteem 
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 For patients with CLBP receiving physiotherapy and taking medications 
on an as required basis, satisfaction and dissatisfaction with treatments is 
a multidimensional concept. 
o Treatment satisfaction was described by patients positively in 
terms of receiving the correct diagnosis, being ‗happy‘ or 
‗pleased‘ with treatment, maintaining general health, and returning 
to normal functioning such as carrying out everyday activities or 
going to work.  
o Treatment dissatisfaction is associated with negative aspects of 
treatment such as being misdiagnosed or undiagnosed, having lack 
of trust and confidence in clinicians, and lack of information about 
back pain and its treatments. Communication with healthcare 
professionals is important and treatment dissatisfaction is also 
related to lack of empathy and lack of active listening from HCPs. 
Ineffective treatment that did not remove or minimise the back 
pain, and consequently did not enable patients to return to normal 
functioning (thus impacting HRQoL) was also associated with 
treatment dissatisfaction. Other key factors of treatment 
dissatisfaction included experiencing side effects and how much 
of a problem they were, inconvenience of treatment regimens,  
lack of regard for patients‘ preferences in terms of treatment 
characteristics. 
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Strengths 
The main strengths of this qualitative study were: 
 It provides an understanding of subjective experiences of treatment 
(medication and physiotherapy) in CLBP, and opinions‘ regarding what 
constitutes treatment satisfaction and dissatisfaction from patients‘ 
perspective, using non-leading questions and probes during the interview and 
a rigorous inductive and data driven process of thematic analysis. 
 Saturation and an exhaustive dataset was achieved with ten interviews 
allowing the development of: 
o A conceptual model to make sense of the various components of 
CLBP and associations between concepts. 
o A proposed operational definition of treatment satisfaction and 
dissatisfaction of treatments (medication and physiotherapy) in CLBP 
based on a thematic map that forms a visual representation of the key 
themes and sub-themes – neither of which have been documented in 
the literature to date. 
 A homogenous sample was obtained where patients shared common criteria: 
having CLBP (pain lasting ≥3 months), taking medication, and receiving 
physiotherapy. 
Limitations 
The limitations of this study were:  
 The use of a purposive homogenous sampling strategy may in part explain a 
sample comprised of mainly females, of narrow age range and occupational 
background.
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Future Research 
Future research would be strengthened by the following: 
 An instrument of treatment satisfaction and dissatisfaction with CLBP is 
needed to quantify the concepts in cross-sectional and longitudinal studies. 
The development of the instrument should be based on:  
o An operational definition of the concept formed from patients‘ 
opinions. 
o A conceptual framework that allows the pre-specification of 
hypothesised associations between items and domains (factors) a 
priori. 
o Good psychometric properties demonstrated within cross-sectional 
and longitudinal samples.  
 A wider range of concepts linked to CLBP need to be assessed quantitatively. 
Treatment satisfaction and dissatisfaction should also be assessesd to 
establish factors associated with the concept. 
 Additional qualitative studies could explore subgroups and identify thematic 
variability within a sample to establish the cohesiveness of themes/subthemes 
and its association to sample heterogeneity.  
 Studies using other purposive sampling strategies could be considered and 
may provide alternative insights into patients‘ subjective experiences. For 
example, maximum variation sampling could help to establish central themes 
across patient variations such as patients with CLBP of different ages, or 
those with different occupational backgrounds. Alternatively, extreme case 
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sampling could help consider patients‘ subjective experiences or the concept 
of treatment satisfaction in cases which are unusual or special in some way. 
For example, one might expect that patients with CLBP who were 
misdiagnosed or undiagnosed on several occasions are likely to have different 
experiences. 
7.4 Objective 3  
To develop a new instrument to measure treatment satisfaction in CLBP, and to 
explore its psychometric properties. 
Development and Psychometric Validation of the CLBP Treatment 
Satisfaction Questionnaire 
Main Findings 
 Based on qualitative analyses, the initial questionnaire had six broad 
categories: 
o ‗Information Provided to You About Back Pain and Treatment‘ 
o ‗About Your Medical Care‘ 
o ‗Your Health‘ 
o ‗Beliefs About Your Back Pain Medication‘ 
o ‗Side Effects from Back Pain Medications‘ 
o ‗Satisfaction with Treatments for Back Pain‘ 
 Cognitive debriefing interviews of the 113-item questionnaire provided 
evidence of face and content validity. 
o Patients with CLBP liked the questionnaire and felt it was relevant to 
them, and all items were well understood. 
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o Twenty-six items were deleted because they overlapped with other 
items in the questionnaire. 
 The PCA found seven factors that explained 52% of the total variance. The 
factors were labelled following close examination of the items: 
o ‗Information Provided About Back Pain and Treatment‘ 
o ‗Burden of Back Pain‘ 
o ‗Impact of Back Pain and Treatment on Relationships‘ 
o ‗Problems with Side Effects of Back PainTreatment‘ 
o ‗Satisfaction with the Back PainTreatment Process‘ 
o ‗Adherence to Physiotherapy‘ 
o ‗Medication Acceptability‘ 
 There were eight items that did not load on any factor and were therefore not 
included as part of the domain scores: 
o ‗I was misdiagnosed‘ 
o ‗I was not involved in treatment decisions‘ 
o ‗I went out of the home‘ 
o ‗I could bend down‘ 
o ‗I had an ache in my back when I woke‘ 
o ‗My back pain medication is helpful to me‘ 
o My back pain medication enables me to be independent (carry out 
everyday activities)‘ 
o ‗I altered the amount of medication I took‘ 
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 Additional psychometric testing provided evidence to support the reliability 
and validity of the questionnaire: 
o All seven domains of the questionnaire had satisfactory internal 
consistency, exceeding Nunnally‘s threshold of 0.70 (Nunnally, 
1978). 
o All seven domains showed low to moderate correlations with both the 
SF-36 and the PETS, providing evidence to support concurrent 
validity. 
o All seven domains were able to discriminate between levels of pain in 
the last seven days with statistical significance being reached for all 
domains except ‗Information about Back Pain and Treatment‘, and 
‗Adherence to Physiotherapy‘. Higher levels of pain were associated 
with less overall satisfaction. 
o In terms of test-retest reliability, although the sample size for stable 
patients was small, there was some evidence to support the 
reproducibility of some domains (Burden of Back Pain and 
Satisfaction with the Treatment Process). As expected, mean 
differences between baseline and week 2 were small and did not reach 
statistical significance for all domains except ‗Information Provided 
about Back Pain and Treatment‘. Pearson‘s correlation coefficients 
ranged from 0.30 for ‗Adherence to Physiotherapy‘ to 0.71 for 
‗Burden of Back Pain‘, and ICCs exceeded 0.70, indicating adequate 
confidence in test-retest reliability (Kline, 2000) for ‗Burden of Back 
Pain‘, and ‗Satisfaction with the Treatment Process‘ domains. 
However, ICCs were poor for Information About Back Pain and its 
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Treatment, Medication Acceptability, and Adherence to 
Physiotherapy. Further, test-retest reliability could not be calculated 
for Problems with Side Effects and Impact of Back Pain on 
Relationships domains.  
o Responsiveness analyses provided some evidence that the following 
domains of the questionnaire were sensitive to change over time: 
‗Burden of Back Pain‘, ‗Information about Back Pain and Treatment‘, 
and Adherence to Physiotherapy‘. As expected, mean changes 
between baseline and week 6 were positive for the improved group, 
and effect sizes were generally moderate, ranging from -0.36 to -0.71. 
 Standard multiple linear regressions showed that different patient and clinical 
factors were associated with the domains of the CLBP Treatment Satisfaction 
Questionnaire. The variances explained for each domain ranged from 14% for 
‗Adherence to Physiotherapy‘ to 53% for ‗Burden of Back Pain‘, and ‗Impact 
of Back Pain and Relationships on Treatment‘).  
Strengths 
The main strengths of this study were: 
 It used an instrument developed based on extensive qualitative research from 
in-depth patient interviews with patients with CLBP, and therefore captures 
important and sensitive issues relevant to these patients pertaining to 
treatment satisfaction.  
 The items and response options of the questionnaire were tested by rigorous 
cognitive debriefing to ensure patients understood what was being asked of 
them, and to rectify any problems with item wording or responses. 
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 The instrument demonstrates some evidence of reliability and validity based 
on a homogoneous sample of patients with CLBP and clearly defined and 
pre-specified inclusion and exclusion criteria. 
 Using the well developed and validiated instrument, potential factors 
associated with each domain of treatment satisfaction were identified.  
Limitations 
The following limitations should be considered: 
 The sample is representative of patients with CLBP who are in receipt of 
services or who attended the Back Show in London in 2008. 
 The sampling was purposive and the sample size was quite small for the 
number of items included in the PCA. 
 Although there was some evidence of test-retest reliability, the sample size of 
stable patients was well below 100 (n=17), and test-retest reliability could not 
be calculated for Problems with Side Effects or Impact of Back Pain on 
Relationships due to insufficient sample sizes. Further, ICCs were poor for 
some domains e.g. Medication Acceptability. 
 The sample size of improved patients was also small at follow-up and well 
below an acceptable sample size for responsiveness analyses. 
 Ethnic origin was measured rather crudely in this study (White, Black, Asian 
and other) and is a weakness of this study. Therefore, MLR analyses related 
to this should be considered with caution. 
 The response options for some questions were collapsed to allow for analysis, 
and it was inevitable that responses to some questions were lost. 
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 There was no control for the Hawthorne effect, so HCPs‘ involvement in the 
the study may have contributed to some bias in scores.  
 As a PRO study, the results are subject to recall bias and respondent honesty. 
7.5 Implications of Research 
The results of these studies point towards a need for the continued treatment and 
care, and a need for a holistic approach that can support patients not only with the pain 
experienced, but also with regard to all other related aspects such as physical 
functioning, and relationships. Further, it is apparent that patients require more 
information about their CLBP, the possible side effects incurred from medication, and 
the various treatment options available. Thus HCPs could try to incorporate an 
educational component to patients‘ treatment and care. In addition, since patients find 
side effects of medication problematic, HCPs could help facilitate discussions with 
patients in order to establish whether patients are taking medication as recommended and 
to consider whether other medications may be more suitable given the side effects and 
impact incurred. A similar approach can be implemented as it relates to aspects of 
physiotherapy such as pacing and goal setting. Such discussions may also facilitate the 
HCP-patient relationship and increase treatment acceptability. 
Further, whilst there are various services available to patients (e.g. medications, 
physiotherapy, pain management programmes etc.), how patients access them needs to 
be further considered. For example, during qualitative interviews (see section 4.4.2), 
some patients reported that they had been misdiagnosed by the doctor, or that the doctor 
did not know what was wrong with them. These findings were supported by quantitative 
responses to items from the CLBP Treatment Satisfaction Questionnaire, where nearly a 
quarter of patients reported they were misdiagnosed (see section 6.4.3). Therefore, there 
is a need to re-assess and standardise the screening process at each stage within the NHS 
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to ensure everyone with CLBP symptoms receives appropriate support and care as 
efficiently as possible.  
HCPs must also be educated regarding issues associated with patients‘ subjective 
experiences and the patient burden of CLBP and its treatment, so that patients are indeed 
offered the most appropriate treatment and care as efficiently as possible. The results of 
these studies should be communicated to HCPs at key target audiences at conferences 
and published in peer-reviewed academic journals. This would get important messages 
to key stakeholders at local and national levels within the UK (e.g. decision makers at 
the Department of Health / National Institute of Clinical Excellence, as well as HCPs, 
GPs and hospitals), which in turn may help support and/or influence decision making. 
7.6 Future Research 
Future research could move forward in two main ways. The first is with regard to 
the development of the CLBP Treatment Satisfaction Questionnaire. Additional studies 
could be performed to confirm the factor structure of the CLBP Treatment Satisfaction 
Questionnaire and further explore its psychometric properties in a larger study using the 
same inclusion and exclusion criterias for patients as in studies II and III. Studies could 
also be implemented to linguistically validate the instrument for use internationally. 
These studies should ideally involve the same kind of approach as in this thesis, i.e. in-
depth interviews with patients in each language to confirm the content validity, followed 
by cognitive debriefing interviews to establish face and content validity, and then 
assessment of the measurement properties. 
The instrument could then be used to help demonstrate burden of illness and 
problems with existing treatments (medications and/or physiotherapy) to key target 
audiences and help them consider what aspects of treatment may require change in 
patients with CLBP. This information may also be useful for planning new medical 
 Page 295 of 458 
products for patients with CLBP, as well as helping to improve the healthcare delivery 
system for patients with CLBP. 
In addition, a shorter version of the CLBP Treatment Satisfaction Questionnaire 
could be devised for use in clinical trials or alternatively to be used in clinical practice to 
facilitate treatment decision making and help with medication management programmes 
such as physiotherapy regimens. In particular, what is the minimal important difference 
in treatment satisfaction scores that would necessitate a change in treatment or would 
constitute a success? 
The second way to move forward is with a large interventional study. This study 
could focus on treatment satisfaction as one of the main outcomes. It would be 
particularly interesting to explore how treatment satisfaction scores change over time, 
whether they are associated with behaviours such as adherence to treatment regimens, 
and the interplay with HRQoL.  
The interventional studies could also explore treatment satisfaction and 
subjective experiences between sub-groups of CLBP patients. For example, whether 
scores vary between patients receiving physiotherapy versus those attending pain 
management programmes. In addition, in this study, patients‘ ethnicity was defined in 
terms of ‗white‘ versus ‗non-white‘ so additional studies could define ethnicity and 
further explore the association with treatment satisfaction.  
Other studies could also be designed to further explore how demographic, 
clinical and treatment factors are associated with CLBP treatment satisfaction, as well as 
how psychological factors such as coping, fear-avoidance behaviour, anxiety, depression 
etc. may be related to CLBP treatment satisfaction. For example, exploring treatment 
satisfaction in CLBP according to patients‘ beliefs, with regard to whether their pain is 
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of organic or psychological nature. The measure of pain beliefs would need to be 
sensitive to discern the possible stigma associated with unexplained pain.  
It would also be interesting to consider whether factors were mediating or 
moderating factors. All of these studies would need to be sufficiently powered to detect 
differences, and adjustments would need to be made for multiple testing.  
7.7 A Personal Reflection  
This section provides an overview of the PhD process with particular attention to 
what I have learned through carrying out this research, some personal reflection 
regarding the limitations, how this may have affected the knowledge produced, and 
further thoughts on how it could be improved in the future. 
To set the scene, I feel I should first explain that I have always found the topic of 
treatment satisfaction intrinsically interesting, and since my B.Sc. days wondered what 
does the concept mean to patients and how can we capture this to adequately assess it in 
studies. At that time, my work was focused on patients with schizophrenia and gradually 
expanded to patients with Alzheimer‘s disease, and those with iron overload such as beta 
thalassemia, sickle cell disease and mylodysplastic syndromes. During these years of 
research, I realised based on talking to patients and reviewing published literature that 
there were some common traits but clearly the topic of treatment satisfaction was also 
different according to the patient‘s disease and the type of treatment. With this in mind, 
and given that a great proportion of individuals experience CLBP, I pursued my interests 
in this population and this formed the basis of my PhD.  
To proceed, during discussions with my PhD supervisor, it became apparent that 
it would be important not only to read around the concept of treatment satisfaction but 
also to gain insight into CLBP and patients‘ subjective experiences. This was extremely 
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challenging given the wealth of knowledge available for both treatment satisfaction and 
CLBP. Also, understanding patients experiences was complicated given the many factors 
that seem to be interlinked, as well as that diagnosis is often difficult given the nature of 
the condition (whereby sometimes no physical cause can be located), and also there are  
diverse treatment options available. Nevertheless, the information obtained from 
electronic databases was collected and summarised appropriately to form Chapter 1 of 
this thesis. Whilst, it provides a good overview of the various issues related to CLBP, it 
is important to emphasise that it is in no way comprehensive. For example, as my 
knowledge in this area has developed, it has become apparent that there are differences 
in healthcare systems between countries and therefore patients may be diagnosed and 
treated differently. Future research could consider how these differences are related to 
treatment satisfaction in CLBP. 
Chapter 2 was written to provide an overview of treatment satisfaction and 
dissatisfaction. Like the topic of CLBP and as mentioned above, this was particularly 
challenging given the wealth of information available in the literature. However, I think 
it was an essential part of the process in trying to establish what were the general 
definitions and theories regarding the concept, where they originated, and what empirical 
evidence there was to support these. Nevertheless, on reflection, when I embarked on 
this journey, I expected that I would have all the answers. But the reality was that whilst 
I gained significant insight into the various issues to help me set the scene for my thesis, 
I became aware that the concept is very broad and that it simply wasn‘t practical to 
expect to capture everything. For example, the field of expectations seem just as broad a 
concept confounded by similar issues to satisfaction e.g. what constitutes expectations, 
how can we operationally define the concept and then adequately measure it, and even if 
we can achieve this, some patients may not feel comfortable to comment on expectations 
and aspects such as locus of control may also contribute to the picture or patients 
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previous experiences. As I continued to read and learn, it became more apparent that 
there are many broad concepts such as convenience, preferences, and doctor-patient 
communication to name but a few, and each of which could form a theses in themselves 
but also seem to be associated with treatment satisfaction. In order to ensure that this 
thesis remained manageable, I considered these aspects but tried as much as possible to 
remain close to the concept of treatment satisfaction. 
This approach transitioned into the systematic review, Chapter 3 and influenced 
the search terms I used to identify papers associated with treatment satisfaction or 
dissatisfaction in CLBP. My goal was to understand what was treatment satisfaction and 
how was it measured in studies of CLBP, so I used the terms treatment satisfaction or 
treatment dissatisfaction with other keywords such as CLBP (see section 3.3.2). I was 
aware that I could use alternative terms to satisfaction such as attitudes, expectations, 
preferences, and convenience, but not only would this explode the search to what would 
be considered not feasible and unmanageable but it also induced other issues. For 
example, if I used the term attitudes and looked at studies that described positive 
experiences of treatment, then I felt that I was imposing my subjective thoughts 
regarding whether that indeed truly constitutes treatment satisfaction. Further, I felt the 
keywords I used focusing on treatment satisfaction and treatment dissatisfaction were 
appropriate given my understanding of the literature which suggested that satisfaction 
was more than a positive feeling or experience but involved an appraisal process or a 
comparison to a subjective standard (see section 2.2). Despite this, on reflection, whilst I 
still feel that my approach is acceptable I acknowledge that if I had used alternative 
terms then other studies that measure treatment satisfaction or treatment dissatisfaction 
may have been identified. Nevertheless, despite this, I am confident that I captured the 
main studies from the literature and sufficient to inform how to proceed with the other 
PhD studies. With this in mind, future studies could consider using alternative terms to 
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consider whether there are other studies not captured within the scope of this PhD but 
which may provide further insights into definitions and measurement of treatment 
satisfaction or dissatisfaction in CLBP. 
Using the information and knowledge acquired from the literature, the next study 
documented in Chapter 4 was to explore patients‘ subjective experiences of CLBP and 
its treatment, as well as what does treatment satisfaction or dissatisfaction mean to 
patients. This was a very valuable and insightful exercise on several accounts. For 
example, it provided me with rich in-depth details from the patient perspective ultimately 
helping to inform the content and structure of the newly developed questionnaire. But I 
also learned from the methods employed. One example of this is that whilst the interview 
guide was intended to be as open-ended as possible by asking questions such as ‗What 
does pain mean to you?‘ or ‗What does the term chronic mean to you?‘, on reflection, 
some of the questions were still rather closed such as ‗Do you experience symptoms 
from CLBP?‘ and then ‗If yes, what are they?‘ Such questions were developed in such a 
way as to try not to lead patients by not assuming that they do experience symptoms. 
However, I recognise that by asking questions in this manner, the control of the 
interview remains predominantly with the interviewer rather than with the patient, and 
this may have affected the information generated. So, future studies could try to address 
this matter by using more open-ended questions. Also, the interviews were performed in 
the hospital for the convenience of the patient. However, I appreciate that the setting in 
which the interviews are performed could also influence the information that patients 
provide. Consequently, future studies could consider performing interviews under 
different environments such as at home or in a neutral area. However, it‘s important to 
realise that whatever context the interviews are performed, may have some bearing on 
the information provided. For example, a home setting may be more familiar to the 
patient but means less control with regard to potential interruptions during the interview 
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(e.g. door bell ringing or phone call), and also that there may be others at home resulting 
in less likelihood of disclosing sensitive matters such as how back pain impacts on 
relationships.   
Perhaps another thing I feel I have learned during the PhD is the meaning of 
purposive sampling within different contexts. I feel I have always recognised the 
importance of qualitative and quantitative research, and I‘m a strong believer that good 
statistics are not really meaningful if from a qualitative perspective we have not captured 
all the important concepts and ensured content validity. But despite this strong personal 
belief, my training in my B.Sc. years was very heavily weighted from a statistical 
perspective. Consequently, when it came to the sampling strategy for the qualitative 
study (see section 4.3.1), I adopted a rather restricted style in which I recruited patients 
who had similar common characteristics such as for example that they had been 
diagnosed with CLBP and were currently receiving treatment for CLBP or advised to do 
so. Thus the sampling strategy I adopted was homogenous and I was focused on 
obtaining theoretical saturation, which resulted in mainly female patients, with narrow 
age range and similar occupational backgrounds. At this time, I should emphasise that 
whilst I was always aware that the purpose of qualitative research is not to draw 
statistical conclusions, I was not aware of the various types of purposive sampling 
strategies such as maximum variation sampling which would establish central themes 
across patient variations e.g. patients of different ages and occupational backgrounds. 
Another alternative is extreme case sampling strategy which would allow exploration of 
unusual cases or ones that are special in some way e.g. exploring patients experiences of 
CLBP in those who had been misdiagnosed or undiagnosed, or those who had been 
advised to take medication every day but did not do so. Employing such sampling 
strategies in qualitative research would provide even greater insights and future 
qualitative studies should consider this. 
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Chapter 5 documents the development and cognitive debriefing process of the 
newly developed CLBP Treatment Satisfaction Questionnaire. It was really great to 
develop a questionnaire that patients thought was relevant and which tapped into the key 
issues related to treatment satisfaction in CLBP. Nevertheless, one challenge I faced was 
that there were so many relevant aspects that the questionnaire was quite lengthy and 
covered many topics such as level of pain, the burden of CLBP and impact on 
relationships, problems with side effects from medications, level of information 
provided, satisfaction with the treatment process, medication acceptability, and 
adherence to physiotherapy. In talking to patients and through informal discussions with 
clinicians it was apparent that there was a need for an instrument that covered all these 
topics and whereby the instructions, questions and response options were asked in a 
consistent manner. However, on reflection, I realise that using such an instrument for 
example within a clinical trial context could be problematic given that pain and 
functioning are likely to be primary and secondary endpoints and thus by including the 
CLBP Treatment Satisfaction Questionnaire in its entirety there would be overlap and 
consequently unnecessary burden to the patient resulting in potential fatigue/responder 
burden. To overcome this, careful consideration is warranted regarding the endpoints of 
CLBP clinical trials. Indeed, this instrument has been developed and validated for use in 
its entirety. However, future research could consider developing a shorter version for the 
purpose described above. 
Also, at this time, I learned just how important cognitive debriefing and pilot 
testing is prior to using a newly developed questionnaire in any study. Whilst I think the 
way that the cognitive debriefing was performed is acceptable, I discovered other 
methods that could be very insightful such as using a think aloud process. This would 
involve the patient reading out the instructions of the questionnaire, as well as each 
question followed by its response option whilst completing it. The process of ‗thinking 
 Page 302 of 458 
aloud‘ would indicate where patients were experiencing difficulties, for example, 
indications of potential problems are if the patient has to re-read a question or the 
response options, or if they pause for a long time. The think aloud technique could be 
used in parallel with other methods such as the ones employed in this thesis and future 
studies could consider this. 
During the main study in Chapter 6, I learned many things that I think have 
positioned me as a knowledgeable researcher and which will no doubt come in good use 
in future studies. An example of one of these relates to the issue of how best to develop a 
scoring algorithm for a questionnaire that measures side effects. In this study, PCA was 
used because the focus was on ‗problems‘ with side effects. However, if it were 
frequency or incidence of side effects then I would be reluctant to consider PCA because 
for example there is no clear rationale for why experiencing one side effect may be 
related to others. I thoroughly enjoyed reading about this topic and realised that 
alternative scoring algorithms may be more appropriate such as cluster analyses or 
regressions where the experience of a side effect and/or how much of a problem it is to a 
patient may help predict for example long-term adherence and in-turn, may help with the 
efficacy of a medication given that if patients take it as recommended then the 
medication is likely to work and help reduce pain. Whilst future studies could consider 
such approaches there will be other potential challenges such as adequately quantifying 
adherence. Something I learned through reading the literature and also when talking to 
patients is that adherence appears to be strongly associated with information, and that 
even if information is provided to the patient, at what point can we be sure that 
knowledge has been acquired or that knowledge will transition into behaviour? Even if 
these aspects can be overcome, many patients are fearful of taking medications given the 
issues of dependency and so either only take medication when they are in excruciating 
pain or sometimes take medication holidays.   
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In addition, during the main study, I discovered how difficult it is to assess test-
retest reliability and I learned a lot about how to define patients in terms of, for example, 
stable. I was very proud to capture relevant data to enable test-retest reliability but the 
data was limited not only in terms of a small sample size, but also in hindsight, there 
were many factors that could not be controlled for and which may have influenced the 
ICCs. For example, the second assessment was scheduled one week after the baseline 
assessment. However, there was diversity in terms of when these patients were seen. For 
example, some may have been seen on day 8 and others on day 10 or 12. Also, what 
constitutes chronicity added complexity to the issue because whilst all the patients 
included in the study had a diagnosis of CLBP defined by pre-specified 
inclusion/exclusion criteria, pain is a very fluctuating concept. Some patients may have 
had a constant pain all day everyday which on a scale of 0 for no pain to 10 for worst 
imaginable pain, was rated as for example 4. Sometimes the pain for these patients may 
have got worse so their rating would go to for example 8 or 9. Alternatively, some 
patients may have had excruciating pain all the time (around 9 or 10), every day and for 
others the pain intensity may have fluctuated from hour to hour within the same day. 
Also, for patients who have had CLBP for 12 weeks, their experience and perception of 
pain may be very different to someone who has lived with the pain for say 40 years. All 
of this would have added to variability in test-retest scores. It should also be emphasised 
that whilst test-retest reliability was not the primary focus of this study, future research 
could consider such aspects to further establish test-retest reliability of the CLBP 
Treatment Satisfaction Questionnaire. 
This reflection is in no way a comprehensive account of all the things I have 
learned during the PhD journey. However, I hope it provides a flavour of some of the 
challenges I‘ve faced, the rationales behind certain decisions and additional 
considerations for future research. 
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Miss Diana Rofail 
Health Psychologist Researcher, Project Manager 
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Dear Miss Rofail 
 
Full title of study: Patients' Satisfaction and Dissatisfaction with 
Treatment(s) for Chronic Low Back Pain: A Qualitative 
Study 
REC reference number: 06/Q1401/41 
 
Thank you for your letter of 21 July 2006, responding to the Committee‘s request for 
further information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair.  
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised. 
 
6) Ethical review of research sites 
The Committee has designated this study as exempt from site-specific assessment (SSA).  
There is no requirement for Local Research Ethics Committees to be informed or for 
site-specific assessment to be carried out at each site. 
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the attached document.  You are advised to study the conditions carefully. 
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Where a substantive contract is not held with the care organisation, it may be necessary 
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APPENDIX C: Patient Screening Script (Inclusion/Exclusion Criteria) 
Study Number: 
 
Clinician Identification Number for this study: 
 
Title of Project: Patient Satisfaction and Dissatisfaction With Treatments in 
Chronic Low Back Pain (CLBP) 
 
The purpose of the screening script is to ensure that patients are eligible to be recruited in 
the study, based on a set of pre-specified inclusion and exclusion criteria. The following 
questions should be completed by the clinician prior to information the potential 
participant about the study and inviting them to participate. 
 
Questions Yes No 
1) Has the patient been diagnosed with Chronic Low Back Pain (Pain lasting 
longer than 12 weeks, affecting the lower back, between the bottom of the ribs 
and top of the legs)?   
2) Is the patient currently receiving treatment for CLBP, or have they been 
advised by their doctor to do so? 
  
3) Is the patient 18 years or older? 
  
4) Is the patient able to understand and communicate in English? 
  
5) Does the patient have known cognitive impairment? 
  
6) Does the patient have any case note diagnosis of co-morbid learning 
disabilities? 
  
7) Is the patient currently abusing alcohol or illegal drugs? 
  
8) Does the patient have brain injury or any other organic disorder? 
  
 
For the patient to be considered eligible for recruitment, the ‗Yes‘ box must be checked 
for the first 4 questions (numbers 1 to 4) AND the ‗No‘ box checked for the following 4 
questions (numbers 5 to 8). 
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APPENDIX D: Patient Information Sheet (Study II) 
March 2006 version 1 
 
Study Title: Patient Satisfaction and Dissatisfaction With Treatments 
in Chronic Low Back Pain (CLBP) 
 
You are being invited to participate in a research study. Before you decide, it is important for 
you to understand why the research is being done and what it will involve. Please take time to 
read the following information carefully. Talk to others about the study if you wish.  
 Part 1 tells you the purpose of this study and what will happen to you if you take part. 
 Part 2 gives you more detailed information about the conduct of the study. 
 
PART 1 
 
1. What is this study about? 
The purpose of this research is to investigate patients‘ experiences with treatments in chronic low 
back pain (CLBP). To do this, we need to learn more about how people with Chronic Low Back 
Pain (CLBP) feel about the effects of their condition. This study will collect information on the 
importance to you of Chronic Low Back Pain (CLBP) symptoms and their effects on you. Also, 
on whether you are satisfied or dissatisfied with the treatment you are receiving, and what 
aspects if any could be improved.  
 
This study is in part fulfilment of a PhD at University College London. 
 
2. Why have I been chosen? 
You have been invited because you have a diagnosis of Chronic Low Back Pain (CLBP). There 
will be a total of 10 participants. 
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3. Do I have to take part? 
No. It is up to you to decide whether or not to take part. If you do, you will be given this 
information sheet to keep and you will be asked to sign a consent form. You are still free to 
withdraw at any time and without giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of care you receive. 
 
4. What will happen to me if I take part? 
If you agree to participate, you will be asked to complete a face-to-face interview with a trained 
interviewer. The interviewer will ask you about your experience of having Chronic Low Back 
Pain (CLBP), and your opinion about your treatments. This usually takes no longer than one 
hour. The researcher will audio tape the interview to minimise the need to take extensive notes, 
and your doctor will be informed that you had taken part in this study. 
 
5. Will I experience any risks or discomforts if I participate in the study? 
There are no risks to participating in this study. You are free to share your questions and 
concerns during the interview, or to speak to the interviewer following the interview. 
 
6. What if there is a problem? 
Any complaint about the way you have been dealt with during this study or any possible harm 
you might suffer will be addressed. The detailed information on this is given in part 2. 
 
For complaints please contact Diana Rofail on 01625 508897 or email at d.rofail@ucl.ac.uk, or 
Dr Lynn Myers on 020 7679 9478. 
 
7. Will my taking part in a study be kept confidential? 
Yes. All the information about your participation will be kept confidential. The details are 
included in Part 2. 
 
8. What will happen if don’t want to carry on with the study? 
You can withdraw from the study at any time, and the information you provided can be 
destroyed immediately. 
 
9. What do I do if I have any questions? 
If you have any questions about the study, you may call or write to Diana Rofail, Research 
Psychologist on 01625 578897 or Susan Wagstaff Physiotherapy Services Manager on 0161 419 
4065. 
 
Part 1 of this information sheet is complete. 
If the information in Part 1 has interested you and you are considering taking part, please 
continue to read the additional information in Part 2 before making a decision. 
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PART 2  
 
10. What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with the 
researchers who will do their best to answer your questions (Diana Rofail on 01625 578897). If 
you remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure. Details can be obtained from the hospital. 
 
11. Will my taking part in this study be kept confidential? 
If you join the study, the data collected for this study will be looked at by authorised persons 
from University College London. The researcher would have your name and contact number but 
these details will immediately be destroyed following the interview. Thus confidentiality is 
agreed. 
 
12. What will happen to the results of the research study? 
The researchers will look at the results from the interviews for themes and ideas that are 
important to people who have taken part in the study and this will form the basis of an 
intervention study to assess satisfaction with treatments in Chronic Low Back Pain (CLBP). The 
results will be documented as part of a PhD thesis, and may be published in a peer reviewed 
academic journal, and disseminated at key conferences to health professionals. 
 
13. Who is organising and funding the research? 
This study is self-funded and is being conducted in part fulfilment of a PhD at University 
College London. 
 
If you agree to take part, your doctor will be informed that you are participating in this study but 
s/he will not be paid for your participation. 
 
14. Who has reviewed this study? 
This study has been reviewed and approved by Stockport Ethics Committee.  
 
Thank you for taking time to read this information sheet. You will be given an information 
sheet and signed consent form to keep. 
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UCL CENTRE FOR BEHAVIOURAL & SOCIAL 
SCIENCES IN MEDICINE 
DIVISION OF MEDICINE 
 
 
APPENDIX E: Patient Consent Form (Study II and III) 
Study Number: 
Patient Identification Number for this study: 
Title of Project: Patient Satisfaction and Dissatisfaction With Treatments in 
Chronic Low Back Pain (CLBP) 
 
Name of researcher: Diana Rofail 
1. I confirm that I have read and understand the information sheet dates March 
2006 for the above study. I have had the opportunity to consider the 
information, ask questions, and have had these answered satisfactorily. 
 
   
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason, without my medical care or legal 
rights being affected. 
 
   
3. I understand that relevant sections of any of my medical notes and data 
collected during the study, may be looked at by responsible individuals from 
the University College London, or from the NHS Trust, where it is relevant to 
my taking part in this research. I give permission for these individuals to have 
access to my records. 
 
   
5.  I agree to take part in the above study.  
   
     
Name of patient Date Signature 
   
     
Name of person taking consent (if 
different from researcher) 
Date Signature 
   
 
When completed, 1 for patient, 1 for researcher site file, 1 (original) to be kept in medical 
records 
Patient # ________ (1-10)    Date of interview ____________  
Gender   ________ (M/F)      
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APPENDIX F: Patient Interview Agenda 
 
 
Patient Satisfaction and Dissatisfaction with Treatments in Chronic Low 
Back Pain (CLBP)  
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1 Introduction  
 
Section length approx. 5 minutes 
 
Introduce yourself by name and Institute of Affiliation. [Tell the service user that the 
interview usually lasts approximately one hour and ensure that he/she has enough time 
to participate] 
 
Please read the following to the patient: 
 
―The purpose of this interview is to find out about your experiences with treatment for 
Chronic Low Back Pain (CLBP) and the impact that it has on your daily life.  The 
information provided by people who take part will allow us to identify themes and ideas 
that are important to people with CLBP and this will form the basis of an intervention 
study to assess satisfaction with treatments in CLBP‖.   
 
―This conversation will be held in total confidence.  None of the information you provide 
will be associated with your name, and in no way will the information you provide affect 
you and/or the treatment you receive.‖ 
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―Do you have any questions at this point?‖ [If yes, please answer the service user’s 
questions] 
“If at any time you do not wish to continue with this interview we can stop at any time. 
Are you still willing to take part in this interview?” [Obtain oral consent]. 
Before we begin, I would like to ask you a few questions about you: 
 
1. When were you born? 
 
2. Are you employed? 
 Yes   No  
 If yes, do you feel your ability at work is affected by your CLBP? 
 If no, did you give up work because of your CLBP? 
 
3. Do you have any qualifications? 
Yes   No   
 
4. Do you ever experience CLBP? 
Yes   No   
If yes, how long have you experienced CLBP? 
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5. Are you currently taking any medications for your CLBP?  
Yes   No  
 If yes, what are they? 
Probes: 
Oral drugs: 
 Analgesics (drugs that reduce pain e.g. aspirin, acetaminophen, and ibuprofen) 
 Antidepressants (drugs used for the treatment of depression e.g. Imipramine 
(Tofranil), amitriptyline (Elavil), and fluoxetine (Prozac)) 
 Non-steroidal anti-inflammatory drugs (NSAIDS: drugs used to reduce 
inflammation and pain but not steroids e.g. paracetamol) 
 Muscle relaxants (drugs which relieve muscle spasms e.g. Diazepam (Valium) 
and carisoprodol (such as Soma) 
  
Injection Therapy 
 Epidural steroid injections (an injection that delivers steroids directly into the 
spine) 
 Local injections (an injection of local anaesthetics, steroids, or narcotics into 
affected local tissue) 
 Facet joint injections (an injection into the facet joints) 
 
6. Are you currently receiving any other treatments for your CLBP? 
 Yes   No  
 If yes, what are they? 
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Probes: 
 Physiotherapy or physical therapy (therapeutic use of massage, exercise, heat, 
or electricity to relieve pain) 
 Cognitive behavioural therapy (talking therapy)  
 Osteopathy (manipulation of the skeleton/muscles) 
 Chiropractic therapy (spinal manipulation therapy) 
 Relaxation therapy 
 Intensive multidisciplinary treatment programmes/Combination therapy 
(please specify) 
 Other (please specify) 
  
7. Do you use any substances (e.g. alcohol/cannabis) to help you with your CLBP 
problems? 
 Yes   No    If yes, what are they? 
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2 Chronic Low Back Pain 
 
Section length approx. 5-10 minutes 
 
Ask the patient: 
 
1. What does ‗pain‘ mean to you? 
 
2. What does ‗CLBP‘ mean to you? 
 
3. What does the term ‗Chronic‘ mean to you? 
 
4. What is the cause of your CLBP? 
 
5. Do you experience symptoms from CLBP? 
Yes   No  
If yes, what are they?  
 
6. Do the symptoms of your CLBP impact on your life? 
Yes   No  
If yes, how does CLBP impact on your life? 
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Probes: 
 Pain/discomfort (how?) 
 Sleep (how?) 
 Appearance (how?) 
 Self-esteem (how?) 
 Self-confidence (how?) 
 How you feel about yourself (how?) 
 Daytime activities (what?) 
 Night-time activities (what?) 
 Social activities (what?) 
 Sex life (how?) 
 Relationships (how?) 
 Dependence (how?) 
 Mental health – anxiety/depression (how?) 
 Trust and confidence in the clinician (how?) 
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3 Treatments in CLBP 
 
Section length approx. 20-30 minutes 
 
Ask the patient: 
1. Why do you take treatment for CLBP? 
2. Do you feel involved in treatment decisions? 
Yes   No  
If yes, why? If no, why not? 
 
Medications 
Note to the interviewer: If the patient takes medication for CLBP, please ask the 
following: 
1. Please describe what taking medication for CLBP involves on a daily basis from 
your perspective 
 
Probe each of the following: 
 Mode of administration (pill/injection) 
 Frequency of administration (e.g. once a day/week/month…) 
 Time to take medication 
 Convenience of taking medication 
 Location of administration (e.g. home, hospital, anywhere) 
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2. Are there any benefits of taking medication for CLBP? 
Yes   No  
If yes, what are they? If no, why not? 
 
3. Does your CLBP medication(s) meet your expectations? 
Yes   No  
If yes, why? If no, why not? 
 
4. Do you feel motivated to take your CLBP medication(s)? 
Yes   No  
If yes, why? If no, why not? 
 
5. Are there any disadvantages to taking CLBP medication(s)? 
Yes   No  
If yes, what are they? 
 
6. Do you experience side effects from your CLBP medication? 
Yes   No  
If yes, what are they? 
 
7. Do you take your CLBP medication(s) exactly as prescribed by your doctor? 
Yes   No  
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If yes or no, please probe: 
 Dose 
 Frequency 
 Time taken 
 
8. Do you sometimes forget to take your CLBP medication(s)? 
Yes   No  
9. Do you alter the amount of CLBP medication(s) you get? 
Yes   No  
 
10. Do medication(s) for CLBP impact on your life? 
Yes   No  
If yes, please probe each of the following: 
 Pain/discomfort (how?) 
 Sleep (how?) 
 Appearance (how?) 
 Self-esteem (how?) 
 Self-confidence (how?) 
 How you feel about yourself (how?) 
 Daytime activities (what?) 
 Night-time activities (what?) 
 Social activities (what?) 
 Sex life (how?) 
 Relationships (how?) 
 Dependence (how?) 
 Mental health – anxiety/depression (how?) 
 Trust and confidence in the clinician (how?) 
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11. Are you able to tell the difference between the symptoms of CLBP and the side 
effects of your medication? 
Yes   No  
 If yes, what is the difference? 
Physiotherapy or Physical Therapy 
Note to the interviewer: If the patient receives physiotherapy for their CLBP, please ask 
the following: 
1. Please describe what physiotherapy for CLBP involves on a daily basis from your 
perspective 
Probe each of the following: 
 Community – based supervised exercise or hospital 
 Frequency of routine (daily/weekly/monthly) 
 Involvement in the planning of the programme 
 Involvement in the evaluation of the programme 
 
2. Do you have any expectations of physiotherapy for CLBP? 
Yes   No  
 If yes, what are they? 
 
3. Have your expectations of physiotherapy for CLBP been met? 
Yes   No  
 If yes, why? If no, why not? 
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4. Do you continue to exercise after attendance as recommended by your 
physiotherapist? 
Yes   No  
 If no, why not? 
 
5. Do you continue to use the advice given after attendance with your physiotherapist? 
Yes   No  
 If no, why not? 
6. Have your physiotherapy activity levels been limited? 
Yes   No  
 If yes, how? 
 Probe each of the following: 
 Pain 
 Type  
 Family constraints 
 
7. Have the type of activities you participate been affected? 
Yes   No  
 If yes, please explain 
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Cognitive Behavioural Therapy (Talking therapies) 
Note to the interviewer: If the patient receives talking therapies for their CLBP, please 
ask the following: 
1. Please describe what cognitive behavioural therapy (cognitive behavioural therapy) 
involves on a daily basis from your perspective 
Probe each of the following: 
 Understanding 
 Usefulness of CBT materials 
 assigned homework exercises 
 
2. Do you have any expectations of CBT for CLBP? 
Yes   No  
 If yes, what are they? 
 
3. Have your expectations of CBT for CLBP been met? 
Yes   No  
 If yes, why? If no, why not? 
 
4. Do you feel motivated to take part in your CBT programme? 
Yes   No  
If yes, why? If no, why not? 
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5. Are there any disadvantages to CBT for CLBP? 
Yes   No  
If yes, what are they? 
 
6. Do you perceive your CBT materials as helpful? 
Yes   No  
 
7. Do you do your assigned CBT homework exercises as recommended by your doctor? 
Yes   No  
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4 Satisfaction with Treatments in CLBP 
 
Section length approx. 10-15 minutes 
 
1. What does ‗satisfaction with treatment‘ mean to you? 
 
2. What does ‗dissatisfaction with treatment‘ mean to you? 
 
3. Are you satisfied with your treatment for CLBP?  
Yes   No  
 If yes/no, why? 
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5 Other Points for Discussion 
 
Section length approx. 5 minutes 
 
Are there any other points that you would like to mention in relation to our discussions 
on treatment for chronic low back pain (CLBP), its impact on your life, satisfaction, or 
adherence? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you very much for participating in this interview. 
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APPENDIX G: Examples of Transcripts of Patient Interviews 
Patient Transcript 001 
Interviewer: When were you born? 
Patient: 1945 
Interviewer: Are you employed? 
Patient: Yes 
Interviewer: Do you feel your ability at work was affected by your CLBP? 
Patient: Yes I gave up work because of the pain in my back. 
Interviewer: Do you have any qualifications? 
Patient: No 
Interviewer: Do you ever experience CLBP? 
Patient: Yes for ages. Probably 20 years. It doesn‘t allow you to have a normal life. It 
happened very slowly and gradually at work. 
Interviewer: Are you currently taking any medications for your CLBP? 
Patient: Yes. My back really went around Mid September. I got a twist and a lump. It 
swelled and got worse. It happened very quickly and I got in to bed. After that I couldn‘t 
stand, get dressed from down below, so I took really strong pain killers. 
Interviewer: When did you experience CLBP? 
Patient: The severe part of CLBP was August to September this year. Since then I am on 
the recovery. 
Interviewer: Are you currently taking any medications? 
Patient: No, no medications at the moment. I find the side effects are worse than the 
pain. The pain is in my back, and the pain stops you carrying on. The tiredness and 
numbness from my CLBP are really bad. But I felt the side effects made me feel as 
though I was on another planet. The medicines definitely stop the pain, but I was losing 
days. It went in a blur. You didn‘t feel you were in control of what was going on. I didn‘t 
like the feeling but it did stop the pain. 
Interviewer: Do you know what medicines you were taking? 
Patient: Yes. Trimladin, Diflopheric, Diazapam, and Cocodomol. It was the Diflopheric 
which made me spaced. You lay there while things are going on but you cant take things 
in. 
Interviewer: Did you take any injections? 
Patient: I had morphine as an injection. It‘s wonderful. It was the first time I was out of 
pain for weeks. 
Interviewer: Did you experience any side effects from the morphine? 
Patient: Not its not a painful process at all. 
Interviewer: Are you currently taking any other treatments for your CLBP? 
Patient: I‘m coming to Physio twice a week and attending the classes. I have also been to 
the chiropractor. I went for two weeks before coming to Physio. I find physio wonderful. 
Interviewer: Have you received any talking therapies? 
Patient: Well I go to a talk after the physio classes. It‘s really good to talk to the staff. 
They push you through the excercises even though I was crying. 
Interviewer: Do you use substances such as alcohol or cannabis to help you with your 
problems? 
Patient: No, not at all. 
Interviewer: Moving on to some questions about CLBP. What does ‗pain‘ mean to you? 
Patient: Pain is where you can‘t put up with a feeling your experiencing. 
Interviewer: What does CLBP mean to you? 
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Patient: CLBP means devastation. I can‘t describe the pain. I would never believe you 
could experience such agony as what happened. It was worse than having kids. The pain 
sometimes extends to my legs. You‘re going through such an experience that I don‘t 
remember. All I know is I was experiencing the pain that was unbelievable. Nothing 
goes in. The pain is just there. Just trying to deal with it and staying calm was all I 
focused on. I was sweating, my blood pressure went through the roof, and I thought I 
was going to die. The most horrible experience I‘ve ever had. If anyone saw me in that 
state I‘d curl up and die. 
Interviewer: What does Chronic mean to you? 
Patient: I can put up with the pain, when it first started and function. I‘m not mad but I 
couldn‘t deal with it when it was chronic. 
Interviewer: What is the cause of your CLBP? 
Patient: I haven‘t got a clue what started it. I can put theories but I can‘t be sure. The 
main thing was at work. We had an office and clinic room decorated and there was only 
the three of us doing moving files, taking things off the walls, and then we had to put 
everything back. But I don‘t think I was fit enough to do it. It all started with moving and 
doing manual stuff. But I never felt anything move out of place. 
Interviewer: Do you experience symptoms from you CLBP? 
Patient: I get a twinge as symptoms in my back. I get a lot of problems with my leg. If I 
start doing something I can‘t continue and that‘s why I haven‘t got back to work. 
They‘ve said I need to get the pain from the leg back into my back. 
I‘m getting lots of nerve twitches in legs after the excercises they‘ve given me. But I 
can‘t carry anything. As I walk I end up dragging my leg. I can‘t stand either. I get 
physical problems but associated with leg. 
Interveiwer: Do the symptoms of your CLBP impact on your life? 
Patient: The symptoms of CLBP stop me from carrying as I would. You don‘t realise 
how important it is until something happens. For example, I can‘t get through my work 
because I physically can‘t keep going. I won‘t give into it though. But as the day goes 
on, I can‘t go on socialising in the evening. I used to do ballroom dancing and play 
bowls but I don‘t have the stamina to carry on. If I was at work I wouldn‘t be able to 
open the drawers and the carrying. It‘s very frustrating because you can‘t do what you 
want. Its just gets you annoyed because you have to stop and rest. But I feel better after 
the excercises. 
Interviewer: Does CLBP affect your sleep? 
Patient: No it doesn‘t affect my sleep as much now but the pain used to keep me awake. 
Now if I wake p its because its very very stiff but not as bad as before. 
Interviewer: Does CLBP affect your appearance? 
Patient: It knocks your confidence so much and I don‘t feel the same about yourself and 
you can‘t look after yourself because you don‘t have the same interest. When you‘re in 
the office you feel really self conscious. 
Interviewer: How about your mood? 
Patient: I felt very low in my mood and associate that with my CLBP. 
Interviewer: Did your CLBP affect your daytime activities? 
Patient: Standing during the day is very difficult especially after five minutes. Then you 
start to feel your leg going. I can‘t do indoor bowling and ball room dancing. If I go out I 
just sit. For example I go to watch the dancing. I still go where I would normally go but I 
don‘t do it. Even when I felt better I didn‘t go out because I didn‘t feel right, so just 
stayed in. 
Interviewer: Does CLBP affect your relationships with people or your sex life? 
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Patient: The sexy part, it‘s difficult anyway. Sex wasn‘t a be all and end all anyway. I 
didn‘t feel different because I was not so active with my husband before then. But my 
husband used to get frustrated because he couldn‘t understand the pain I was in. 
Interviewer: Did your CLBP make you anxious or depression? 
Patient: It made me very anxious but I didn‘t get very depressed because I started getting 
better very quickly once I started coming to physio so I could be positive. 
Interviewer: How about your trust and confidence in clinicians? 
Patient: I saw two locums at open clinics and they haven‘t a clue and no I dident trust the 
clinicians. That‘s why I went to the chiropractor. I was taken to A&E and they got me 
into physio, well to the first one, and then just got referred to back clinics. So the 
hospital has done something good getting me the treatment. After the second time at 
A&E when my back and leg got really bad, doctors don‘t do emergency calls after 10pm 
so I ended up in A&E.  
I don‘t know if that‘s in the right order because that period was very fuzzy. I was in 
agony and nearly on the floor. But I couldn‘t take a seat. I got discharged and asked to sit 
in the canteen. If anyone had slit my throat I would have been glad. My sister was crying 
because she couldn‘t do anything. I got morphine when I got back in. The doctor wasn‘t 
pleased with it all but I got referred to the back clinic and now I do the exercises. 
But I had a lot of sympathy from everybody because they haven‘t had it and they don‘t 
know. The physio part has just been marvellous. 
Interviewer: Moving on to treatments of CLBP. Why do you take treatment for CLBP? 
Patient: I take treatment to make me feel better and get right again. 
Interviewer: Do you feel involved in treatment decisions? 
Patient: I‘ve just gone along with all the decisions. But I feel involved by doing my 
exercises at home and I know it‘s important to keep my back strong so that it doesn‘t 
happen again. 
Interviewer: Are you actually taking medication at the moment? 
Patient: No, just physio.  
Interviewer: Okay we can move to the physio part then. Can you please describe what 
physiotherapy for their CLBP involves on a daily basis from your perspective? 
Patient: Physio makes everything easier and keeps you relaxed. Its making me stronger 
especially my muscles and I realise its important. I have exercises everyday and I fid the 
talks after each session very useful as it makes me understand whats happening. 
Interviewer: Do you have any expectations of physiotherapy for CLBP? 
Patient: My expectations of physiotherapy is to get back to work and back to normal 
again. Carrying on with my daily life without having to stop. 
Interviewer: Have your expectations of physiotherapy for CLBP been met? 
Patient: My expectations have been met but I am not back to work and my daily 
activities are not the same but mentally much happier that way. 
Interviewer: Do you continue to exercises after attendance as recommended by your 
doctor? 
Patient: Yes I try to. 
Interviewer: Do you continue to use the advice given after attendance with your 
physiotherapist? 
Patient: Yes the advice is very helpful. I‘ve never been pushed. They‘ve always said to 
pace yourself and go as far as can but don‘t over do it. 
Interviewer: Do you do any talking therapies? 
Patient: Just the talks after the physio sessions. 
Interviewer: Okay, I have some questions now which relate to satisfaction with 
treatments. What does satisfaction mean to you? 
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Patient: Satisfaction with treatment means everything to me because it gets better. They 
are treating me to get back to fitness and everything done so far has really helped 
towards that. There haven‘t been any backward steps. Satisfaction is feeling happy with 
treatment. 
Interviewer: Are you satisfied with your treatment? 
Patient: I‘m satisfied with treatment. There is nothing I am not satisfied with. 
Interviewer: What does dissatisfaction mean to you? 
Patient: Dissatisfaction would mean if you didn‘t get the time or if the treatment wasn‘t 
appropriate, if their attitude wasn‘t good. If your left waiting too ling or if they weren‘t 
interested and just going through the motions. 
Interviewer: Are there any other points that you would like to mention in relation to our 
discussions on treatment for CLBP, its impact on your life, satisfaction, or adherence? 
Patient: I cant think of anything. The doctors don‘t have a clue. Because they didn‘t have 
it they don‘t know. The doctor said we need to get you back to work. That made me feel 
as if he thought I was faking it. He had no understanding of what I‘ve been through. So 
does he even understand whats wrong with me? 
Mentally I could go back but physically this isn‘t right. He said I didn‘t have a problem. 
I didn‘t say anything to him but he didn‘t give me that sick note. 
He asked me if my headaches were better but I haven‘t had headaches so I don‘t think 
they have understanding or sympathy.  
The side effects would affect my satisfaction. Everybody in my class come off the 
medications because you don‘t feel right. I don‘t like the tables because I am not as ill 
without them. 
Interviewer: Thank you for your time and for coming in especially to see me. If you have 
any questions or concerns regarding our discussions then I can be reached on the number 
on the information sheet. 
 
Patient Transcript 002 
Interviewer: When were you born? 
Patient: 26th June 1953 
Interviewer: Are you employed? 
Patient: Yes 
Interviewer: Do you feel your work is affected by your CLBP? 
Patient: Yes my work is impacted by CLBP. I‘m struggling to bend down. It‘s an effort 
to stand up, bend my knees, lean over. I need to then think about how I‘m going to get 
up before doing it. 
Interviewer: Do you have any qualifications? 
Patient: No 
Interviewer: Do you experience CLBP? 
Patient: I have back pain. Rehab makes it difficult and stiff. Sitting still can be a bit of a 
problem. 
Interviewer: How long have you experienced CLBP? 
Patient: About 30 years ago now playing squash was when it first started. I had no 
problem until about 5 years ago. I had a scan and then an injection in my back. It started 
again at the end of June and carried on again. 
Interviewer: Are you currently taking any medications for your CLBP? 
Patient: No I‘m not taking medications. I made a decision not to take them unless I was 
absolutely desperate. No one explained to me how drugs make you feel. I couldn‘t eat 
breakfast, and I was unable to sleep anytime after 2pm.  
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Diazapam is habit forming and I was afraid of that. But when I started physio I decided 
to come off them. The medicines made me not know if it was Xmas or Easter and I was 
told to go and see a counsellor and I was not happy.  
Interviewer: So, do you know what medicines you took? 
Patient: Diazapam, codeine, paracetamol and ibuprofen. Not sure what does what. I just 
wanted to remove the pain. 
Interviewer: Are you currently receiving any other treatments for your CLBP? 
Patient:  Yes I had a n injection and that was fantastic. The most unpleasanbnt thing was 
having something cold and I didn‘t like the recovery room. There were no nasty side 
effects. I have nothing but praise for injection therapy. Shame it didn‘t last more than a 
few years though. 
Interviewer: Are there any other treatments you took? 
Patient: Just the rehabilitation class. I‘ve stopped driving and do lots of walking now. 
When I stopped taking the diazepam then I felt a lot better. I tried all sorts of things 
though. Osteopathy, Chiropractic therapy, and physio. Chiro is nice but I‘m not sure it 
was doing anything good.  
Interviewer: Do you use any substances such as alcohol or cannabis to help you with 
your problems? 
Patient: No I don‘t but I thought about it especially with the pain I had. 
Interviewer: Okay, I‘m going to ask you a few questions about CLBP now. What does 
pain mean to you? 
Patient: Pain means to me that it makes you feel miserable, not able to cope, and gets 
things out of perspective. Pain is stabbing, burning, pins and needles in toes 
etc…Something hurts and you think flip pin heck. But if you go to bed with it, and wake 
up with it, and it‘s like that all day, it‘s just intolerable.  
Interviewer: What does CLBP mean to you? 
Patient: I get the pain in my back and hip and an ache sometimes in the front of my leg. 
But I can usually walk that off. 
Interviewer: What does chronic mean to you? 
Patient: A nuisance pain with no value. 
Interviewer: What is the cause of your CLBP? 
Patient: I don‘t know, I have no idea. 
Interviewer: Do you experience any symptoms from CLBP? 
Patient: Nothing apart from the pain.  I get an ache, tingling, and pins and needles in my 
toes. But it‘s not as bad as it was. 
Interviewer: How does CLBP impact on your life? 
Patient: I feel fed up and miserable. It makes me not want to do anything. I know I 
should. I‘m scared to do too much to set the pain of. I never do anything without 
thinking about how I‘m going to do it, even the ironing. 
I have to get up and get ready for work. I just get on with it. Say I just get on with the 
ironing. I was a doer and not a thinker but now I think before I do. 
Interviewer: How does CLBP affect your sleep? 
Patient: I had to buy a new bed mattress but that‘s not a bad thing. I get cramp in my left 
foot and then it takes ages to get back to sleep. Generally not sleeping well and 
something always aches in my back in the morning. But it doesn‘t last all day. 
Interviewer: Does CLBP affect our appearance? 
Patient: Well just look at my hair! I cant do my hair because it hurts my back trying to do 
it. Every time I try it catches right in the middle of my back. 
Interviewer: Does CLBP affect your self confidence? 
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Patient: My self confidence has taken a knock because I don‘t think I was treated well. I 
had 8 weeks off work and when I got back they change my job.  I didn‘t want them to 
change my job. It was all arranged previously, I had sponsorship, training…I had plans 
and they all got changed. 
I also had to cancel my holiday. The holiday involved going round wildlife and nature 
and I couldn‘t do that. Eveeryone else went but when they came back and said they had a 
great time, and that they saw dolphins etc…my family and sister made me feel awful.  
I don‘t want to go too far away from comfort zones such as home. I don‘t want to go far 
away from where I can get help if something goes wrong. I just need to get home. I dint 
go far for shopping etc…certainly not further then 2 hours away. I tried it once and I just 
wanted to go home. 
Interviewer: Does CLBP affect your daytime activities? 
Patient: It doesn‘t affect daytime activities. I still have to go to work. But I‘ve been to the 
cinema once and out for a meal one night but chairs were uncomfortable. 
Interviewer: Does CLBP affect your relationships or sex life? 
Patient: There‘s nobody in my life. You can forget sex with my back. When you get to 
my age there‘s no one nice anyway. I rely on my mum and dad even though I have my 
own home simply because there were no alternatives. I keep getting stuck when I‘m on 
my own. So they‘re taking care of me and helping me. 
Interviewer: Does your CLBP make you anxious or depressed? 
Patient: I‘ve been fed up, frustrated and cross. Miserable but not desperate. 
Interveiwer: Do you have trust and confidence in the clinicians who manage your 
CLBP? 
Patient: Well just with regard to pain killers. I had to wait in A&E for 2 hours. The 
doctors showed me in a room and moved my leg up and down. They sent me to the back 
pain clinic. There was nothing they would do. They won‘t admit you. The CLBP clinic 
was on Thursdays. She, the physio, asked me what drugs I was taking. The whole 
process annoyed me. People with brain injury etc…could have shown more interest. I 
didn‘t know what was going on. I didn‘t know if it was something serious or something 
temporary. 
Interviewer: Why do you take treatment for CLBP? 
Patient: Just the back class, exercises including those from the physio class. 
Interviewer: Do you feel involved in treatment decisions? 
Patient: I never felt involved. I trust them now they know. But I choose to do the 
exercises and attend the classes, but they know whats best for me. I‘m ignorant.  
Interviewer: Please describe what physiotherapy involves on a daily basis from your 
perspective. 
Patient: Exercises each day for half an hour a day. But I do some in the morning, some at 
lunch time and some in the evening. It makes it more pleasant and helps me. 
Interviewer: Do you have any help from the community, any supervision, or is it all 
hospital based? 
Patient: No I don‘t have any community support. 
Interviewer: Are you involved in the planning and evaluation of your exercise 
programme? 
Patient: No not at all. The physio makes all the decisions. 
Interviewer: Do you have any expectations of physiotherapy for CLBP? 
Patient: My expectation is a plan for how to manage my CLBP in the future. When I 
finish I want to be able to do the plan myself and implement the plan so long as it works. 
Interviewer: Have your expectations been met? 
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Patient: The rehab class is fantastic. Its like a life line. Everyone in the class feels the 
same so it‘s a great support. Its not me whose crazy. When they suggested counselling it 
made me feel really awkward an I though flippin heck! 
Interviewer: Do you continue the exercises after attendance as recommended by your 
physiotherapist? 
Patient: I do exactly what they tell me. I sometimes cheat for one or two of them but I 
don‘t really like doing that and then I try and make up for it. My conscience always gets 
the better of me. 
Interviewer: Do you continue to use the advice given after attendance with your 
physiotherapist? 
Patient: I‘m getting better with the activities and exercises. It takes a while. 
Interviewer: Have the type of activities you participate in been affected? 
Patient: There no impact on my family. Everyone just carries on as normal and ignores 
me. 
Interviewer: What does satisfaction with treatment mean to you? 
Patient: Satisfaction with treatment means you are satisfied with the treatment you 
receive and you‘re happy with it. 
Interviewer: What does dissatisfaction mean to you? 
Patient: I‘m not satisfied with treatment. I‘m miffed with A&E because they weren‘t 
interested. I know there are more important things. But they gave me a prescription and 
shoved me out the door. 
Medicines make me feel awful.  I didn‘t know if it was Xmas or Easter. My head was all 
over the place. And I was muddled up. I needed to walk for miles to clear my head. My 
back was important to me and A&E ignored me. 
And the medicines stopped me eating…I guess every cloud has a silver lining because I 
lost weight! 
Interviewer: Are you satisfied with your treatment? 
Patient: Satisfaction is being pleased. But I didn‘t know about the side effects. If I‘d 
known I wouldn‘t have taken the medication for as long.  I‘m satisfied but I had to go 
through a lot to get to where I am now. 
 
Patient Transcript 003  
Interviewer: When were you born? 
Patient: 9th March 1956 
Interviewer: Are you employed? 
Patient:  Yes 
Interviewer: Is your employment affected by your CLBP?  
Patient: It is yes. 
Interviewer: Could you tell me how? 
Patient: Since the accident I was off for 8 months, and I‘ve been back at work as a nurse 
since August 14th and I‘ve been on restricted hours and restricted duties. So, I haven‘t 
been doing manual handling up until a month ago and I‘m just gradually returning to full 
time employment and full time strength really. 
Interviewer: Okay and do you have any qualifications? 
Patient: I have yes. I am a parish nurse. 
Interviewer: Do you experience CLBP? 
Patient:  Yes 
Interviewer: And, how long have you had it?  
Patient: Since January. 
Interviewer: Are you currently taking any medications for your back pain? 
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Patient:  I am yes. It wasn‘t chronic at first its become chronic. It was acute at first. Yes I 
take ibuprofen and paracetamol. I also take renitedin which is for the stomach for the 
effects of the ibuprofen. 
Interviewer: Okay so let‘s go back a little bit. So, you said it was acute first and then it 
became chronic. So, did it become chronic around January? 
Patient: No I fell in Jan and had an undiagnosed fracture T11 till June. So I was being 
treated for muscular CLBP until they found there was a fracture. For them the physio has 
changed and it‘s left me with rib pain and LBP. The fracture has healed and I am still 
waiting for investigations to see if there is anything mechanical with the rib. 
Interviewer: Okay and you‘ve told me what medications you‘re on. 
Patient:  I also take HRT. 
Interviewer: And are you taking any injection therapies at all? 
Patient: No. 
Interviewer: Okay and are you taking any other treatments? 
Patient:  At the moment no.  
Interviewer: And what about cognitive therapies, talking therapy, relaxation therapy, 
anything like that? 
Patient: I‘ve had to go to staff counselling because they‘ve actually told me that I have 
post traumatic stress syndrome which I didn‘t realise I had. But just coming to terms 
with the accident, and how it‘s affected my life. So I have had one session for 
counselling and another 5 booked. 
Interviewer: Okay have you gone for any chiropractic therapies or anything else? 
Patient:  I went to an osteopath. That was about April because the physio wasn‘t happy 
doing anything on my back because any time he touched my wrist it became really 
painful. So, he wasn‘t happy doing my back so I went to an osteopath who I had seen in 
the past for joint problems and he again wasn‘t happy touching my back and said he 
wasn‘t going to touch my back unless I see an x-ray because theres something not right. 
So that pushed me to go and see someone privately and I had to have an MRI scan which 
proved I had a fracture. So I went to the osteopath but he wouldn‘t do anything, luckily! 
Good osteopath really. 
Interviewer: And just to check, do you use any substances such as alcohol and cannabis 
to help you with your problems? 
Patient: No. 
Interviewer: What does pain mean to you? 
Patient: To me the pain is something that either irritates me or stops me doing my normal 
functions. Sort of limiting me. 
Interviewer: And, how severe would you describe your pain? 
Patient: If I‘m having a good day then I forget, which is lovely, but I forget to take my 
Ibuprofen. The next day without treatment its about 60, and with the Ibuprofen I get pain 
of 30 to 40. 
Interviewer: So what is CLBP? 
Patient:  My idea of CLBP is something that tires me, brings me down, and stops me 
from what I want to do. But it tires me, and I find I don‘t sleep well. I find it tires me. 
It‘s a tiring type of pain. 
Interviewer: What does chronic mean to you? 
Patient: Its something long term. Something over 6 months. Its something long term that 
you just get used to, or either put up with it or find a way of coping with it. 
Interviewer: And do you know the cause of your back pain? 
Patient: Yes I got a fracture in my wrist. 
Interviewer: And do you experience symptoms of CLBP? 
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Patient: Pain on inhaling deeply. It‘s a slicing pain. I get a sort of a rib pain on inhaling 
deeply. The rib feels tender but if I take a deep breath it feels like its slicing. 
Interviewer: Are there any other symptoms from you CLBP? 
Patient:  My posture, I tend to lean to one side. My balance was quite poor but I feel the 
back class has helped with that. Irritability, and frustration because I was quite fit before. 
Also I can‘t do what I used to do. And it‘s left me with a lack of confidence. I don‘t 
know if it‘s CLBP or the accident itself but its left me with a lack of confidence in 
physical things like go ice skating if it‘s on at Piccadily. The thought of going on the ice 
and falling just knocks me stomach. I‘m really cautious. I‘m cautious driving, I‘m 
cautious going down steps, and I‘m just cautious doing everything really. 
Interviewer: Okay so how does the CLBP impact on your sleep? 
Patient: I‘ve got to about twice a night where I would wake up. In the early days I would 
wake up when I couldn‘t move and I‘d wake up where I feel num.  I probably wake up a 
couple of times in the night but its getting easier. Im not comfortable lying on my left 
side but my right side is comfortable.  So its still impacting on my sleep but not as badly. 
Interviewer: And has CLBP affected your appearance at all? 
Patient:  I have been told that I walk with my head down more when I‘m walking but 
whether its the accident or the pain I don‘t know. I do feel that I walk with my head 
down. Its more of an effort to stand up right. Slouching is a lot more comfortable. I don‘t 
think anything else about my appearance apart from feeling miserable all the time.  
Interviewer: Do you feel your mood is affected? 
Patient: I don‘t feel I‘m as bright as I was and I think that‘s down to the chronic pain that 
hasn‘t been sorted yet. So yeah I‘m not as happy and cheerful. Its more of an effort at 
times, you know at work, to be positive, just because its impacted on my job so much 
and its still impacting a bit. 
Interviewer: How about your self esteem? 
Patient: It‘s difficult because it goes back to the accident rather than the CLBP. Because 
I was undiagnosed for so long, I was having physio, and every time I was having physio 
it was getting worse. The frustrations of not being able to get it sorted, when I finally had 
the MRI scan privately which cost me thousands of pounds that I couldn‘t afford. That 
was a relief but at least, because I was beginning to think that everybody was thinking I 
was just playing on it, including my husband. You know ‗get back to work; you‘ve got a 
bad back, so what?‘ And I was struggling to get acknowledged so that didn‘t do anything 
for my self esteem anymore. 
Interviewer: And what about your self confidence? 
Patient: No Im not as confident on my feet anymore as I was. Im not happy like going 
ice skating. I‘ve not run anywhere. My driving is more slower. People have noticed that 
you know I‘m just more cautious in everything I do because it‘s such a freak accident. 
Interviewer: How about the way you feel about yourself? 
Patient:  Yeah I am different. I‘m different because Im frustrated, and I‘m trying to work 
on my self confidence. I‘m very self aware of what I am because I do know that I need to 
deal with a few issues with my accident and CLBP. I was under no-bodies no care. So I 
went to BUPA, and he said he would see me as an outpatient as I needed. So I wasn‘t 
under anyone‘s care. And I went to one doctor who said there is no point referring you 
because there‘s nothing else they can do. So I went to another GP and I insisted on 
seeing a consultant, so that I am certain that yes we‘ve done as much as we can. 
Interviewer: What about your day and night time activities? 
Patient: Well with work yes. I don‘t walk as usual as I used to do at work. And I am just 
being re-introduced to manual handling with patients. So I‘ve started doing it but I‘m 
quite wary. So I can do it at my own pace. As for outside activities, I wasn‘t sporty but 
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I‘ve put a stone one weight nearly, so I need to exercise.  But its just because of 
irritability.  
Interviewer: Okay, anything like going to the pub or restaurants? 
Patient:  I don‘t drink. I‘ve been involved in the church and that has helped me a lot, and 
I walk a dog with a friend. And I go to a choir still.  
Interviewer: What about relationships and sex life and things like that? 
Patient: Because in the early days of doing it, once I‘d got over the acute stage and it had 
gone in to a couple of months, my husband was obviously, right come on get back on 
with it. So when he found there was something seriously wrong, he treated me like glass. 
So, since then hes totally backed of and its not like it used to be before the back pain. 
Interviewer: And how do you feel about that? 
Patient: Frustrated I suppose but then I just get on with it. But we have been married for 
31 years so you go through phases anyway where your sex life suffers with things and 
then you pick things up again. I think we just got out of habit now because of his fear 
factor. I think he feels guilty about everything. 
Interviewer: What about other relationships, children, friends? 
Patient: My children live away from home, and my friend, she has CLBP so she‘s very 
helpful.  
Interviewer: Okay, what about your mental health, anxiety or depression? 
Patient:  I don‘t think Ive been depressed. Yes, anxious because I wanted to go back to 
work and I couldn‘t because I knew I wasn‘t fit enough. Luckily they were quite 
supportive here. How long that will go on for? But I am decreasing all the time. 
Interviewer: And what about the trust and confidence in the clinicians? 
Patient: No. The only people I trust are the physio‘s.  
Interviewer: Could you tell me a bit more about that? 
Patient: When I fell on the ward here, I was in absolute agony, I was put in a wheelchair, 
taken to A&E which is what A&E said. I was shoved in awaiting room in A&E there for 
4 and half hours, in a nurses uniform, in agony, I was triaged, I had 14 x-rays, they 
couldn‘t find anything, they thought I‘d fractured my wrist, and they thought I must just 
have some back pain. They sent me home with a prescription for me to take. I couldn‘t 
even walk let alone go to the pharmacist to get it. No regard that I was in uniform. Just 
not nice. Had to go back to the clinic, and they were just not interested. They were just 
interested in my wrist. They put me on a splint rather than plaster. After 2 weeks they 
arranged for an [inaudible] which too ages. They had the splint on and off for about 7 
weeks, and then they decided that I had had a minimally displaced fractured bone. Which 
was actually on the other side of where the pain was. The physio wasn‘t convinced 
himself. I kept telling them about my back, and they said don‘t worry its getting better 
all the time. So then they decided to send me to physio for my wrist and I said what 
about my back? And as an after thought he wrote and back on the notes. So the clinic I 
have no confidence whatsoever. And I couldn‘t get myself out of all this. Its only as 
occupational health got involved, and then I went to the osteopath and then I went to see 
someone privately. Its just that they didn‘t listen and they didn‘t document. And its only 
the physio that have taken that pain seriously. I couldn‘t get past the GPs either so its 
poor confidence with them as well.  
Interviewer: So, did you say you‘ve had physio? 
Patient: I had physio on my back for a good few months before I was diagnosed. I had 
hydrotherapy, then acupuncture, and the physio class. 
Interviewer: Okay, so why do you take treatments for CLBP? 
Patient:  So that I can mobilise better and I stop getting so irritable when the pain gets so 
bad.  
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Interviewer: Do you feel involved in treatment decisions? 
Patient: Yes no one else is involved. 
Interviewer: Can you describe what taking treatment involves on a daily basis from your 
perspective? 
Patient:  I don‘t like take medication. I have a sensitive stomach anyway. So, when I 
don‘t take something like a non-steroidal anti-inflammatory, it gives me loose stools, 
horrendous heart burn, so then I have to take another medication, Renitidine, to counter 
the effects of that. I stopped taking co-codamol because it doesn‘t suit me, and I take 
paracetamol. 
Interviewer: And when you say it doesn‘t suit you, what do you mean? 
Patient: The cocodamol – it makes me very light headed, and where the steroids make 
me loose, the co-codamol make me so constipated that I have to take laxatives. So Ive 
found sort of if Im just taking two lots of Ibuprofen a day, I can supplement that with a 
Paractamol and the Renitidine. But as Ive said, I‘ve tried to cut it down to as little as 
possible.  
Interviewer: Did you say they are pills? 
Patient: Yes. I have used the gel but I don‘t know if it works or not. 
Interviewer: And what about frequency of administration? 
Patient: I take the Ibuprofen twice a day, and sometimes, the paracetamol as well. But 
generally, twice a day with or without the paracetamol.  
Interviewer: Does it take long to take the medication? 
Patient:  No. 
Interviewer: And, is it convenient?  
Patient: Yes but I have to take it with food and I don‘t like to take it in front of people. 
Interviewer: Can you tell me more about that? 
Patient: I don‘t know, I‘ve no idea, never thought about it. But I definitely wait until 
everyones gone. It‘s a very private thing and I don‘t want to disclose it to anyone.   
Interviewer: Are there any benefits of taking medication for CLBP? 
Patient: Personally I think the benefit is that I can be more mobile. And I know that 
that‘s important, you know that you don‘t stop. And if it stops me being irritable because 
the pain is getting to me then yeah. 
Interviewer: And does CLBP medication meet your expectations? 
Patient:  No. I‘d like to have no pain at all. I know if I up the doses a lot, it probably 
would be. But I don‘t feel as though I want to take high doses of medication, I feel like 
I‘ve got to try and work through it.  
Interviewer: And do you feel motivated to take the CLBP medications? 
Patient: The pain motivates me because when I haven‘t taken it, I know about it, so then 
I have to take it. 
Interviewer: And are there any disadvantages to taking it? 
Patient:  Yeah, the stomach lining, and the bowl movements, and the cost. Yeah and just 
the psychology thing of you don‘t want to take the tablets. The tablets are cheaper than 
on prescription. 
Interviewer: And do you experience side effects? 
Patient: Yes as I said earlier. 
Interviewer: Okay, and do you take your medication as prescribed by your doctor? 
Patient:  I am taking them as prescribed but I play about with them so I might take more 
if I need more. If I forget at tea time its good cause it means I am not having discomfort 
through the night so then I take it later.  
Interviewer: Do medications impact on your life? 
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Patient: They do when they upset my stomach. I get a lot of heart burn, a lot of 
horendouus hear burn. You get a cough from it and it impacts on what I‘m doing like 
singing the choir.  
Interviewer: Does medication for CLBP affect your self esteem, self-confidence? 
Patient:  I think its more related to the pain but the ones I‘m on don‘t. 
Interviewer: Are you able to tell the difference between the symptom of CLBP and the 
side effects of your treatment? 
Patient: Yes. Yes. Yeah. The CLBP is pain, the side effects are gastric. 
Interviewer: Can you describe what physiotherapy involves on daily basis from your 
perspective? 
Patient:  Its remembering the exercises you‘ve been given. And your posture, and more 
aware of your lifting techniques.  
Interviewer: Do you feel you get support from the community for physio? 
Patient: No I just come into the hospital. It started off once a day, then twice a week, and 
now once a week. 
Interviewer: Were you involved in the physio programme? 
Patient: I was consulted all the way. And you work with the physio. 
Interviewer: Do you have any expectations of physio? 
Patient: Yes, I didn‘t have before but I do now. Its to help so that you don‘t stiffen up. I 
didn‘t realise how Id been holding myself so stiffly because I‘ve been stiffening up. My 
idea of physio now are to help keep the muscles moving in the same way. 
Interviewer: And have your expectations of physio been met so far? 
Patient:  I think the physio has been excellent once I received the correct diagosis. When 
the got the diagnosis wrong then that was quite stressful as well as the physio, knowing 
what they‘d been doing. So, yes my expectations have been met now. I‘d say 90%. I‘d 
like to be more mobile and more confident but I think its just more time. 
Interviewer: Do you continue to exercise as recommended after attendance for physio? 
Patient: No not really cause none of us do, do we? I do do a lot of the things that they 
did. Things like step ups and all that, cause I had arthritis in the knee that made if worse 
so I‘m not doing that. I‘m doing the balance ones and the twisting and stretching. So I‘m 
doing 70% of what they‘ve recommended. 
Interviewer: Have your physiotherapy activity levels been affected? 
Patient: I was limited in what I could do as some of them weren‘t easy in what I could 
do. I was embarresed by the pain because of my body‘s response to the pain. It was just 
so painful. 
Interviewer: So, can you tell me what does dissatisfaction with treatment mean to you? 
Patient: Not being listened to. Long waiting lists to get seen to things. Long referral 
processes. Treatment not working, not helping, hindering. Causing more discomfort. 
Like the physio would make me feel worse for 4 days that I was in pain afterwards. So at 
the time it wasn‘t helping. It was causing me more pain than I arrived with.   
Interviewer: Are you satisfied with your treatment for CLBP? 
Patient: Since getting the correct diagnosis yes. Apart from the medical side of it, but 
from the physio part yes. Paying privately was excellent but the NHS no. And I don‘t 
believe in private health care so I had to go against my beliefs. So that‘s hard.  
Interviewer: And is there any of the treatments and or satisfaction that you felt we havent 
covered? 
Patient: The hydrotherapy was extremely beneficial.  
Interviewer: Anything else you‘d like to share. 
Patient:  I think we‘ve covered everything. 
Interviewer: Okay thank you very much for your time and participation. 
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Patient Transcript 004 
Interviewer: When were you born? 
Patient: Specifically? 16th of September 1966. 
Interviewer: And, are you employed? 
Patient: Yes. 
Interviewer: Do you feel your ability to work has been affected by your CLBP?  
Patient: I think my ability to do certain jobs is affected. I only work part-time. And, I 
actually don‘t think I could work full-time, because I get too tired and then it all kicks in. 
So, I suppose that‘s a yes. 
Interviewer: Do you have any qualifications? 
Patient: GCSEs or O-levels. 
Interviewer: Okay and you‘ve already told me that you experience CLBP. Can you tell 
me how long for? 
Patient: About 11 years, and related to a car accident. 
Interviewer: Okay, and are you currently taking any medications for your CLBP? 
Patient: I try not to. If I do take them, it tends to be paracetamol or codeine. I mean at 
one time I was on stronger prescriptions of other types of medicines.  
Interviewer: When you say stronger, can you give me an idea of what stronger types of 
medication you‘ve taken in the past? If anything. 
Patient: I don‘t remember because it was that long ago. But I decided not to take them 
because I was dopey all the time and I didn‘t have any quality of life or anything. That‘s 
what I want you know. My back pain relates to two car accidents, neither of which were 
my fault but that‘s where it all stemmed from. I didn‘t have any pain before then. I don‘t 
want the medication living my life for me. I want to take it over. I mean I am probably in 
pain all the time but I just deal with it. 
Interviewer: So, you said you take paracetamol and codeine. Do you take any 
antidepressants at all, do you know? 
Patient: I was actually on antidepressants because I was misdiagnosed with a Thyroid a 
problem, and they put me on that, and I was like zombie.  
Interviewer: Right so you didn‘t like antidepressants? 
Patient: No, that‘s why I stopped taking them. 
Interviewer: And, how about any muscle relaxants like diazepam? 
Patient: No. 
Interviewer: Have you tried any injections?  
Patient: No. 
Interviewer: Are you currently receiving any other treatments?  
Patient: Physiotherapy and that‘s it. I‘ve got the one session left to go to. 
Interviewer: Have you tried any relaxation therapies? 
Patient: Only self relaxation therapy. I do use it and can use it. I‘m so tense that I don‘t 
need to tense up in order to relax. Maybe some weeks I do it a lot and sometimes I don‘t. 
Mainly when I get too stressed and I need to relax. But its not that I have been on a 
course, or had treatment from the doctors. 
Interviewer: Okay. Do you use any substances such as alcohol or cannabis to help you 
with your problems? 
Patient: Not really no. Sometimes I‘ve had the odd glass of wine and I‘ve though ―oh 
that helped‖ but I don‘t think I‘ve done it deliberately. Or, I‘ve gone to the pub to have a 
drink and I may have, you know had a drink, and then thought I feel quite good now. But 
never knowingly. 
Interviewer: And, how about cannabis? 
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Patient: No never. The only thing I do use, is I have a tans machine. I use that more than 
I use pain killers. But, you haven‘t mentioned that.  
Interviewer: Well, you can tell me about it if you want. 
Patient: No no, I was just thinking I use the tans machine which I find invaluable. Its 
really good and sometimes it‘s the only way of getting through the day. I bought one 
about six years ago, maybe not even that. And, if I had to get one every year I would get 
one. It‘s very helpful. And, a hot water bottle. Every night I go to bed with a hot water 
bottle. 
Interviewer: Right, and does that help? 
Patient: Yes, it just eases it. 
Interviewer: Would you use it where the pain is? 
Patient: I actually lie on me back and put it between my back and the bed. 
Interviewer: Okay so I am going to ask you a few questions about CLBP now. There are 
no right or wrong answers. We are just interested in your experiences and opinions. So, 
if we start with, what does pain mean to you? 
Patient: Well it‘s a physical thing and I know myself that if I get a pain anywhere, I tend 
to be aware of it and then I do things differently. And, then I end up getting pain 
somewhere else. But it is quite debilitating and does stop me doing quite a lot of things. 
It‘s a way of life really. You want it the same way of life as if you were pain free. It can 
be that, if my back is very bad, then I am up for a few days and I‘m very cautious. I don‘t 
know if it‘s a psychological thing. Because it‘s a general and physical pain but you do 
get ―oh don‘t do that because it will end up hurting, or don‘t do that because it will come 
back again‖, it does affect your whole way of life. I mean some days I think to hell with 
it, I‘m just gonna get on and do it, or I rely on the tens machine which does help and I 
don‘t know if it‘s the right thing to do but I don‘t want to have to rely on drugs or 
something like that. Because ultimately long term, relying on things like that, if you get 
any ailments of pain, then it doesn‘t even touch it. You know its like if you get tooth 
ache, your average Joe would just take a paracetamol, not just dull it and keep on going. 
I felt I got to a stage where I was taking strong pain killers and you know it wasn‘t even 
touching it. 
Interviewer: So, what does chronic mean to you? 
Patient: Well, what I think it is is that it‘s more or less always there. Its almost like a 
tooth ache. But, there‘s always an element of consistency. It‘s always there. 
Interviewer: So, what does CLBP mean to you? 
Patient: Its just pain in your lower back really. I do have problems with my shoulder and 
my neck. I had a whip lash injury but it‘s my lower back, and I find hard to sit down. 
Interviewer: On a scale of zero which is no pain, and 100 which is worst imaginable 
pain, where is your pain today? 
Patient: It wasn‘t too bad this morning, but I‘ve been out and about all day, sitting at 
work this morning and sitting now, so I would say about 25. Its there but a 25 is 
probably about where it is because I am used to it.  
Interviewer: Throughout the course of the 11 years that you have had CLBP, how bad 
has your pain been on that scale? 
Patient: It sounds really bad but I would have to say 100 cause I mean I used think I had 
no pain threshold until I gave birth and they gave me gas and air. And that was about 16 
years ago. So, I thought I could get through that if I could get some air, but this is just 
horrendous.  
Interviewer: So, does your pain ever go to a zero? 
Patient: I don‘t think it ever goes to a zero. As I say today at 20 to 25 that‘s probably as 
low as it would go. There is never a day when the pain is never there.  
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Interviewer: Do you know what the cause of your CLBP is? 
Patient: Well I think I get muscle spasms that‘s when it gets worse and it tightens. But it 
all came from the car accident, that‘s when the tissue injury occurred. 
Interviewer: Okay so you had the car accindent and then you started to have pain, and 
sometime your muscles tense and then it triggers right? 
Patient: Yes. Or it may be that something triggers it and then I tense and it triggers it. I 
don‘t know. 
Interviewer: Okay, so do you experience any symptoms from CLBP? 
Patient: Just pain. Pain is the thing. 
Interviewer: Is there anything else, or is it just the pain? 
Patient: Just pain although I do feel as though I am quite num in that area even though 
I‘ve got pain, it feels numb on the outside. 
Interviewer: So, is that you almost don‘t feel from the outside but you hurt from inside. 
Patient: Yes. 
Interviewer: Is there anything else?  
Patient: I have had pain in the shoulder but I don‘t think its related to the back pain. 
Interviewer: Did your CLBP impact on your life? 
Patient: Yes.  
Interviewer: Can you tell me more about that? 
Patient: As I said before, the fact that as I said before, it does affect your day to day life 
because you are aware that its there. Even though its mild, its still there. But particularly 
when you get flare-ups, that stops you doing lots of things. 
Interviewer: So, in what way does it stop your life? When you say it stops your 
activities? 
Patient: It stops your activities, it stops your social life, it can affect your work. I‘ve had 
it when its really bad and I can even get out of bed. But there are times when you think I 
cant be bothered. 
Interviewer: So, it impacts on your life in quite a way really. Does it affect your sleep at 
all? 
Patient: Yes.  
Interviewer: How? 
Patient: It just, its very difficult to get comfortable to go to sleep in the first place. It can 
wake you up in the night and then you have the same scenario all over again of trying to 
get back to sleep.  
Interviewer: Why do you wake up? 
Patient: Because the pain is so bad. And, then you can be stiff in the morning.  
Interviewer: What about self-esteem, self-confidence, and self-appearance? Does it 
affect any of those in any way? 
Patient: Yes again because your whole life has changed and it affects your life so much. 
Cause you cant do certain things that you could do before, or your worried about things 
so you stop doing those things, and then you stop doing whatever it is socially that you 
do.  
Interviewer: And how‘s your self esteem, or self confidence? 
Patient: Well I am lucky in that I am extremely outgoing and confident and I talk to 
anybody. But, I know that when it was really bad I didn‘t go anywhere and I didn‘t do 
anything and then there is that having to get back into it which I didn‘t find easy but for 
some people I imagine, some people find it extremely difficult depending their nature 
anyway. 
Interviewer: Right, so it‘s like your motivation, and once you stop going out that 
motivation is gone.  
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Patient: Yes. 
Interviewer: And you‘ve mentioned day time activities in terms of work and just doing 
your day to day things.  What sort of things do you mean? 
Patient: Yes all sorts of things, shopping, housework. 
Interviewer: And night time activities, and going out are affected? 
Patient: Yes.  
Interviewer: Could you give me an idea of how often you go out? 
Patient: Well I used to be involved in a lot more things than I am now. But that‘s not 
necessarily related to my back as much as to my personal situation I think. But I do, I try 
and go out and see my friends one evening a week. But I would have gone out more than 
that and doing social things. 
Interviewer: Okay, and how about relationships, and sex life, your family life, does it 
affect any of that? 
Patient: Well I just recently got divorced but that wasn‘t necessarily anything to do with 
my back pain.  
Interviewer: Did it have anything to do with it though? 
Patient: No. I think there were times when it does affect you so much that you don‘t 
want any one near you, you don‘t want to know, and you‘re in a bad mood, and you‘d 
bite the head off the person who was nearest to you. So, I mean yes, it does affect 
relationships. 
Interviewer: And do you get anxious or depressed at all? 
Patient: It would get me down. It would get me down and I can get frustrated because I 
cant do what I want to do.  
Interviewer: So, you get quite a bit of frustration. How about anger? 
Patient: No not really. You get a bit snappy but I don‘t get angry. Snappy is the word. 
Interviewer: How about trust and confidence in any of the clinicians? It could be nurses, 
doctors, physiotherapists, any health professional. 
Patient: I actually do feel quite let down from the point of view of the long standing 
problem that I‘ve got. I mean I paid privately to get treatment purely because you know 
the waiting list was so long that I would have ended ten times as worse before I would 
have got some treatment. But then I went to my GPs and I said I need some treatment 
and I can‘t afford to pay privately, and they were very good. But originally from that 
point of view, I maybe didn‘t try enough, but maybe not. 
Interviewer: So, when you say maybe not, was it that you weren‘t happy with the 
treatments, or? 
Patient: It was just that really long wait. I just couldn‘t have waited. But as I say I went 
and I thought no its bothering me more and I can see going on a slippery slope. Cause 
physio really does help me. I mean what we have done in the classes thing has helped as 
well.  But its keeping it up. And I know we have a bit in our folder where we can ring up 
and find out about classes in your area and that‘s a thing I need to do. Because doing it in 
the group and what we did helped me. It gives you that, we are all in the same boat, you 
don‘t particularly want to go to the gym on your own and everybody is like super fit and 
your there with a bad back. You know. 
Interviewer: Okay so I am just going to talk to you about the treatments that you‘re 
taking. 
Patient: Well I take a physio class, pain killers, and the tens machine. 
Interviewer: Okay so if we start with medication first. Why do you take medication? 
Patient: Because it helps to num the pain really. It‘s as simple as that. Just to get rid of 
the pain. 
Interviewer: Do you feel involved in the treatment decisions of your medications? 
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Patient: Yes because I am doing it myself. You know its paracetamol and codeine and 
that‘s it. 
Interviewer: So it‘s over the counter?  
Patient: Yes.  
Interviewer: So, can you describe what taking medication involves from your perspective 
on a daily basis? 
Patient: On a daily basis I don‘t. I only use it when it gets particularly bad. And as I said 
I take some pain killers and hope for the best really. Bacuse I don‘t want to rely on 
tablets all my life. I am probably living with more pain than other people because I don‘t 
want to take the tablets. But I can deal with it if the pain is 20 or 25, its when it gets to 
60, that‘s when its bad.  
Interviewer: What about taking the pills, I presume their tablets? Is it easy to take? 
Patient: Yes but theyre not easy to take. I buy the capsules, as I find the tablets hard to 
swallow. I mean I would quite like some sort of patches you just stick on you know, 
stick it on you‘re your lower back and you‘d go ooh because it would get to the spot 
quicker. 
Interviewer: So, its not ideal but its okay. 
Patient: No, its not ideal. 
Interviewer: And how do you feel about taking them in front of people? Are you okay 
with that? 
Patient: It doesn‘t really bother me. If anyone really wanted to ask me, I‘d just say period 
pains as its so embarresing really. It‘s like whats it to you. Know one‘s ever asked.  
Interviewer: Okay and what about the time you take the medication? Do you just take it 
when you need it?  
Patient: Yes I just take it as I need it. I have a box in my drawer at work so they are 
always dotted about, and I always know that there are some. 
Interviewer: And what about the convenience of taking them? Do you experience any 
problems? 
Patient: Well if you‘re travelling somewhere you know of a train or vehicle then that 
might be a bit inconvenient. But I always make sure that if Im going anywhere I‘ve got 
them with me. 
Interviewer: And are there any benefits of taking medication for CLBP? 
Patient: Well it does help a bit. I mean that‘s why I won‘t take strong ones. I mean in one 
of the classes they talked about taking your medication, and taking it and taking it and 
taking it and then not needing to top it up. But the thought of taking, you know, if we are 
talking paracetamols, 8 paracetamols a day for the rest of your life, its not really good. 
Interviewer: Right, so you‘d rather not take tablets at all? 
Patient: Yes I‘d rather not take tablets at all. And that‘s why I don‘t and I always live 
with the level of pain that I live with. And then its only when it gets above a manageable, 
or tolerable level I should say, that I take them. 
Interviewer: Do your CLBP medications meet your expectations? 
Patient: No. They need to be stronger probably but I don‘t want to go there.  
Interviewer: Will you tell me a bit more? 
Patient: Well my expectations were to remove pain but I know the tablets wont do it. 
Interviewer: Right so the over the counter medications don‘t do it? Have you tried the 
other medications, the stronger things? 
Patient: Well yes, but as I say I don‘t want to take them. 
Interviewer: Is that because of dependency? 
Patient: I think dependency and tolerance really. You know you get to a point where it 
isn‘t going to do anything.  
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Interviewer: Right, cause you get so used to it. 
Patient: Yes and cause I got to that and that‘s why I stopped taking them. You know this 
is zombified you know. It‘s taking pain killers to live. You know I need tablets to live 
because I have thyroid problems but taking pain killers to live, its not. 
Interviewer: And when you say zombified, can you expand on that? 
Patient: Just to the point where you feel spaced out and not really fully aware and I don‘t 
feel like I feel in control of my life frankly and you get to the point where your just 
living from one tablet to the next.  
Interviewer: Do you feel motivated to take the CLBP medication? 
Patient: I‘m only motivated by the pain. 
Interviewer: And are there any disadvantages of taking CLBP medications? 
Patient: Well yes, getting zombified if you take them all the time. You don‘t feel in 
control.  
Interviewer: Is there anything else? 
Patient: Well it makes you lethargic, it‘s all part and parcel of not really being with it 
when you‘re taking strong pain killers and taking a lot of them because you need them. I 
would rather live as I‘m living with a certain amount of pain, than to have no pain and 
really no quality of life, that‘s how I look at it.  
Interviewer: Do you take the medication as recommended by the doctor? 
Patient: I just take them when I need them. 
Interviewer: Does the doctor tell you to take your medication more than that? 
Patient: Yes originally when I was on prescribed pain killers, I was taking substantially 
more. You know I don‘t take pain killers everyday.  
Interviewer: Right, was it recommended to take the medications everyday and then you 
decided this isn‘t working for me. So, do you alter the amount of medication for your 
CLBP? 
Patient: Yes I do. Because of the side effects and because of the tolerability. They used 
to make me feel zombified.  If I took the prescribed medication that the GP had 
prescribed, I‘d just have been spaced out really. You felt okay but you don‘t feel much 
else. 
Interviewer: And if you felt that way how did it affect other things?  
Patient: Well it stopped me from doing anything. Relationships, friends, family, going 
out, basically all the things we talked about. 
Interviewer: Are you able to tell the difference between the symptoms of your CLBP, 
from the side effects of your treatment? 
Patient: Yes. I get pain from my lower back, and I feel spaced out or zombified from my 
treatment. 
Interviewer: Okay, I am going to speak to you a bit about physiotherapy now. 
Patient: Okay. 
Interviewer: Can you please describe what physiotherapy involves on a daily basis for 
CLBP from your perspective? 
Patient: When I first came to physio, I mean they go through lots of movement 
etc…that‘s why the classes really benefited me. Because its doing exercises to strengthen 
areas there which I can feel benefits from. I was one of the unfortunate ones who pulled 
a muscle on the last day. I just moved funny. But we did a lot of, if you move that way 
then you need to move that way. That really, I use that now. Not necessarily my lower 
back, but you know any kind of movement that you do is good. So I found that really. I 
mean to me, it was never obvious and I thought, oh that might work and yeah that‘s 
good.  
Interviewer: Were you recommended to do any exercises? 
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Patient: Yeah. 
Interviewer: Do you do them? 
Patient: Yeah. 
Interviewer: Do you do them as recommended by your physiotherapist? 
Patient: Some of them are not particularly easy to do in your daily life so some of them 
you need to improvise. I mean its like when we had to do exercises with a medicine ball. 
I know I‘m doing that because I‘m getting things out of my cupboard and putting things 
in my fridge. So, I‘m doing that without really knowing I‘m doing it. Some of them you 
wouldn‘t do and you have to consciously do. But I do find it helpful and its really 
benefited. 
Interviewer: Do you have any expectations of physiotherapy for CLBP? 
Patient: I don‘t think I have any expectations now, but I think I‘ve already seen benefits 
from what I‘ve done from the physio. I mean as I say I can see why we do that and I can 
see the benefit from it and I can see that I need to do this more and I wont have to you 
know, have the pain. 
Interviewer: Did you have expectations before you started the physiotherapy? 
Patient: I sort of had. Well I‘d give everything a go. But if I can keep this up I thought, 
you know I can see that it strengthens these muscles. Therefore I wont get this problem, 
and you know what to if you get a problem. So, I didn‘t particularly have expectations, 
and I didn‘t particularly think it was going to be a miracle cure, but really appreciate 
doing it. I mean obviously at this time, I‘m still not pain free. I don‘t know but it 
certainly helped me.  
Interviewer: So, have your expectations then, been met now? 
Patient:  Well because I didn‘t really have any expectations that much, then I think its 
over exceeded. I mean because I didn‘t go in thinking ―oh, this is a miracle cure‖ so it 
exceeded. I mean you have got to be realistic, I mean I‘ve had pain for 11 years, its not 
going to cure itself over night and its not going to go away.  But I certainly know that its 
improved. 
Interviewer: And so when you say you don‘t have any expecations, did you go in with 
the view of, ‗I‘ll give this a go?‘ 
Patient: Yes. 
Interviewer: And you said you continue the exercises as recommended although 
sometimes you improvise. 
Patient: Yes. 
Interviewer: And, do you continue to use the advise given after attendance? 
Patient: Yes. Yes. Things like that. I mean there are some things that we were advised 
about, you know, like shopping. Strangely enough when I started on this course, I met 
someone whose just finished the course. And she‘s a single mum. And she said that they 
said ―don‘t do big shops, do little shops‖. But the reality is, you cant. The advise is great 
but the reality is, no body, unless they don‘t have anything better to do, can go shopping 
all their life. 
Interviewer: Why did they ask you to do shopping to do everyday? 
Patient: Well they didn‘t ask me, and I didn‘t took it like that. But that‘s how she did. Its 
so that your not doing lots of you know picking up. But I said that at the end of the day 
you can come in and just take the things that you need into the house, and wait till the 
kids get them to empty your boot. You know at the end of the day there are ways round 
things and its sort of how you interpret what you‘re told. 
Interviewer: Okay, did you say you‘ve had any talking therapies like cognitive 
behavioural therapy, or counselling? 
Patient: We‘ve had lots of lectures and talks and things. 
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Interviewer: Okay but have you been seeing a psychologist or counsellor? 
Patient: No. 
Interviewer: Okay weve nearly finished now. Can you tell me what satisfaction with 
treatment means to you? 
Patient: No I think that…well going back to what you were saying ‗do I think my 
expectations were met?‘ I don‘t really think that‘s what it means because everyone‘s 
different and every bodies way of being satisfied is different. I actually have really 
benefited from, particularly this class. And maybe more than, well as I say I didn‘t really 
go in with any expectations so my expectations were more than met in that respects.  
Interviewer: So, what is satisfaction to you? Is there any way that you could describe it? 
Patient: Well satisfaction is having everything that you want and being happy, healthy 
and something like that. 
Interviewer:  So, when you say happy with everything? So, do you mean happy with the 
aspects of treatment? 
Patient: Yes. I actually thought it was good. There were a lot of things that I took on 
board and thought, you know just certain things like, wow that makes sense, you know, 
I‘d never thought it before. But what I particularly thought at the time is wow that really 
makes sense that. Cause we have this talk about your pain can never be shut down and so 
its always there. Some people took great offense at that, you know that its your brain 
telling you that your in great pain, so your in pain and don‘t shut this down because pain 
is not as bad as your thinking. I though yeah I can understand that in a certain aspect. So 
there were a lot of things that I really gained from it like personally, and not just you 
know I gained not just that I gained from learning that, but I also gained from thinking 
―ah that‘s how people perceive you‖. So, its not just about what your saying but its also 
about how people perceive you. And you know you‘ve got this pain but it may not be as 
bad as you think because of this. 
Interviewer: So, could you elaborate a bit more on the perception side of things? 
Patient: Well, I could sit here and say to you ―My back‘s killing me‖ and there‘s only my 
word for it. There is no physical proof. I think there is a big element of that. So its just 
your opinion. 
Interviewer: Okay, so do you feel people judge you on that? 
Patient: I think there are. I think there are. Bacaeuse you can have good days and bad 
days whereby today I could do this, and tomorrow I couldn‘t do it. And theres an 
element of ―oh well you were alright last week and now you can hardly do anything for 
all you know‖. And I do believe that there is an element of I‘ve overdone it and then I‘m 
suffering after that. And then people say oh well you were well enough to do that and 
now you‘re not well enough to do this. And I think, no but I am genuinely not. And it‘s 
my own fault for saying anything because I did too much because I felt alright. I mean 
its not like I have a severe case of acne, and people say oh yeah, of course we can see 
that, or whatever. So there is an element of that. 
Interviewer: So can you tell me what dissatisfaction means to you? 
Patient: Well not meeting your expectations really because I came into it with not 
expecting anything.  
Interviewer: So, when you say your not expecting anything, is that because of something 
that has happened before? 
Patient: Possibly there is an element of yeah I don‘t think this is going to be the cure. But 
I don‘t think that that‘s necessarily related to my back as I suppose other things in life. 
Interviewer: And are you satisfied with your treatment at the moment? 
Patient: Yeah. But I guess if I can carry it on then I know I haven‘t been satisfied. 
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Interviewer: Is there anything else that you feel we have perhaps haven‘t covered that 
you think I should know about in relation to everything that we have talked about? 
Patient: No not really. Just that you know that every bodies life outside of CLBP are 
different. Like we were saying, your expectations and satisfaction are different. Because 
I was misdiagnosed with a thyroid problem, I was treated for being depressed for quite a 
while actually; I mean that‘s always bothered me. I mean at the end of the day I was on 
these tablets, I was playing scrabble and the rest of the world was playing monopoly 
when I was on the antidpressants. Because quite clearly I didn‘t need them because that 
wasn‘t what was wrong. And it was brilliant when I got diagnosed with my thyroid 
problem and you know, most people wouldn‘t say that but you know. So there is always 
that element and obviously it relates to the medical industry as such. Because I have had, 
after I had my sons, I had problems and I had to have a couple of operations to make it 
right and that was again well I could put it down to medical problems, and that could be 
wrong but technically it would be. So, I got those two issues, well not issues to me but 
there there and it happened. I mean its gone, its dealt with, and theres nothing else, but 
ultimately there is that here we go again possibly. All I want is to be right and because of 
those other things. And then there are personal life things where you get to a point where 
it is really worth it. 
Interviewer: So there personal things that are not related to CLBP? 
Patient: They‘re not related to CLBP what so ever but they could be related to how I 
think about, maybe that why I think I won‘t go into it with any expectations because then 
it will go…possibly there is an element there that it could be. I‘m not saying that that‘s 
the case but there is an element there that it could be. Because I‘ve had a couple of 
medical things in the past that haven‘t been dealt with appropriately and there could be 
an element of ―oh I‘m not expecting anything because I‘ll get let down.‖ But if anything 
happens which improves it then it‘s a bonus. But there is and that could be related to my 
personal life as well. So I may just be the sort of person who doesn‘t want to try anything 
because then you won‘t get disappointed. I don‘t know if I am that sort of person but I 
think its fair to say that there is an element of it. If I don‘t have big expectations then it 
can only go one way. And because maybe you should have expectations and you get 
something out of it, then you‘re satisfied. So, it‘s where your line is really, or your 
marker is on that line as to what your expectations are because yes I think your 
expectations and your satisfaction are related. I don‘t know if all that helps. 
Interviewer: It does indeed. Thank you very much. 
 
Patient Transcript 005 
Interviewer: When were you born? 
Patient: 1958 
Interviewer: Are you employed? 
Patient: Yes, full-time. I sit at a desk. I work as a PC administrator. So most of my work 
involves dealing with fault computer parts. So I gather them, I put them in like sheets, 
sort them all them, then I have to pack them in the box, and then send them back to the 
manufacturer. So my job basically involves sitting down, standing up, and most of the 
time lifting heavy boxes. It just depends what part of the computer I am handling. If its 
hard drives they can be quite heavy. Because I don‘t just do one, I do twenty. Or mother 
boards, or anything. 
Interviewer: Did you give up work because of your CLBP? 
Patient: As soon as my back gives me trouble again I have to take time off of course. 
And I haven‘t been back since. Until recently I had been given disability status. So I 
have not been back to work since last year, last January. 
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Interviewer: Do you have any qualifications? 
Patient: No. 
Interviewer: Do you ever experience CLBP? 
Patient: Yes, all the time. 
Interviewer: How long have you experienced CLBP? 
Patient: Since 1997. In 1997 I had back pain and I was basically in the bed for about 3 
months. And I was referred by my doctor to see my consultant, and they diagnosed that I 
have a bad back. And it was about after 3 months and after then it was about normal. 
And then I was okay until the year 2000. In the year 2000 my back flared up again. I 
couldn‘t do any thing. I was off work for about a month. After physiotherapy it went 
back to what you call near normal. Since then it was okay until November last year. 
November last year I was working, and I was helping to move departments at work and 
that‘s when it started again. From then up to now it‘s just been really painful experience. 
I went to see the consultant again about six months ago. They looked at my history and 
they recommended I take physiotherapy sessions again. They looked at my past X-rays 
and everything again. They said they think it‘s the same problems. They said go have the 
physiotherapy. If that doesn‘t work then you probably need an operation. Since I started 
the physiotherapy about 6 months ago, the pain moved from my calf to my back, and I 
am still suffering from it all on a daily basis. Because of attending the physiotherapy, I 
have learned a great deal about managing my pain. Basically, its there all the time. And I 
am trying to live with it. In the last two months I started suffering from neck pain, and I 
have pain inside my head. So, Cathy Riley referred me to Mandy Evans who was dealing 
with my neck pain. Just after X-mas, in fact on the 2nd of January this year I attended 
the last session and she asked me if there was any improvement or pain in my head and 
unfortunately not. So she decided to refer me to my doctor and see if he wants to 
investigate it more. That‘s in brief, yeah? 
Interviewer: Okay, well thank you. We will be touching more on some of the things you 
have mentioned on a bit. Are you currently receiving treatment? 
Patient: Yes I take pain killers and anti-inflammatory tablets. The pain killer is called 
anti-tirex and a tablet called retrinol. For the last I would say 3 weeks, I stopped taking 
them. It was with the advise of Mandy Evans to see if my head pain is a side effect of my 
treatment or not. And apparently on the 2nd of January again this year, she decided that 
it was not the effect of the drugs. So I am taking them again. 
Interviewer: Do you experience any side effects of those treatments? 
Patient: Not what I could say, but definitely I get stomach ache sometimes, when I go to 
the loo. I don‘t know if its side effects of the drugs or just the condition itself.  
Interviewer: Do you use substances to help you with your problems? 
Patient: No. Prior to last January I was working and I was doing normal things. I always 
had up until 1997, I always had a sort of a back pain. But I always put it in the back of 
mind and just carry on with life as normal. Thinking it‘s probably my age, you know as 
you get older, I‘m not doing the things I used to, I‘m not clubbing any more, you know 
I‘m not doing sport anymore. There is a fact there, that I have problems with my knees 
as well, so I think that‘s a big factor relating to my knees. Because I have a long time 
knee injury. I‘ve had a couple of operations but it really didn‘t solve the problems. And 
that‘s affected the way I walk, I can‘t run, I cant do any physical sport. Because of that, 
so if I play football now, which I doubt it now because I know that my knees give way. 
Interviewer: What does pain mean to you? 
Patient: Pain means when I feel pain. It‘s very hard for me to explain. It‘s just painful if I 
cant bend, If I cant sort of stand up, I sleep on the floor for the last several weeks. It 
helps a bit. Every time I sleep on the bed it makes my back worse. So, what‘s the 
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definition of pain? There‘s a lot of things I can say about pain. I cant sleep sometimes. I 
am sorting of turning all the time. Pain to me is sort of discomfort, its so painful 
sometimes it just cause discomfort. I don‘t know if you understand what I mean? 
Interviewer: Well I understand what you‘re saying but I never had chronic. 
Patient: Well what‘s chronic? Is it just relates to back pain or is it pain just all the time? 
Interviewer: Well, that‘s actually my next question to you. 
Patient: I would say my back is just. I mean it gets from bad to worse sometimes, and it 
improves as well. I mean when I started physiotherapy my sciatic nerve was a problem. 
As soon as I got the pain it related to my leg. Where it is now in the back, it‘s not as bad. 
Its still bad, but not as bad. So it just depends what you call chronic. 
Interviewer: So, if you had to rate your pain today from 0 which is no pain to 100 which 
is worst imaginable pain, where would you say your pain would be? 
Patient: I would say it‘s at 50. In the middle. At its worst I would say it‘s about 97, 95 to 
97. It‘s never no pain at all. The lowest when I am just ignoring it is that it‘s about 30. 
But like I said sometimes you don‘t want to moan about it and you don‘t want to go on 
about it. And like I said, my wife she has low back problems sometimes. So like I said I 
don‘t want to go on about it. And my wife has just recently been diagnosed with breast 
cancer recently so compared to her sort of illness, mines nothing. So it‘s always there, 
it‘s always been there. But on a scale of 0-100, I would say its 30, when it gets worse it‘s 
around 97, 90, obviously after the physiotherapy I do the exercises every day. I‘ve 
learned to manage my back pain. 
Interviewer: What is the cause of your CLBP? 
Patient: My back pain goes back to 1997.  At that time I wasn‘t playing any sports or 
anything. At that time I just played snooker, and I don‘t even do that now. Whether its 
something to do with my knees, you know my back pain relates to my knees, I‘m really 
not sure. 
Interviewer: Do you experience symptoms of CLBP? 
Patient: Yes. Its always there. The pain of course, and the pain then stops you doing 
things. Like again, it makes you walk wobbly etc…I am self conscious all the time, 
trying to sort of balance things. You know not to hurt my back and not to give way. If 
that happens it will be disaster really. So it‘s just a matter of being self conscious all the 
time. I don‘t walk as I used to like a lot of people. If you see me walking I don‘t walk as 
I used to. I try to rush it. Not because I‘m a fast walker or anything, but just because it 
gives me a better balance. If I walk slowly, you know I am not confident walking in a 
straight line. You know if the police see me, they probably think I am drunk. So, that‘s 
what I experience all the time. 
Interviewer: How does CLBP impact on your life? 
Patient: I don‘t know but my wife has noticed that probably my sex life has been 
affected because I hardly do it anymore because of the pain and all the surroundings that 
goes with it. So I would say that activity wise I don‘t do much of sport, or social life. 
Like I said I don‘t go out. I go to snooker club to watch my friends play and if I feel well 
enough then I take part. You know I don‘t go to pubs, so I use it as a social place. So I go 
there every Saturday four o‘clock to half seven. But I don‘t go to pubs. I don‘t go to 
clubs. 
Interviewer: Is that because of your pain? 
Patient: Yes it‘s because of my pain of course. There are a lot of other things that go with 
that. I can‘t afford it. That‘s the main thing. You know I‘m not working but even when I 
was working I couldn‘t afford it because of other things in life. You know I‘ve got a 
baby which is 3 years old, you know, I‘ve got family, so its very hard when you earn 
£800. You know by the time you pay all your bills there‘s nothing left. But as far as 
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activities are concerned, I don‘t do any sport. I walk whenever I can, that‘s the only thing 
I can do, or try to do. That‘s the advice is to keep moving. I discovered that sitting down 
doesn‘t help at all. You know by the time you get your blood circulation going again, 
you‘re tired anyway. So I would rather keep moving until I drop. 
Interviewer: Right, and how about the impact on your family? 
Patient: Well my family is in Libya. We only socialise with my wife‘s family or my 
friends. My family know about my back problem from a long time ago, about years ago.  
My mum and my dad are nearly 90 years, and they have their own problems. So 
whenever they ask me I just say I am fine. Because they have their own problems. When 
I ask them my mum say, she‘s got bad back, bad knees. I understand it you know 
because of the age. So I tend not to really worry them with more worries. I mean now 
they know I have been suffering with a bad back, and I‘ve been off work. Cause you 
know, I had to tell them in the end because I couldn‘t just pretend. And they knew about 
my wife‘s condition but whenever they ask, I say yes I‘m fine. Have you been back to 
work? Yes, yes, I would say. To give them less worries and I wouldn‘t say it affects my 
families, because it affects me.  
Interviewer: How about your self esteem? 
Patient: Well when you‘re not working, your not mixing, the brain tends to get less 
active. So I don‘t know I always think that my self esteem is not affected by this. You 
know I have highs and lows. Some days you feel great, the next thing you feel down. 
Back pain give you an uncertainty for the future – you don‘t know if you‘re gonna get fit 
again or whether you will be doing this and that. And everybody has an ambition, you 
know, try to do better, try to improve their lives you know. In that respects yeah, it 
probably affects my self esteem, and my confidence. On the other hand I would say no. 
Maybe I am being stubborn but that‘s probably something, you know it keeps me 
thinking no no, it shouldn‘t affect me, why should it? So, I try to think, I don‘t want to be 
affected by this or by anything.  
Interviewer: How about trust and confidence in the clinicians? 
Patient: I just leave it to them. My problem is in their hands and I leave it up to them to 
come up with a solution. So far, I‘ve been told that this is it, you know, you do this you 
do that. Like with the physiotherapy, I‘ve been advised to do my exercises with the view 
to it improving my quality of life. Its true, its been improving. Like I said when my back 
pain started it was a big pain down to my leg but now its moving back to the low part of 
my back. So, yeah I do trust them. But it‘s a slow process of course. It‘s frustrating 
sometimes. By the time I see my GP and by the time he referred me, I was doing nothing 
for about 3 months, until I got an appointment with the consultant. I was hoping that they 
would take up to date x-rays and MRI scans, but they went on the past MRI which was 
done 10 years ago. So, my life is in their hands basically. I can‘t condemn them because 
they know what they‘re doing. But I can‘t say its great because I‘m not well yet. But I 
can‘t blame them, because it‘s my problem and I understand that. It‘s my problem. I 
would like, or I would hope that things can be done faster and quicker, for my sake.  
Interviewer: What treatments are you taking again? 
Patient: Pain killers 
Interviewer: How often do you take them? 
Patient: Its one tablet each. I was on two for pain killers at one stage and my doctor said 
two of each is okay. But I hate taking medication. Just from being young, whenever I 
had headaches, whatever, even in my teen times, even if I had hangover from drinking or 
something I try to sleep it off. You know, try and avoid chemicals really. You know try 
and sleep it off. So, being on tablets for the last 11 months, it‘s not something that I like 
 Page 373 of 458 
to do but if it helps taking them. I take them but now and again if I feel okay I don‘t take 
them just to get it out of my system. I don‘t want to rely on medication basically. 
Interviewer: Do you take your medication as recommended by your doctors? 
Patient: Yes. But I told my GP if I feel okay I don‘t want to take them, and he said yeah, 
just take them when you need them. I am worried about dependency. I don‘t want to rely 
on them. I mean just before Xmas I saw the physiotherapist who though my headaches 
were from my medication. So we left them out for a couple of weeks. Unfortunately, the 
pain I am experiencing in my head were not from my medication. During that time, I had 
to put up with a lot of pain in my back. I had the pain in my back but I tend not take 
anything. I smoke, so I just go out and whenever I feel really, you know have a cigarette 
just to give it a chance to help the problem. So, I would like to find out why this has all 
occurred and I will see my GP, and hopefully he will investigate the pain more. 
Interviewer: Are there any benefits of taking medication? 
Patient: Yes I have less pain. 
Interviewer: Does CLBP medications meet your expectations? 
Patient: Well, I was expecting to be pain free. But what I‘ve learned from the past 6-7 
months is that once your there, you can never be free from the pain so you might as well 
just learn to manage it. So that‘s what I‘m doing on a daily basis. If I‘m feeling bad I 
tend to just do less. 
Interviewer: Have your expectations been met? 
Patient: Not yet. Because you move from one thing to another. You start with my back, 
then my neck, then I have a headache. It‘s a very weird headache, its not like I can take a 
tablet and it will go away. When I shake my head I get a very painful sensation, and in 
the last 2 weeks I‘ve started experiencing pain around the back of my eye. So I don‘t 
know whats that. Whether its to do with my back or something completely different. So I 
am still hoping to get back to normal. You know at some stage I will be fully 
functioning, and go back to work, and just do normal things like every body else. I will 
never be 20 again, I‘m nearly 48. But I expect to be a good healthy 48, you know at 
some stage I expect to be healthy and able to go back to work again.   
Interviewer: Do you experience any side effects from your CLBP medication? 
Patient: Like I said sometimes it makes me go to the bathroom, sometimes I have light 
diarrhoea, or the other one, constipation. I think it‘s the body getting used to the tablet 
but apart from that nothing abnormal. 
Interviewer: Are there any disadvantages to taking the medication? 
Patient: I just close my eyes and swallow them. Basically, try and do it as quickly as 
possible. Because of the pain you know I just want to get it over with.  
Interviewer: What does satisfaction with treatment mean to you? 
Patient: Satisfaction with treatment means when I am 100% satisfied with my body. Like 
I said because the pain has been there a long time, and its probably going to be there for 
the rest of my life. So, I don‘t expect satisfaction to me is just, going back to work, 
feeling fit, I can do daily things, you know daily activities, it doesn‘t have to be 
something extreme. You know I‘m not going to do a bungee jump, or something like 
that, I don‘t expect to do something like that. My satisfaction is just going about doing 
my daily life as normal as possible. 
Interviewer: Okay, and what does dissatisfaction with treatment mean to you? 
Patient: If my back collapses totally, then I would go back to square one. Like last 
January then that would be really disappointing. I don‘t want to go back to that stage, 
because that was severe pain because that would be my worse nightmare. I would be 
very dissatisfied if I get to that stage. That‘s something I don‘t even want to think about 
it. 
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Interviewer: Okay and are you satisfied or dissatisfied with your treatment?  
Patient: I cant say otherwise. They do their best. They can only go so far with the 
treatment with any illness. You know they‘re doing there best. I totally understand that. I 
would have liked to do more physiotherapy because it gives me the motivation to do 
more or try harder. So I would like to carry on with that but I will need to ask my GP. 
You know I can understand that they have probably had enough of my face being around 
for a couple of months. So, yes I am satisfied. 
Interviewer: Okay, and is there anything else you would like to share with me? 
Patient: I think we covered a lot. But I would say that everyone has different opinions 
about how to express their pain and their condition. I would say that probably my 
condition is worse than a lot of people. But when I seen some people, I thought, still I 
could move about. So, seeing other people helps you to have a wider knowledge of the 
problem and it shows you it‘s not the end, there is always a light at the end of the tunnel. 
You know there is always room for improvement there. 
Interviewer: Right well thank you for that.  
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APPENDIX H: Draft CLBP Treatment Satisfaction Questionnaire 
 
This questionnaire asks for your views about your back pain and your treatment. Please read the 
following statements carefully and then place a circle around the most appropriate number that applies to 
you. If there are any statements you do not feel comfortable responding to, please feel free to miss them 
out.  
 
1. ABOUT YOUR BACK PAIN 
 
a. In general, how do you rate your health? 
 1 2 3 4 5 
 Excellent Very Good Good Fair poor 
  
b. How much back pain do you have right now? 
 No 
pain 
        Severe 
Pain 
 1 2 3 4 5 6 7 8 9 10 
           
c.  How much back pain have you had in the last 24 hours? 
 No 
pain 
        Severe 
Pain 
 1 2 3 4 5 6 7 8 9 10 
           
d.  How much back pain have you had in the last week? 
 No 
pain 
        Severe 
Pain 
 1 2 3 4 5 6 7 8 9 10 
           
 
2. SYMPTOMS OF BACK PAIN 
 
In the last 7 days 
how much of a 
problem were the 
following symptoms: 
Please circle one number only for each side effect 
NO YES I had this side effect and it was…. 
I did not 
have this 
symptom 
Not a 
problem 
A little bit of 
a problem 
A 
problem 
A big 
problem 
A severe 
problem 
a. Pain in back 0 1 2 3 4 5 
b. Pain in legs 0 1 2 3 4 5 
c. Pins and needles 0 1 2 3 4 5 
d. Numbness 0 1 2 3 4 5 
e. Stiffness 0 1 2 3 4 5 
 
3. ABOUT YOUR MEDICAL CARE 
 
During the last 7 days, how do you rate 
the following statements? 
Strongly 
agree 
Agree Not sure Disagree Strongly 
disagree 
a. My doctors did not know what was 
wrong with me 
1 2 3 4 5 
b. I was misdiagnosed 1 2 3 4 5 
c. I was involved in treatment 
decisions 
1 2 3 4 5 
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4. INFORMATION PROVIDED TO YOU ABOUT BACK PAIN AND TREATMENT 
 
How much information would you 
have liked to have received about 
the following: 
More A little 
more 
I was happy 
with the level 
of information 
provided 
A little 
less 
None 
a. My condition or injury 1 2 3 4 5 
b. The causes of my back pain 1 2 3 4 5 
c. Treatment options available 
(apart from back pain 
medication) 
1 2 3 4 5 
d. Back pain medications 1 2 3 4 5 
e. The potential side effects of back 
pain medications 
1 2 3 4 5 
f. Posture and positioning 1 2 3 4 5 
g. Goal setting 1 2 3 4 5 
h. Pacing (taking things gradually) 1 2 3 4 5 
i. Exercise 1 2 3 4 5 
j. Injections 1 2 3 4 5 
 
5. YOUR HEALTH AND WELL-BEING 
 
During the last 7 days, to what 
extent has your back pain interfered 
with your regular daily activities? 
All of the 
time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I cut down on the amount of 
time I spent on tasks 
1 2 3 4 5 
b. I was limited in the type of tasks 
I could do 
1 2 3 4 5 
c. I stopped doing my everyday 
tasks 
1 2 3 4 5 
d. I stopped doing tasks I wanted to 
do 
1 2 3 4 5 
e. I stopped doing sports 1 2 3 4 5 
 
During the last 7 days, to what 
extent has your back pain interfered 
with your regular work? 
All of the 
time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I went to work 1 2 3 4 5 
b. I was unable to work due to my 
physical limitations 
1 2 3 4 5 
c. It was difficult to be positive at 
work 
1 2 3 4 5 
 
During the last 7 days, to what extent 
has your back pain interfered with 
your physical functioning? 
All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I was able to do physical activities 1 2 3 4 5 
b. I was unable to walk  1 2 3 4 5 
c. I had poor balance 1 2 3 4 5 
d. I leaned on one side 1 2 3 4 5 
e. I could bend down 1 2 3 4 5 
f. It was difficult to keep standing 1 2 3 4 5 
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During the last 7 days, to what extent 
has your back pain interfered with 
your social activities? 
All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I went out 1 2 3 4 5 
b. I socialised 1 2 3 4 5 
 
During the last 7 days, to what extent 
has your back pain interfered with 
your self-confidence? 
All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I planned before I did things 1 2 3 4 5 
b. I was cautious in everything I did 1 2 3 4 5 
c. I had low belief in my abilities 1 2 3 4 5 
d. I was scared to do too much 1 2 3 4 5 
e. I had low self esteem 1 2 3 4 5 
 
During the last 7 days, to what extent 
has your back pain interfered with 
your appearance? 
All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I felt I gained weight 1 2 3 4 5 
b. Slouching was more comfortable 1 2 3 4 5 
c. I was unable to brush/comb my 
hair 
1 2 3 4 5 
d. I had difficulty getting dressed 1 2 3 4 5 
e. I was not interested in my 
appearance 
1 2 3 4 5 
f. I was embarrassed about my 
image 
1 2 3 4 5 
 
During the last 7 days, to what extent 
has your back pain interfered with 
your mood? 
All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I was sad 1 2 3 4 5 
b. I was irritable 1 2 3 4 5 
c. I was frustrated 1 2 3 4 5 
d. I felt tired 1 2 3 4 5 
e. I was annoyed 1 2 3 4 5 
f. I did not want to do anything 1 2 3 4 5 
g. I could not cope with the pain 1 2 3 4 5 
h. I felt life was not worth living 1 2 3 4 5 
i. I felt depressed 1 2 3 4 5 
k. I was anxious 1 2 3 4 5 
l. I felt uncertain of the future 1 2 3 4 5 
 
During the last 7 days, to what extent 
has your back pain interfered with 
your sleep? 
All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I did not sleep well 1 2 3 4 5 
b. It was difficult to get comfortable 
to get to sleep 
1 2 3 4 5 
c. I tossed and turned in my sleep 1 2 3 4 5 
d. I woke up in the night 1 2 3 4 5 
e. I had an ache in my back when I 
woke up 
1 2 3 4 5 
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During the last 7 days, to what extent 
has your back pain interfered with 
your relationships? 
All of the 
time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None 
of the 
time 
a. I did not want anyone near me 1 2 3 4 5 
b. I was interested in relationships 1 2 3 4 5 
c. I did not want to burden others 
with my problems 
1 2 3 4 5 
d. I tried not to worry my family 1 2 3 4 5 
e. Sex was very uncomfortable 1 2 3 4 5 
f. I did not have sex 1 2 3 4 5 
g. I could not relax with my partner 1 2 3 4 5 
h. My partner was frustrated 1 2 3 4 5 
i. My partner felt guilty 1 2 3 4 5 
j. My partner treated me as fragile 1 2 3 4 5 
k. People around me were 
sympathetic 
1 2 3 4 5 
l. People thought I was faking it 1 2 3 4 5 
m. People around me did not 
understand 
1 2 3 4 5 
 
 
6. ABOUT YOUR CURRENT TREATMENT 
During the last 7 days, how do you 
rate the following statements? 
Strongly 
agree 
Agree Not sure Disagree Strongly 
disagree 
a. My back pain medication is 
helpful to me 
1 2 3 4 5 
b. My back pain medication 
prevents future problems 
1 2 3 4 5 
c. My back pain medication 
enables me to be independent 
(carry out everyday activities) 
1 2 3 4 5 
d. By taking back medication, I felt 
out of control 
1 2 3 4 5 
e. I altered the amount of back pain 
medication I took 
1 2 3 4 5 
 
During the last 7 days, how do you 
rate the following statements? 
Strongly 
agree 
Agree Not sure Disagree Strongly 
disagree 
a. I set realistic goals  1 2 3 4 5 
b. I remembered to do my exercises 1 2 3 4 5 
c. I paced my activities 1 2 3 4 5 
 
 
7. SIDE EFFECTS FROM MEDICATION 
Because of your back 
pain medication, in 
the last 7 days how 
much of a problem 
were the following: 
Please circle one number only for each side effect 
NO YES I had this side effect and it was…. 
I did not 
have this 
side effect 
Not a 
problem 
A little 
bit of a 
problem 
A 
problem 
A big 
problem 
A severe 
problem 
a. Loss of appetite 0 1 2 3 4 5 
b. Weight gain 0 1 2 3 4 5 
c. Inability to 
concentrate 
0 1 2 3 4 5 
d. Drowsiness 0 1 2 3 4 5 
e. Nausea 0 1 2 3 4 5 
f. Constipation 0 1 2 3 4 5 
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Because of your back 
pain medication, in 
the last 7 days how 
much of a problem 
were the following: 
Please circle one number only for each side effect 
NO YES I had this side effect and it was…. 
I did not 
have this 
side effect 
Not a 
problem 
A little 
bit of a 
problem 
A 
problem 
A big 
problem 
A severe 
problem 
g. Diarrhoea 0 1 2 3 4 5 
h. Stomach aches 0 1 2 3 4 5 
i. Heartburn 0 1 2 3 4 5 
j. Inability to sleep 0 1 2 3 4 5 
 
8. SATISFACTION WITH CURRENT MEDICATION AND CARE 
In the last 7 days, how satisfied or 
dissatisfied were you with the 
following: 
Very 
satisfied 
Satisfied Neither  Dissatisfied Very 
Dissatisfied 
a. The care provided for my back 
pain 
1 2 3 4 5 
b. The communication between 
myself and health professionals 
regarding my back pain 
medication 
1 2 3 4 5 
c. The information provided 
about the treatment options 
1 2 3 4 5 
d. The information provided 
about the possible side effects 
from my back pain medication 
1 2 3 4 5 
e. The form of administration 
(e.g. tablet, injection, patch) of 
my back pain medication 
1 2 3 4 5 
f. The amount of medication 
prescribed 
1 2 3 4 5 
g. The amount of time taken to 
take my back pain medication 
1 2 3 4 5 
h. The way health professionals 
have dealt with the side effects 
of my back pain medication 
1 2 3 4 5 
 
9. MODE OF ADMINISTRATION 
 
How is your back pain medication administered? Please check () all that apply and complete the 
relevant sections. 
a. Orally (e.g. tablet or 
syrup) 
 If yes, go to section A 
b. Injections  If yes, go to section 10 
c. Patch  If yes, go to section 10 
 
 
SECTION A: ORAL BACK PAIN MEDICATIONS 
During the last 7 days, how do you 
rate the following statements? 
Strongly 
agree 
Agree Not sure Disagree Strongly 
disagree 
a. My oral back pain medication is 
difficult to swallow 
1 2 3 4 5 
b. My oral back pain medication 
leaves an unpleasant taste in 
mouth 
1 2 3 4 5 
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10. ADDITIONAL COMMENTS you would like to add about your experiences of treatment: 
 
 
 
 
 
 
Thank you for taking time to fill in this questionnaire 
Patient # ________ (1-10)    Date of interview ____________  
Gender   ________ (M/F)      
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APPENDIX I: Cognitive Debriefing Guide 
 
 
 
Patient Satisfaction and Dissatisfaction with Treatments in 
Chronic Low Back Pain (CLBP) 
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COGNITIVE DEBRIEFING 
Chronic Low Back Pain (CLBP) Treatment Satisfaction Questionnaire 
 
 
In order to assess the clarity, comprehension and appropriateness of wording in the 
questionnaire it will be tested on patients.  
 
The aim of this cognitive debriefing is to: 
 
1) Identify questions which are problematic 
2) Determine reason(s) why 
3) Record the solutions proposed  
4) Determine the relevance of each question to the patient. 
 
 
The interview should be conducted as follows: 
 
 
General impression 
Enquire about the participant‘s general feeling about the questionnaire 
 
1. What is your overall opinion about the questionnaire? 
 Easy/ difficult to understand? 
 Clear/ not clear? 
 Easy/ difficult to answer? 
 Length? 
 
2. What is your opinion about the instructions? 
 
3. What is your opinion about the length of the instructions? 
- PROBE: Are they long enough?  Are they too detailed?   
 
4. What is your opinion about the length of the questionnaire? 
 
5. Would you add anything?  What?  Why? 
 
6. Would you delete anything?  What?  Why? 
 
7. Are there any questions that are unclear?  Which ones?  Why? 
 
8. When you completed the questionnaire, how far back were you thinking?  
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9. What do you think of the way the questionnaire is laid out? 
 Too long?   
 Too repetitive? 
 Is it clear how you answer the questions?   
 Did you find it confusing at all? 
 Would you lay out the questionnaire differently at all?   
o How? 
 
10. Do you think the answer choices are appropriate? 
 Would you prefer there to be more or less answer choices, or is the 
number about right? 
 Did you think the length of the description for each answer choice is 
appropriate?  
 Did you think the descriptions for each answer choice are appropriate 
and relevant? 
 
  
3 - Specific questions 
 
 Read each question to the participant one at a time. 
 (remind the participant that we are not interested in his/her responses but in the 
formulation of the questions) 
 
 Check whether: 
 
 Each question was difficult to understand or to answer. If so, why? 
 
 The underlying concept is interpreted correctly i.e. there are no ambiguous wordings that 
would make more than one interpretation possible; the wording used is easily 
understandable and colloquial. 
 
 The participant would ask the question another way. 
 
 The response choices are clear and consistent with the question. 
 
 
The aim of the cognitive debriefing is to produce a version of the questionnaire that is clear, 
comprehensive and relevant to all participants receiving treatment for CLBP. 
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COGNITIVE DEBRIEFING FORM 
 
 
Age: ___________ 
 
Sex: _____________             
 
Time to complete the questionnaire: __________________________ 
 
 
 
General Impression 
 
 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
__________________  
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Did you have difficulty 
understanding the title? 
Are there words that you find difficult to 
understand? 
How would you have 
worded the title? 
Is there anything missing in the title? 
Title: 
 
 
 
 
    
 
 
 
Are the instructions clear & 
comprehensive? 
Are there any words/ terms that patients 
may find difficult to understand? 
How would you have 
worded the 
instructions? 
Is there anything missing in the 
Instructions? 
Instructions – front 
page: 
* The following pages ask 
some questions about 
your treatment. Within 
this questionnaire 
‗treatment‘ refers to your 
current treatment for 
CLBP. 
 
* Please read each one 
and answer as honestly as 
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Are the instructions clear & 
comprehensive? 
Are there any words/ terms that patients 
may find difficult to understand? 
How would you have 
worded the 
instructions? 
Is there anything missing in the 
Instructions? 
you can without the help 
of anyone. 
* There are no right or 
wrong answers. 
* All of your answers will 
remain confidential.   
* This questionnaire will 
take about 10 minutes to 
complete. 
 
 
Your thoughts about treatment for CLBP 
 Did you have difficulty 
understanding these 
instructions? 
Are there words that you find 
difficult to understand? 
How would you 
have worded the 
instructions? 
Is there anything missing in the 
Instructions? 
_ 
Instructions at top of 
page 1: 
     
Statement before 
questions x-x: 
In general,  
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 Did you have difficulty 
understanding this 
question? 
What does it mean to you? Is it relevant to 
your situation? 
How would you have worded the 
question? 
Are the response 
choices clear and 
consistent with 
the question? 
Question 1:      
Question 2:      
Question 3:      
Question 4:      
Question 5:      
Question 6:      
Question 7:      
Question 8:      
Question 9:      
Question 10:      
Question 11:      
Question 12:      
Question 13:      
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Did you have difficulty 
understanding the 
response choices?  
What do they mean to you? Are they relevant 
to your 
situation? 
How would you have worded the response 
choices? 
- 
Response choices      
 
Impact of treatment on your daily life 
 Did you have difficulty 
understanding these 
instructions? 
 
Are there words that you find 
difficult to understand? 
How would you 
have worded the 
instructions? 
Is there anything missing in the 
Instructions? 
_ 
Statement before 
questions x-x: 
     
 
 Did you have difficulty 
understanding this 
question? 
What does it mean to you? Is it relevant to 
your situation? 
How would you have worded the 
question? 
Are the response 
choices clear and 
consistent with the 
question? 
Question 14:      
Question 15:      
Question 16:      
Question 17:      
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 Did you have difficulty 
understanding this 
question? 
What does it mean to you? Is it relevant to 
your situation? 
How would you have worded the 
question? 
Are the response 
choices clear and 
consistent with the 
question? 
Question 18:      
Question 19:      
Question 20:      
Question 21:      
Question 22:      
Question 23:      
Question 24:      
 
Remembering to take treatment for CLBP 
 Did you have difficulty 
understanding these 
instructions? 
Are there words that you find 
difficult to understand? 
How would you have 
worded the 
instructions? 
Is there anything missing 
in the Instructions? 
_ 
Statement:      
Statement before 
Question x-x 
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 Did you have difficulty 
understanding this 
question? 
What does it mean to you? Is it relevant to your 
situation? 
How would you have 
worded the question? 
Are the response choices 
clear and consistent with 
the question? 
Question 25:      
Question 26:      
Question 27:      
Question 28:      
Out of pocket costs for taking treatment for CLBP 
 Did you have difficulty 
understanding these 
instructions? 
 
Are there words that you find 
difficult to understand? 
How would you 
have worded the 
instructions? 
Is there anything missing in the 
Instructions? 
_ 
Statement before 
Questions x-x: 
     
 Did you have difficulty 
understanding this 
question? 
What does it mean to you? Is it relevant to your 
situation? 
How would you have worded the 
question? 
Are the response 
choices clear and 
consistent with the 
question? 
Question 29:      
Question 30:      
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Satisfaction with current treatment for CLBP 
 Did you have difficulty 
understanding these 
instructions? 
Are there words that you find 
difficult to understand? 
How would you 
have worded the 
instructions? 
Is there anything missing in the 
Instructions? 
_ 
Statement before 
Questions x-x: 
     
 Did you have difficulty 
understanding this 
question? 
What does it mean to you? Is it relevant to your 
situation? 
How would you have worded the 
question? 
Are the response 
choices clear and 
consistent with the 
question? 
Question 31:      
Question 32:      
Question 33:      
Question 34:      
Question 35:      
Question 36:      
Question 37:      
Question 38:      
Question 39:      
Question 40:      
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Treatment preferences/ trade-offs 
 Did you have difficulty 
understanding these 
instructions? 
Are there words that you find 
difficult to understand? 
How would you 
have worded the 
instructions? 
Is there anything missing in the 
Instructions? 
_ 
Statement before 
Question 41: 
     
 
 
Did you have difficulty 
understanding this 
question? 
What does it mean to you? Is it relevant to your 
situation? 
How would you have worded the 
question? 
Are the response 
choices clear and 
consistent with 
the question? 
Question 41:      
Are there any  
questions/ areas 
missing from the 
questionnaire in 
your opinion? 
 
 
 
 
 
 
 
 
 
 
List here: 
 
.. 
.. 
.. 
.. 
.. 
.. 
 
End of interview. 
   
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APPENDIX J: Revised CLBP Treatment Satisfaction Questionnaire 
This questionnaire asks for your views about your back pain and your treatment (medication and/or 
physiotherapy). Please read the following statements carefully and then place a circle around the most 
appropriate number that applies to you. If there are any statements you do not feel comfortable responding 
to, please feel free to miss them out.  
 
1. ABOUT YOUR HEALTH 
a. In general, how do you rate your health? 
 1 2 3 4 5 
 Excellent Very Good Good Fair poor 
  
b. How much back pain do you have right now? 
 No pain         Severe 
Pain 
 1 2 3 4 5 6 7 8 9 10 
           
c.  How much back pain have you had in the last 7 days? 
 No pain         Severe 
Pain 
 1 2 3 4 5 6 7 8 9 10 
           
 
2. INFORMATION PROVIDED TO YOU ABOUT BACK PAIN AND TREATMENT 
How much information would 
you have liked to have received 
about the following: 
More A little 
more 
I was happy 
with the level 
of information 
provided 
A little 
less 
None 
a. My condition or injury 1 2 3 4 5 
b. The causes of my back pain 1 2 3 4 5 
c. Back pain medications 1 2 3 4 5 
d. The potential side effects of 
back pain medications 
1 2 3 4 5 
e. Treatment options available 
(apart from back pain 
medication) 
1 2 3 4 5 
f. Posture and positioning 1 2 3 4 5 
g. Goal setting (Setting tasks 
to do) 
1 2 3 4 5 
h. Pacing (taking things 
gradually) 
1 2 3 4 5 
i. Exercise 1 2 3 4 5 
 
3. ABOUT YOUR MEDICAL CARE 
How do you rate the following statements? Strongly 
agree 
Agree Not 
sure 
Disagree Strongly 
disagree 
a. My doctors did not know what was 
wrong with me 
1 2 3 4 5 
b. I was misdiagnosed 1 2 3 4 5 
c. I was involved in treatment decisions 1 2 3 4 5 
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4. YOUR HEALTH  
During the last 7 days, to what extent has 
your back pain interfered with your 
regular daily activities? 
All of the 
time 
Most 
of the 
time 
Some of 
the time 
A little 
of the 
time 
None of 
the time 
1a. I spent less time on tasks than I would 
have liked to 
1 2 3 4 5 
1b. I was limited in the type of tasks I 
could do 
1 2 3 4 5 
1c. I stopped doing everyday tasks 1 2 3 4 5 
1d. I was unable to work  1 2 3 4 5 
1e. I went out of my home 1 2 3 4 5 
 
During the last 7 days, to what extent has 
your back pain interfered with your 
physical functioning? 
All of the 
time 
Most 
of the 
time 
Some of 
the time 
A little 
of the 
time 
None of 
the time 
2a. I was unable to walk  1 2 3 4 5 
2b. I had poor balance 1 2 3 4 5 
2c. I leaned on one side 1 2 3 4 5 
2d. I could bend down 1 2 3 4 5 
2e. It was difficult to keep standing 1 2 3 4 5 
 
During the last 7 days, to what extent has 
your back pain interfered with your 
confidence? 
All of the 
time 
Most 
of the 
time 
Some of 
the time 
A little 
of the 
time 
None of 
the time 
3a. I planned before I did things 1 2 3 4 5 
3b. I was cautious in everything I did 1 2 3 4 5 
3c. I had low beliefs in my abilities 1 2 3 4 5 
3d. I was scared to do too much 1 2 3 4 5 
3e. I had low self esteem 1 2 3 4 5 
3f. I felt uncertain of the future 1 2 3 4 5 
 
During the last 7 days, to what extent has 
your back pain interfered with your 
appearance? 
All of the 
time 
Most 
of the 
time 
Some of 
the time 
A little 
of the 
time 
None of 
the time 
4a. I slouched 1 2 3 4 5 
4b. I was unable to brush/comb my hair 1 2 3 4 5 
4c. I had difficulty getting dressed 1 2 3 4 5 
4d. I was not interested in my appearance 1 2 3 4 5 
4e. I was embarrassed about my image 1 2 3 4 5 
 
During the last 7 days, to what extent has 
your back pain interfered with your 
mood? 
All of the 
time 
Most 
of the 
time 
Some of 
the time 
A little 
of the 
time 
None of 
the time 
5a. I was sad 1 2 3 4 5 
5b. I was irritable 1 2 3 4 5 
5c. I was frustrated 1 2 3 4 5 
5d. I was tired 1 2 3 4 5 
5e. I did not want to do anything 1 2 3 4 5 
5f. I could not cope with the pain 1 2 3 4 5 
5g. I felt life was not worth living 1 2 3 4 5 
5h. I was worried 1 2 3 4 5 
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5. RELATIONSHIPS & SLEEP 
During the last 7 days, to what 
extent has your back pain interfered 
with your relationships? 
All of 
the 
time 
Most 
of the 
time 
Some 
of the 
time 
A little 
of the 
time 
None of 
the time 
Not 
applicable 
1a. I did not want anyone near me 1 2 3 4 5 6 
1b. I did not want to burden others 
with my problems 
1 2 3 4 5 6 
1c. I could not relax with my partner 1 2 3 4 5 6 
1d. People around me did not 
understand my back pain 
1 2 3 4 5 6 
1e. People thought I was faking my 
back pain 
1 2 3 4 5 6 
1f. I was sexually active 1 2 3 4 5 6 
1g. Sex was very uncomfortable 1 2 3 4 5 6 
 
 
During the last 7 days, to what 
extent has your back pain interfered 
with your sleep? 
All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of the 
time 
2a. I tossed and turned in my sleep 1 2 3 4 5 
2b. I woke up in the night 1 2 3 4 5 
2c. I had an ache in my back when I 
woke up 
1 2 3 4 5 
 
 
6. BELIEFS ABOUT YOUR BACK PAIN MEDICATION 
 
How do you rate the following 
statements? 
Strongly 
agree 
Agree Not sure Disagree Strongly 
disagree 
1a. My back pain medication is 
helpful to me 
1 2 3 4 5 
1b. My back pain medication 
prevents future problems 
1 2 3 4 5 
1c. My back pain medication 
enables me to be independent 
(carry out everyday activities) 
1 2 3 4 5 
1d. By taking back medication, I felt 
out of control 
1 2 3 4 5 
1e. I altered the amount of back pain 
medication I took 
1 2 3 4 5 
 
 
During the last 7 days, how do you 
rate the following statements? 
Strongly 
agree 
Agree Not sure Disagree Strongly 
disagree 
2a. I set realistic goals  1 2 3 4 5 
2b. I remembered to do my exercises 1 2 3 4 5 
2c. I paced my activities 1 2 3 4 5 
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7. SIDE EFFECTS FROM BACK PAIN MEDICATION 
 
Because of your back 
pain medication, in the 
last 7 days how much of 
a problem were the 
following: 
 Please circle one number only for each side effect 
 
Did Side 
Effect 
Occur? 
YES I had this side effect and it was…. 
Not a 
proble
m 
A little 
bit of a 
problem 
A 
problem 
A big 
problem 
A severe 
problem 
a. Loss of appetite  No      
 Yes → 1 2 3 4 5 
b. Weight gain  No      
 Yes → 1 2 3 4 5 
c. Inability to 
concentrate 
 No      
 Yes → 1 2 3 4 5 
d. Drowsiness  No      
 Yes → 1 2 3 4 5 
e. Nausea  No      
 Yes → 1 2 3 4 5 
f. Constipation  No      
 Yes → 1 2 3 4 5 
g. Diarrhoea  No      
 Yes → 1 2 3 4 5 
h. Stomach aches  No      
 Yes → 1 2 3 4 5 
i. Heartburn  No      
 Yes → 1 2 3 4 5 
j. Inability to sleep  No      
 Yes → 1 2 3 4 5 
 
8. SATISFACTION WITH TREATMENTS FOR BACK PAIN RELIEF 
How satisfied or dissatisfied are you 
with the following: 
Very 
satisfied 
Satisfied Neither  Dissatisfied Very 
Dissatisfied 
a. The communication between my 
doctor and I regarding my back 
pain medication 
1 2 3 4 5 
b. The information provided about 
the possible side effects from my 
back pain medication 
1 2 3 4 5 
c. The form of administration (e.g. 
tablet, injection, patch) of my 
back pain medication 
1 2 3 4 5 
d. The amount of medication 
prescribed 
1 2 3 4 5 
e. The way doctors have dealt with 
the side effects of my back pain 
medication 
1 2 3 4 5 
 
9. MODE OF ADMINISTRATION 
 
How is your back pain medication administered? Please check () all that apply and complete the 
relevant sections. 
a. Orally (e.g. tablet or 
syrup) 
 If yes, go to section A 
b. Injections  Go to section 10  
c. Patch  Go to section 10  
   
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SECTION A: ORAL BACK PAIN MEDICATIONS 
During the last 7 days, how do you 
rate the following statements? 
Strongly 
agree 
Agree Not sure Disagree Strongly 
disagree 
a. My oral back pain medication is 
difficult to swallow 
1 2 3 4 5 
b. My oral back pain medication 
leaves an unpleasant taste in 
mouth 
1 2 3 4 5 
c. My oral back pain medication 
does not work quickly 
1 2 3 4 5 
 
 
10. ADDITIONAL COMMENTS you would like to add about your experiences of treatment: 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking time to fill in this questionnaire 
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APPENDIX K: Revised Conceptual Framework of the CLBP 
Treatment Satisfaction Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Page 399 of 458 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Page 400 of 458 
 
 
 
 
4.3a. I planned before I did things 
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North Manchester Research Ethics Committee 
Room 181 
1st Floor 
Gateway House 
Piccadilly South 
Manchester 
M60 7LP 
 
Telephone: 0161 237 2166 
Facsimile: 0161 237 2383  
11 July 2007 
 
 
Miss D Rofail 
Health Psychologist Researcher, Project Manager 
Mapi Values Limited 
Adelphi Mill, Grimshaw Lane, 
Macclesfield, Bollington 
Cheshire 
SK10 5JB 
 
 
Dear Miss Rofail 
 
Full title of study: Patients' Satisfaction and Dissatisfaction with Treatments 
for Chronic Low Back Pain 
REC reference number: 07/Q1406/50 
 
Thank you for your letter of 09 July 2007, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised. 
 
Ethical review of research sites 
 
The Committee has designated this study as exempt from site-specific assessment (SSA.  
There is no requirement for [other] Local Research Ethics Committees to be informed or for 
site-specific assessment to be carried out at each site. 
 
Conditions of approval 
 
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document.  You are advised to study the conditions carefully. 
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version    Date      
Application  5.3  06 July 2007    
Investigator CV  (Lynn B      
 
APPENDIX K: Ethics Approval (Study III) 
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Investigator CV  (Miss Diana 
Rofail)  
     
Protocol  1.0 
(Appendix A)  
     
Covering Letter    06 June 2007    
Statistician Comments  (Appendix M)  01 May 2007    
Questionnaire: (Problematic Experiences of Therapy Scale (PETS) - 
Appendix I)  
       
Questionnaire: (SF-36 Health Survey - Appendix H)  1.0       
Questionnaire: (Satisfaction and Dissatisfaction with treatments for 
Chronic Low Back Pain - Appendix G)  
       
Questionnaire: (Roland and Morris - Appendix F)         
Questionnaire: (Short-Form McGill Pain Questionnaire- Appendix E)         
Questionnaire: (Appendix K)         
GP/Consultant Information Sheets  1 (Appendix 
L)  
     
Participant Information Sheet  2  11 July 2007    
Participant Consent Form: (Appendix D)  1  06 June 2007    
Response to Request for Further Information  Diana Rofail  09 July 2007    
(Statement of Indemnity arrangements - Appendix N)         
 
Research governance approval 
 
All researchers and research collaborators who will be participating in the research at NHS 
sites should apply for Research governance approval from the relevant care organisation, if 
they have not yet done so.  Research governance approval is required, whether or not the 
study is exempt from SSA.  You should advise researchers and local collaborators 
accordingly. 
 
Further guidance is available from http://www.rdforum.nhs.uk/rdform.htm. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
 
Feedback on the application process 
 
Now that you have completed the application process you are invited to give your view of 
the service you received from the National Research Ethics Service.  If you wish to make 
your views known please use the feedback form available on the NRES website at: 
 
https://www.nresform.org.uk/AppForm/Modules/Feedback/EthicalReview.aspx 
 
We value your views and comments and will use them to inform the operational 
process and further improve our service. 
 
07/Q1406/50 Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project 
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Yours sincerely 
 
 
 
 
 
Mrs Gillian Rimington 
Chair 
 
Email: stephen.tebbutt@northwest.nhs.uk 
 
Enclosures: Standard approval conditions  
 
Copy to: Professor T Wydell 
Head of Psychology 
School of Social Sciences 
Brunel University 
Uxbridge 
Middlesex UB8 3PH 
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APPENDIX L: Patient Information Sheet (Study 3) 
 
Professor Lynn B. Myers 
Centre for the Study of Health & Illness 
Psychology Group 
School of Social Sciences and Law 
Brunel University 
Uxbridge 
Middlesex, UB8 3PH 
UK 
tel: 01895 265879 
fax 01895  269724 
webpage  
http://www.brunel.ac.uk/about/acad/sssl/ssslstaff/psychstaff/lynnmyers 
 
 
JULY 2007  
 
Study Title: Patient Satisfaction and Dissatisfaction With Treatments in 
Chronic Low Back Pain (CLBP) 
 
You are being invited to participate in a research study. Before you decide, it is important for you 
to understand why the research is being done and what it will involve. Please take time to read the 
following information carefully. Talk to others about the study if you wish.  
 Part 1 tells you the purpose of this study and what will happen to you if you take part. 
 Part 2 gives you more detailed information about the conduct of the study. 
 
PART 1 
 
1. What is this study about? 
 
The purpose of this research is to investigate patients‘ experiences with treatments in chronic low 
back pain (CLBP). To do this, we need to learn more about how people with Chronic Low Back 
Pain (CLBP) feel about the effects of their condition. This study will collect information on the 
importance to you of Chronic Low Back Pain (CLBP) symptoms and their effects on you. Also, 
on whether you are satisfied or dissatisfied with the treatment you are receiving, and what aspects 
if any could be improved.  
 
This study is in part fulfilment of a PhD at Brunel University. 
 
 
 
2. Why have I been chosen? 
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You have been invited because you have a diagnosis of Chronic Low Back Pain (CLBP) and are 
receiving treatment. There will be approximately 380 participants. 
 
3. Do I have to take part? 
 
No. It is up to you to decide whether or not to take part. If you do, you will be given this 
information sheet to keep and you will be asked to sign a consent form. You are still free to 
withdraw at any time and without giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of care you receive. 
 
4. What will happen to me if I take part? 
 
If you agree to participate, you will be asked to complete seven questionnaires at three different 
time points (start of study, two weeks later, and at week 6 which is the end of the study). The 
questionnaires ask you about your experience of having Chronic Low Back Pain (CLBP), and 
your opinion about your treatments for back pain. This usually takes no longer than thirty minutes 
each time you complete the questionnaires. Your doctor will be informed that you had taken part 
in this study. 
 
5. Will I experience any risks or discomforts if I participate in the study? 
 
There are no risks to participating in this study. You are free to share your questions and concerns 
during the interview, or to speak to the interviewer following the interview. 
 
6. What if there is a problem? 
 
Any complaint about the way you have been dealt with during this study or any possible harm 
you might suffer will be addressed. The detailed information on this is given in part 2. 
 
For complaints please contact Diana Rofail on 01625 578897 or email at 
diana@rofail.freeserve.co.uk, or Professor Lynn Myers on 01895 265879. 
 
7. Will my taking part in a study be kept confidential? 
 
Yes. All the information about your participation will be kept confidential. The details are 
included in Part 2. 
 
8. What will happen if don’t want to carry on with the study? 
 
You can withdraw from the study at any time, and the information you provided can be destroyed 
immediately. 
 
9. What do I do if I have any questions? 
 
If you have any questions about the study, you may call or write to Diana Rofail, Research 
Psychologist on 01625 578897. 
 
 
 
Part 1 of this information sheet is complete.  
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If the information in Part 1 has interested you and you are considering taking part, please 
continue to read the additional information in Part 2 before making a decision. 
 
PART 2  
 
10. What if there is a problem? 
 
If you have a concern about any aspect of this study, you should ask to speak with the 
researchers who will do their best to answer your questions (Diana Rofail on 01625 
578897). If you remain unhappy and wish to complain formally, you can do this through 
the NHS Complaints Procedure. Details can be obtained from the hospital. 
 
11. Will my taking part in this study be kept confidential? 
 
If you join the study, the data collected for this study will be looked at by authorised 
persons from Brunel University. The researcher would have your name and contact 
number but these details will immediately be destroyed following the interview. Thus 
confidentiality is agreed. 
 
12. What will happen to the results of the research study? 
 
The researchers will look at the results from the interviews for themes and ideas that are 
important to people who have taken part in the study and this will form the basis of an 
intervention study to assess satisfaction with treatments in Chronic Low Back Pain 
(CLBP). The results will be documented as part of a PhD thesis, and may be published in a 
peer reviewed academic journal, and disseminated at key conferences to health 
professionals. 
 
12. Who is organising and funding the research? 
 
This study is self-funded and is being conducted in part fulfilment of a PhD at Brunel 
University. 
 
If you agree to take part, your doctor will be informed that you are participating in this 
study but s/he will not be paid for your participation. 
 
13. Who has reviewed this study? 
 
This study has been reviewed and approved by Manchester Research Ethics Committee.  
 
Thank you for taking time to read this information sheet. You will be given an 
information sheet and signed consent form to keep. 
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APPENDIX M: The Adherence Questionnaire 
 
Please read each statement clearly and mark a cross (x) for each 
statement in the appropriate box 
 Always Often Sometimes Rarely Never 
I forget 
to take 
my 
medicines 
     
I alter 
the dose 
of my 
medicines 
     
I stop 
taking 
my 
medicines 
for a 
while 
     
I decided 
to miss a 
dose 
     
I take 
less than 
instructed 
     

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APPENDIX N: The SF-36 Health Survey 
 
INSTRUCTIONS:  This survey asks for your views about your health.  This information will help keep track of 
how you feel and how well you are able to do your usual activities. 
 
Answer every question by marking the answer as indicated.  If you are unsure about how to answer a 
question, please give the best answer you can. 
 
 
 
1. In general, would you say your health is: 
 
 (circle one) 
 
    Excellent ....................................................................................................................... 1 
 
    Very good ..................................................................................................................... 2 
 
    Good ............................................................................................................................. 3 
 
    Fair ............................................................................................................................... 4 
 
    Poor .............................................................................................................................. 5 
 
 
 
 
 
2. Compared to one year ago, how would you rate your health in general now? 
 
 (circle one) 
 
    Much better now than one year ago ............................................................................ 1 
 
    Somewhat better now than one year ago .................................................................... 2 
 
    About the same as one year ago ................................................................................. 3 
 
    Somewhat worse now than one year ago ................................................................... 4 
 
    Much worse now than one year ago ............................................................................ 5  
 
 

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
 
The following questions are about activities you might do during a typical day.  Does your health now 
limit you in these activities?  If so, how much? 
 
 (circle one number on each line) 
 
 ACTIVITIES 
Yes, 
Limited 
A Lot 
Yes, 
Limited 
A Little 
No, Not 
Limited 
At All 
 a. Vigorous activities, such as running, lifting heavy objects, 
participating in strenuous sports 
1 2 3 
 b. Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf 
1 2 3 
 c. Lifting or carrying groceries 1 2 3 
 d. Climbing several flights of stairs 1 2 3 
 e. Climbing one flight of stairs 1 2 3 
 f. Bending, kneeling, or stooping 1 2 3 
 g. Walking more than a mile 1 2 3 
 h. Walking half a mile 1 2 3 
 i. Walking one hundred yards 1 2 3 
 j. Bathing or dressing yourself 1 2 3 
 
 
4. During the past 4 weeks, have you had any of the following problems with your work or other regular 
daily activities as a result of your physical health? 
 (circle one number on each line) 
 YES NO 
 a. Cut down on the amount of time you spent on work or other 
activities 
1 2 
 b. Accomplished less than you would like 1 2 
 c. Were limited in the kind of work or other activities 1 2 
 d. Had difficulty performing the work or other activities (for 
example, it took extra effort) 
1 2 
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5. During the past 4 weeks, have you had any of the following problems with your work or other regular 
daily activities as a result of any emotional problems (such as feeling depressed or anxious)? 
 
 (circle one number on each line) 
 YES NO 
 a. Cut down on the amount of time you spent on work or other activities 1 2 
 b. Accomplished less than you would like 1 2 
 c. Didn't do work or other activities as carefully as usual 1 2 
 
 
 
 
6. During the past 4 weeks, to what extent has your physical health or emotional problems interfered with 
your normal social activities with family, friends, neighbours, or groups? 
 (circle one) 
 
    Not at all ....................................................................................................................... 1 
 
    Slightly .......................................................................................................................... 2 
 
    Moderately ................................................................................................................... 3 
 
    Quite a bit..................................................................................................................... 4 
 
    Extremely ..................................................................................................................... 5 
 
 
 
7. How much bodily pain have you had during the past 4 weeks? 
 
 (circle one) 
 
    None ............................................................................................................................ 1 
 
    Very mild ...................................................................................................................... 2 
 
    Mild .............................................................................................................................. 3 
 
    Moderate ...................................................................................................................... 4 
 
    Severe.......................................................................................................................... 5 
 
    Very severe .................................................................................................................. 6 
 
 

Page 411 of 458 
8. During the past 4 weeks, how much did pain interfere with your normal work (including both work 
outside the home and housework)? 
 (circle one) 
 
    Not at all ....................................................................................................................... 1 
 
    A little bit ...................................................................................................................... 2 
 
    Moderately ................................................................................................................... 3 
 
     Quite a bit .................................................................................................................... 4 
 
    Extremely ..................................................................................................................... 5 
 
 
 
9. These questions are about how you feel and how things have been with you during the past 4 weeks.  
For each question, please give the one answer that comes closest to the way you have been feeling.  
How much of the time during the past 4 weeks - 
 (circle one number on each line) 
  
All 
of the 
Time 
 
Most 
of the 
Time 
A Good 
Bit of 
the Time 
 
Some 
of the 
Time 
A Little 
of the 
Time 
 
None 
of the 
Time 
 a. Did you feel full of life? 1 2 3 4 5 6 
 b. Have you been a very nervous 
person? 
1 2 
 
3 4 5 6 
 c. Have you felt so down in the 
dumps that nothing could cheer 
you up? 
1 2 3 4 5 6 
 d. Have you felt calm and peaceful? 1 2 3 4 5 
 
6 
 e. Did you have a lot of energy? 1 2 3 4 5 6 
 f. Have you felt downhearted and 
low? 
1 2 3 4 5 6 
 g. Did you feel worn out? 1 2 3 4 5 6 
 h. Have you been a happy person? 1 2 3 4 5 6 
 
 i. Did you feel tired? 1 2 3 4 5 6 
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10. During the past 4 weeks, how much of the time has your physical health or emotional problems 
interfered with your social activities (like visiting with friends, relatives, etc.)? 
 
 (circle one) 
 
    All of the time ............................................................................................................... 1 
  
    Most of the time ........................................................................................................... 2 
 
    Some of the time ......................................................................................................... 3 
 
    A little of the time ......................................................................................................... 4 
 
    None of the time .......................................................................................................... 5 
 
 
 
 
 
 
 
 
11. How TRUE or FALSE is each of the following statements for you? 
 
 (circle one number on each line) 
 Definitely 
True 
Mostly 
True 
Don't 
Know 
Mostly 
False 
Definitely 
False 
 a. I seem to get ill more easily than other 
people 
1 2 3 4 5 
 b. I am as healthy as anybody I know 1 2 3 4 5 
 c. I expect my health to get worse 1 2 3 4 5 
 d. My health is excellent 1 2 3 4 5 
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APPENDIX O: Problematic Experiences with Therapy Scale (PETS) 
We would like to know how easy or difficult it was for you to carry out the therapy.  
We want to find out if it was difficult in any way for you to carry out at home, and if 
so, what difficulties were and how often they prevented you from practicing the 
techniques you have learnt.  Please circle the most appropriate response. 
Problems due to symptoms 
1 
I had to skip the therapy because it made 
my symptoms worse. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
2 
I was prevented from carrying out the 
therapy by severe symptoms. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
3 
I could not carry out the therapy because it 
caused more symptoms. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
Problems due to uncertainty or doubts about the therapy 
4 
I could not carry out the therapy because I 
was unsure how to do it properly. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
5 
I was unable to carry out the therapy 
because it was difficult to know what to do. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
6 
I skipped the therapy because I was not 
sure if it was helping. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
7 
I skipped the therapy because it did not 
seem relevant to my symptoms and 
problems. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
8 
I did not carry out the therapy because I 
was not convinced it was right for me. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
Practical Problems 
9 
Lack of time prevented me from carrying 
out the therapy. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
10 
It was not possible to find suitable 
opportunities to carry out the therapy. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
11 
I was too busy or tired to carry out the 
therapy. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
12 
I found it difficult to remember to carry out 
the therapy. 
Agree 
Strongly 
Agree 
Slightly 
Not Sure 
Disagree 
Slightly 
Disagree 
Strongly 
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APPENDIX P: The Short Form McGill Questionnaire 
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APPENDIX Q: The Roland and Morris Disability Questionnaire 
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APPENDIX R: Proportion of patient responding to CLBP Treatment 
Satisfaction Items 
Table 30: Proportion of Participants Responding to Items on Health and Pain 
  Recruitment Site*  
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
1a. In 
general, 
how do 
you rate 
your 
health? 
Excellent 1 1.7 0 0 0 0 4 3.3 5 2.1 
Very 
good 
14 23.7 7 15.6 0 0 39 32.0 62 26.1 
Good 26 44.1 23 51.1 1 14.3 43 35.2 96 40.3 
Fair 13 22.0 14 31.1 5 71.4 30 24.6 64 26.9 
Poor 2 3.4 1 2.2 1 14.3 6 4.9 11 4.6 
MD 3 - 5 - 0 - 2 - 10 - 
1b. 
How 
much 
back 
pain do 
you 
have 
right 
now? 
1 1 1.8 2 4.7 0 0 6 4.8 10 4.2 
2 1 1.8 7 16.3 0 0 14 11.3 22 9.2 
3 5 8.9 4 9.3 0 0 13 10.5 23 9.7 
4 12 21.4 2 4.7 0 0 19 15.3 33 13.9 
5 8 14.3 5 11.6 0 0 14 11.3 29 12.2 
6 9 16.1 6 14.0 4 57.1 21 16.9 40 16.8 
7 11 19.6 14 32.6 3 42.9 19 15.3 49 20.6 
8 6 10.7 1 2.3 0 0 15 12.1 24 10.1 
9 0 0 1 2.3 0 0 1 0.8 2 0.8 
10 3 5.4 1 2.3 0 0 2 1.6 6 2.5 
MD 3 - 7 - 0 - 0 - 10 - 
1c. 
How 
much 
back 
pain 
have 
you had 
in the 
last 7 
days? 
1 1 1.8 2 4.4 0 0 3 2.4 6 2.5 
2 1 1.8 2 4.4 0 0 6 4.9 10 4.2 
3 6 10.7 4 8.9 0 0 10 8.1 21 8.8 
4 4 7.1 7 15.6 0 0 18 14.6 29 12.1 
5 9 16.1 1 2.2 0 0 16 13.0 26 10.9 
6 9 16.1 8 17.8 1 14.3 15 12.2 34 14.2 
7 10 17.9 11 24.4 3 42.9 26 21.1 52 21.8 
8 5 8.9 6 13.3 2 28.6 20 16.3 35 14.6 
9 6 10.7 2 4.4 1 14.3 7 5.7 17 7.1 
10 5 8.9 2 4.4 0 0 2 1.6 9 3.8 
MD 3 - 5 - 0 - 1 - 9 - 
*Please note some cases were not classified by recruitment site 
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Table 31: Proportion of Participants Responding to Items on Information About Back Pain 
and Its Treatments  
  Recruitment Site*  
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Respons
e options 
n % n % n % n % n % 
2a. My 
condition or 
injury   
More 28 50 15 31.9 1 14.3 50 40.3 101 41.7 
A little 
more 
11 19.6 9 19.1 3 42.9 25 20.2 49 20.2 
I was 
happy 
with the 
level of 
informati
on 
17 30.4 22 46.8 3 42.9 40 32.3 82 33.9 
A little 
less 
0 0 1 2.1 0 0 2 1.6 7 2.9 
None 0 0 0 0 0 0 7 5.6 3 1.2 
MD 3 - 3 - 0 - 0 - 6 - 
2b. The 
causes of my 
back pain 
More 29 51.8 9 19.1 1 14.3 52 42.6 96 40 
A little 
more 
11 19.6 17 36.2 3 42.9 24 19.7 55 22.9 
I was 
happy 
with the 
level of 
informati
on 
16 28.6 19 40.4 3 42.9 38 31.1 78 32.5 
A little 
less 
0 0 2 4.3 0 0 2 1.6 4 1.7 
None 0 0 0 0 0 0 6 4.9 7 2.9 
MD 3 - 3 - 0 - 2 - 8 - 
2c. Back pain 
medications 
More 21 37.5 11 23.4 0 0 42 34.1 78 32.4 
A little 
more 
14 25.0 17 36.2 3 42.9 28 22.8 64 26.6 
I was 
happy 
with the 
level of 
informati
on 
19 33.9 16 34.0 3 42.9 47 38.2 87 36.1 
A little 
less 
1 1.8 1 2.1 0 0 2 1.6 4 1.7 
None 1 1.8 2 4.3 1 14.3 4 3.3 8 3.3 
MD 3 - 3 - 0 - 1 - 7 - 
2d. The 
potential side 
effects of 
back pain 
medications 
More 18 32.1 11 23.4 0 0 42 34.1 76 31.5 
A little 
more 
18 32.1 19 40.4 3 42.9 22 17.9 64 26.6 
I was 
happy 
with the 
level of 
informati
on 
16 28.6 15 31.9 3 42.9 54 43.9 89 36.9 
A little 
less 
2 3.6 0 0 0 0 2 1.6 4 1.7 
None 2 3.6 2 4.3 1 14.3 3 2.4 8 3.3 
MD 3 - 3 - 0 - 1 - 7 - 
2e. 
Treatment 
options 
available 
(apart from 
back pain 
medication) 
More 31 55.4 15 31.9 3 42.9 59 49.2 113 47.5 
A little 
more 
11 19.6 13 27.7 3 42.9 22 18.3 51 21.4 
I was 
happy 
with the 
level of 
informati
on 
13 23.2 19 40.4 1 14.3 31 25.8 64 26.9 
A little 
less 
1 1.8 0 0 0 0 4 3.3 6 2.5 
None 0 0 0 0 0 0 4 3.3 4 1.7 
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  Recruitment Site*  
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Respons
e options 
n % n % n % n % n % 
MD 3 - 3 - 0 - 4 - 10 - 
2f. Goal 
setting 
(Setting tasks 
to do) 
More 19 34.5 8 17.8 1 14.3 48 38.7 79 33.1 
A little 
more 
12 21.8 17 37.8 1 14.3 27 21.8 61 25.5 
I was 
happy 
with the 
level of 
informati
on 
21 38.2 16 35.6 5 71.4 46 37.1 89 37.2 
A little 
less 
0 0 3 6.7 0 0 0 0 3 1.3 
None 3 5.5 1 2.2 0 0 3 2.4 7 2.9 
MD 4 - 5 - 0 - 0 - 9 - 
2g. Posture 
and 
positioning 
More 27 48.2 12 25.5 1 14.3 50 41.0 95 39.6 
A little 
more 
14 25.0 15 31.9 3 42.9 25 20.5 59 24.6 
I was 
happy 
with the 
level of 
informati
on 
15 26.8 19 40.4 3 42.9 40 32.8 78 32.5 
A little 
less 
0 0 1 2.1 0 0 0 0 1 0.4 
None 0 0 0 0 0 0 7 5.7 7 2.9 
MD 3 - 3 - 0 - 2 - 8 - 
2h. Pacing 
(taking things 
gradually) 
More 16 29.1 10 21.3 2 28.6 39 31.5 69 28.6 
A little 
more 
16 29.1 18 38.3 0 0 23 18.5 60 24.9 
I was 
happy 
with the 
level of 
info 
21 38.2 15 31.9 5 71.4 58 46.8 102 42.3 
A little 
less 
0 0 3 6.4 0 0 0 0 3 1.2 
None 2 3.6 1 2.1 0 0 4 3.2 7 2.9 
MD 4 - 3 - 0 - 0 - 7 - 
2i. Exercise More 26 47.3 13 27.7 2 28.6 34 27.4 79 32.8 
A little 
more 
12 21.8 18 38.3 0 0 27 21.8 60 24.9 
I was 
happy 
with the 
level of 
informati
on 
16 29.1 13 27.7 5 71.4 55 44.4 89 36.9 
A little 
less 
0 0 2 4.3 0 0 4 3.2 6 2.5 
None 1 1.8 1 2.1 0 0 4 3.2 7 2.9 
MD 4 - 3 - 0 - 0 - 7 - 
*Please note some cases were not classified by recruitment site; - Not applicable 
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Table 32: Proportion of Participants Responding to Items About Your Medical Care 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
3a. My 
doctors did 
not know 
what was 
wrong with 
me 
Strongly 
agree 
10 17.9 1 2.1 0 0 29 23.8 41 17.2 
Agree 10 17.9 5 10.6 0 0 23 18.9 42 17.6 
Not sure 15 26.8 22 46.8 3 50.0 25 20.5 65 27.2 
Disagree 17 30.4 14 29.8 3 50.0 31 25.4 67 28.0 
Strongly 
disagree 
4 7.1 5 10.6 0 0 14 11.5 24 10.0 
MD 3 - 3 - 1 - 2 - 9 - 
3b. I was 
misdiagnosed 
Strongly 
agree 
5 9.1 1 2.1 0 0 19 15.6 26 10.9 
Agree 6 10.9 7 14.9 0 0 16 13.1 29 12.2 
Not sure 13 23.6 16 34.0 2 33.3 28 23.0 62 26.1 
Disagree 21 38.2 15 31.9 4 66.7 40 32.8 82 34.5 
Strongly 
disagree 
10 18.2 8 17.0 0 0 19 15.6 39 16.4 
MD 4 - 3 - 1` - 2 - 10 - 
3c. I was 
involved in 
treatment 
decisions 
Strongly 
agree 
5 9.1 2 4.3 0 0 8 6.6 17 7.1 
Agree 12 21.8 10 21.3 3 50.0 29 23.8 54 22.7 
Not sure 12 21.8 11 23.4 0 0 18 14.8 42 17.6 
Disagree 23 41.8 24 51.1 3 50.0 42 34.4 95 39.9 
Strongly 
disagree 
3 5.5 0 0 0 0 25 20.5 30 12.6 
MD 4 - 3 - 1 - 2 - 10 - 
 
Table 33: Proportion of Participants Responding to Items on the Impact of Back Pain on 
Regular Activities 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.1a. I 
spent less 
time on 
tasks than I 
would have 
liked to 
All of the 
time 
12 21.1 6 12.8 1 14.3 14 11.7 36 15.1 
Most of 
the time 
17 29.8 12 25.5 3 42.9 32 26.7 65 27.2 
Some of 
the time 
19 33.3 18 38.3 3 42.9 37 30.8 80 33.5 
A little of 
the time 
4 7.0 8 17.0 0 0 25 20.8 37 15.5 
None of 
the time 
5 8.8 3 6.4 0 0 12 10.8 21 8.8 
MD 2 - 3 - 0 - 4 - 9 - 
4.1b. I was 
limited in 
the type of 
tasks I 
could do 
All of the 
time 
15 26.8 6 13.3 1 14.3 17 13.9 43 18.1 
Most of 
the time 
13 23.2 14 31.1 3 42.9 36 29.5 66 27.7 
Some of 
the time 
13 23.2 15 33.3 3 42.9 36 29.5 69 29.0 
A little of 
the time 
12 21.4 3 6.7 0 0 18 14.8 34 14.3 
None of 
the time 
3 5.4 7 15.6 0 0 15 12.3 26 10.9 
MD 3 - 5 - 0 - 2 - 10 - 
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  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.1c. I 
stopped 
doing 
everyday 
tasks 
All of the 
time 
3 5.5 1 2.2 1 14.3 4 3.3 10 4.3 
Most of 
the time 
6 10.9 5 11.1 0 0 18 15.0 29 12.3 
Some of 
the time 
18 32.7 15 33.3 3 42.9 38 31.7 78 33.2 
A little of 
the time 
12 21.8 8 17.8 3 42.9 21 17.5 45 19.1 
None of 
the time 
16 29.1 16 35.6 0 0 39 32.5 73 31.1 
MD 4 - 5 - 0 - 4 - 13 - 
4.1d. I was 
unable to 
work 
All of the 
time 
5 9.3 5 11.4 3 60.0 16 13.6 31 13.5 
Most of 
the time 
3 5.6 2 4.5 0 0 11 9.3 16 7.0 
Some of 
the time 
11 20.4 14 31.8 0 0 19 16.1 45 19.7 
A little of 
the time 
7 13.0 5 11.4 2 40.0 13 11.0 28 12.2 
None of 
the time 
28 51.9 18 40.9 0 0 59 50.0 109 47.6 
MD 5 - 6 - 2 - 6 - 19  
4.1e. I 
went out of 
my home 
All of the 
time 
10 17.9 10 22.2 1 16.7 43 35.8 67 28.5 
Most of 
the time 
9 16.1 8 17.8 4 66.7 6 5.0 24 10.2 
Some of 
the time 
20 35.7 9 20.0 1 16.7 39 32.5 75 31.9 
A little of 
the time 
5 8.9 8 17.8 0 0 15 12.5 28 11.9 
None of 
the time 
12 21.4 10 22.2 0 0 17 14.2 41 17.4 
MD 3 - 5 - 1 - 4 - 13 - 
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Table 34: Proportion of Participants Responding to Items on the Impact of Back Pain on 
Physical Functioning 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.2a. I was 
unable to 
walk  
All of the 
time 
2 3.6 0 0 0 0 7 6.0 9 3.9 
Most of 
the time 
4 7.1 0 0 0 0 6 5.2 10 4.4 
Some of 
the time 
14 25.0 6 14.0 3 50.0 27 23.3 53 23.1 
A little of 
the time 
12 21.4 8 18.6 2 33.3 17 14.7 41 17.9 
None of 
the time 
24 42.9 29 67.4 1 16.7 59 50.9 116 50.7 
MD 3 - 7 - 1 - 8 - 19 - 
4.2b. I had 
poor 
balance 
All of the 
time 
2 3.5 0 0 0 0 0 0 4 1.7 
Most of 
the time 
4 7.0 0 0 1 14.3 11 9.0 18 7.6 
Some of 
the time 
15 26.3 11 25.0 3 42.9 32 26.2 62 26.1 
A little of 
the time 
13 22.8 11 25.0 2 28.6 28 23.0 56 23.5 
None of 
the time 
23 40.4 22 50.0 1 14.3 51 41.8 98 41.2 
MD 2 - 6 - 0 - 2 - 10 - 
4.2c. I 
leaned on 
one side 
All of the 
time 
3 5.4 1 2.2 1 14.3 10 8.5 19 8.1 
Most of 
the time 
6 10.7 4 8.9 0 0 20 16.9 31 13.2 
Some of 
the time 
12 21.4 11 24.4 2 28.6 27 22.9 54 23.1 
A little of 
the time 
13 23.2 10 22.2 3 42.9 22 18.6 48 20.5 
None of 
the time 
22 39.3 19 42.4 1 14.3 39 33.1 82 35.0 
MD 3 - 5 - 0 - 6 - 14 - 
4.2d. I 
could bend 
down 
All of the 
time 
14 24.6 5 11.1 3 42.9 33 27.5 55 23.2 
Most of 
the time 
10 17.5 10 22.2 0 0 25 20.8 45 19.0 
Some of 
the time 
15 26.3 12 26.7 4 57.1 32 26.7 68 28.7 
A little of 
the time 
13 22.8 12 26.7 0 0 17 14.2 43 18.1 
None of 
the time 
5 8.8 6 13.3 0 0 13 10.8 26 11.0 
MD 2 - 5 - 0 - 4 - 11 - 
4.2e. It was 
difficult to 
keep 
standing 
All of the 
time 
4 7.1 3 6.4 0 0 12 9.8 20 8.3 
Most of 
the time 
14 25.0 9 19.1 2 28.6 20 16.4 46 19.2 
Some of 
the time 
14 25.0 13 27.7 2 28.6 32 26.2 65 27.1 
A little of 
the time 
10 17.9 9 19.1 3 42.9 22 18.0 44 18.3 
None of 
the time 
14 25.0 13 27.7 0 0 36 29.5 65 27.1 
MD 3 - 3 - 0 - 2 - 8 - 
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Table 35: Proportion of Participants Responding to Items on the Impact of Back Pain on 
Confidence 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.3a. I 
planned 
before I 
did things 
All of the 
time 
11 19.6 13 27.7 0 0 27 22.5 54 22.7 
Most of 
the time 
11 19.6 8 17.0 1 14.3 10 8.3 30 12.6 
Some of 
the time 
12 21.4 5 10.6 2 28.6 26 21.7 47 19.7 
A little of 
the time 
12 21.4 16 34.0 1 14.3 30 25.0 60 25.2 
None of 
the time 
10 17.9 5 10.6 3 42.9 27 22.5 47 19.7 
MD 3 - 3 - 0 - 4 - 10 - 
4.3b. I was 
cautious in 
everything 
I did 
All of the 
time 
11 20.0 3 6.7 1 14.3 23 19.2 42 17.9 
Most of 
the time 
11 20.0 12 26.7 2 28.6 32 26.7 58 24.7 
Some of 
the time 
14 25.5 15 33.3 0 0 31 25.8 60 25.5 
A little of 
the time 
11 20.0 8 17.8 4 57.1 18 15.0 43 18.3 
None of 
the time 
8 14.5 7 15.6 0 0 16 13.3 32 13.6 
MD 4 - 5 - 0 - 4 - 13 - 
4.3c. I had 
low beliefs 
in my 
abilities 
All of the 
time 
5 8.9 3 6.5 0 0 4 3.3 14 5.9 
Most of 
the time 
11 19.6 3 6.5 1 14.3 20 16.7 36 15.2 
Some of 
the time 
11 19.6 17 37.0 0 0 34 28.3 63 26.6 
A little of 
the time 
7 12.5 9 19.6 2 28.6 21 17.5 39 16.5 
None of 
the time 
22 39.3 14 30.4 4 57.1 41 34.2 85 35.9 
MD 3 - 4 - 0 - 4 - 11 - 
4.3d. I was 
scared to 
do too 
much 
All of the 
time 
7 12.5 3 6.4 0 0 15 12.5 27 11.3 
Most of 
the time 
9 16.1 9 19.1 1 14.3 18 15.0 38 16.0 
Some of 
the time 
14 25.0 10 21.3 0 0 34 28.3 61 25.6 
A little of 
the time 
14 25.0 10 21.3 4 57.1 26 21.7 54 22.7 
None of 
the time 
12 21.4 15 31.9 2 28.6 27 22.5 58 24.4 
MD 3 - 3 - 0 - 4 - 10 - 
4.3e. I had 
low self 
esteem 
All of the 
time 
7 12.5 4 8.5 0 0 10 8.3 22 9.2 
Most of 
the time 
7 12.5 6 12.8 0 0 9 7.5 22 9.2 
Some of 
the time 
13 23.2 11 23.4 3 42.9 26 21.7 56 23.5 
A little of 
the time 
8 14.3 10 21.3 2 28.6 20 16.7 41 17.2 
None of 
the time 
21 37.5 16 34.0 2 28.6 55 45.8 97 40.8 
MD 3 - 3 - 0 - 4 - 10 - 
4.3f. I felt 
uncertain 
of the 
future 
All of the 
time 
9 16.1 7 14.9 0 0 14 11.5 32 13.3 
Most of 
the time 
8 14.3 9 19.1 0 0 19 15.6 37 15.4 
Some of 
the time 
15 26.8 6 12.8 1 14.3 33 27.0 56 23.3 
A little of 
the time 
7 12.5 8 17.0 3 42.9 17 13.9 35 14.6 
None of 
the time 
17 30.4 17 36.2 3 42.9 39 32.0 80 33.3 
MD 3 - 3 - 0 - 2 - 8 - 
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Table 36: Proportion of Participants Responding to Items on the Impact of Back Pain on 
Appearance 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.4a. I 
slouched 
All of the 
time 
7 12.5 2 4.3 0 0 17 13.9 30 12.5 
Most of 
the time 
8 14.3 9 19.1 2 28.6 17 13.9 37 15.4 
Some of 
the time 
16 28.6 12 25.5 1 14.3 30 24.6 61 25.4 
A little of 
the time 
10 17.9 7 14.9 3 42.9 21 17.2 42 17.5 
None of 
the time 
15 26.8 17 36.2 1 14.3 37 30.3 70 29.2 
MD 3 - 3 - 0 - 2 - 8 - 
4.4b. I was 
unable to 
brush/comb 
my hair 
All of the 
time 
0 0 0 0 0 0 0 0 0 0 
Most of 
the time 
3 5.5 2 4.3 0 0 6 5.0 11 4.7 
Some of 
the time 
3 5.5 4 8.5 0 0 13 10.8 20 8.5 
A little of 
the time 
4 7.3 7 14.9 4 66.7 10 8.3 26 11.0 
None of 
the time 
45 81.8 34 72.3 2 33.3 91 75.8 179 75.8 
MD 4 - 3 - 1 - 4 - 12 - 
4.4c. I had 
difficulty 
getting 
dressed 
All of the 
time 
2 3.5 2 4.3 1 14.3 1 0.8 6 2.5 
Most of 
the time 
4 7.0 1 2.1 0 0 11 9.2 17 7.1 
Some of 
the time 
9 15.8 10 21.3 2 28.6 16 13.3 38 15.9 
A little of 
the time 
14 24.6 15 31.9 4 57.1 30 25.0 63 26.4 
None of 
the time 
28 49.1 19 40.4 0 0 62 51.7 115 48.1 
MD 2 - 3 - 0 - 4 - 9 - 
4.4d. I was 
not interested 
in my 
appearance 
All of the 
time 
1 1.8 4 8.5 0 0 6 5.0 12 5.0 
Most of 
the time 
3 5.4 1 2.1 0 0 6 5.0 10 4.2 
Some of 
the time 
9 16.1 4 8.5 1 14.3 19 15.8 34 14.3 
A little of 
the time 
11 19.6 13 27.7 4 57.1 19 15.8 48 20.2 
None of 
the time 
32 57.1 25 53.2 2 28.6 70 58.3 134 56.3 
MD 3 - 3 - 0 - 4 - 10 - 
4.4e. I was 
embarrassed 
about my 
image 
All of the 
time 
3 5.4 0 0 0 0 6 5.0 9 3.8 
Most of 
the time 
2 3.6 2 4.4 0 0 5 4.2 10 4.3 
Some of 
the time 
8 14.3 6 13.3 1 14.3 19 16.0 35 14.9 
A little of 
the time 
9 16.1 16 35.6 2 28.6 21 17.6 49 20.9 
None of 
the time 
34 60.7 21 46.7 4 57.1 68 57.1 132 56.2 
MD 3 - 5 - 0 - 5 - 13 - 
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Table 37: Proportion of Participants Responding to Items on the Impact of Back Pain on 
Mood 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.5a. I was 
sad 
All of the 
time 
4 7.1 2 4.5 0 0 16 13.6 24 10.3 
Most of 
the time 
6 10.7 5 11.4 0 0 7 5.9 19 8.2 
Some of 
the time 
14 25.0 15 34.1 1 14.3 29 24.6 61 26.2 
A little of 
the time 
16 28.6 6 13.6 5 71.4 23 19.5 51 21.9 
None of 
the time 
16 28.6 16 36.4 1 14.3 43 36.4 78 33.5 
MD 3 - 6 - 0 - 6 - 15 - 
4.5b. I was 
irritable 
All of the 
time 
6 10.7 4 8.5 0 0 9 7.6 20 8.4 
Most of 
the time 
9 16.1 8 17.0 0 0 30 25.2 50 21.1 
Some of 
the time 
20 35.7 18 38.3 5 71.4 33 27.7 79 33.3 
A little of 
the time 
10 17.9 8 17.0 2 28.6 23 19.3 44 18.6 
None of 
the time 
11 19.6 9 19.1 0 0 24 20.2 44 18.6 
MD 3 - 3 - 0 - 5 - 11 - 
4.5c. I was 
frustrated 
All of the 
time 
8 14.3 0 0 0 0 11 9.1 20 8.4 
Most of 
the time 
15 26.8 17 37.0 0 0 33 27.3 67 28.2 
Some of 
the time 
13 23.2 16 34.8 4 57.1 38 31.4 74 31.1 
A little of 
the time 
13 23.2 7 15.2 3 42.9 19 15.7 42 17.6 
None of 
the time 
7 12.5 6 13.0 0 0 20 16.5 35 14.7 
MD 3 - 4 - 0 - 3 - 10 - 
4.5d. I was 
tired 
All of the 
time 
11 19.3 6 13.0 2 28.6 15 12.4 36 15.1 
Most of 
the time 
12 21.1 16 34.8 0 0 39 32.2 70 29.3 
Some of 
the time 
22 38.6 14 30.4 4 57.1 34 28.1 77 32.2 
A little of 
the time 
5 8.8 4 8.7 1 14.3 15 12.4 24 10.0 
None of 
the time 
7 12.3 6 13.0 0 0 18 14.9 32 13.4 
MD 2 - 4 - 0 - 3 - 9 - 
4.5e. I did 
not want to 
do 
anything 
All of the 
time 
1 1.8 2 4.3 0 0 8 6.7 12 5.0 
Most of 
the time 
11 19.3 7 14.9 0 0 17 14.2 37 15.5 
Some of 
the time 
15 26.3 15 31.9 0 0 34 28.3 65 27.2 
A little of 
the time 
11 19.3 11 23.4 6 85.7 32 26.7 62 25.9 
None of 
the time 
19 33.3 12 25.5 1 14.3 29 24.2 63 26.4 
MD 2 - 3 - 0 - 4 - 9 - 
4.5f. I 
could not 
cope with 
the pain 
All of the 
time 
3 5.3 0 0 0 0 8 6.7 14 5.9 
Most of 
the time 
7 12.3 1 2.1 0 0 11 9.2 19 7.9 
Some of 
the time 
13 22.8 16 34.0 1 14.3 34 28.3 66 27.6 
A little of 
the time 
16 28.1 15 31.9 3 42.9 22 18.3 56 23.4 
None of 
the time 
18 31.6 15 31.9 3 42.9 45 37.5 84 35.1 
MD 2 - 3 - 0 - 4 - 9 - 
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  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.5g. I felt 
life was 
not worth 
living 
All of the 
time 
1 1.8 2 4.3 0 0 4 3.3 9 3.8 
Most of 
the time 
4 7.1 0 0 0 0 9 7.5 14 5.9 
Some of 
the time 
7 12.5 5 10.9 0 0 16 13.3 28 11.8 
A little of 
the time 
4 7.1 10 21.7 0 0 8 6.7 22 9.3 
None of 
the time 
40 71.4 29 63.0 7 100 83 69.2 164 69.2 
MD 3 - 4 - 0 - 4 - 11 - 
4.5h. I was 
worried 
All of the 
time 
7 12.3 2 4.3 5 71.4 11 9.2 23 9.6 
Most of 
the time 
3 5.3 5 10.6 0 0 11 9.2 20 8.4 
Some of 
the time 
15 26.3 8 17.0 0 0 36 30.0 59 24.7 
A little of 
the time 
15 26.3 15 31.9 0 0 27 22.5 63 26.4 
None of 
the time 
17 29.8 17 36.2 2 28.6 35 29.2 74 31.0 
MD 2 - 3 - 0 - 4 - 9 - 
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Table 38: Proportion of Participants Responding to Items on the Impact of Back Pain on 
Relationships 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.6a. I did not 
want anyone 
near me 
All of the 
time 
3 7.3 0 0 1 20.0 5 5.4 10 5.5 
Most of 
the time 
5 12.2 6 14.6 0 0 7 7.6 18 9.9 
Some of 
the time 
9 22.0 7 17.1 0 0 28 30.4 46 25.3 
A little of 
the time 
4 9.8 11 26.8 1 20.0 20 21.7 36 19.8 
None of 
the time 
20 48.8 17 41.5 3 60.0 32 34.8 72 39.6 
MD 18 - 9 - 2 - 32 - 66 - 
4.6b. I did not 
want to 
burden others 
with my 
problems 
All of the 
time 
7 14.6 8 19.5 0 0 8 7.9 24 11.9 
Most of 
the time 
11 22.9 10 24.4 5 71.4 28 27.7 56 27.9 
Some of 
the time 
9 18.8 8 19.5 1 14.3 26 25.7 45 22.4 
A little of 
the time 
11 22.9 10 24.4 1 14.3 16 15.8 38 18.9 
None of 
the time 
10 20.8 5 12.2 0 0 23 22.8 38 18.9 
MD 11 - 9 - 0 - 23 - 47 - 
4.6c. I could 
not relax with 
my partner 
All of the 
time 
6 15.0 2 5.3 0 0 3 3.4 12 7.0 
Most of 
the time 
8 20.0 5 13.2 1 25.0 8 9.2 22 12.8 
Some of 
the time 
6 15.0 13 34.2 0 0 22 25.3 41 23.8 
A little of 
the time 
8 20.0 5 13.2 2 50.0 19 21.8 36 20.9 
None of 
the time 
12 30.0 13 34.2 1 25.0 35 40.2 61 35.5 
MD 19 - 38 - 3 - 37 - 76 - 
4.6d. People 
around me did 
not 
understand 
my back pain 
All of the 
time 
0 0 3 7.3 0 0 13 12.7 18 8.7 
Most of 
the time 
10 20 11 26.8 0 0 17 16.7 38 18.4 
Some of 
the time 
17 34.0 7 17.1 2 28.6 9 28.4 57 27.7 
A little of 
the time 
9 18.0 13 31.7 2 28.6 20 19.6 44 21.4 
None of 
the time 
14 28.0 7 17.1 3 42.9 23 22.5 49 23.8 
MD 9 - 9 - 0 - 22 - 42 - 
4.6e. People 
thought I was 
faking my 
back pain 
All of the 
time 
2 4.4 2 4.9 0 0 6 6.5 11 5.8 
Most of 
the time 
2 4.4 3 7.3 0 0 14 15.2 19 9.9 
Some of 
the time 
9 20.0 9 22.0 2 28.6 19 20.7 39 20.4 
A little of 
the time 
4 8.9 8 19.5 5 71.4 8 8.7 22 11.5 
None of 
the time 
28 62.0 19 46.3 0 0 45 48.9 100 52.4 
MD 14 - 9 - 0 - 32 - 57 - 
4.6f. I was 
sexually 
active 
All of the 
time 
17 40.5 10 35.7 3 50.0 28 36.4 59 37.8 
Most of 
the time 
12 28.6 5 17.9 2 33.3 14 18.2 33 21.2 
Some of 
the time 
11 26.2 6 21.4 1 16.7 29 37.7 49 31.4 
A little of 
the time 
2 4.8 3 10.7 0 0 4 5.2 9 5.8 
None of 
the time 
0 0 4 14.3 0 0 2 2.6 6 3.8 
MD 17 - 22 - 1 - 47 - 92 - 
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  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.6g. Sex was 
very 
uncomfortable 
All of the 
time 
3 8.6 1 3.1 0 0 4 6.3 9 6.6 
Most of 
the time 
5 14.3 5 15.6 1 25.0 10 15.9 21 15.4 
Some of 
the time 
11 31.4 5 15.6 1 25.0 8 12.7 26 19.1 
A little of 
the time 
7 20.0 11 34.4 2 50.0 13 20.6 33 24.3 
None of 
the time 
9 25.7 10 31.3 0 0 28 44.4 47 34.6 
MD 24 - 18 - 3 - 61 - 112 - 
 
Table 39: Proportion of Participants Responding to Items on the Impact on Sleep 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
4.7a. I 
tossed and 
turned in 
my sleep 
All of the 
time 
10 17.5 8 17.8 2 28.6 26 21.3 47 19.7 
Most of 
the time 
16 28.1 15 33.3 3 42.9 37 30.3 74 31.0 
Some of 
the time 
17 29.8 12 26.7 2 28.6 26 21.3 61 25.5 
A little of 
the time 
3 5.3 7 15.6 0 0 13 10.7 23 9.6 
None of 
the time 
11 19.3 3 6.7 0 0 20 16.4 34 14.2 
MD 2 - 5 - 0 - 2 - 9 - 
4.7b. I 
woke up in 
the night 
All of the 
time 
12 21.1 9 19.1 2 28.6 27 22.5 52 21.8 
Most of 
the time 
12 21.1 15 31.9 4 57.1 33 27.5 66 27.6 
Some of 
the time 
18 31.6 9 19.1 1 14.3 28 23.3 58 24.3 
A little of 
the time 
7 12.3 9 19.1 0 0 18 15.0 36 15.1 
None of 
the time 
8 14.0 5 10.6 0 0 14 11.7 27 11.3 
MD 2 - 3 - 0 - 4 - 9 - 
4.7c. I had 
an ache in 
my back 
when I 
woke up 
All of the 
time 
26 46.4 14 30.4 4 57.1 48 39.3 95 39.7 
Most of 
the time 
10 17.9 12 26.1 1 14.3 28 23.0 53 22.2 
Some of 
the time 
12 21.4 10 21.7 2 28.6 27 22.1 52 21.8 
A little of 
the time 
4 7.1 8 17.4 0 0 9 7.4 22 9.2 
None of 
the time 
4 7.1 2 4.3 0 0 10 8.2 17 7.1 
MD 3 - 4 - 0 - 2 - 9 - 
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Table 40: Proportion of Participants Responding to Items on Beliefs About Back Pain 
Medication 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No.r 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
6.1a. My 
back pain 
medication is 
helpful to me 
Strongly 
agree 
3 5.7 2 4.8 0 0 3 2.5 3 3.9 
Agree 7 13.2 5 11.9 1 14.3 10 8.5 25 11.0 
Not sure 19 35.8 9 21.4 1 14.3 38 32.2 69 30.3 
Disagree 19 35.8 24 57.1 4 57.1 46 39.0 96 42.1 
Strongly 
disagree 
5 9.4 2 4.8 1 14.3 21 17.8 29 12.7 
MD 6 - 8 - 0 - 6 - 20 - 
6.1b. My 
back pain 
medication 
prevents 
future 
problems 
Strongly 
agree 
9 17.0 6 15.0 2 28.6 27 22.5 46 20.2 
Agree 17 32.1 10 25.0 4 57.1 34 28.3 67 29.4 
Not sure 23 43.4 19 47.5 1 14.3 39 32.5 85 37.3 
Disagree 3 5.7 3 7.5 0 0 18 15.0 24 10.5 
Strongly 
disagree 
1 1.9 2 5.0 0 0 2 1.7 6 2.6 
MD 6 - 10 - 0 - 4 - 20 - 
6.1c. My 
back pain 
medication 
enables me to 
be 
independent 
(carry out 
everyday 
activities) 
Strongly 
agree 
3 5.7 1 2.4 0 0 5 4.2 9 4.0 
Agree 17 32.1 4 9.8 0 0 35 29.7 58 25.7 
Not sure 18 34.0 12 29.3 1 16.7 31 26.3 64 37.6 
Disagree 13 24.5 22 53.7 5 83.3 42 35.6 85 37.6 
Strongly 
disagree 
2 3.8 2 4.9 0 0 5 4.2 10 4.4 
MD 6 - 9 - 1 - 6 - 22 - 
6.1d. By 
taking back 
medication, I 
felt out of 
control 
Strongly 
agree 
2 3.8 1 2.3 1 14.3 8 6.7 12 5.2 
Agree 7 13.5 4 9.3 1 14.3 18 15.0 32 13.9 
Not sure 10 19.2 13 30.2 0 0 25 20.8 50 21.7 
Disagree 20 38.5 13 30.2 2 28.6 43 35.8 81 35.2 
Strongly 
disagree 
13 25.0 12 27.9 3 42.9 26 21.7 55 23.9 
MD 7 - 7 - 0 - 4 - 18 - 
6.1e. I altered 
the amount 
of back pain 
medication I 
took 
Strongly 
agree 
2 3.9 4 9.8 0 0 17 14.2 24 10.7 
Agree 21 41.2 16 39.0 4 57.1 46 38.3 89 39.6 
Not sure 7 13.7 6 14.6 0 0 13 10.8 27 12.0 
Disagree 12 23.5 11 26.8 3 42.9 30 25.0 58 25.8 
Strongly 
disagree 
9 17.6 4 9.8 0 0 14 11.7 27 12.0 
MD 8 - 9 - 0 - 4 - 23 - 
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Table 41: Proportion of Participants Responding to Items on Adherence 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
I set realistic 
goals  
Strongly 
agree 
0 0 2 4.3 1 14.3 3 2.5 6 2.6 
Agree 11 20.8 6 13.0 2 28.6 9 7.4 30 12.8 
Not sure 11 20.8 16 34.8 0 0 20 16.4 47 20.0 
Disagree 27 50.9 18 39.1 1 14.3 73 59.8 121 51.5 
Strongly 
disagree 
4 7.5 4 8.7 3 42.9 17 13.9 31 13.2 
MD 6 - 4 - 0 - 2 - 13 - 
I remembered 
to do my 
exercises 
Strongly 
agree 
4 7.8 0 0 1 14.3 5 4.1 11 4.7 
Agree 9 17.6 9 19.6 0 0 22 18.0 42 18.0 
Not sure 9 17.6 10 21.7 0 0 11 9.0 30 12.9 
Disagree 19 37.3 21 45.7 4 57.1 53 43.4 100 42.9 
Strongly 
disagree 
10 19.6 6 13.0 2 28.6 31 25.4 50 21.5 
MD 8 - 4 - 0 - 2 - 15 - 
I paced my 
activities 
Strongly 
agree 
0 0 1 2.1 1 14.3 5 4.1 7 3.0 
Agree 8 15.4 4 8.5 0 0 15 12.3 31 13.2 
Not sure 7 13.5 3 6.4 0 0 10 8.2 20 8.5 
Disagree 32 61.5 29 61.7 3 42.9 71 58.2 138 58.7 
Strongly 
disagree 
5 9.6 10 21.3 3 42.9 21 17.2 39 16.6 
MD 7 - 3 - 0 - 2 - 13 - 
 
Table 42: Proportion of Participants Responding to Items on Problems with Side Effects 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Loss of 
appetite 
Not a 
problem 
0 0 0 0 0 0 0 0 0 0 
A bit of a 
problem 
1 5.6 0 0 0 0 5 13.9 7 10.1 
A 
problem 
1 5.6 2 18.2 0 0 2 5.6 5 7.2 
A big 
problem 
9 50.0 5 45.5 0 0 15 41.7 30 43.5 
A severe 
problem 
7 38.9 4 36.4 2 100 14 38.9 27 39.1 
MD 41 - 39 - 5 - 88 - 179 - 
Weight gain Not a 
problem 
1 4.5 0 0 0 0 5 10.9 6 6.9 
A bit of a 
problem 
2 9.1 1 9.1 0 0 17 37.0 21 24.1 
A 
problem 
7 31.8 2 18.2 4 66.7 9 19.6 22 25.3 
A big 
problem 
5 22.7 4 36.4 0 0 8 17.4 17 19.5 
A severe 
problem 
7 31.8 4 36.4 2 33.3 7 15.2 21 24.1 
MD 37 - 39 - 1 - 78 - 161 - 
Inability to 
concentrate 
Not a 
problem 
0 0 0 0 1 14.3 2 4.1 2 1.9 
A bit of a 
problem 
2 7.4 0 0 0 0 12 24.5 15 14.2 
A 
problem 
6 22.2 8 44.4 4 57.1 16 32.7 36 34.0 
A big 
problem 
16 59.3 8 44.4 1 14.3 16 32.7 44 41.5 
A severe 
problem 
3 11.1 2 11.1 1 14.3 3 6.1 9 8.5 
MD 32 - 32 - 0 - 75 - 142 - 
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  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Drowsiness Not a 
problem 
0 0 1 6.3 1 16.7 0 0 2 1.9 
A bit of a 
problem 
1 3.2 0 0 0 0 16 33.3 18 17.3 
A 
problem 
3 9.7 7 43.8 0 0 10 20.8 22 21.2 
A big 
problem 
21 67.7 6 37.5 5 83.3 19 39.6 51 49.0 
A severe 
problem 
6 19.4 2 12.5 0 0 3 6.3 11 10.6 
MD 28 - 34 - 1 - 76 - 144 - 
Nausea Not a 
problem 
0 0 0 0 0 0 0 0 0 0 
A bit of a 
problem 
0 0 2 20.0 0 0 5 16.1 8 11.8 
A 
problem 
5 26.3 2 20.0 3 50.0 6 19.4 17 25.0 
A big 
problem 
6 31.6 0 0 3 50.0 11 35.5 20 29.4 
A severe 
problem 
8 42.1 6 60.0 0 0 9 29.0 23 33.8 
MD 40 - 40 - 1 - 93 - 180 - 
Constipation Not a 
problem 
1 4.0 0 0 3 50.0 2 4.9 6 6.7 
A bit of a 
problem 
4 16.0 0 0 0 0 9 22.0 14 15.7 
A 
problem 
6 24.0 2 14.3 0 0 7 17.1 16 18.0 
A big 
problem 
4 16.0 10 71.4 2 33.3 13 31.7 29 32.6 
A severe 
problem 
10 40.0 2 14.3 1 16.7 10 24.4 24 27.0 
MD 34 - 36 - 1 - 83 - 159 - 
Diarrhoea Not a 
problem 
0 0 0 0 1 33.3 0 0 1 2.0 
A bit of a 
problem 
1 5.9 0 0 0 0 4 18.2 6 11.8 
A 
problem 
2 11.8 0 0 2 66.7 5 22.7 9 17.6 
A big 
problem 
4 23.5 1 14.3 0 0 3 13.6 8 15.7 
A severe 
problem 
10 58.8 6 85.7 0 0 10 45.5 27 52.9 
MD 42 - 43 - 4 - 102 - 197 - 
Stomach 
aches 
Not a 
problem 
0 0 1 10.0 1 20.0 0 0 2 2.9 
A bit of a 
problem 
3 15.8 0 0 0 0 10 31.3 14 20.6 
A 
problem 
5 26.3 1 10.0 0 0 5 15.6 12 17.6 
A big 
problem 
4 21.1 6 60.0 4 80.0 10 31.3 24 35.3 
A severe 
problem 
7 36.8 2 20.0 0 0 7 21.9 16 23.5 
MD 40 - 40 - 2 - 92 - 180 - 
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  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Heartburn Not a 
problem 
1 4.2 0 0 0 0 2 5.3 3 3.8 
A bit of a 
problem 
3 12.5 2 15.4 0 0 8 21.1 13 16.5 
A 
problem 
1 4.2 3 23.1 0 0 9 23.7 13 16.5 
A big 
problem 
11 45.8 4 30.8 2 66.7 12 31.6 29 36.7 
A severe 
problem 
8 33.3 4 30.8 1 33.3 7 18.4 21 26.6 
MD 35 - 37 - 4 - 86 - 169 - 
Inability to 
sleep 
Not a 
problem 
4 13.3 0 0 1 14.3 6 11.1 12 11.0 
A bit of a 
problem 
8 26.7 4 26.7 2 28.6 16 29.6 30 27.5 
A 
problem 
6 20.0 8 53.3 1 14.3 9 16.7 25 22.9 
A big 
problem 
8 26.7 3 20.0 2 28.6 17 31.5 31 28.4 
A severe 
problem 
4 13.3 0 0 1 14.3 6 11.1 11 10.1 
MD 29 - 35 - 0 - 70 - 139 - 
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Table 43: Proportion of Participants Responding to Items on Satisfaction with the 
Treatment Process 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
The 
communication 
between my 
doctor and I 
regarding my 
back pain 
medication 
Very 
satisfied 
2 3.7 2 4.5 0 0 10 8.5 14 6.1 
Satisfied 11 20.4 4 9.1 0 0 25 21.2 42 18.3 
Neither 14 25.9 8 18.2 4 57.1 28 23.7 57 24.8 
Dissatisfied 18 33.3 29 65.9 1 14.3 33 28.0 81 35.2 
Very 
dissatisfied 
9 16.7 1 2.3 2 28.6 22 18.6 36 15.7 
MD 5 - 6 - 0 - 6 - 18 - 
The 
information 
provided about 
the possible 
side effects 
from my back 
pain 
medication 
Very 
satisfied 
3 5.7 2 4.9 0 0 10 8.5 15 6.6 
Satisfied 12 22.6 5 12.2 2 28.6 30 25.4 53 23.3 
Neither 17 32.1 17 41.5 2 28.6 36 30.5 75 33.0 
Dissatisfied 15 28.3 17 41.5 3 42.9 31 26.3 66 29.1 
Very 
dissatisfied 
6 11.3 0 0 0 0 11 9.3 18 7.9 
MD 6 - 9 - 0 - 6 - 21 - 
The form of 
administration 
(e.g. tablet, 
injection, 
patch) of my 
back pain 
medication 
Very 
satisfied 
1 2.0 0 0 0 0 6 5.2 7 3.2 
Satisfied 7 14.0 3 7.7 0 0 15 12.9 27 12.3 
Neither 11 22.0 11 28.2 2 28.6 40 34.5 67 30.5 
Dissatisfied 25 50.0 24 61.5 5 71.4 38 32.8 94 42.7 
Very 
dissatisfied 
6 12.0 1 2.6 0 0 17 14.7 25 11.4 
MD 9 - 11 - 0 - 8 - 28 - 
The amount of 
medication 
prescribed 
Very 
satisfied 
1 2.0 1 2.4 0 0 4 3.4 6 2.7 
Satisfied 10 19.6 4 9.8 1 14.3 29 25.0 46 20.6 
Neither 13 25.5 10 24.4 1 14.3 29 25.0 57 25.6 
Dissatisfied 25 49.0 22 53.7 5 71.4 45 38.0 98 43.9 
Very 
dissatisfied 
2 3.9 4 9.8 0 0 9 7.8 16 7.2 
MD 8 - 9 - 0 - 8 - 25 - 
The way 
doctors have 
dealt with the 
side effects of 
my back pain 
medication 
Very 
satisfied 
2 3.8 2 5.1 0 0 10 8.7 14 6.3 
Satisfied 10 19.2 5 12.8 3 42.9 28 24.3 50 22.6 
Neither 20 38.5 21 53.8 1 14.3 35 30.4 80 36.2 
Dissatisfied 14 26.9 11 28.2 1 14.3 28 24.3 54 24.4 
Very 
dissatisfied 
6 11.5 0 0 2 28.6 14 12.2 23 10.4 
MD 7 - 11 - 0 - 9 - 27 - 
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Table 44: Proportion of Participants Responding to Items on Back Pain Medication 
Acceptability 
  Physiotherapy Pain Clinic Charities Back Show Total 
Item Response 
options 
No. 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
Number 
(n) 
Percent 
(%) 
My oral 
medication 
is difficult 
to swallow 
Strongly 
agree 
0 0 0 0 0 0 4 3.6 4 1.9 
Agree 12 24.5 8 19.5 3 60.0 20 18.0 44 20.7 
Not sure 3 6.1 5 12.2 0 0 5 4.5 14 6.6 
Disagree 19 38.8 14 34.1 2 40.0 44 39.6 81 38.0 
Strongly 
disagree 
15 30.6 14 34.1 0 0 38 34.2 70 32.9 
MD 10 - 9 - 2 - 13 - 35 - 
My oral 
medication 
leaves an 
unpleasant 
taste in my 
mouth 
Strongly 
agree 
2 4.1 0 0 0 0 2 1.8 5 2.4 
Agree 12 24.5 7 17.9 1 20.0 19 17.4 40 19.1 
Not sure 3 6.1 8 20.5 0 0 14 12.8 27 12.9 
Disagree 17 34.7 10 25.6 2 40 44 40.4 75 35.9 
Strongly 
disagree 
15 30.6 14 35.9 2 40 30 27.5 62 29.7 
MD 10 - 11 - 2 - 15 - 39 - 
My oral 
medication 
doesn‘t 
work 
quickly 
Strongly 
agree 
6 12.5 2 5.3 2 40 10 9.3 22 10.7 
Agree 16 33.3 20 52.6 2 40 33 30.8 74 36.1 
Not sure 14 29.2 5 13.2 1 20 22 20.6 43 21.0 
Disagree 8 16.7 7 18.4 0 0 29 27.1 45 22.0 
Strongly 
disagree 
4 8.3 4 10.5 0 0 13 12.1 21 10.2 
MD 11 - 12 - 2 - 17 - 43 - 
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APPENDIX S: Normality and Outlier Tests for the CLBP Treatment 
Satisfaction Questionnaire Domains 
Table 45. Descriptive Statistics of the CLBP Treatment Satisfaction Questionnaire 
Domains 
CLBP Treatment 
Satisfaction 
Questionnaire Domains  Statistic 
Std. 
Error 
Burden of Back Pain  Mean 96.85 1.45 
  95% Confidence 
Interval for 
Mean 
Lower Bound 
93.98   
    Upper Bound 99.71   
  5% Trimmed Mean 97.44   
  Median 100.00   
  Variance 436.32   
  Std. Deviation 20.89   
  Minimum 43.00   
  Maximum 131.00   
  Range 88.00   
  Interquartile Range 32.00   
  Skewness -.31 .17 
  Kurtosis -.64 .34 
Problems with Side 
Effects 
Mean 
38.84 1.45 
  95% Confidence 
Interval for Mean 
Lower Bound 
35.89   
    Upper Bound 41.80   
  5% Trimmed Mean 39.27   
  Median 40.50   
  Variance 67.23   
  Std. Deviation 8.20   
  Minimum 20.00   
  Maximum 50.00   
  Range 30.00   
  Interquartile Range 12.75   
  Skewness -.65 .41 
  Kurtosis -.06 .81 
Information about back 
pain/treatment 
Mean 
21.40 .48 
  95% Confidence 
Interval for Mean 
Lower Bound 
20.44   
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CLBP Treatment 
Satisfaction 
Questionnaire Domains  Statistic 
Std. 
Error 
    Upper Bound 22.35   
  5% Trimmed Mean 21.26   
  Median 21.00   
  Variance 52.41   
  Std. Deviation 7.24   
  Minimum 10.00   
  Maximum 50.00   
  Range 40.00   
  Interquartile Range 13.00   
  Skewness .29 .16 
  Kurtosis -.29 .32 
Satisfaction with 
treatment process 
Mean 
16.31 .28 
  95% Confidence 
Interval for Mean 
Lower Bound 
15.76   
    Upper Bound 16.85   
  5% Trimmed Mean 16.34   
  Median 16.00   
  Variance 16.64   
  Std. Deviation 4.08   
  Minimum 5.00   
  Maximum 25.00   
  Range 20.00   
  Interquartile Range 5.00   
  Skewness -.19 .17 
  Kurtosis .30 .33 
Adherence to 
physiotherapy 
Mean 
10.90 .17 
  95% Confidence 
Interval for Mean 
Lower Bound 
10.56   
    Upper Bound 11.23   
  5% Trimmed Mean 11.01   
  Median 12.00   
  Variance 6.78   
  Std. Deviation 2.60   
  Minimum 3.00   
  Maximum 15.00   
  Range 12.00   
  Interquartile Range 3.00   
  Skewness -.70 .16 
  Kurtosis .41 .32 
Impact of back pain on 
relationships 
Mean 
23.84 .61 
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CLBP Treatment 
Satisfaction 
Questionnaire Domains  Statistic 
Std. 
Error 
  95% Confidence 
Interval for Mean 
Lower Bound 
22.63   
    Upper Bound 25.05   
  5% Trimmed Mean 23.98   
  Median 23.00   
  Variance 36.97   
  Std. Deviation 6.08   
  Minimum 9.00   
  Maximum 35.00   
  Range 26.00   
  Interquartile Range 9.00   
  Skewness -.12 .24 
  Kurtosis -.79 .48 
Medication Acceptability Mean 10.41 .18 
  95% Confidence 
Interval for Mean 
Lower Bound 
10.05   
    Upper Bound 10.77   
  5% Trimmed Mean 10.41   
  Median 11.00   
  Variance 6.70   
  Std. Deviation 2.59   
  Minimum 5.00   
  Maximum 15.00   
  Range 10.00   
  Interquartile Range 3.50   
  Skewness -.11 .17 
  Kurtosis -.83 .34 
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Table 46. Kolmogorov-Smirnov Statistic for the CLBP Treatment Satisfaction 
Questionnaire Domains 
 CLBP Treatment Satisfaction 
Questionnaire Domains 
Kolmogorov-Smirnov
†
 
Statistic df p-value 
Burden of Back Pain  .07 207 p≤0.01* 
Problems with Side Effects .15 32 p=0.07 
Information about back pain/treatment 
.08 223 p≤0.0001** 
Satisfaction with treatment process .11 217 p≤0.0001** 
Adherence to physiotherapy .19 232 p≤0.0001** 
Impact of back pain on relationships .15 99 p≤0.0001** 
Medication Acceptability .12 205 p≤0.0001** 
†Lilliefors Significance Correction  
*p≤0.01; **p≤0.0001 
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Figure 14: Histogram to Show Distribution of Scores for the Burden of Back Pain Domain 
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Figure 15: Normal Q-Q Plot for the Burden of Back Pain Domain 
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Figure 16: Detrended Normal Q-Q Plot of the Burden of Back Pain Domain 
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Figure 17: Boxplot of the Burden of Back Pain Domain 
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Figure 18: Histogram to Show Distribution of Scores for the Problems with Side Effects 
Domain 
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Figure 19: Normal Q-Q Plot of the Problems with Side Effects Domain 
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Figure 20: Detrended Normal Q-Q Plot of the Problems with Side Effects Domain 
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Figure 21: Boxplot for the Problems with Side Effects Domain 
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Figure 22: Histogram to Show Distribution of Scores for the Information About Back Pain 
and Treatment Domain 
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Figure 23: Normal Q-Q Plot of the Information About Back Pain and Treatment Domain 
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Figure 24: Detrended Normal Q-Q Plot of the Information About Back Pain and Treatment 
Domain 
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Figure 25: Boxplot for The Information About Back Pain and Treatment Domain 
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Figure 26: Histogram to Show Distribution of Scores for the Satisfaction with Treatment 
Process Domain 
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Figure 27: Normal Q-Q Plot of the Satisfaction with Treatment Process Domain 
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Figure 28: Detrended Normal Q-Q Plot of the Satisfaction with Treatment Process Domain 
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Figure 29: Boxplot of the Satisfaction with Treatment Process Domain 
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Figure 30: Histogram to Show Distribution of Scores for the Adherence to Physiotherapy 
Domain 
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Figure 31: Normal Q-Q Plot of the Adherence to Physiotherapy Domain 
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Figure 32: Detrended Normal Q-Q Plot of the Adherence to Physiotherapy Domain  
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Figure 33: Boxplot of the Adherence to Physiotherapy Domain 
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Figure 34: Histogram to Show Distribution of Scores for the Impact of Back Pain and 
Treatment on Relationships Domain 
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Figure 35: Normal Q-Q Plot of the Impact of Back Pain and Treatment on Relationships 
Domain 
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Figure 36: Detrended Normal Q-Q Plot of the Impact of Back Pain and Treatment on 
Relationships Domain 
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Figure 37: Boxplot of the Impact of Back Pain and Treatment on Relationships Domain 
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Figure 38: Histogram to Show Distribution of Scores for the Medication Acceptability 
Domain  
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Figure 39: Normal Q-Q Plot for the Medication Acceptability Domain 
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Figure 40: Detrended Normal Q-Q Plot of the Medication Acceptability Domain 
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Figure 41: Boxplot of the Medication Acceptability Domain 
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APPENDIX T: Assumption Testing for Multiple Linear Regressions 
Figure 42. Normal P-P Plot of Regression Standardized Residual for the Burden of Back 
Pain Domain 
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Figure 43. Scatterplot of the Burden of Back Pain Domain 
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Figure 44. Normal P-P Plot of Regression Standardized Residual for the Problems with 
Side Effects Domain 
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Figure 45. Scatterplot of the Problems with Side Effects Domain 
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Figure 46. Normal P-P Plot of Regression Standardized Residual for the Information 
About Back Pain and Treatment Domain 
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Figure 47. Scatterplot for the Information About Back Pain Treatment Domain 
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Figure 48. Normal P-P Plot of Regression Standardized Residual for the Satisfaction with 
Treatment Process Domain 
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Figure 49. Scatterplot for the Satisfaction with Treatment Process Domain  
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Figure 50. Normal P-P Plot of Regression Standardized Residual for the Adherence to 
Physiotherapy Domain 
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Figure 51. Scatterplot for the Adherence to Physiotherapy Domain 
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Figure 52. Normal P-P Plot of Regression Standardized Residual for the Impact of Back 
Pain and Treatment on Relationships Domain 
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Figure 53. Scatterplot for the Impact of Back Pain and Treatment on Relationships Domain 
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Figure 54. Normal P-P Plot of Regression Standardized Residual for the Medication 
Acceptability Domain 
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Figure 55. Scatterplot for the Medication Acceptability Domain  
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